AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BlackRock Enhanced Global Dividend Trust

Regulatory Filings Mar 6, 2017

Preview not available for this file type.

Download Source File

N-CSR 1 d318510dncsr.htm BLACKROCK GLOBAL OPPORTUNITIES EQUITY TRUST BlackRock Global Opportunities Equity Trust

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number: 811-21729

Name of Fund: BlackRock Global Opportunities Equity Trust (BOE)

Fund Address: 100 Bellevue Parkway, Wilmington, DE 19809

Name and address of agent for service: John M. Perlowski, Chief Executive Officer, BlackRock Global Opportunities Equity Trust, 55 East 52 nd Street, New York, NY 10055

Registrant’s telephone number, including area code: (800) 882-0052, Option 4

Date of fiscal year end: 12/31/2016

Date of reporting period: 12/31/2016

Item 1 – Report to Stockholders

DECEMBER 31, 2016

ANNUAL REPORT B LACK R OCK ®

BlackRock Energy and Resources Trust (BGR)

BlackRock Enhanced Capital and Income Fund, Inc. (CII)

BlackRock Enhanced Equity Dividend Trust (BDJ)

BlackRock Global Opportunities Equity Trust (BOE)

BlackRock Health Sciences Trust (BME)

BlackRock International Growth and Income Trust (BGY)

BlackRock Resources & Commodities Strategy Trust (BCX)

BlackRock Science and Technology Trust (BST)

BlackRock Utility and Infrastructure Trust (BUI)

Not FDIC Insured ◾ May Lose Value ◾ No Bank Guarantee

Section 19(a) Notices

BlackRock Energy and Resources Trust’s (BGR), BlackRock Enhanced Capital and Income Fund, Inc.’s (CII), BlackRock Enhanced Equity Dividend Trust’s (BDJ), BlackRock Global Opportunities Equity Trust’s (BOE), BlackRock Health Sciences Trust’s (BME), BlackRock International Growth and Income Trust’s (BGY), BlackRock Resources & Commodities Strategy Trust’s (BCX), BlackRock Science and Technology Trust’s (BST) and BlackRock Utility and Infrastructure Trust’s (BUI) (each, a “Trust” and collectively, the “Trusts”), amounts and sources of distributions reported are estimates and are being provided to you pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources for tax reporting purposes will depend upon each Trust’s investment experience during the fiscal year and may be subject to changes based on tax regulations. Each Trust will provide a Form 1099-DIV each calendar year that will tell you how to report these distributions for federal income tax purposes.

December 31, 2016

Net Investment Income Net Realized Capital Gains Short-Term Net Realized Capital Gains Long-Term Return of Capital Total Per Common Share Net Investment Income Net Realized Capital Gains Short-Term Net Realized Capital Gains Long-Term Return of Capital Total Per Common Share
BGR* $ 0.275184 — — $ 0.720816 $ 0.996000 28 % 0 % 0 % 72 % 100 %
CII* $ 0.122292 — — $ 1.026108 $ 1.148400 11 % 0 % 0 % 89 % 100 %
BDJ* $ 0.158965 — — $ 0.401435 $ 0.560400 28 % 0 % 0 % 72 % 100 %
BOE* $ 0.118299 — — $ 0.931701 $ 1.050000 11 % 0 % 0 % 89 % 100 %
BME $ 0.028393 — $ 2.971607 — $ 3.000000 1 % 0 % 99 % 0 % 100 %
BGY* $ 0.081617 — — $ 0.440383 $ 0.522000 16 % 0 % 0 % 84 % 100 %
BCX* $ 0.135692 — — $ 0.441308 $ 0.577000 24 % 0 % 0 % 76 % 100 %
BST* $ 0.006420 — — $ 1.193580 $ 1.200000 1 % 0 % 0 % 99 % 100 %
BUI* $ 0.536110 $ 0.095500 $ 0.373052 $ 0.447337 $ 1.452000 37 % 6 % 26 % 31 % 100 %
  • Certain Trusts estimate that they have distributed more than the amount of earned income and net realized gains; therefore, a portion of the distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder’s investment in a Trust is returned to the shareholder. A return of capital does not necessarily reflect a Trust’s investment performance and should not be confused with “yield” or “income.” When distributions exceed total return performance, the difference will reduce the Trust’s net asset value per share.

Section 19(a) notices for the Trusts, as applicable, are available on the BlackRock website http://www.blackrock.com .

Section 19(b) Disclosure

The Trusts, acting pursuant to a U.S. Securities and Exchange Commission (“SEC”) exemptive order and with the approval of each Trust’s Board of Trustees/Directors (the “Board”), each have adopted a plan, consistent with its investment objectives and policies to support a level distribution of income, capital gains and/or return of capital (the “Plan”). In accordance with the Plans, the Trusts distribute the following fixed amounts per share on a monthly basis as of December 31, 2016:

Exchange Symbol Amount Per Common Share
BGR $0.0776
CII $0.0828
BDJ $0.0467
BOE $0.0780
BME $0.2000
BGY $0.0380
BCX $0.0446
BST $0.1000
BUI $0.1210

The fixed amounts distributed per share are subject to change at the discretion of each Trust’s Board. Under its Plan, each Trust will distribute all available investment income to its shareholders, consistent with its primary investment objectives and as required by the Internal Revenue Code of 1986, as amended (the “Code”). If sufficient investment income is not available on a monthly basis, the Trusts will distribute long-term capital gains and/or return of capital to shareholders in order to maintain a level distribution. Each monthly distribution to shareholders is expected to be at the fixed amount established by the Board, except for extraordinary distributions and potential distribution rate increases or decreases to enable the Trusts to comply with the distribution requirements imposed by the Code.

Shareholders should not draw any conclusions about each Trust’s investment performance from the amount of these distributions or from the terms of the Plan. Each Trust’s total return performance on net asset value is presented in its financial highlights table.

The Board may amend, suspend or terminate a Trust’s Plan at any time without prior notice to the Trust’s shareholders if it deems such actions to be in the best interests of the Trust or its shareholders. The suspension or termination of the Plan could have the effect of creating a trading discount (if the Trust’s stock is trading at or above net asset value) or widening an existing trading discount. The Trusts are subject to risks that could have an adverse impact on their ability to maintain level distributions. Examples of potential risks include, but are not limited to, economic downturns impacting the markets, decreased market volatility, companies suspending or decreasing corporate dividend distributions and changes in the Code. Please refer to each Trust’s prospectus for a more complete description of its risks.

2 ANNUAL REPORT DECEMBER 31, 2016

Table of Contents

Page
Section 19(a) Notices 2
Section 19(b) Disclosure 2
The Markets in Review 4
Annual Report:
The Benefits and Risks of Option Over-Writing 5
Trust Summaries 6
Derivative Financial Instruments 25
Financial Statements:
Schedules of Investments 26
Statements of Assets and Liabilities 102
Statements of Operations 104
Statements of Changes in Net Assets 106
Statements of Cash Flows 111
Financial Highlights 114
Notes to Financial Statements 123
Report of Independent Registered Public Accounting Firm 138
Important Tax Information 139
Automatic Dividend Reinvestment Plans 140
Officers and Trustees 141
Additional Information 145

ANNUAL REPORT DECEMBER 31, 2016 3

The Markets in Review

Dear Shareholder,

The year 2016 started on a fraught note with worries about slowing growth in China, plunging oil prices and sliding share prices. Then reflationary expectations in the United States helped drive a second-half global growth pick-up and big market reversals. As such, higher-quality asset classes such as Treasury bonds, municipals and investment grade credit prevailed in the first half of the year, only to struggle in the second. In contrast, risk assets sold off at the start of the year and rebounded in the latter half, with some asset classes posting strong year-end returns.

A key takeaway from 2016’s market performance is that economics can trump politics. The global reflationary theme – governments taking policy action to support growth – was the dominant driver of 2016 asset returns, outweighing significant political upheavals and uncertainty. This trend accelerated after the U.S. election on expectations for an extra boost to U.S. growth via fiscal policy.

Markets were remarkably resilient during the year. Spikes in equity volatility after big surprises such as the U.K.’s vote to leave the European Union and the outcome of the U.S. presidential election were short-lived. Instead, political surprises and initial sell-offs were seized upon as buying opportunities. We believe this reinforces the case for taking the long view rather than reacting to short-term market noise.

Asset returns varied widely in 2016. Perceived safe assets such as government bonds and low-volatility shares underperformed the higher-risk areas of the market. And the reversal of longstanding trends created opportunities, such as in the recovery of value stocks and commodities.

We expect some of these trends to extend into 2017 and see the potential for more flows into risk assets this year. Learn more by reading our market insights at blackrock.com .

Sincerely,

Rob Kapito

President, BlackRock Advisors, LLC

Rob Kapito

President, BlackRock Advisors, LLC

Total Returns as of December 31, 2016 — 6-month 12-month
U.S. large cap
equities (S&P 500 ® Index) 7.82% 11.96%
U.S. small cap equities (Russell
2000 ® Index) 18.68 21.31
International equities (MSCI Europe, Australasia, Far East Index) 5.67 1.00
Emerging market equities (MSCI Emerging Markets Index) 4.49 11.19
3-month Treasury bill (BofA Merrill Lynch 3-Month Treasury Bill Index) 0.18 0.33
U.S. Treasury securities (BofA Merrill Lynch 10- Year U.S. Treasury Index) (7.51) (0.16)
U.S. investment grade bonds (Bloomberg Barclays U.S. Aggregate Bond Index) (2.53) 2.65
Tax-exempt municipal bonds (S&P Municipal Bond Index) (3.43) 0.77
U.S. high yield bonds (Bloomberg Barclays U.S. Corporate High Yield 2% Issuer Capped Index) 7.40 17.13
Past performance is no guarantee of future results. Index performance is shown for illustrative purposes only. You cannot invest
directly in an index.

4 THIS PAGE NOT PART OF YOUR TRUST REPORT

The Benefits and Risks of Option Over-Writing

In general, the goal of each of the Trusts is to provide total return through a combination of current income and realized and unrealized gains (capital appreciation). The Trusts seek to pursue this goal primarily by investing in a portfolio of equity securities and utilizing an option over-writing strategy in an effort to enhance the Trusts’ distribution rate and total return performance. However, these objectives cannot be achieved in all market conditions.

The Trusts primarily write single stock covered call options, and may also from time to time write single stock put options. When writing (selling) a covered call option, the Trust holds an underlying equity security and enters into an option transaction which allows the counterparty to purchase the equity security at an agreed-upon price (“strike price”) within an agreed-upon time period. The Trusts receive cash premiums from the counterparties upon writing (selling) the option, which along with net investment income and net realized gains, if any, are generally available to support current or future distributions paid by the Trusts. During the option term, the counterparty may elect to exercise the option if the market value of the equity security rises above the strike price, and the Trust is obligated to sell the equity security to the counterparty at the strike price, realizing a gain or loss. Premiums received increase gains or reduce losses realized on the sale of the equity security. If the option remains unexercised upon its expiration, the Trusts realize gains equal to the premiums received. Alternatively, an option may be closed out by an offsetting purchase or sale of an option prior to expiration. The Trust realizes a capital gain from a closing purchase or sale transaction if the premium paid is less than the premium received from writing the option. The Trust realizes a capital loss from a closing purchase or sale transaction if the premium received is less than the premium paid to purchase the option.

Writing covered call options entails certain risks, which include, but are not limited to, the following: an increase in the value of the underlying equity security above the strike price can result in the exercise of a written option (sale by the Trust to the counterparty) when the Trust might not otherwise have sold the security; exercise of the option by the counterparty may result in a sale below the current market value and a gain or loss being realized by the Trust; and limiting the potential appreciation that could be realized on the underlying equity security to the extent of the strike price of the option. As such, an option over-writing strategy may outperform the general equity market in flat or falling markets but underperform in rising markets.

Each Trust employs a plan to support a level distribution of income, capital gains and/or return of capital. The goal of the plan is to provide shareholders with consistent and predictable cash flows by setting distribution rates based on expected long-term returns of the Trusts. Such distributions, under certain circumstances, may exceed a Trust’s total return performance. When total distributions exceed total return performance for the period, the difference reduces the Trust’s total assets and net asset value per share (“NAV”) and, therefore, could have the effect of increasing the Trust’s expense ratio and reducing the amount of assets, the Trust has available for long term investment. In order to make these distributions, a Trust may have to sell portfolio securities at less than opportune times.

The final tax characterization of distributions is determined after the fiscal year and is reported in the Trust’s annual report to shareholders. Distributions can be characterized as ordinary income, capital gains and/or return of capital. The Trust’s taxable net investment income or net realized capital gains (“taxable income”) may not be sufficient to support the level of distributions paid. To the extent that distributions exceed the Trust’s current and accumulated earnings and profits, the excess may be treated as a non-taxable return of capital. Distributions that exceed a Trust’s taxable income but do not exceed the Trust’s current and accumulated earnings and profits, may be classified as ordinary income which are taxable to shareholders. Such distributions are reported as distributions in excess of net investment income.

A return of capital distribution does not necessarily reflect a Trust’s investment performance and should not be confused with ‘yield’ or ‘income.’ A return of capital is a return of a portion of an investor’s original investment. A return of capital is not taxable, but it reduces a shareholder’s tax basis in his or her shares, thus reducing any loss or increasing any gain on a subsequent disposition by the shareholder of his or her shares. It is possible that a substantial portion of the distributions paid during a calendar year may ultimately be classified as return of capital or as distributions in excess of net investment income for income tax purposes when the final determination of the source and character of the distributions is made.

To illustrate these concepts, assume the following: (1) a common stock purchased at and currently trading at $37.15 per share; (2) a three-month call option is written by a Trust with a strike price of $40 (i.e., 7.7% higher than the current market price); and (3) the Trust receives $2.45, or 6.6% of the common stock’s value, as a premium. If the stock price remains unchanged, the option expires and there would be a 6.6% return for the three-month period. If the stock were to decline in price by 6.6% (i.e., decline to $34.70 per share), the option strategy would “break-even” from an economic perspective resulting in neither a gain nor a loss. If the stock were to climb to a price of $40 or above, the option would be exercised and the stock would return 7.7% coupled with the option premium received of 6.6% for a total return of 14.3%. Under this scenario, the Trust loses the benefit of any appreciation of the stock above $40, and thus is limited to a 14.3% total return. The premium from writing the call option serves to offset some of the unrealized loss on the stock in the event that the price of the stock declines, but if the stock were to decline more than 6.6% under this scenario, the Trust’s downside protection is eliminated and the stock could eventually become worthless.

Each Trust intends to write covered call options to varying degrees depending upon market conditions. Please refer to each Trust’s Schedule of Investments and the Notes to Financial Statements for details of written options.

ANNUAL REPORT DECEMBER 31, 2016 5

Trust Summary as of December 31, 2016 BlackRock Energy and Resources Trust

Trust Overview

BlackRock Energy and Resources Trust’s (BGR) (the “Trust”) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry. The Trust may invest directly in such securities or synthetically through the use of derivatives. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and utilizing an option over-writing strategy in an effort to seek total return performance and enhance distributions.

No assurance can be given that the Trust’s investment objective will be achieved.

Trust Information

Symbol on New York Stock Exchange (“NYSE”) BGR
Initial Offering Date December 29, 2004
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($ 14.44) 1 6.45%
Current Monthly Distribution per Common
Share 2 $0.0776
Current Annualized Distribution per Common Share 2 $0.9312

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions.

Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Returns Based On — Market Price Net Asset Value
BGR 1,2 24.01% 25.07%
Lipper Natural Resources Funds 3 37.40% 32.14%

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV widened during the period, which accounts for the difference between performance based on price and performance based on NAV.

3 Average return.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s absolute performance based on NAV:

What factors influenced performance?

• The Trust’s positions in the U.S. exploration & production companies Laredo Petroleum, Inc. and Energen Corp. were the largest detractors from performance. The investment adviser exited both positions early in the period due to its concerns about the two companies’ significant financial leverage. As a result, the Trust was not in a position to benefit from their subsequent recovery.

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a negative impact on performance given the strength in the overall sector.

• After losing ground in the initial weeks of the year, energy stocks rallied to close as one of the top-performing market segments of 2016. An improving balance of supply and demand for oil, together with expectations for stronger global growth, provided a firm underpinning for the sector. Consistent with the broader environment, the Trust produced a robust absolute return in the 12-month period.

• Royal Dutch Shell PLC and BG Energy Holdings Ltd. completed a merger in February, whereby the Trust’s substantial position in the latter stock made a positive contribution to performance.

• ExxonMobil Corp., which announced a significant oil discovery off the coast of Guyana in conjunction with Hess Corp., was the largest contributor in the period. The deep-water Liza field could hold as many as 1.4 billion barrels of oil equivalent, making it one of a handful of billion-barrel discoveries in the last half-decade. Exxon found oil in the Liza field in 2015 when it drilled its first well in the area, and a second well revealed the potential for twice as much crude. ExxonMobil shares were also boosted by the significant increase in oil prices that occurred during 2016.

6 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Energy and Resources Trust

Performance and Portfolio Management Commentary (concluded)

Describe recent portfolio activity.

• After holding an underweight position in the refining subsector for much of 2015, the Trust moved to reduce the extent of this underweight early in the period by adding positions in the refining stocks Valero Energy and Tesoro Corp., both of which are benefiting from strong U.S. gasoline consumption. Additionally, the Trust rotated its oil services exposure by reducing its weighting in Schlumberger Ltd. and initiating a position in Baker Hughes, Inc.

Describe portfolio positioning at period end.

• The investment adviser positioned the Trust with a higher-quality bias, focusing on companies with robust balance sheets, below-average costs and higher-quality management teams. At the sub-sector level, the Trust remained overweight in the exploration and production industry and underweight in larger, integrated producers. The investment adviser saw the former group as being in a better position to benefit from the improving backdrop for oil prices.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Market Price and Net Asset Value Per Share Summary

Market Price 12/31/16 — $14.44 12/31/15 — $12.53 15.24% High — $15.00 $10.05
Net Asset Value $16.33 $14.05 16.23% $16.71 $11.84

Market Price and Net Asset Value History For the Past Five Years

Overview of the Trust’s Total Investments*

Ten Largest Holdings 12/31/16
Exxon Mobil Corp. 10%
Royal Dutch Shell PLC, A Shares — ADR 8
BP PLC 6
Chevron Corp. 6
ConocoPhillips 5
EOG Resources, Inc. 5
Anadarko Petroleum Corp. 4
Baker Hughes, Inc. 4
Schlumberger Ltd. 4
Occidental Petroleum Corp. 4
  • Excludes option positions and money market funds.
Industry Allocation 12/31/16 12/31/15
Oil, Gas & Consumable Fuels 91% 93%
Energy Equipment & Services 9% 7%

For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

ANNUAL REPORT DECEMBER 31, 2016 7

Trust Summary as of December 31, 2016 BlackRock Enhanced Capital and Income Fund, Inc.

Trust Overview

BlackRock Enhanced Capital and Income Fund, Inc.’s (CII) (the “Trust”) investment objective is to provide investors with a combination of current income and capital appreciation. The Trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. The Trust may invest directly in such securities or synthetically through the use of derivatives. The Trust seeks to achieve its investment policy by employing a strategy of writing (selling) call and put options.

No assurance can be given that the Trust’s investment objectives will be achieved.

Trust Information

Symbol on NYSE CII
Initial Offering Date April 30, 2004
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($ 13.71) 1 7.25%
Current Monthly Distribution per Common
Share 2 $0.0828
Current Annualized Distribution per Common Share 2 $0.9936

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Market Price Net Asset Value
CII 1,2 5.56 % 8.66 %
S&P
500 ® Index N/A 11.96 %

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV widened during the period, which accounts for the difference between performance based on price and performance based on NAV.

N/A—Not applicable as the index does not have a market price

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s relative performance based on the index cited above:

What factors influenced performance?

• In sector terms, health care was the prime detractor from relative performance due to weakness in pharmaceuticals and, to a lesser extent, biotechnology. Consumer discretionary also weighed, in particular specialty retail and household durables, as did the Trust’s underweight exposure to telecommunication services and energy. Helping to partially offset negative results was strong selection in financials, where banks were a standout. An underweight to real estate and stock selection in materials proved advantageous as well.

• On a stock-specific basis, Teva Pharmaceutical Industries Ltd. was the largest single detractor. The stock underperformed amid concerns over exclusivity for the company’s key drug Copaxone, as well as broad pricing pressures in the generic segment throughout the year. Earlier in the period, concerns that the Allergan deal would be delayed also weighed on the stock. The deal ultimately closed, but it was considerably later than expected, thereby depriving Teva of capturing revenue from a high volume generic launch. Teva’s management turnover in the fourth quarter and a need to revise guidance twice over the last six months further contributed to negative sentiment.

• Positions in CVS Health Corp. and Gilead Sciences Inc. were also a drag. CVS underperformed as the company lost a number of high-profile contracts to rival Walgreens (also a holding). While the value of any individual contract is

small, investors were concerned that CVS’s advantage may be under threat as the UnitedHealth-Walgreens Boots Alliance partnership combines UnitedHealth’s PBM offering with Walgreens Boots Alliance’s convenient store locations, a combination previously unique to CVS. Later in the reporting period, the company lowered its long-term guidance, causing additional share weakness. The major reason behind lower growth rates is lost scripts due to a narrow network arrangement in favor of Walgreens and pharmacy reimbursement changes. Gilead continues to execute well in its HIV business segment, but is facing significant uncertainty in the HCV (Hepatitis C) business following several years of exceptional revenue growth. The investment adviser believes that, at current levels, Gilead shares are pricing in significant revenue declines in HCV and is comfortable owning shares for eventual stabilization in the HCV segment and a likely deployment of cash toward value-creating business development opportunities.

• The top individual contributors in the 12 months were Bank of America Corp. and JPMorgan Chase & Co. The stocks outperformed most notably in the second half of the reporting period on strong earnings reports led by solid fee-based revenue performance (trading, payments & mortgage), as well as the increased likelihood of a December rate hike. Bank holdings’ strong price momentum continued (even accelerated) following the election of Donald Trump as investors positioned for improving future earnings power driven by higher economic growth, inflation, corporate tax reform, and interest rates (the Fed ultimately raised rates), as well as a softening of regulations that could lead to accelerating capital returns and potentially lower legal & compliance costs.

• Consumer finance name SLM also added value. Shares outperformed as the “bear case” scenario of government subsidized tuition plans, as proposed by the Clinton campaign, was eliminated with a Trump victory. Moreover, Trump has proposed restoring private sector participation in student financing, which holds the potential to materially expand the market for private student loans, where SLM holds a dominant 50%+ market share.

8 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Enhanced Capital and Income Fund, Inc.

Performance and Portfolio Management Commentary (concluded)

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a negative impact on performance during the period.

Describe recent portfolio activity.

• Due to a combination of portfolio trading activity and market movement during the 12-month period, the Trust’s exposure to the information technology (“IT”) and energy sectors increased, particularly semiconductors, soft-

ware and oil, gas & consumable fuels. Materials exposure increased as well. The largest reduction was in health care, largely with respect to providers & services. Consumer discretionary exposure also declined.

Describe portfolio positioning at period end.

• Relative to the S&P 500 ® Index, the Trust ended the period with its largest overweights in the IT, consumer discretionary and financials sectors. The Trust’s largest relative underweights were in industrials, real estate and telecommunication services.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Market Price and Net Asset Value Per Share Summary

Market Price 12/31/16 — $13.71 12/31/15 — $14.14 (3.04 )% High — $14.14 $11.62
Net Asset Value $15.08 $15.11 (0.20 )% $15.29 $13.06

Market Price and Net Asset Value History For the Past Five Years

Overview of the Trust’s Total Investments*

Ten Largest Holdings
Apple, Inc. 5 %
JPMorgan Chase & Co. 4
Alphabet, Inc., Class A 4
Bank of America Corp. 4
Microsoft Corp. 4
Comcast Corp., Class A 3
Altria Group, Inc. 3
Cisco Systems, Inc. 3
U.S. Bancorp 2
Chevron Corp. 2
  • Excludes option positions and money market funds.
Sector Allocation — Information Technology 26 % 23 %
Financials 17 18
Consumer Discretionary 15 17
Health Care 14 18
Consumer Staples 9 8
Energy 8 5
Industrials 6 7
Materials 4 3
Utilities 1 1

For Trust compliance purposes, the Trust’s sector classifications refer to any one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

ANNUAL REPORT DECEMBER 31, 2016 9

Trust Summary as of December 31, 2016 BlackRock Enhanced Equity Dividend Trust

Trust Overview

BlackRock Enhanced Equity Dividend Trust’s (BDJ) (the “Trust”) primary investment objective is to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing in common stocks that pay dividends and have the potential for capital appreciation and by utilizing an option writing (selling) strategy to seek total return performance and enhance distributions. The Trust invests, under normal market conditions, at least 80% of its total assets in dividend paying equities. The Trust may invest directly in such securities or synthetically through the use of derivatives.

No assurance can be given that the Trust’s investment objectives will be achieved.

Trust Information

Symbol on NYSE BDJ
Initial Offering Date August 31, 2005
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($ 8.15) 1 6.88%
Current Monthly Distribution per Common
Share 2 $0.0467
Current Annualized Distribution per Common Share 2 $0.5604

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Market Price Net Asset Value
BDJ 1,2 15.11 % 13.90 %
Russell
1000 ® Value Index N/A 17.34 %

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV narrowed during the period, which accounts for the difference between performance based on price and performance based on NAV.

N/A—Not applicable as the index does not have a market price.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s relative performance based on the index cited above:

What factors influenced performance?

• The largest detractor from relative return came from a combination of stock selection and allocation decisions within the industrials sector. An underweight to the machinery and airlines industries weighed on relative performance. The Trust’s underweight to machinery was predicated on the view that weak end-market fundamentals limit attractive investment opportunities in the near term. Overweight positions in General Electric Co. and Honeywell International, Inc. also detracted from relative returns. Additionally, stock selection in the consumer staples sector subtracted from relative performance. In particular, non-benchmark holding Kroger Co. lagged after lowering its earnings forecast and reporting weaker-than-consensus earnings, due in part to food price deflation and increased competition. Lastly, stock selection within the materials and information technology sectors detracted from relative return.

• The largest contribution to relative performance for the 12-month period came from stock selection and allocation decisions within the financials sector. Notably, the Trust’s large overweight position in the banking industry proved beneficial. Bank earnings in the second half of 2016 were generally positive and the sector’s relative outperformance accelerated following the November 8 presidential election results. Stock selection in the health care sector also added to relative return. Notable outperformers in the sector included overweight positions in UnitedHealth Group, Inc. and Quest Diagnostics, Inc. UnitedHealth Group outperformed due to above-consensus growth in its Optum business and robust membership gains within its Medicare, Medicaid and commercial segments. Shares of Quest Diagnostics, a low-cost provider of laboratory services, advanced due to solid pricing growth amid the continued shift to more complex esoteric testing. Lastly, an underweight to real estate and stock selection in utilities added to relative performance.

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a negative impact on performance during the period.

Describe recent portfolio activity.

• During the 12-month period, the Trust’s exposure to the energy sector was increased by initiating new positions in Hess Corp. and Suncor Energy, Inc. Other notable new purchases included Qualcomm Inc., a manufacturer of digital wireless communications equipment, and the property & casualty insurer The Allstate Corporation. Conversely, the Trust reduced exposure to the industrials sector by exiting positions in Tyco International PLC and United Technologies Corp., as well as by trimming

10 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Enhanced Equity Dividend Trust

Performance and Portfolio Management Commentary (concluded)

its holdings in General Electric Co. and Raytheon Co. Other notable sales from the portfolio included McDonald’s Corp. and Bristol-Myers Squibb Co.

Describe portfolio positioning at period end.

• Relative to the benchmark, the Trust’s largest overweight positions were in the health care, financials and industrials sectors. Conversely, the Trust’s largest relative underweights were in the real estate, energy and telecommunication services sectors.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Market Price and Net Asset Value Per Share Summary

Market Price 12/31/16 — $8.15 12/31/15 — $7.61 7.10 % High — $8.25 $6.42
Net Asset Value $9.22 $8.70 5.98 % $9.33 $7.76

Market Price and Net Asset Value History For the Past Five Years

Overview of the Trust’s Total Investments*

Ten Largest Holdings
Bank of America Corp. 5 %
JPMorgan Chase & Co. 4
Exxon Mobil Corp. 3
Pfizer, Inc. 3
Citigroup, Inc. 3
Wells Fargo & Co. 3
Hess Corp. 3
General Electric Co. 3
Microsoft Corp. 2
SunTrust Banks, Inc. 2
  • Excludes option positions and money market funds.
Sector Allocation — Financials 30 % 27 %
Health Care 14 14
Energy 12 9
Industrials 12 14
Information Technology 9 7
Consumer Staples 7 10
Consumer Discretionary 6 7
Utilities 5 6
Materials 3 4
Telecommunication Services 2 2

For Trust compliance purposes, the Trust’s sector classifications refer to any one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

ANNUAL REPORT DECEMBER 31, 2016 11

Trust Summary as of December 31, 2016 BlackRock Global Opportunities Equity Trust

Trust Overview

BlackRock Global Opportunities Equity Trust’s (BOE) (the “Trust”) primary investment objective is to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing primarily in equity securities issued by companies located in countries throughout the world and utilizing an option writing (selling) strategy to seek total return performance and enhance distributions. The Trust invests, under normal market conditions, at least 80% of its assets in equity securities or options on equity securities or indices or sectors of equity securities. Under normal circumstances, the Trust invests a substantial amount of its total assets in foreign issuers, issuers that primarily trade in a market located outside the United States or issuers that do a substantial amount of business outside the United States. The Trust may invest directly in such securities or synthetically through the use of derivatives.

No assurance can be given that the Trust’s investment objectives will be achieved.

Trust Information

Symbol on NYSE BOE
Initial Offering Date May 31, 2005
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($11.57) 1 8.09%
Current Monthly Distribution per Common
Share 2 $0.078
Current Annualized Distribution per Common Share 2 $0.936

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change in the future. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Market Price Net Asset Value
BOE 1,2 (0.90 )% 2.62 %
MSCI All Country World Index N/A 7.86 %

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV widened during the period, which accounts for the difference between performance based on price and performance based on NAV.

N/A—Not applicable as the index does not have a market price.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s relative performance based on the index cited above:

What factors influenced performance?

• Stock selection within the industrials and information technology (“IT”) sectors led detractors for the period. Within industrials, stock selection in the construction machinery & heavy trucks sub-industry led detractors after the Trust’s position in CRRC Corp. Ltd., a Chinese transportation vehicle company, sold off sharply due to concerns around growth in the region. The downturn in the stock was exacerbated given the company’s exposure to the manufacturing sector of the Chinese economy, and the Trust exited the position. Within IT, stock selection in the internet software

& services sub-industry was the next largest detractor as Hortonworks, Inc. reported mixed financial results coupled with an announcement that it was planning a secondary stock offering. The market received the news of additional financing negatively given that the company’s share price was trading near all-time lows. The Trust sold the position during the period and rotated into more attractive opportunities.

• The Trust’s underweight positioning and stock selection within the health care sector led contributors during the 12-month period. In particular, the Trust’s underweight to lagging stocks such as Novo Nordisk A/S in the pharmaceuticals sub-industry added to performance. In the energy sector, the Trust’s position in EOG Resources, Inc. from the oil & gas exploration & production sub-industry benefited from a strengthening in energy prices.

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a negative impact on performance during the period.

Describe recent portfolio activity.

• The Trust reduced exposure to the health care and industrials sectors, while increasing exposure to the energy and materials sectors. Regionally, these sector decisions resulted in reduced exposure to Europe and increased positions within North America, the Pacific Basin and the emerging markets.

12 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Global Opportunities Equity Trust

Performance and Portfolio Management Commentary (concluded)

Describe portfolio positioning at period end.

• Relative to the MSCI All Country World Index, the Fund ended the period with its largest overweights in the IT, materials and consumer discretionary sectors, and its largest underweights in the industrials, financials and

health care sectors. Regionally, the Trust was most overweight in Europe and the emerging markets, funded by a large underweight to the Pacific Basin.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Market Price and Net Asset Value Per Share Summary

Market Price 12/31/16 — $11.57 12/31/15 — $12.76 (9.33 )% High — $12.76 $10.37
Net Asset Value $13.38 $14.25 (6.11 )% $14.25 $12.21

Market Price and Net Asset Value History For the Past Five Years

Overview of the Trust’s Total Investments*

Ten Largest Holdings
Alphabet, Inc., Class C 2 %
Apple, Inc. 2
Anheuser-Busch InBev SA 2
Citigroup, Inc. 2
Alibaba Group Holding Ltd. - ADR 2
Wells Fargo & Co. 2
Starbucks Corp. 1
SoftBank Group Corp. 1
Sumitomo Mitsui Financial Group, Inc. 1
Uber Technologies, Inc., Series D (Acquired 6/6/14, Cost $3,845,800) 1
  • Excludes option positions and money market funds.
Geographic Allocation — United States 59 % 53 %
United Kingdom 6 14
Japan 6 5
India 3 3
China 3 3
France 2 2
Italy 2 1
Belgium 2 2
Germany 2 1
Switzerland 2 2
Spain 1 2
Canada 1 2
Other 1 11 10

1 Other includes a 1% holding or less in each of the following countries: Australia, Hong Kong, Indonesia, Ireland, Israel, Mexico, Netherlands, New Zealand, Norway, Peru, Philippines, Portugal, South Africa, South Korea, Sweden, Taiwan and Thailand.

ANNUAL REPORT DECEMBER 31, 2016 13

Trust Summary as of December 31, 2016 BlackRock Health Sciences Trust

Trust Overview

BlackRock Health Sciences Trust’s (BME) (the “Trust”) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and utilizing an option over-writing strategy in an effort to seek total return performance and enhance distributions.

No assurance can be given that the Trust’s investment objective will be achieved.

Trust Information

Symbol on NYSE BME
Initial Offering Date March 31, 2005
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($31.75) 1 7.56%
Current Monthly Distribution per Common
Share 2 $0.20
Current Annualized Distribution per Common Share 2 $2.40

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Market Price Net Asset Value
BME 1,2 (11.71 )% (5.36 )%
Russell
3000 ® Healthcare Index N/A (3.33 )%

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s premium to NAV narrowed during the period, which accounts for the difference between performance based on price and performance based on NAV.

N/A—Not applicable as the index does not have a market price.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s relative performance based on the index cited above:

What factors influenced performance?

• Health care stocks finished the year with a loss and trailed the broader market by a wide margin, due in part by concerns about increased regulatory scrutiny of pharmaceutical and biotechnology companies’ pricing practices. Consistent with the overall environment, the Trust’s negative absolute return was driven by its allocations to these two sub-sectors. In the former, performance was hampered by specialty pharmaceutical companies such as Allergan PLC, Teva Pharmaceuticals Ltd. and Mylan NV, combined with several non-U.S. holdings such as Roche Holding AG, AstraZeneca PLC and Bayer AG. In the biotechnology group, broader weakness pressured higher-beta small- to mid-cap positions. In addition, a number of large-cap biotechnology holdings — including Vertex Pharmaceuticals, Alexion Pharmaceuticals, Inc., Gilead Sciences, Inc. and Celgene Corp. — weighed on absolute returns.

• The medical devices & supplies sub-sector was the largest positive contributor. Performance was particularly favorable in the health care equipment industry, where several holdings reported solid financial results. Among these were Boston Scientific Corp., Stryker Corp., St. Jude Medical, Inc., C.R. Bard, Inc., Baxter International, Inc., Edwards Lifesciences Corp. and Masimo Corp. The health care providers & services sub-sector was another large contributor to absolute performance, led by managed care stocks such as UnitedHealth Group, Inc., Humana, Inc. and Aetna, Inc.

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a positive impact on performance during the period. The Trust also owned private securities during the period, although this was not a principal strategy.

Describe recent portfolio activity.

• The Trust reduced its allocations to the pharmaceutical and biotechnology sub-sectors, while maintaining an emphasis on identifying innovative companies in these areas. The Trust increased its weightings in the medical devices & supplies and health care providers & services sub-sectors. In the latter industry, the investment adviser was focused on companies that can benefit from favorable health care policies in their respective industries.

Describe portfolio positioning at period end.

• The Trust continued to employ a bottom-up, fundamental investment process in an effort to construct a balanced, diversified portfolio of health care stocks.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

14 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Health Sciences Trust

Market Price and Net Asset Value Per Share Summary

12/31/16 12/31/15 High Low
Market Price $31.75 $39.35 (19.31)% $39.98 $29.86
Net Asset Value $31.30 $36.17 1 (13.46)% $36.17 $30.37

1 The net asset value does not reflect adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles and therefore differs from the amounts reported in the Financial Highlights.

Market Price and Net Asset Value History For the Past Five Years

Overview of the Trust’s Total Investments*

Ten Largest Holdings 12/31/16
UnitedHealth Group, Inc. 8%
Pfizer, Inc. 5
Medtronic PLC 4
Celgene Corp. 4
Amgen, Inc. 4
Bristol-Myers Squibb Co. 3
Stryker Corp. 3
Allergan PLC 3
Humana, Inc. 3
Anthem, Inc. 3
  • Excludes option positions and money market funds.
Industry Allocation 12/31/16 12/31/15
Health Care Providers & Services 30% 18%
Biotechnology 24 33
Pharmaceuticals 23 29
Health Care Equipment & Supplies 21 17
Life Sciences Tools & Services 1 2
Diversified Consumer Services 1 —
Electronic Equipment, Instruments & Components — 1

For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

ANNUAL REPORT DECEMBER 31, 2016 15

Trust Summary as of December 31, 2016 BlackRock International Growth and Income Trust

Trust Overview

BlackRock International Growth and Income Trust’s (BGY) (the “Trust”) primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing primarily in equity securities issued by companies of any market capitalization located in countries throughout the world and utilizing an option writing (selling) strategy to seek total return performance and enhance distributions. The Trust invests, under normal market conditions, at least 80% of its assets in equity securities issued by non-U.S. companies of any market capitalization located in countries throughout the world. The Trust may invest directly in such securities or synthetically through the use of derivatives.

No assurance can be given that the Trust’s investment objectives will be achieved.

Trust Information

Symbol on NYSE BGY
Initial Offering Date May 30, 2007
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($5.51) 1 8.28%
Current Monthly Distribution per Common
Share 2 $0.038
Current Annualized Distribution per Common Share 2 $0.456

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change in the future. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Returns Based On — Market Price Net Asset Value
BGY 1,2 (3.37)% (1.12)%
MSCI All Country World Index ex-US N/A 4.50%

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV widened during the period, which accounts for the difference between performance based on price and performance based on NAV.

N/A—Not applicable as the index does not have a market price.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s relative performance based on the index cited above:

What factors influenced performance?

• An underweight position in materials and negative stock selection within the sector represented the largest detractor from relative performance. The sector was one of the top performers in the benchmark and the Trust’s limited exposure to the metals & mining industry was particularly detrimental to performance. In addition, an underweight to financials, combined with negative stock selection there, detracted from relative returns. Unfavorable stock selection within consumer staples also detracted from relative returns. One of the largest individual detractors during the period was the Trust’s position in Worldpay Group PLC, as shares of the U.K.-based payment services company sold off during the fourth quarter.

• For the period, exposure to a Japan-focused ETF provided the largest contribution to relative performance. Underweight exposures to the health care and utilities sectors also were additive, as these sectors were two of the worst performers within the benchmark. One of the largest individual contributors was Nintendo Co. Ltd., as investors reacted very positively to the release of Pokémon Go.

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a negative impact on performance during the period.

Describe recent portfolio activity.

• During the period, the largest change to sector positioning was a reduction in the Trust’s underweight exposure to materials. This was largely driven by the addition of two new chemicals companies. In contrast, a modest overweight to health care was trimmed to a meaningful underweight, as two pharmaceuticals positions were sold and two were significantly reduced. From a regional perspective, these changes resulted in increased exposure to Europe ex-U.K., particularly France and Germany, and decreased exposure to the United Kingdom.

Describe portfolio positioning at period end.

• Relative to the MSCI All Country World Index ex-US, the Trust’s largest sector overweights were information technology (in particular software & services) and financials (especially diversified financials). In contrast, the largest sector underweights were industrials, especially the capital goods industry, and utilities. From a regional perspective, the Trust’s largest overweight was in Europe, and its largest regional underweight was the Pacific Basin, mainly driven by a large underweight in Japan.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

16 ANNUAL REPORT DECEMBER 31, 2016

BlackRock International Growth and Income Trust

Market Price and Net Asset Value Per Share Summary

12/31/16 12/31/15 High Low
Market Price $5.51 $6.24 (11.70)% $6.24 $5.23
Net Asset Value $6.28 $6.94 1 (9.51)% $6.94 $5.98

1 The net asset value does not reflect adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles and therefore differs from the amounts reported in the Financial Highlights.

Market Price and Net Asset Value History For the Past Five Years

Overview of the Trust’s Total Investments*

Ten Largest Holdings 12/31/16
WisdomTree Japan Hedged Equity Fund 5%
Sumitomo Mitsui Financial Group, Inc. 3
Royal Dutch Shell PLC, B Shares 2
Nestle SA 2
Anheuser-Busch InBev SA 2
BNP Paribas SA 2
Unilever PLC 2
AIA Group Ltd. 2
Toronto-Dominion Bank 2
AXA SA 2
  • Excludes option positions and money market funds.
Geographic Allocation — United Kingdom 16% 25%
France 9 6
United States 8 4
Japan 8 9
Germany 6 4
Netherlands 6 3
Italy 6 4
Canada 5 4
China 5 5
Switzerland 5 9
India 4 5
South Korea 3 —
Belgium 2 2
Ireland 2 4
Hong Kong 2 2
Sweden 1 2
Spain 1 2
Mexico 1 2
Other 1 10 8

1 Other includes a 1% holding or less in each of the following countries: Australia, Indonesia, Israel, New Zealand, Norway, Peru, Philippines, Portugal, South Africa, Taiwan and Thailand.

ANNUAL REPORT DECEMBER 31, 2016 17

Trust Summary as of December 31, 2016 BlackRock Resources & Commodities Strategy Trust

Trust Overview

BlackRock Resources & Commodities Strategy Trust’s (BCX) (the “Trust”) primary investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The Trust will seek to achieve its investment objectives, under normal market conditions, by investing at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources. While permitted, the Trust does not currently expect to invest in securities and derivatives linked to the underlying price movement of commodities or natural resources. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and utilizing an option overwriting strategy in an effort to seek total return performance and enhance distributions.

No assurance can be given that the Trust’s investment objectives will be achieved.

Trust Information

Symbol on NYSE BCX
Initial Offering Date March 30, 2011
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($ 8.27) 1 6.47%
Current Monthly Distribution per Common
Share 2 $0.0446
Current Annualized Distribution per Common Share 2 $0.5352

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Returns Based On — Market Price Net Asset Value
BCX 1,2 25.50% 27.41%
Lipper Natural Resources Funds 3 37.40% 32.14%

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV widened during the period, which accounts for the difference between performance based on price and performance based on NAV.

3 Average return.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s absolute performance based on NAV:

What factors influenced performance?

• Within the portfolio’s agriculture exposure, a position in Mosaic Co. — the world’s leading producer of phosphate and potash crop nutrients — detracted from performance. After performing well through the first half of the year, the stock lost ground on rumors that the company would acquire the fertilizer division of Vale SA. Mosaic would have required a capital raising to fund the acquisition, and the stock price declined as a result.

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a negative impact on performance given the strength in the overall sector.

• After losing ground in the initial weeks of the year, natural resources stocks rallied to close as one of the top-performing market segments of 2016. Expectations for stronger global growth, together with an improving balance of supply and demand in the commodity market, provided a firm underpinning for the sector. Consistent with the broader environment, the Trust produced a robust absolute return in the 12-month period.

• The copper-mining company First Quantum Minerals Ltd. was the leading contributor to the Trust’s absolute return. The company announced the sale of its Kevitsa mine for a price that exceeded the market’s expectations. Later in the year, First Quantum continued to please markets when the company reported lower costs. In contrast, the majority of companies in the sector reported higher-than-expected costs.

• The strong upward move in the price of coking coal had a positive impact on absolute performance by fueling gains for the Trust’s positions in Rio Tinto Ltd. and Glencore PLC.

• Gold experienced volatility in 2016, shifting between a high of $1,369 per ounce and a low of $1,062 per ounce. The metal ultimately finished the year in positive territory, and the Fund’s gold exposure contributed positively to performance. A position in Barrick Gold Corp., the world’s largest gold producer, was a notable contributor at the individual stock level.

Describe recent portfolio activity.

• The investment adviser reduced the Trust’s mining exposure following the sector’s strong relative performance, and it increased exposure to the energy and agriculture sectors. The Trust also shifted its energy weighting throughout the year to manage the portfolio’s sensitivity to oil prices.

18 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Resources & Commodities Strategy Trust

Performance and Portfolio Management Commentary (concluded)

Describe portfolio positioning at period end.

• At the end of the year, the natural resources sector remained supported by a backdrop of improving growth and expectations for rising inflation. In addition, producers’ efforts at cost-cutting and greater capital spen-

ding discipline led to lower supply in 2016, bringing the commodity market back into balance. In this environment, the Trust held an overweight position in the energy sector, a neutral position in agriculture and an underweight in mining.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Market Price and Net Asset Value Per Share Summary

12/31/16 12/31/15 Change High Low
Market Price $8.27 $7.11 16.32% $ 8.66 $5.57
Net Asset Value $9.86 $8.35 18.08% $10.05 $7.07

Market Price and Net Asset Value History For Past Five Years

Overview of the Trust’s Total Investments*

Ten Largest Holdings 12/31/16
Royal Dutch Shell PLC, A Shares - ADR 6%
BP PLC - ADR 5
Syngenta AG 5
Monsanto Co. 5
Rio Tinto PLC - ADR 4
Glencore PLC 4
International Paper Co. 3
Vale SA - ADR 3
Potash Corp. of Saskatchewan, Inc. 3
CF Industries Holdings, Inc. 3
  • Excludes option positions and money market funds.
Industry Allocation 12/31/16 12/31/15
Oil, Gas & Consumable Fuels 34% 34%
Metals & Mining 30 32
Chemicals 18 14
Containers & Packaging 6 2
Food Products 5 10
Energy Equipment & Services 3 1
Food & Staples Retailing 2 1
Paper & Forest Products 1 3
Other 1 1 3

1 Other includes less than 1% in each of the following industries: Building Products, Electric Utilities, Electrical Equipment, Electronic Equipment, Independent Power and Renewable Electricity Producers, Instruments & Components, Machinery, Multi-Utilities, Real Estate Investment Trusts (REITs), Semiconductors & Semiconductor Equipment and Water Utilities.

For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

ANNUAL REPORT DECEMBER 31, 2016 19

Trust Summary as of December 31, 2016 BlackRock Science and Technology Trust

Trust Overview

BlackRock Science and Technology Trust’s (BST) (the “Trust”) investment objective is to provide income and total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of science and technology companies. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and utilizing an option over-writing strategy in an effort to seek total return performance and enhance distributions.

No assurance can be given that the Trust’s investment objective will be achieved.

Trust Information

Symbol on NYSE BST
Initial Offering Date October 30, 2014
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($17.94) 1 6.69%
Current Monthly Distribution per Common
Share 2 $0.10
Current Annualized Distribution per Common Share 2 $1.20

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Returns Based On — Market Price Net Asset Value
BST 1,2 11.08% 9.36%
MSCI World Information Technology Index N/A 11.45%

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV narrowed during the period, which accounts for the difference between performance based on price and performance based on NAV.

N/A—Not applicable as the index does not have a market price.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s relative performance based on the index cited above:

What factors influenced performance?

• Holdings in 58.com, Inc., a Chinese classified advertising and listing platform holding company, represented the largest individual detractor during the period. The company announced that the Chinese government’s steps to tighten the country’s property market would have a substantial negative effect on its property listing revenue, and the Trust exited the position. The next largest detractor was the Trust’s position in Imperva, Inc., a provider of cyber-security solutions. Imperva substantially reduced its earnings forecast given shifts in consumer and client trends. The Trust also exited this position.

• The top individual contributor stock during the period was NVIDIA Corp., which handily exceeded its earnings forecasts throughout the year. NVIDIA provides semiconductor technology to high-growth segments

including gaming, data centers and automotive companies. Holdings in Acacia Communications, Inc., a provider of technology to communications networks, represented the second largest contributor to performance as the company had a successful initial public offering and met earnings projections.

• The Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a negative impact on performance during the period.

Describe recent portfolio activity.

• Over the 12-month period, the largest additions to the portfolio came from within the semiconductor & semiconductor equipment industry groups, funded by reductions in both software & services and media industry holdings. Regionally, these shifts resulted in additional exposure to the Pacific Basin and decreased exposure to the emerging markets and North America.

Describe portfolio positioning at period end.

• At period end, the Trust held its largest allocation within the software & services industry group, particularly idiosyncratic opportunities in the internet software & services and data processing & outsourced services sub-industries. The Trust also held large positions in more stable cash flow businesses within the semiconductor & semiconductor equipment and technology hardware & equipment industries. Regionally, the Trust maintained most of its exposure in North America, followed by notable weights to the emerging markets, Europe and the Pacific Basin.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

20 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Science and Technology Trust

Market Price and Net Asset Value Per Share Summary

Market Price $ 17.94 $ 17.31 3.64 % $ 19.09 $ 14.01
Net Asset Value $ 20.10 $ 19.71 1 1.98 % $ 21.04 $ 16.52

1 The net asset value does not reflect adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles and therefore differs from the amounts reported in the Financial Highlights.

Market Price and Net Asset Value History Since Inception

1 Commencement of operations.

Overview of the Trust’s Total Investments*

Ten Largest Holdings 12/31/16
Alphabet, Inc., Class A 6%
Apple, Inc. 6
Microsoft Corp. 6
Amazon.com, Inc. 4
Tencent Holdings Ltd. 3
Facebook, Inc., Class A 3
Alibaba Group Holding Ltd. - ADR 3
Broadcom Ltd. 3
Visa, Inc., A Shares 2
Mastercard, Inc., Class A 2
  • Excludes option positions and money market funds.
Industry Allocation 12/31/16 12/31/15
Internet Software & Services 23% 26%
Software 21 20
Semiconductors & Semiconductor Equipment 19 11
IT Services 11 13
Internet & Direct Marketing Retail 7 6
Technology Hardware, Storage & Peripherals 7 7
Equity Real Estate Investment Trusts (REITs) 4 5
Electronic Equipment, Instruments & Components 2 1
Media 2 5
Diversified Telecommunication Services 1 2
Other 2 3 4

2 Other includes a 1% holding or less in each of the following industries; Communications Equipment, Hotels, Restaurants & Leisure, Professional Services, Household Durables and Wireless Telecommunication Services.

For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

ANNUAL REPORT DECEMBER 31, 2016 21

Trust Summary as of December 31, 2016 BlackRock Utility and Infrastructure Trust

Trust Overview

BlackRock Utility and Infrastructure Trust’s (BUI) (the “Trust”) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing primarily in equity securities issued by companies that are engaged in the Utilities and Infrastructure business segments anywhere in the world and by utilizing an option writing (selling) strategy in an effort to seek total return performance and enhance distributions. The Trust considers the “Utilities” business segment to include products, technologies and services connected to the management, ownership, operation, construction, development or financing of facilities used to generate, transmit or distribute electricity, water, natural resources or telecommunications and the “Infrastructure” business segment to include companies that own or operate infrastructure assets or that are involved in the development, construction, distribution or financing of infrastructure assets. Under normal circumstances, the Trust invests a substantial amount of its total assets in foreign issuers, issuers that primarily trade in a market located outside the United States or issuers that do a substantial amount of business outside the United States. The Trust may invest directly in such securities or synthetically through the use of derivatives.

No assurance can be given that the Trust’s investment objective will be achieved.

Trust Information

Symbol on NYSE BUI
Initial Offering Date November 25, 2011
Current Distribution Rate on Closing Market Price as of December 31, 2016 ($18.41) 1 7.89%
Current Monthly Distribution per Common
Share 2 $0.121
Current Annualized Distribution per Common Share 2 $1.452

1 Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results.

2 The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.

Performance and Portfolio Management Commentary

Returns for the 12-month period ended December 31, 2016 were as follows:

Market Price Net Asset Value
BUI 1,2 18.50 % 7.57 %
Lipper Utility
Funds 3 17.44 % 13.23 %

1 All returns reflect reinvestment of dividends and/or distributions.

2 The Trust’s discount to NAV narrowed during the period, which accounts for the difference between performance based on price and performance based on NAV.

3 Average return.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The following discussion relates to the Trust’s absolute performance based on NAV:

What factors influenced performance?

• The largest detractor from absolute returns was the Trust’s position in the transportation infrastructure industry. In this vein, notable detractors from performance included Australian airport operator Sydney Airport Ltd. and Atlantia SpA, which constructs and manages airports and highways in its home country of Italy and abroad. The Trust’s exposure to the construction & engineering industry also detracted from performance, in particular a position in Spanish toll-road and airport construction operator Ferrovial SA. Broadly, European construction and infrastructure companies underperformed in the aftermath of the U.K. vote to exit from the European Union (“Brexit”).

• The Trust’s international exposure detracted from absolute returns from a country allocation perspective, driven largely by portfolio holdings based in France and Spain.

• Utilities performed strongly during the first half of the 12-month period, as central bank policy decisions and historically low U.S. interest rates created a strong demand for higher-yielding equities. However, utilities weakened somewhat in the second half of the period as investors anticipated higher interest rates. The Trust’s exposure to the electric utilities industry was the largest contributor to performance, led by regulated utility operators Exelon Corp. and NextEra Energy, Inc. The Trust’s exposure to the multi-utilities industry also benefited performance, as CMS Energy Corporation and Dominion Resources Inc. performed strongly. Finally, exposure to the energy sector and to the water utilities industry contributed modestly to the Trust’s absolute returns.

• Also, during the period, the Trust made use of options, principally written call options on individual stocks, in order to seek enhanced income returns while continuing to participate in the performance of the underlying equities. The Trust’s option writing strategy had a modestly positive impact on returns for the period.

Describe recent portfolio activity.

• During the period, the Trust increased exposure to electric utilities, adding to existing positions in NextEra Energy, Inc. and Enel S.p.A and initiating a position in FirstEnergy Corp. The Trust reduced exposure to the

22 ANNUAL REPORT DECEMBER 31, 2016

BlackRock Utility and Infrastructure Trust

Performance and Portfolio Management Commentary (concluded)

gas utilities industry, notably exiting its positions in Italy’s Snam SpA and U.S.-based Spire Inc. (formerly known as The Laclede Group). Lastly, the Trust reduced its position size in water utility operator American Water Works Company, primarily on the basis of valuation after strong absolute performance during the period.

Describe portfolio positioning at period end.

• At period end, the utilities sector accounted for approximately 57% of the Trust’s assets, with holdings concentrated in U.S. electric and multi- utilities. Against a backdrop of historically low interest rates, the demand for equity yield has led to valuations for U.S. utilities that are high relative to their historical levels, placing even greater importance on stock selection. As such, the Fund was focused on owning companies with

strong management teams that offer the potential for above-sector growth in earnings and dividends. The Fund had a preference for regulated utilities over their non-regulated counterparts given their existing barriers to entry, strong balance sheets, and lower sensitivity to commodity prices.

• Additionally, about 37% of the Trust’s assets were in global construction and infrastructure operators and master limited partnerships at period end. This positioning was based on the healthy dividend yields and potential long-term capital growth these assets offer, along with diversification across geographies, economies and industries globally.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Market Price and Net Asset Value Per Share Summary

12/31/16 12/31/15 Change High Low
Market Price $18.41 $16.78 9.71% $20.58 $14.80
Net Asset Value $19.42 $19.50 (0.41)% $21.08 $17.98

Market Price and Net Asset Value History For the Past Five Years

ANNUAL REPORT DECEMBER 31, 2016 23

BlackRock Utility and Infrastructure Trust

Overview of the Trust’s Total Investments*

Ten Largest Holdings
NextEra Energy, Inc. 8 %
CMS Energy Corp. 6
Dominion Resources, Inc. 5
Atlantia SpA 3
Exelon Corp. 3
Public Service Enterprise Group, Inc. 3
Duke Energy Corp. 3
Sempra Energy 3
Transurban Group 3
Dominion Midstream Partners LP 2
  • Excludes option positions and money market funds.
Industry Allocation — Electric Utilities 28 % 23 %
Multi-Utilities 22 20
Oil, Gas & Consumable Fuels 20 21
Transportation Infrastructure 14 17
Independent Power and Renewable Electricity Producers 4 5
Construction & Engineering 3 4
Equity Real Estate Investment Trusts (REITs) 3 3
Water Utilities 2 4
Diversified Telecommunication Services 2 1
Gas Utilities 1 2
Other 1 1 —

1 Other includes a 1% holding or less in each of the following industries: Road & Rail and Wireless Telecommunication Services.

For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

24 ANNUAL REPORT DECEMBER 31, 2016

Derivative Financial Instruments

The Trusts may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other asset without owning or taking physical custody of securities, commodities and/or other referenced assets to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction

or illiquidity of the instrument. The Trusts’ successful use of a derivative financial instrument depends on the investment adviser’s ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation a Trust can realize on an investment and/or may result in lower distributions paid to shareholders. The Trusts’ investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 25

Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Value
Energy Equipment & Services — 9.4%
Baker Hughes, Inc. (a) 320,250 $ 20,806,643
Halliburton Co. (a) 79,800 4,316,382
Schlumberger Ltd. (a) 247,774 20,800,627
45,923,652
Oil, Gas & Consumable Fuels — 91.2%
Anadarko Petroleum Corp. (a) 306,483 21,371,060
BP PLC 5,030,000 31,505,236
Cabot Oil & Gas Corp. (a) 283,900 6,631,904
Cairn Energy PLC (b) 1,810,176 5,259,467
Chevron Corp. (a) 234,450 27,594,765
Cimarex Energy Co. (a) 100,600 13,671,540
ConocoPhillips (a) 502,150 25,177,801
Devon Energy Corp. (a) 270,350 12,346,885
Enbridge, Inc. (a) 310,500 13,066,134
Encana Corp. (a) 1,021,450 11,989,761
Eni SpA 533,450 8,647,826
EOG Resources, Inc. (a) 243,600 24,627,960
EQT Corp. (a) 133,400 8,724,360
Exxon Mobil Corp. (a)(c) 555,450 50,134,917
Hess Corp. (a) 200,700 12,501,603
Kosmos Energy Ltd. (b) 673,707 4,722,686
Lundin Petroleum AB (b) 239,277 5,185,525
Marathon Oil Corp. (a) 702,800 12,165,468
Noble Energy, Inc. (a) 287,292 10,934,334
Occidental Petroleum Corp. (a) 279,900 19,937,277
Oil Search Ltd. 1,754,013 9,027,515
Phillips 66 (a) 96,400 8,329,924
Pioneer Natural Resources Co. (a) 92,750 16,701,493
Common Stocks Value
Oil, Gas & Consumable Fuels (continued)
Royal Dutch Shell PLC, A Shares 713,948 $ 19,707,610
Royal Dutch Shell PLC, A Shares — ADR (a) 689,800 37,511,324
Tesoro Corp. (a) 46,650 4,079,543
TransCanada Corp. (a) 254,550 11,477,643
Valero Energy Corp. (a) 163,500 11,170,320
444,201,881
Total Long-Term Investments (Cost — $442,857,418) — 100.6% 490,125,533
Short-Term Securities
BlackRock Liquidity Funds, T-Fund, Institutional
Class, 0.36% (d)(e) 3,936,617 3,936,617
Total Short-Term Securities (Cost — $3,936,617) — 0.8% 3,936,617
Total Investments Before Options
Written (Cost — $446,794,035) — 101.4% 494,062,150
Options Written
(Premiums Received — $4,804,608) — (1.2)% (6,152,354 )
Total Investments Net of Options Written — 100.2% 487,909,796
Liabilities in Excess of Other Assets — (0.2)% (845,826 )
Net Assets — 100.0% $ 487,063,970

Notes to Schedule of Investments

(a) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(b) Non-income producing security.

(c) All or a portion of security has been pledged as collateral in connection with outstanding OTC derivatives.

(d) Current yield as of period end.

(e) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliate — BlackRock Liquidity Funds, TempFund, Institutional Class 5,394,590 (5,394,590 ) — — $28,453 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 3,936,617 3,936,617 $3,936,617 3,593 $ 18
SL Liquidity Series, LLC, Money Market Series 944,554 (944,554 ) — — 26,579 1 1,435
Total $3,936,617 $58,625 $1,453

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

Portfolio Abbreviations

ADR American Depositary Receipts HKD Hong Kong Dollar SEK Swedish Krona
AUD Australian Dollar JPY Japanese Yen SGD Singapore Dollar
CAD Canadian Dollar KRW Korean Won TWD Taiwan Dollar
CHF Swiss Franc NOK Norwegian Krone USD U.S. Dollar
EUR Euro NZD New Zealand Dollar ZAR South African Rand
GBP British Pound REIT Real Estate Investment Trust

See Notes to Financial Statements.

26 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Energy and Resources Trust (BGR)

• For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Exxon Mobil Corp. Call 1/04/17 USD 89.00 113 $ (17,754 )
Devon Energy Corp. Call 1/06/17 USD 49.00 96 (528 )
Devon Energy Corp. Call 1/06/17 USD 49.50 94 (564 )
Exxon Mobil Corp. Call 1/06/17 USD 89.00 123 (19,311 )
Halliburton Co. Call 1/06/17 USD 55.00 140 (4,200 )
Marathon Oil Corp. Call 1/06/17 USD 18.50 281 (1,124 )
Occidental Petroleum Corp. Call 1/06/17 USD 70.00 221 (33,592 )
Occidental Petroleum Corp. Call 1/06/17 USD 73.00 134 (2,010 )
Pioneer Natural Resources Co. Call 1/06/17 USD 195.00 121 (3,025 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/06/17 USD 52.50 400 (109,000 )
Schlumberger Ltd. Call 1/06/17 USD 86.00 171 (2,223 )
Anadarko Petroleum Corp. Call 1/13/17 USD 69.00 180 (35,640 )
ConocoPhillips Call 1/13/17 USD 49.00 127 (21,971 )
Devon Energy Corp. Call 1/13/17 USD 50.00 454 (6,810 )
EOG Resources, Inc. Call 1/13/17 USD 105.00 159 (10,176 )
Exxon Mobil Corp. Call 1/13/17 USD 90.00 245 (31,483 )
Halliburton Co. Call 1/13/17 USD 55.50 140 (7,140 )
Hess Corp. Call 1/13/17 USD 58.00 173 (79,580 )
Marathon Oil Corp. Call 1/13/17 USD 18.50 281 (3,934 )
Occidental Petroleum Corp. Call 1/13/17 USD 73.50 133 (4,522 )
Phillips 66 Call 1/13/17 USD 87.50 120 (11,400 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/13/17 USD 53.00 400 (74,000 )
Schlumberger Ltd. Call 1/13/17 USD 86.50 172 (5,418 )
Tesoro Corp. Call 1/13/17 USD 85.00 50 (17,750 )
Anadarko Petroleum Corp. Call 1/20/17 USD 65.00 275 (145,063 )
Baker Hughes, Inc. Call 1/20/17 USD 62.50 117 (38,493 )
Baker Hughes, Inc. Call 1/20/17 USD 65.00 500 (85,000 )
Cabot Oil & Gas Corp. Call 1/20/17 USD 25.00 225 (8,438 )
Chevron Corp. Call 1/20/17 USD 108.75 386 (372,098 )
Cimarex Energy Co. Call 1/20/17 USD 140.00 86 (17,845 )
ConocoPhillips Call 1/20/17 USD 46.00 403 (183,365 )
ConocoPhillips Call 1/20/17 USD 47.50 80 (24,600 )
Devon Energy Corp. Call 1/20/17 USD 45.00 98 (18,326 )
Enbridge, Inc. Call 1/20/17 CAD 58.00 330 (7,737 )
Encana Corp. Call 1/20/17 CAD 17.00 565 (5,260 )
EOG Resources, Inc. Call 1/20/17 USD 105.00 56 (5,432 )
EOG Resources, Inc. Call 1/20/17 USD 95.00 107 (72,225 )
EQT Corp. Call 1/20/17 USD 70.00 234 (17,550 )
Exxon Mobil Corp. Call 1/20/17 USD 90.00 236 (36,344 )
Hess Corp. Call 1/20/17 USD 60.00 98 (33,565 )
Marathon Oil Corp. Call 1/20/17 USD 16.00 1,047 (162,285 )
Noble Energy, Inc. Call 1/20/17 USD 37.50 390 (54,600 )
Occidental Petroleum Corp. Call 1/20/17 USD 70.00 75 (16,425 )
Occidental Petroleum Corp. Call 1/20/17 USD 72.50 96 (8,496 )
Phillips 66 Call 1/20/17 USD 90.00 120 (4,500 )
Pioneer Natural Resources Co. Call 1/20/17 USD 180.00 87 (43,500 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/20/17 USD 52.50 228 (54,150 )
Schlumberger Ltd. Call 1/20/17 USD 82.50 259 (69,801 )
Schlumberger Ltd. Call 1/20/17 USD 87.50 173 (8,650 )
TransCanada Corp. Call 1/20/17 CAD 62.00 225 (5,530 )
Valero Energy Corp. Call 1/20/17 USD 65.00 48 (19,080 )
Anadarko Petroleum Corp. Call 1/27/17 USD 75.00 272 (14,824 )
Baker Hughes, Inc. Call 1/27/17 USD 65.50 196 (58,016 )
Cabot Oil & Gas Corp. Call 1/27/17 USD 23.50 548 (57,540 )
Chevron Corp. Call 1/27/17 USD 118.00 91 (20,293 )
ConocoPhillips Call 1/27/17 USD 51.50 256 (23,296 )
ConocoPhillips Call 1/27/17 USD 52.00 249 (18,302 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 27

Schedule of Investments (continued) BlackRock Energy and Resources Trust (BGR)

Description — Devon Energy Corp. Call 1/27/17 USD 50.00 96 Value — $ (3,408 )
EOG Resources, Inc. Call 1/27/17 USD 110.00 85 (3,570 )
Exxon Mobil Corp. Call 1/27/17 USD 89.00 297 (72,765 )
Exxon Mobil Corp. Call 1/27/17 USD 92.00 227 (19,295 )
Hess Corp. Call 1/27/17 USD 65.50 194 (26,384 )
Marathon Oil Corp. Call 1/27/17 USD 20.50 167 (4,175 )
Occidental Petroleum Corp. Call 1/27/17 USD 74.00 320 (20,160 )
Phillips 66 Call 1/27/17 USD 88.00 98 (12,740 )
Pioneer Natural Resources Co. Call 1/27/17 USD 195.00 118 (17,110 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/27/17 USD 53.00 486 (112,995 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/27/17 USD 54.00 900 (146,250 )
Tesoro Corp. Call 1/27/17 USD 90.50 60 (10,200 )
EOG Resources, Inc. Call 1/30/17 USD 96.00 85 (54,538 )
ConocoPhillips Call 2/03/17 USD 53.00 159 (11,448 )
Devon Energy Corp. Call 2/03/17 USD 48.50 112 (9,968 )
Marathon Oil Corp. Call 2/03/17 USD 18.35 195 (8,806 )
EOG Resources, Inc. Call 2/09/17 USD 105.00 257 (47,226 )
ConocoPhillips Call 2/10/17 USD 52.00 75 (8,625 )
Tesoro Corp. Call 2/10/17 USD 90.50 53 (13,967 )
Chevron Corp. Call 2/17/17 USD 115.00 347 (168,295 )
ConocoPhillips Call 2/17/17 USD 49.00 275 (77,550 )
ConocoPhillips Call 2/17/17 USD 55.00 129 (6,644 )
Enbridge, Inc. Call 2/17/17 CAD 58.00 186 (12,052 )
EOG Resources, Inc. Call 2/17/17 USD 105.00 103 (25,647 )
Exxon Mobil Corp. Call 2/17/17 USD 92.50 496 (60,760 )
Hess Corp. Call 2/17/17 USD 60.00 240 (114,600 )
Marathon Oil Corp. Call 2/17/17 USD 19.00 321 (15,087 )
Noble Energy, Inc. Call 2/17/17 USD 42.50 160 (6,800 )
Schlumberger Ltd. Call 2/17/17 USD 87.50 92 (10,672 )
EQT Corp. Call 3/17/17 USD 70.00 235 (49,350 )
Total $ (3,364,871 )
OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
Marathon Oil Corp. Call Barclays Bank PLC 1/03/17 USD 15.90 16,700 $ (23,941 )
BP PLC Call Credit Suisse International 1/04/17 GBP 4.46 90,000 (70,881 )
BP PLC Call UBS AG 1/04/17 GBP 5.06 200,000 (16,161 )
Royal Dutch Shell PLC, A Shares Call Credit Suisse International 1/04/17 GBP 20.02 111,000 (327,669 )
Exxon Mobil Corp. Call Citibank N.A. 1/05/17 USD 89.45 20,700 (27,295 )
Valero Energy Corp. Call Deutsche Bank AG 1/06/17 USD 64.50 26,300 (102,972 )
Eni SpA Call Credit Suisse International 1/10/17 EUR 13.21 87,000 (202,769 )
Lundin Petroleum AB Call Credit Suisse International 1/10/17 SEK 161.16 44,000 (175,563 )
Cabot Oil & Gas Corp. Call Barclays Bank PLC 1/11/17 USD 23.90 22,500 (10,908 )
Eni SpA Call Bank of America N.A. 1/11/17 EUR 13.85 13,000 (21,231 )
Oil Search Ltd. Call Morgan Stanley & Co. International PLC 1/11/17 AUD 6.60 215,000 (85,245 )
TransCanada Corp. Call Citibank N.A. 1/11/17 CAD 61.81 23,000 (5,057 )
BP PLC Call Credit Suisse International 1/12/17 GBP 4.46 90,000 (70,955 )
BP PLC Call Morgan Stanley & Co. International PLC 1/12/17 GBP 4.58 210,000 (130,749 )
Encana Corp. Call Credit Suisse International 1/12/17 CAD 15.00 57,000 (38,585 )
Noble Energy, Inc. Call Citibank N.A. 1/17/17 USD 36.48 46,000 (110,389 )
BP PLC Call Credit Suisse International 1/18/17 GBP 4.49 90,000 (67,817 )
BP PLC Call Morgan Stanley & Co. International PLC 1/18/17 GBP 4.58 210,000 (131,493 )
Lundin Petroleum AB Call Bank of America N.A. 1/18/17 SEK 183.99 40,000 (61,696 )
Valero Energy Corp. Call Deutsche Bank AG 1/19/17 USD 64.50 26,300 (114,216 )
Eni SpA Call Credit Suisse International 1/26/17 EUR 15.19 87,000 (44,439 )
Encana Corp. Call Morgan Stanley & Co. International PLC 1/27/17 CAD 15.71 65,100 (32,225 )
TransCanada Corp. Call Morgan Stanley & Co. International PLC 1/30/17 CAD 60.92 43,500 (34,317 )
BP PLC Call Credit Suisse International 2/01/17 GBP 4.51 280,000 (200,372 )
Oil Search Ltd. Call Deutsche Bank AG 2/02/17 AUD 7.35 190,000 (19,992 )
Anadarko Petroleum Corp. Call Barclays Bank PLC 2/07/17 USD 70.90 35,000 (90,393 )
Enbridge, Inc. Call Goldman Sachs International 2/07/17 CAD 56.92 38,000 (35,012 )
Encana Corp. Call Morgan Stanley & Co. International PLC 2/08/17 CAD 17.25 127,500 (28,272 )
BP PLC Call Credit Suisse International 2/09/17 GBP 4.86 300,000 (108,572 )

See Notes to Financial Statements.

28 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Energy and Resources Trust (BGR)

Description — Oil Search Ltd. Call Deutsche Bank AG 2/09/17 AUD 7.22 209,000 Value — $ (32,954 )
Royal Dutch Shell PLC, A Shares Call Morgan Stanley & Co. International PLC 2/09/17 GBP 22.52 138,900 (106,887 )
Cimarex Energy Co. Call UBS AG 2/14/17 USD 138.00 26,600 (151,023 )
Encana Corp. Call Morgan Stanley & Co. International PLC 2/15/17 CAD 16.89 53,000 (18,970 )
BP PLC Call UBS AG 2/22/17 GBP 4.92 300,000 (76,686 )
Enbridge, Inc. Call Deutsche Bank AG 3/06/17 CAD 58.60 19,000 (11,777 )
Total $ (2,787,483 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
Outstanding options at beginning of year 3,555,178 $ 3,279,955 — —
Options written 24,961,528 31,529,453 — —
Options exercised (299 ) (40,401 ) — —
Options expired (12,680,026 ) (9,218,878 ) — —
Options closed (12,266,029 ) (20,745,521 ) — —
Outstanding options at end of year 3,570,352 $ 4,804,608 — —

As of period end, the value of portfolio securities subject to covered call options written was $166,279,525.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Total
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $6,152,354 — — $ 6,152,354

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: Commodity Contracts Credit Contracts Equity Contracts Foreign Currency Exchange Contracts Interest Rate Contracts Total
Options purchased 1 — — $ (406 ) — — $ (406 )
Options written — — (4,190,501 ) — — (4,190,501 )
Total — — $ (4,190,907 ) — — $ (4,190,907 )
Net Change in Unrealized Appreciation (Depreciation)
on:
Options written — — $ (3,690,895 ) — — $ (3,690,895 )

1 Options purchased are included in net realized gain (loss) from investments.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 29

Schedule of Investments (continued) BlackRock Energy and Resources Trust (BGR)

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Options:
Average value of option contracts
purchased 1 $ 406
Average value of option contracts written $ 5,499,043

1 Actual amounts for the period are shown due to limited outstanding derivative financial instruments as of each quarter.

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments — Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Assets Liabilities
Derivative Financial Instruments:
Options — $ 6,152,354
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — $ (3,364,871 )
Total derivative assets and liabilities subject to an MNA — $ 2,787,483

The following table presents the Trust’s derivative liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (“MNA”) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not Offset in the Consolidated Statements of Assets and Liabilities and
Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged 1 | | Cash Collateral Pledged | Net Amount of Derivative Liabilities 2 |
| --- | --- | --- | --- | --- | --- | --- |
| Bank of America N.A. | $ 82,927 | — | — | | — | $ 82,927 |
| Barclays Bank PLC | 125,242 | — | — | | — | 125,242 |
| Citibank N.A. | 142,741 | — | $ (142,741 | ) | — | — |
| Credit Suisse International | 1,307,622 | — | (1,307,622 | ) | — | — |
| Deutsche Bank AG | 281,911 | — | — | | — | 281,911 |
| Goldman Sachs International | 35,012 | — | — | | — | 35,012 |
| Morgan Stanley & Co. International PLC | 568,158 | — | (402,650 | ) | — | 165,508 |
| UBS AG | 243,870 | — | — | | — | 243,870 |
| Total | $2,787,483 | — | $ (1,853,013 | ) | — | $934,470 |

1 Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net Amount may be offset further by net options written receivable/payable on the Statements of Assets and Liabilities.

See Notes to Financial Statements.

30 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (concluded) BlackRock Energy and Resources Trust (BGR)

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Level 1 Level 2 Total
Assets:
Investments:
Long-Term Investments:
Common Stocks:
Energy Equipment & Services $ 45,923,652 — — $ 45,923,652
Oil, Gas & Consumable Fuels 364,868,702 $ 79,333,179 — 444,201,881
Short-Term Securities 3,936,617 — — 3,936,617
Total Investments $ 414,728,971 $ 79,333,179 — $ 494,062,150
Derivative Financial Instruments 1
Liabilities:
Equity contracts $ (2,864,449 ) $ (3,287,905 ) — $ (6,152,354 )

1 Derivative financial instruments are options written, which are shown at value.

During the year ended December 31, 2016, there were no transfers between levels.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 31

Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Value
Aerospace & Defense — 1.1%
Huntington Ingalls Industries, Inc. 1,801 $ 331,726
L-3 Communications Holdings, Inc. (a) 21,457 3,263,824
Raytheon Co. (a) 26,845 3,811,990
7,407,540
Airlines — 1.8%
Delta Air Lines, Inc. (a) 219,360 10,790,318
Southwest Airlines Co. (a) 27,834 1,387,247
12,177,565
Auto Components — 2.7%
Goodyear Tire & Rubber Co. (a) 271,497 8,381,112
Lear Corp. (a) 71,363 9,446,320
17,827,432
Banks — 13.5%
Bank of America Corp. (a) 1,167,499 25,801,728
Citigroup, Inc. (a) 104,010 6,181,314
JPMorgan Chase & Co. (a)(b) 325,683 28,103,186
Regions Financial Corp. (a) 138,799 1,993,154
SunTrust Banks, Inc. (a) 218,766 11,999,315
U.S. Bancorp (a) 304,941 15,664,819
89,743,516
Beverages — 1.4%
Dr. Pepper Snapple Group, Inc. 100,907 9,149,238
Biotechnology — 3.9%
Amgen, Inc. (a) 7,304 1,067,918
Biogen, Inc. (a)(c) 44,579 12,641,713
Gilead Sciences, Inc. (a) 169,175 12,114,622
25,824,253
Building Products — 0.4%
Owens Corning 51,108 2,635,128
Capital Markets — 2.2%
Goldman Sachs Group, Inc. (a) 60,296 14,437,877
Chemicals — 1.3%
Dow Chemical Co. (a) 148,005 8,468,846
Communications Equipment — 2.5%
Cisco Systems, Inc. (a) 559,348 16,903,497
Construction & Engineering — 0.4%
EMCOR Group, Inc. (a) 38,519 2,725,604
Consumer Finance — 1.2%
SLM Corp. (c) 713,666 7,864,599
Containers & Packaging — 1.5%
Avery Dennison Corp. (a) 49,267 3,459,529
Packaging Corp. of America 79,712 6,761,172
10,220,701
Diversified Telecommunication Services — 0.2%
AT&T Inc. (a) 37,700 1,603,381
Electric Utilities — 0.7%
FirstEnergy Corp. 143,866 4,455,530
Electronic Equipment, Instruments & Components — 1.9%
CDW Corp. (a) 112,240 5,846,582
Flex Ltd. (a)(c) 458,631 6,590,527
12,437,109
Energy Equipment & Services — 0.3%
Schlumberger Ltd. (a) 25,469 2,138,123
Food & Staples Retailing — 4.5%
CVS Health Corp. (a)(b) 138,171 10,903,074
Walgreens Boots Alliance, Inc. (a) 173,444 14,354,225
Common Stocks Value
Food & Staples Retailing (continued)
Wal-Mart Stores, Inc. (a) 69,669 $ 4,815,521
30,072,820
Health Care Providers & Services — 7.0%
Aetna, Inc. (a)(b) 66,410 8,235,504
Centene Corp. (c) 92,304 5,216,099
Cigna Corp. (a) 17,787 2,372,608
Humana, Inc. (a) 64,918 13,245,220
Laboratory Corp. of America Holdings (a)(c) 37,064 4,758,276
UnitedHealth Group, Inc. (a) 78,738 12,601,230
46,428,937
Hotels, Restaurants & Leisure — 2.7%
Carnival Corp. (a) 275,660 14,350,860
Wyndham Worldwide Corp. (a) 50,284 3,840,189
18,191,049
Household Durables — 1.4%
DR Horton, Inc. (a) 175,163 4,787,205
Lennar Corp., Class A (a) 60,253 2,586,661
NVR, Inc. (c) 1,234 2,059,546
9,433,412
Insurance — 0.0%
Prudential Financial, Inc. 3,196 332,576
Internet Software & Services — 4.0%
Alphabet, Inc., Class A (a)(b)(c) 33,504 26,550,245
IT Services — 2.1%
Amdocs Ltd. (a) 99,436 5,792,147
Cognizant Technology Solutions Corp., Class A (a)(c) 147,712 8,276,303
14,068,450
Life Sciences Tools & Services — 0.0%
Quintiles IMS Holdings, Inc. (c) 4,104 312,109
Machinery — 0.4%
WABCO Holdings, Inc. (a)(c) 22,204 2,356,955
Media — 3.8%
Comcast Corp., Class A (a)(b) 294,633 20,344,409
Omnicom Group, Inc. (a) 54,869 4,669,901
25,014,310
Metals & Mining — 1.0%
Rio Tinto PLC — ADR (a) 177,867 6,840,765
Multiline Retail — 0.0%
Kohl’s Corp. 6,022 297,366
Multi-Utilities — 0.6%
Public Service Enterprise Group, Inc. 88,510 3,883,819
Oil, Gas & Consumable Fuels — 7.3%
Anadarko Petroleum Corp. (a) 38,023 2,651,344
BP PLC — ADR (a) 269,558 10,076,076
Chevron Corp. (a) 130,394 15,347,374
Hess Corp. (a) 54,589 3,400,349
Marathon Oil Corp. (a) 131,595 2,277,909
Statoil ASA — ADR (a)(d) 142,650 2,601,936
Suncor Energy, Inc. (a) 217,235 7,101,412
TOTAL SA — ADR (a) 47,521 2,422,145
Valero Energy Corp. (a) 34,800 2,377,536
48,256,081
Pharmaceuticals — 2.8%
Allergan PLC (a)(c) 16,929 3,555,259
Johnson & Johnson (a) 23,980 2,762,736
Mallinckrodt PLC (a)(c) 76,452 3,808,839

See Notes to Financial Statements.

32 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

Common Stocks Value
Pharmaceuticals (continued)
Merck & Co., Inc. (a) 54,299 $ 3,196,582
Pfizer, Inc. (a)(b) 51,521 1,673,402
Teva Pharmaceutical Industries Ltd. — ADR (a) 108,027 3,915,979
18,912,797
Professional Services — 0.6%
Robert Half International, Inc. 82,003 4,000,106
Road & Rail — 0.9%
Norfolk Southern Corp. (a) 54,370 5,875,766
Semiconductors & Semiconductor Equipment — 4.2%
Applied Materials, Inc. 51,857 1,673,425
Intel Corp. (a)(b) 266,433 9,663,525
Lam Research Corp. (a) 119,379 12,621,942
NVIDIA Corp. (a) 36,675 3,914,690
27,873,582
Software — 5.9%
Activision Blizzard, Inc. (a) 337,290 12,179,542
Dell Technologies, Inc., Class V (a)(c) 36,076 1,983,098
Microsoft Corp. (a)(b) 400,842 24,908,322
39,070,962
Specialty Retail — 4.1%
Home Depot, Inc. (a)(b) 102,046 13,682,328
Lowe’s Cos., Inc. (a)(b) 188,311 13,392,678
27,075,006
Technology Hardware, Storage & Peripherals — 4.8%
Apple, Inc. (a)(b) 273,458 31,671,906
Tobacco — 2.5%
Altria Group, Inc. (a)(b) 250,661 16,949,697
Total Common Stocks — 97.6% 649,488,655
Total Long-Term
Investments (Cost — $583,835,019) — 97.6% 649,488,655
Short-Term Securities Shares Value
Money Market Funds
BlackRock Liquidity Funds, T-Fund, Institutional Class, 0.36% (e)(f) 24,715,046 $ 24,715,046
SL Liquidity Series, LLC Money Market Series, 0.95% (e)(f)(g) 695,518 695,588
Time Deposits Par (000)
Brown Brothers Harriman & Co., 0.63%, 1/03/16 $ 232 232,266
Total Short-Term
Securities (Cost — $25,642,846) — 3.9% 25,642,900
Total Investments Before Options
Written (Cost — $609,477,865) — 101.5% 675,131,555
Options Written
(Premiums Received — $8,212,203) — (1.5)% (10,302,482 )
Total Investments Net of Options Written — 100.0% 664,829,073
Other Assets Less Liabilities — 0.0% 330,374
Net Assets — 100.0% $ 665,159,447

Notes to Schedule of Investments

(a) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(b) All or a portion of security has been pledged as collateral in connection with outstanding OTC derivatives.

(c) Non-income producing security.

(d) Security, or a portion of security, is on loan.

(e) Current yield as of period end.

(f) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliate — BlackRock Liquidity Funds, TempFund, Institutional Class 15,619,710 (15,619,710 — — Income — $ 52,615 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 24,715,046 24,715,046 $24,715,046 22,040 $160
SL Liquidity Series, LLC, Money Market Series — 695,518 695,518 695,588 2,681 1 3
Total $25,410,634 $ 77,336 $163

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

(g) Security was purchased with the cash collateral from loaned securities.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 33

Schedule of Investments (continued) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

• For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Financial Futures Contracts — Contracts Long Issue Expiration Notional Value Unrealized Depreciation
105 Mini S&P 500 Index Futures March 2017 USD 11,740,313 $ (128,627 )
Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Norfolk Southern Corp. Call 1/05/17 USD 104.00 57 $ (24,896 )
Amgen, Inc. Call 1/06/17 USD 147.00 6 (687 )
Apple, Inc. Call 1/06/17 USD 115.00 303 (46,814 )
Biogen, Inc. Call 1/06/17 USD 310.00 124 (3,100 )
Cisco Systems, Inc. Call 1/06/17 USD 30.50 149 (968 )
Citigroup, Inc. Call 1/06/17 USD 56.50 298 (90,890 )
Cognizant Technology Solutions Corp., Class A Call 1/06/17 USD 55.00 200 (37,000 )
Comcast Corp., Class A Call 1/06/17 USD 70.00 131 (4,520 )
Delta Air Lines, Inc. Call 1/06/17 USD 53.50 155 (388 )
Gilead Sciences, Inc. Call 1/06/17 USD 75.00 192 (1,440 )
Goodyear Tire & Rubber Co. Call 1/06/17 USD 31.50 110 (1,925 )
Intel Corp. Call 1/06/17 USD 35.50 117 (11,115 )
Johnson & Johnson Call 1/06/17 USD 116.00 119 (5,414 )
Lowe’s Cos., Inc. Call 1/06/17 USD 76.00 28 (84 )
Marathon Oil Corp. Call 1/06/17 USD 18.50 13 (52 )
Merck & Co., Inc. Call 1/06/17 USD 62.00 75 (450 )
Microsoft Corp. Call 1/06/17 USD 60.50 275 (50,050 )
Schlumberger Ltd. Call 1/06/17 USD 86.00 43 (559 )
Walgreens Boots Alliance, Inc. Call 1/06/17 USD 87.50 14 (504 )
Amgen, Inc. Call 1/09/17 USD 151.75 20 (1,770 )
EMCOR Group, Inc. Call 1/09/17 USD 70.10 77 (12,898 )
Goldman Sachs Group, Inc. Call 1/09/17 USD 198.00 88 (365,573 )
Citigroup, Inc. Call 1/10/17 USD 54.80 78 (36,864 )
Apple, Inc. Call 1/11/17 USD 113.00 108 (36,597 )
Activision Blizzard, Inc. Call 1/13/17 USD 38.00 736 (14,352 )
Anadarko Petroleum Corp. Call 1/13/17 USD 69.00 32 (6,336 )
Apple, Inc. Call 1/13/17 USD 113.00 110 (38,500 )
Apple, Inc. Call 1/13/17 USD 114.00 108 (29,538 )
Biogen, Inc. Call 1/13/17 USD 295.00 98 (41,650 )
Cisco Systems, Inc. Call 1/13/17 USD 30.00 104 (4,004 )
Cisco Systems, Inc. Call 1/13/17 USD 30.50 465 (6,743 )
Cognizant Technology Solutions Corp., Class A Call 1/13/17 USD 57.00 147 (11,392 )
Comcast Corp., Class A Call 1/13/17 USD 70.00 432 (29,160 )
Delta Air Lines, Inc. Call 1/13/17 USD 53.50 155 (1,860 )
Dow Chemical Co. Call 1/13/17 USD 59.50 108 (1,728 )
DR Horton, Inc. Call 1/13/17 USD 30.50 305 (1,220 )
Goodyear Tire & Rubber Co. Call 1/13/17 USD 31.50 110 (4,125 )
Goodyear Tire & Rubber Co. Call 1/13/17 USD 33.00 275 (4,125 )
Hess Corp. Call 1/13/17 USD 58.00 78 (35,880 )
Intel Corp. Call 1/13/17 USD 36.00 553 (39,540 )
JPMorgan Chase & Co. Call 1/13/17 USD 85.50 364 (65,156 )
Lowe’s Cos., Inc. Call 1/13/17 USD 72.00 301 (24,230 )
Mallinckrodt PLC Call 1/13/17 USD 58.50 121 (8,470 )
Marathon Oil Corp. Call 1/13/17 USD 18.50 13 (182 )
Merck & Co., Inc. Call 1/13/17 USD 62.00 67 (570 )
Microsoft Corp. Call 1/13/17 USD 61.00 137 (21,783 )
Microsoft Corp. Call 1/13/17 USD 61.50 137 (16,851 )
Schlumberger Ltd. Call 1/13/17 USD 86.50 42 (1,323 )
Suncor Energy, Inc. Call 1/13/17 USD 33.00 174 (7,569 )
U.S. Bancorp Call 1/13/17 USD 51.00 225 (20,025 )
UnitedHealth Group, Inc. Call 1/13/17 USD 162.50 49 (6,982 )

See Notes to Financial Statements.

34 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

Description — Walgreens Boots Alliance, Inc. Put/ Call — Call Expiration Date — 1/13/17 USD 84.50 300 Value — $ (42,150 )
Bank of America Corp. Call 1/17/17 USD 20.08 800 (171,247 )
Activision Blizzard, Inc. Call 1/20/17 USD 40.00 192 (1,728 )
Aetna, Inc. Call 1/20/17 USD 125.00 25 (8,250 )
Aetna, Inc. Call 1/20/17 USD 130.00 180 (29,430 )
Alphabet, Inc., Class A Call 1/20/17 USD 820.00 57 (21,660 )
Altria Group, Inc. Call 1/20/17 USD 67.50 218 (24,852 )
Amdocs Ltd. Call 1/20/17 USD 60.00 257 (8,995 )
Anadarko Petroleum Corp. Call 1/20/17 USD 65.00 27 (14,242 )
Apple, Inc. Call 1/20/17 USD 115.00 123 (29,151 )
Apple, Inc. Call 1/20/17 USD 117.00 110 (14,575 )
AT&T Inc. Call 1/20/17 USD 38.00 94 (42,770 )
Avery Dennison Corp. Call 1/20/17 USD 72.90 185 (6,414 )
BP PLC — ADR Call 1/20/17 USD 35.00 174 (43,761 )
BP PLC — ADR Call 1/20/17 USD 37.00 149 (13,559 )
Carnival Corp. Call 1/20/17 USD 52.50 358 (32,220 )
Chevron Corp. Call 1/20/17 USD 108.75 171 (164,841 )
Cigna Corp. Call 1/20/17 USD 140.00 34 (7,123 )
Cisco Systems, Inc. Call 1/20/17 USD 30.00 103 (4,790 )
Cisco Systems, Inc. Call 1/20/17 USD 31.00 736 (8,096 )
Citigroup, Inc. Call 1/20/17 USD 50.00 25 (23,812 )
Citigroup, Inc. Call 1/20/17 USD 55.00 69 (32,948 )
Cognizant Technology Solutions Corp., Class A Call 1/20/17 USD 57.50 200 (16,500 )
Comcast Corp., Class A Call 1/20/17 USD 67.50 131 (31,768 )
Comcast Corp., Class A Call 1/20/17 USD 72.50 325 (8,288 )
CVS Health Corp. Call 1/20/17 USD 82.50 254 (6,731 )
Dell Technologies, Inc., Class V Call 1/20/17 USD 55.00 180 (24,300 )
Delta Air Lines, Inc. Call 1/20/17 USD 49.00 200 (32,600 )
DR Horton, Inc. Call 1/20/17 USD 30.00 240 (1,080 )
Flex Ltd. Call 1/20/17 USD 15.00 950 (6,650 )
Gilead Sciences, Inc. Call 1/20/17 USD 77.50 200 (6,500 )
Goldman Sachs Group, Inc. Call 1/20/17 USD 210.00 153 (461,678 )
Goodyear Tire & Rubber Co. Call 1/20/17 USD 31.00 145 (10,512 )
Goodyear Tire & Rubber Co. Call 1/20/17 USD 34.00 290 (2,900 )
Hess Corp. Call 1/20/17 USD 60.00 44 (15,070 )
Home Depot, Inc. Call 1/20/17 USD 127.75 205 (150,193 )
Humana, Inc. Call 1/20/17 USD 210.00 199 (113,430 )
Intel Corp. Call 1/20/17 USD 35.00 66 (10,362 )
Intel Corp. Call 1/20/17 USD 37.00 102 (3,516 )
JPMorgan Chase & Co. Call 1/20/17 USD 77.50 199 (176,115 )
L-3 Communications Holdings, Inc. Call 1/20/17 USD 160.00 47 (3,525 )
Laboratory Corp. of America Holdings Call 1/20/17 USD 130.00 92 (12,420 )
Lam Research Corp. Call 1/20/17 USD 105.00 447 (136,335 )
Lam Research Corp. Call 1/20/17 USD 115.00 150 (3,375 )
Lear Corp. Call 1/20/17 USD 135.00 133 (27,265 )
Lennar Corp., Class A Call 1/20/17 USD 45.00 200 (3,900 )
Lowe’s Cos., Inc. Call 1/20/17 USD 75.00 612 (16,830 )
Merck & Co., Inc. Call 1/20/17 USD 62.50 75 (825 )
Microsoft Corp. Call 1/20/17 USD 60.00 333 (84,083 )
Microsoft Corp. Call 1/20/17 USD 62.50 528 (45,408 )
Norfolk Southern Corp. Call 1/20/17 USD 105.00 160 (70,400 )
NVIDIA Corp. Call 1/20/17 USD 90.00 90 (156,825 )
NVIDIA Corp. Call 1/20/17 USD 95.00 93 (121,598 )
Omnicom Group, Inc. Call 1/20/17 USD 87.50 302 (18,120 )
Pfizer, Inc. Call 1/20/17 USD 34.00 367 (3,120 )
Raytheon Co. Call 1/20/17 USD 145.00 139 (16,958 )
Raytheon Co. Call 1/20/17 USD 150.00 16 (416 )
Regions Financial Corp. Call 1/20/17 USD 15.00 233 (3,961 )
Rio Tinto PLC — ADR Call 1/20/17 USD 40.00 125 (7,188 )
Schlumberger Ltd. Call 1/20/17 USD 87.50 42 (2,100 )
Southwest Airlines Co. Call 1/20/17 USD 47.00 200 (64,000 )
Statoil ASA — ADR Call 1/20/17 USD 17.50 313 (34,430 )
Suncor Energy, Inc. Call 1/20/17 USD 32.00 183 (21,136 )
SunTrust Banks, Inc. Call 1/20/17 USD 55.00 263 (34,190 )
Teva Pharmaceutical Industries Ltd. — ADR Call 1/20/17 USD 45.00 100 (200 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 35

Schedule of Investments (continued) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

Description — TOTAL SA — ADR Call Expiration Date — 1/20/17 USD 47.50 85 Value — $ (30,600 )
UnitedHealth Group, Inc. Call 1/20/17 USD 150.00 207 (229,252 )
Valero Energy Corp. Call 1/20/17 USD 65.00 15 (5,962 )
WABCO Holdings, Inc. Call 1/20/17 USD 110.00 64 (6,080 )
Walgreens Boots Alliance, Inc. Call 1/20/17 USD 85.00 223 (31,554 )
Wal-Mart Stores, Inc. Call 1/20/17 USD 72.50 100 (1,400 )
Wyndham Worldwide Corp. Call 1/20/17 USD 75.00 164 (37,720 )
CDW Corp. Call 1/23/17 USD 50.10 350 (82,850 )
Activision Blizzard, Inc. Call 1/27/17 USD 38.00 200 (8,000 )
Aetna, Inc. Call 1/27/17 USD 129.00 25 (6,438 )
Allergan PLC Call 1/27/17 USD 200.00 42 (59,010 )
Alphabet, Inc., Class A Call 1/27/17 USD 830.00 56 (61,040 )
Altria Group, Inc. Call 1/27/17 USD 66.00 367 (93,769 )
Anadarko Petroleum Corp. Call 1/27/17 USD 75.00 26 (1,417 )
Apple, Inc. Call 1/27/17 USD 113.00 246 (114,390 )
BP PLC — ADR Call 1/27/17 USD 36.50 188 (25,756 )
Chevron Corp. Call 1/27/17 USD 118.00 237 (52,851 )
Cisco Systems, Inc. Call 1/27/17 USD 30.50 465 (14,880 )
Citigroup, Inc. Call 1/27/17 USD 60.00 27 (4,185 )
Citigroup, Inc. Call 1/27/17 USD 61.00 35 (3,955 )
Cognizant Technology Solutions Corp., Class A Call 1/27/17 USD 58.00 104 (8,580 )
Cognizant Technology Solutions Corp., Class A Call 1/27/17 USD 58.50 105 (7,088 )
Comcast Corp., Class A Call 1/27/17 USD 71.00 131 (13,231 )
Delta Air Lines, Inc. Call 1/27/17 USD 51.00 180 (18,000 )
Dow Chemical Co. Call 1/27/17 USD 60.00 31 (1,348 )
DR Horton, Inc. Call 1/27/17 USD 30.00 330 (5,940 )
Goodyear Tire & Rubber Co. Call 1/27/17 USD 33.50 275 (4,812 )
Goodyear Tire & Rubber Co. Call 1/27/17 USD 34.00 152 (4,180 )
Hess Corp. Call 1/27/17 USD 65.50 67 (9,112 )
Humana, Inc. Call 1/27/17 USD 217.50 40 (18,000 )
Mallinckrodt PLC Call 1/27/17 USD 57.00 180 (13,950 )
Marathon Oil Corp. Call 1/27/17 USD 20.50 142 (3,550 )
Microsoft Corp. Call 1/27/17 USD 64.00 594 (60,588 )
Norfolk Southern Corp. Call 1/27/17 USD 110.00 55 (13,475 )
Suncor Energy, Inc. Call 1/27/17 USD 33.00 171 (12,226 )
Suncor Energy, Inc. Call 1/27/17 USD 34.00 368 (12,696 )
Teva Pharmaceutical Industries Ltd. — ADR Call 1/27/17 USD 38.50 200 (9,900 )
U.S. Bancorp Call 1/27/17 USD 52.00 134 (10,251 )
Walgreens Boots Alliance, Inc. Call 1/27/17 USD 86.00 330 (42,570 )
Aetna, Inc. Call 1/30/17 USD 124.25 193 (85,537 )
Bank of America Corp. Call 1/30/17 USD 20.08 800 (183,090 )
Goldman Sachs Group, Inc. Call 1/30/17 USD 211.60 60 (177,348 )
Home Depot, Inc. Call 1/30/17 USD 131.60 172 (81,716 )
JPMorgan Chase & Co. Call 1/30/17 USD 79.60 429 (288,980 )
UnitedHealth Group, Inc. Call 1/30/17 USD 157.00 63 (41,382 )
TOTAL SA — ADR Call 1/31/17 USD 47.50 85 (31,627 )
Activision Blizzard, Inc. Call 2/02/17 USD 40.00 280 (8,430 )
Avery Dennison Corp. Call 2/02/17 USD 73.60 61 (2,770 )
Alphabet, Inc., Class A Call 2/03/17 USD 815.00 54 (93,960 )
CVS Health Corp. Call 2/03/17 USD 80.50 218 (23,108 )
CVS Health Corp. Call 2/03/17 USD 81.00 218 (19,402 )
Dow Chemical Co. Call 2/03/17 USD 59.50 301 (20,318 )
JPMorgan Chase & Co. Call 2/03/17 USD 88.00 306 (44,982 )
Mallinckrodt PLC Call 2/03/17 USD 54.00 81 (14,985 )
Marathon Oil Corp. Call 2/03/17 USD 18.35 63 (2,845 )
Aetna, Inc. Call 2/07/17 USD 129.50 42 (12,767 )
Flex Ltd. Call 2/08/17 USD 14.80 419 (9,713 )
Bank of America Corp. Call 2/09/17 USD 20.16 600 (135,482 )
BP PLC — ADR Call 2/10/17 USD 37.50 224 (23,072 )
EMCOR Group, Inc. Call 2/10/17 USD 71.00 78 (19,859 )
UnitedHealth Group, Inc. Call 2/13/17 USD 157.00 63 (47,700 )
Activision Blizzard, Inc. Call 2/17/17 USD 39.00 270 (19,440 )
Altria Group, Inc. Call 2/17/17 USD 67.50 334 (68,136 )
Apple, Inc. Call 2/17/17 USD 120.00 259 (49,987 )
Bank of America Corp. Call 2/17/17 USD 21.00 1,264 (214,248 )

See Notes to Financial Statements.

36 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

Description — BP PLC — ADR Call 2/17/17 USD 37.00 388 Value — $ (51,604 )
Chevron Corp. Call 2/17/17 USD 115.00 243 (117,855 )
Citigroup, Inc. Call 2/17/17 USD 60.00 11 (2,332 )
Comcast Corp., Class A Call 2/17/17 USD 72.50 323 (31,331 )
Dow Chemical Co. Call 2/17/17 USD 60.00 301 (24,231 )
Gilead Sciences, Inc. Call 2/17/17 USD 77.50 206 (26,059 )
Hess Corp. Call 2/17/17 USD 60.00 83 (39,632 )
Home Depot, Inc. Call 2/17/17 USD 131.60 172 (96,495 )
Humana, Inc. Call 2/17/17 USD 205.00 85 (108,375 )
JPMorgan Chase & Co. Call 2/17/17 USD 85.00 330 (112,200 )
Laboratory Corp. of America Holdings Call 2/17/17 USD 130.00 92 (28,980 )
Marathon Oil Corp. Call 2/17/17 USD 19.00 284 (13,348 )
Pfizer, Inc. Call 2/17/17 USD 34.00 120 (3,360 )
Suncor Energy, Inc. Call 2/17/17 USD 33.00 190 (22,040 )
U.S. Bancorp Call 2/17/17 USD 50.00 134 (30,619 )
U.S. Bancorp Call 2/17/17 USD 52.50 1,031 (94,852 )
Wal-Mart Stores, Inc. Call 2/17/17 USD 75.00 125 (2,062 )
Wyndham Worldwide Corp. Call 2/17/17 USD 77.50 87 (21,968 )
Bank of America Corp. Call 2/24/17 USD 20.86 604 (115,496 )
Bank of America Corp. Call 2/28/17 USD 20.40 526 (119,097 )
Altria Group, Inc. Call 3/17/17 USD 67.50 334 (82,498 )
Bank of America Corp. Call 3/17/17 USD 23.00 1,245 (105,203 )
BP PLC — ADR Call 3/17/17 USD 38.00 224 (22,176 )
WABCO Holdings, Inc. Call 3/17/17 USD 110.00 64 (21,440 )
Total $ (8,046,010 )
OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
Marathon Oil Corp. Call Barclays Bank PLC 1/03/17 USD 15.90 14,200 $ (20,357 )
SLM Corp. Call Barclays Bank PLC 1/03/17 USD 7.39 159,200 (577,976 )
Flex Ltd. Call Barclays Bank PLC 1/05/17 USD 14.14 92,400 (27,506 )
Owens Corning Call Goldman Sachs International 1/05/17 USD 53.06 13,600 (2,233 )
Rio Tinto PLC — ADR Call Barclays Bank PLC 1/06/17 USD 34.10 5,200 (23,385 )
Valero Energy Corp. Call Deutsche Bank AG 1/06/17 USD 64.50 8,000 (31,322 )
Owens Corning Call Goldman Sachs International 1/11/17 USD 53.06 13,600 (5,003 )
Robert Half International, Inc. Call Barclays Bank PLC 1/11/17 USD 45.47 14,500 (52,516 )
Centene Corp. Call Barclays Bank PLC 1/12/17 USD 59.86 32,000 (9,006 )
Public Service Enterprise Group, Inc. Call Morgan Stanley & Co. International PLC 1/12/17 USD 43.21 13,500 (23,503 )
Lear Corp. Call UBS AG 1/13/17 USD 126.80 4,600 (29,154 )
Dr. Pepper Snapple Group, Inc. Call Citibank N.A. 1/17/17 USD 83.76 28,000 (197,803 )
L-3 Communications Holdings, Inc. Call Barclays Bank PLC 1/17/17 USD 158.65 6,000 (4,559 )
Packaging Corp. of America Call Goldman Sachs International 1/17/17 USD 86.10 6,200 (7,133 )
SLM Corp. Call Morgan Stanley & Co. International PLC 1/17/17 USD 8.60 92,000 (222,926 )
Rio Tinto PLC — ADR Call Deutsche Bank AG 1/19/17 USD 36.58 7,200 (17,268 )
Valero Energy Corp. Call Deutsche Bank AG 1/19/17 USD 64.50 8,000 (34,743 )
Rio Tinto PLC — ADR Call Deutsche Bank AG 1/25/17 USD 42.60 32,000 (5,540 )
Lear Corp. Call UBS AG 1/26/17 USD 136.28 17,700 (35,056 )
Dr. Pepper Snapple Group, Inc. Call Deutsche Bank AG 1/31/17 USD 91.81 22,500 (28,018 )
Packaging Corp. of America Call Citibank N.A. 1/31/17 USD 86.80 20,000 (28,620 )
Public Service Enterprise Group, Inc. Call Morgan Stanley & Co. International PLC 2/02/17 USD 42.23 31,000 (96,953 )
SunTrust Banks, Inc. Call Bank of America N.A. 2/02/17 USD 52.00 41,500 (162,626 )
Carnival Corp. Call UBS AG 2/03/17 USD 52.20 51,000 (68,681 )
Rio Tinto PLC — ADR Call Goldman Sachs International 2/06/17 USD 39.35 17,800 (22,455 )
Rio Tinto PLC — ADR Call Morgan Stanley & Co. International PLC 2/06/17 USD 40.90 10,000 (6,728 )
Anadarko Petroleum Corp. Call Barclays Bank PLC 2/07/17 USD 70.90 10,500 (27,118 )
Statoil ASA — ADR Call Barclays Bank PLC 2/08/17 USD 18.50 40,000 (25,438 )
Cigna Corp. Call Goldman Sachs International 2/09/17 USD 134.75 5,400 (33,912 )
Robert Half International, Inc. Call Morgan Stanley & Co. International PLC 2/10/17 USD 48.55 12,600 (34,779 )
Amdocs Ltd. Call Morgan Stanley & Co. International PLC 2/13/17 USD 60.25 24,000 (20,748 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 37

Schedule of Investments (continued) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

Description — Carnival Corp. Call Counterparty — Citibank N.A. 2/13/17 USD 52.80 51,000 Value — $ (65,683 )
SLM Corp. Call Barclays Bank PLC 2/13/17 USD 10.85 105,600 (75,336 )
CDW Corp. Call Barclays Bank PLC 2/15/17 USD 53.75 21,100 (39,482 )
SunTrust Banks, Inc. Call Barclays Bank PLC 2/16/17 USD 52.75 41,500 (157,741 )
Packaging Corp. of America Call Citibank N.A. 2/22/17 USD 86.70 13,600 (35,165 )
Total $ (2,256,472 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
Outstanding options at beginning of year 921,779 $ 6,490,809 — —
Options written 8,140,087 58,049,114 — —
Options exercised (17,286 ) (353,479 ) — —
Options expired (2,320,909 ) (13,447,925 ) — —
Options closed (5,593,882 ) (42,526,316 ) — —
Outstanding options at end of year 1,129,789 $ 8,212,203 — —

As of period end, the value of portfolio securities subject to covered call options written was $309,093,073.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Commodity Contracts Credit Contracts Equity Contracts Foreign Currency Exchange Contracts Interest Rate Contracts Total
Liabilities — Derivative Financial Instruments
Futures contracts Net unrealized depreciation 1 — — $ 128,627 — — $ 128,627
Options written Options written, at value — — 10,302,482 — — 10,302,482
Total — — $ 10,431,109 — — $ 10,431,109

1 Includes cumulative appreciation (depreciation) on futures contracts, if any, as reported in the Schedules of Investments. Only current day’s variation margin is reported within the Statements of Assets and Liabilities.

See Notes to Financial Statements.

38 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: Commodity Contracts Credit Contracts Equity Contracts Foreign Currency Exchange Contracts Interest Rate Contracts Total
Futures — — $ 301,677 — — $ 301,677
Options purchased 1 — — (607 ) — — (607 )
Options written — — (8,774,735 ) — — (8,774,735 )
Total — — $ (8,473,665 ) — — $ (8,473,665 )
Net Change in Unrealized Appreciation (Depreciation) on:
Futures — — $ (128,627 ) — — $ (128,627 )
Options written — — (3,640,497 ) — — (3,640,497 )
Total — — $ (3,769,124 ) — — $ (3,769,124 )

1 Options purchased are included in net realized gain (loss) from investments.

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Financial futures contracts:
Average notional value of contracts — long $ 2,935,078
Options:
Average value of option contracts written $ 8,149,367

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments — Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Liabilities
Derivative Financial Instruments:
Futures contracts — $ 45,938
Options — 10,302,482
Total derivative assets and liabilities in the Statements of Assets and Liabilities $ 10,348,420
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — (8,091,948 )
Total derivative assets and liabilities subject to an MNA — $ 2,256,472

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 39

Schedule of Investments (concluded) BlackRock Enhanced Capital and Income Fund, Inc. (CII)

The following table presents the Trust’s derivative liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (“MNA”) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not
Offset in the Consolidated Statements of Assets and Liabilities and Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged 1 | Cash Collateral Pledged | | Net Amount
of Derivative Liabilities 2 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Bank of America N.A. | $ 162,626 | — | — | | — | | $ 162,626 |
| Barclays Bank PLC | 1,040,420 | — | $ (1,040,420 | ) | — | | — |
| Citibank N.A. | 327,271 | — | (232,767 | ) | — | | 94,504 |
| Deutsche Bank AG | 116,891 | — | — | | $ (116,891 | ) | — |
| Goldman Sachs International | 70,736 | — | — | | — | | 70,736 |
| Morgan Stanley & Co. International PLC | 405,637 | — | (313,399 | ) | — | | 92,238 |
| UBS AG | 132,891 | — | (132,891 | ) | — | | — |
| Total | $ 2,256,472 | — | $ (1,719,477 | ) | $ (116,891 | ) | $ 420,104 |

1 Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net Amount may be offset further by net options written receivable/payable on the Statements of Assets and Liabilities.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Level 1 Level 2 Total
Assets:
Investments:
Long-Term Investments:
Common Stocks 1 $ 649,488,655 — — $ 649,488,655
Short-Term Investments:
Money Market Funds 24,715,046 — — 24,715,046
Time Deposits — $ 232,266 — 232,266
Subtotal $ 674,203,701 $ 232,266 — $ 674,435,967
Investments Valued at NAV 2 695,588
Total Investments $ 675,131,555
Derivative Financial Instruments 3
Liabilities:
Equity contracts $ (5,660,160 ) $ (4,770,949 ) — $ (10,431,109 )

1 See above Schedule of Investments for values in each industry.

2 As of December 31, 2016, certain of the Fund’s investments were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

3 Derivative financial instruments are futures contracts and options written. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument and options written are shown at value.

During the year ended December 31, 2016, there were no transfers between levels.

See Notes to Financial Statements.

40 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Value
Aerospace & Defense — 4.4%
Lockheed Martin Corp. (a) 81,330 $ 20,327,620
Northrop Grumman Corp. (a) 113,300 26,351,314
Raytheon Co. (a) 212,400 30,160,800
76,839,734
Air Freight & Logistics — 1.1%
United Parcel Service, Class B (a) 167,000 19,144,880
Banks — 18.8%
Bank of America Corp. (a)(b) 3,745,210 82,769,141
Citigroup, Inc. (a) 902,620 53,642,707
JPMorgan Chase & Co. (a)(b) 840,718 72,545,556
KeyCorp (a) 411,160 7,511,893
SunTrust Banks, Inc. (a) 689,640 37,826,754
U.S. Bancorp (a) 473,943 24,346,452
Wells Fargo & Co. (a)(b) 891,951 49,155,420
327,797,923
Beverages — 1.7%
Coca-Cola Co. (a) 392,800 16,285,488
Diageo PLC — ADR (a) 132,200 13,740,868
30,026,356
Capital Markets — 4.6%
CME Group, Inc. (a) 163,700 18,882,795
Goldman Sachs Group, Inc. (a) 69,300 16,593,885
Invesco Ltd. (a) 354,864 10,766,574
Morgan Stanley (a) 785,400 33,183,150
79,426,404
Chemicals — 2.9%
Dow Chemical Co. (a) 401,200 22,956,664
EI du Pont de Nemours & Co. (a) 303,100 22,247,540
Praxair, Inc. (a) 43,900 5,144,641
50,348,845
Communications Equipment — 0.9%
Motorola Solutions, Inc. (a) 190,800 15,815,412
Consumer Finance — 0.2%
American Express Co. (a) 42,300 3,133,584
Diversified Telecommunication Services — 1.7%
BCE, Inc. (a) 115,700 5,002,868
Verizon Communications, Inc. (a) 467,200 24,939,136
29,942,004
Electric Utilities — 2.3%
Exelon Corp. (a) 350,500 12,439,245
FirstEnergy Corp. (a) 141,500 4,382,255
NextEra Energy, Inc. (a) 201,600 24,083,136
40,904,636
Electrical Equipment — 0.3%
Rockwell Automation, Inc. (a) 37,900 5,093,760
Energy Equipment & Services — 0.5%
Schlumberger Ltd. (a) 98,300 8,252,285
Equity Real Estate Investment Trusts (REITs) — 0.4%
Weyerhaeuser Co. (a) 244,500 7,357,005
Food & Staples Retailing — 1.3%
Kroger Co. (a) 653,700 22,559,187
Food Products — 0.6%
Mondelez International, Inc., Class A (a) 249,485 11,059,670
Health Care Equipment & Supplies — 0.7%
Becton Dickinson and Co. (a) 72,800 12,052,040
Common Stocks Value
Health Care Providers & Services — 6.1%
Aetna, Inc. (a) 244,956 $ 30,376,993
Anthem, Inc. (a) 203,400 29,242,818
Quest Diagnostics, Inc. (a) 245,100 22,524,690
UnitedHealth Group, Inc. (a) 154,800 24,774,192
106,918,693
Household Products — 1.0%
Procter & Gamble Co. (a) 212,120 17,835,050
Industrial Conglomerates — 4.6%
3M Co. (a) 42,900 7,660,653
General Electric Co. (a) 1,444,800 45,655,680
Honeywell International, Inc. (a) 224,600 26,019,910
79,336,243
Insurance — 6.6%
Allstate Corp. (a) 118,900 8,812,868
American International Group, Inc. (a) 403,100 26,326,461
Marsh & McLennan Cos., Inc. (a) 126,200 8,529,858
MetLife, Inc. (a) 410,400 22,116,456
Prudential Financial, Inc. (a) 298,900 31,103,534
Travelers Cos., Inc. (a) 145,000 17,750,900
114,640,077
Media — 2.3%
Comcast Corp., Class A (a) 481,900 33,275,195
Publicis Groupe SA 99,200 6,835,357
40,110,552
Multiline Retail — 1.3%
Dollar General Corp. (a) 308,877 22,878,519
Multi-Utilities — 2.8%
CMS Energy Corp. (a) 261,300 10,875,306
Dominion Resources, Inc. (a) 246,600 18,887,094
DTE Energy Co. (a) 31,800 3,132,618
Public Service Enterprise Group, Inc. (a) 341,700 14,993,796
47,888,814
Oil, Gas & Consumable Fuels — 11.6%
Anadarko Petroleum Corp. (a) 82,400 5,745,752
Chevron Corp. (a) 218,600 25,729,220
Exxon Mobil Corp. (a) 643,000 58,037,180
Hess Corp. (a) 781,110 48,655,342
Marathon Oil Corp. (a) 359,400 6,221,214
Marathon Petroleum Corp. (a) 156,000 7,854,600
Occidental Petroleum Corp. (a) 125,700 8,953,611
Pioneer Natural Resources Co. (a) 25,140 4,526,960
Suncor Energy, Inc. (a) 1,038,840 33,959,680
TOTAL SA — ADR (a) 34,700 1,768,659
201,452,218
Personal Products — 0.8%
Unilever NV (a) 318,400 13,073,504
Pharmaceuticals — 7.4%
AstraZeneca PLC 359,236 19,617,190
Johnson & Johnson (a) 163,200 18,802,272
Merck & Co., Inc. (a) 625,600 36,829,072
Pfizer, Inc. (a) 1,670,690 54,264,011
129,512,545
Professional Services — 0.7%
Experian PLC 286,400 5,545,206
Nielsen Holdings PLC (a) 145,700 6,112,115
11,657,321

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 41

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

Common Stocks Value
Road & Rail — 0.9%
Union Pacific Corp. (a) 147,000 $ 15,240,960
Semiconductors & Semiconductor Equipment — 2.3%
Intel Corp. (a) 504,370 18,293,500
QUALCOMM, Inc. (a) 341,800 22,285,360
40,578,860
Software — 3.9%
Microsoft Corp. (a) 638,600 39,682,604
Oracle Corp. (a) 745,700 28,672,165
68,354,769
Specialty Retail — 2.5%
Gap, Inc. (a) 457,800 10,273,032
Home Depot, Inc. (a) 245,840 32,962,227
43,235,259
Technology Hardware, Storage & Peripherals — 2.0%
Lenovo Group Ltd. 11,934,000 7,193,893
Samsung Electronics Co. Ltd. — GDR 36,600 27,212,420
34,406,313
Tobacco — 1.6%
Altria Group, Inc. (a) 128,990 8,722,304
Philip Morris International, Inc. (a) 104,200 9,533,258
Reynolds American, Inc. (a) 170,538 9,556,949
27,812,511
Common Stocks Value
Water Utilities — 0.2%
American Water Works Co., Inc. (a) 57,800 $ 4,182,408
Wireless Telecommunication Services — 0.5%
SK Telecom Co. Ltd. — ADR (a) 387,800 8,105,020
Total Long-Term Investments (Cost — $1,278,067,603) — 101.5% 1,766,973,361
Short-Term Securities
BlackRock Liquidity Funds, T-Fund, Institutional Class, 0.36% (c)(d) 3,630,472 3,630,472
Total Short-Term Securities (Cost — $3,630,472) — 0.2% 3,630,472
Total Investments Before Options
Written (Cost — $1,281,698,075) — 101.7% 1,770,603,833
Options Written
(Premiums Received — $20,925,252) — (1.7)% (29,467,237 )
Total Investments Net of Options Written — 100.0% 1,741,136,596
Other Assets Less Liabilities — 0.0% 512,239
Net Assets — 100.0% $ 1,741,648,835

Notes to Schedule of Investments

(a) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(b) All or a portion of security has been pledged as collateral in connection with outstanding OTC derivatives.

(c) Current yield as of period end.

(d) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliate — BlackRock Liquidity Funds, TempFund, Institutional Class 13,770,944 (13,770,944 — — Income — $ 21,382 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 3,630,472 3,630,472 $3,630,472 3,808 —
SL Liquidity Series, LLC, Money Market Series — — — — 133 1 $36
Total $3,630,472 $ 25,323 $36

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

• For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Exxon Mobil Corp. Call 1/04/17 USD 89.00 177 $ (27,810 )
3M Co. Call 1/06/17 USD 175.00 90 (36,450 )
Anthem, Inc. Call 1/06/17 USD 147.00 135 (9,112 )
Bank of America Corp. Call 1/06/17 USD 22.00 1,755 (69,322 )
Citigroup, Inc. Call 1/06/17 USD 56.50 560 (170,800 )
Coca-Cola Co. Call 1/06/17 USD 41.00 1,084 (64,498 )
Comcast Corp., Class A Call 1/06/17 USD 70.00 360 (12,420 )
Exxon Mobil Corp. Call 1/06/17 USD 89.00 588 (92,316 )

See Notes to Financial Statements.

42 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

Description — Gap, Inc. Put/ Call — Call Expiration Date — 1/06/17 USD 26.00 546 Value — $ (3,549 )
General Electric Co. Call 1/06/17 USD 32.00 618 (5,562 )
Goldman Sachs Group, Inc. Call 1/06/17 USD 230.00 104 (105,820 )
Intel Corp. Call 1/06/17 USD 35.50 457 (43,415 )
Marathon Oil Corp. Call 1/06/17 USD 18.50 538 (2,152 )
Merck & Co., Inc. Call 1/06/17 USD 62.00 480 (2,880 )
Microsoft Corp. Call 1/06/17 USD 60.50 376 (68,432 )
Occidental Petroleum Corp. Call 1/06/17 USD 70.00 20 (3,040 )
Occidental Petroleum Corp. Call 1/06/17 USD 73.00 26 (390 )
Pfizer, Inc. Call 1/06/17 USD 31.50 481 (51,226 )
Procter & Gamble Co. Call 1/06/17 USD 85.50 248 (3,968 )
QUALCOMM, Inc. Call 1/06/17 USD 69.00 204 (1,224 )
Schlumberger Ltd. Call 1/06/17 USD 86.00 172 (2,236 )
Union Pacific Corp. Call 1/06/17 USD 102.00 247 (55,204 )
Wells Fargo & Co. Call 1/06/17 USD 57.50 560 (3,640 )
Weyerhaeuser Co. Call 1/06/17 USD 32.00 410 (6,150 )
Goldman Sachs Group, Inc. Call 1/09/17 USD 198.00 73 (303,259 )
Wells Fargo & Co. Call 1/09/17 USD 51.00 1,008 (422,526 )
Citigroup, Inc. Call 1/10/17 USD 54.80 301 (142,257 )
MetLife, Inc. Call 1/10/17 USD 53.50 526 (61,339 )
MetLife, Inc. Call 1/10/17 USD 54.51 263 (18,010 )
CME Group, Inc. Call 1/11/17 USD 117.00 175 (15,059 )
Diageo PLC — ADR Call 1/11/17 USD 103.01 560 (106,907 )
American Water Works Co., Inc. Call 1/12/17 USD 72.71 40 (4,230 )
American International Group, Inc. Call 1/13/17 USD 64.50 200 (28,800 )
American International Group, Inc. Call 1/13/17 USD 65.50 404 (32,522 )
Bank of America Corp. Call 1/13/17 USD 22.50 1,755 (68,445 )
Bank of America Corp. Call 1/13/17 USD 23.00 527 (11,594 )
Coca-Cola Co. Call 1/13/17 USD 42.50 474 (3,792 )
Comcast Corp., Class A Call 1/13/17 USD 70.00 577 (38,948 )
Dollar General Corp. Call 1/13/17 USD 75.50 934 (86,395 )
Dow Chemical Co. Call 1/13/17 USD 59.50 504 (8,064 )
EI du Pont de Nemours & Co. Call 1/13/17 USD 74.00 415 (48,140 )
Exxon Mobil Corp. Call 1/13/17 USD 90.00 211 (27,114 )
General Electric Co. Call 1/13/17 USD 32.00 997 (19,442 )
Hess Corp. Call 1/13/17 USD 58.00 1,103 (507,380 )
Intel Corp. Call 1/13/17 USD 36.00 458 (32,747 )
Johnson & Johnson Call 1/13/17 USD 112.00 1,048 (387,760 )
JPMorgan Chase & Co. Call 1/13/17 USD 85.50 1,510 (270,290 )
Marathon Oil Corp. Call 1/13/17 USD 18.50 538 (7,532 )
Marathon Petroleum Corp. Call 1/13/17 USD 49.00 299 (62,790 )
Marsh & McLennan Cos., Inc. Call 1/13/17 USD 66.60 237 (39,865 )
Merck & Co., Inc. Call 1/13/17 USD 62.00 827 (7,030 )
Microsoft Corp. Call 1/13/17 USD 61.00 188 (29,892 )
Microsoft Corp. Call 1/13/17 USD 61.50 190 (23,370 )
Mondelez International, Inc., Class A Call 1/13/17 USD 43.50 126 (19,530 )
Occidental Petroleum Corp. Call 1/13/17 USD 73.50 26 (884 )
Pfizer, Inc. Call 1/13/17 USD 32.50 1,289 (56,716 )
Pioneer Natural Resources Co. Call 1/13/17 USD 195.00 40 (2,100 )
Procter & Gamble Co. Call 1/13/17 USD 83.00 394 (70,132 )
QUALCOMM, Inc. Call 1/13/17 USD 67.50 40 (1,220 )
QUALCOMM, Inc. Call 1/13/17 USD 69.50 512 (4,608 )
Schlumberger Ltd. Call 1/13/17 USD 86.50 173 (5,450 )
Suncor Energy, Inc. Call 1/13/17 USD 33.00 735 (31,973 )
U.S. Bancorp Call 1/13/17 USD 51.00 323 (28,747 )
United Parcel Service, Class B Call 1/13/17 USD 119.00 186 (2,976 )
UnitedHealth Group, Inc. Call 1/13/17 USD 162.50 325 (46,312 )
Verizon Communications, Inc. Call 1/13/17 USD 52.00 201 (30,652 )
Bank of America Corp. Call 1/17/17 USD 20.08 1,318 (282,130 )
SK Telecom Co. Ltd. — ADR Call 1/19/17 USD 21.01 997 (44,886 )
3M Co. Call 1/20/17 USD 175.00 32 (15,840 )
Aetna, Inc. Call 1/20/17 USD 125.00 28 (9,240 )
Aetna, Inc. Call 1/20/17 USD 130.00 312 (51,012 )
Allstate Corp. Call 1/20/17 USD 72.50 393 (83,512 )
Altria Group, Inc. Call 1/20/17 USD 67.50 226 (25,764 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 43

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

Description — American Express Co. Put/ Call — Call Expiration Date — 1/20/17 USD 70.00 129 Value — $ (58,695 )
American International Group, Inc. Call 1/20/17 USD 62.50 186 (58,590 )
Anadarko Petroleum Corp. Call 1/20/17 USD 65.00 207 (109,192 )
Anthem, Inc. Call 1/20/17 USD 130.00 167 (237,140 )
Anthem, Inc. Call 1/20/17 USD 145.00 159 (47,064 )
Bank of America Corp. Call 1/20/17 USD 23.00 527 (16,600 )
Chevron Corp. Call 1/20/17 USD 108.75 487 (469,461 )
Citigroup, Inc. Call 1/20/17 USD 50.00 317 (301,942 )
Citigroup, Inc. Call 1/20/17 USD 55.00 649 (309,898 )
Coca-Cola Co. Call 1/20/17 USD 41.00 995 (83,580 )
Comcast Corp., Class A Call 1/20/17 USD 67.50 539 (130,708 )
Diageo PLC — ADR Call 1/20/17 USD 105.00 300 (35,250 )
Dollar General Corp. Call 1/20/17 USD 77.50 17 (1,148 )
Dominion Resources, Inc. Call 1/20/17 USD 72.50 433 (190,520 )
DTE Energy Co. Call 1/20/17 USD 95.00 160 (70,400 )
EI du Pont de Nemours & Co. Call 1/20/17 USD 70.00 114 (45,030 )
EI du Pont de Nemours & Co. Call 1/20/17 USD 72.50 114 (24,909 )
Exelon Corp. Call 1/20/17 USD 34.00 249 (44,198 )
Exxon Mobil Corp. Call 1/20/17 USD 90.00 762 (117,348 )
FirstEnergy Corp. Call 1/20/17 USD 32.00 266 (6,650 )
FirstEnergy Corp. Call 1/20/17 USD 35.00 181 (1,810 )
FirstEnergy Corp. Call 1/20/17 USD 36.00 88 (880 )
Gap, Inc. Call 1/20/17 USD 27.00 989 (6,923 )
General Electric Co. Call 1/20/17 USD 31.00 1,854 (174,276 )
Goldman Sachs Group, Inc. Call 1/20/17 USD 210.00 94 (283,645 )
Hess Corp. Call 1/20/17 USD 60.00 1,379 (472,308 )
Home Depot, Inc. Call 1/20/17 USD 127.75 450 (329,693 )
Honeywell International, Inc. Call 1/20/17 USD 113.05 733 (292,723 )
Honeywell International, Inc. Call 1/20/17 USD 120.00 726 (27,951 )
Intel Corp. Call 1/20/17 USD 37.00 906 (31,257 )
Invesco Ltd. Call 1/20/17 USD 32.00 1,416 (24,780 )
Johnson & Johnson Call 1/20/17 USD 115.00 311 (51,470 )
JPMorgan Chase & Co. Call 1/20/17 USD 77.50 792 (700,920 )
KeyCorp Call 1/20/17 USD 17.00 349 (49,209 )
Kroger Co. Call 1/20/17 USD 33.75 730 (94,900 )
Kroger Co. Call 1/20/17 USD 35.00 1,420 (85,200 )
Lockheed Martin Corp. Call 1/20/17 USD 257.75 98 (13,680 )
Marathon Oil Corp. Call 1/20/17 USD 16.00 470 (72,850 )
Marathon Petroleum Corp. Call 1/20/17 USD 46.25 200 (89,000 )
Marathon Petroleum Corp. Call 1/20/17 USD 50.00 106 (18,020 )
Marsh & McLennan Cos., Inc. Call 1/20/17 USD 70.00 394 (7,880 )
Merck & Co., Inc. Call 1/20/17 USD 62.50 931 (10,241 )
MetLife, Inc. Call 1/20/17 USD 55.00 631 (48,903 )
Microsoft Corp. Call 1/20/17 USD 60.00 269 (67,922 )
Microsoft Corp. Call 1/20/17 USD 62.50 508 (43,688 )
Mondelez International, Inc., Class A Call 1/20/17 USD 43.00 339 (71,868 )
Mondelez International, Inc., Class A Call 1/20/17 USD 44.00 258 (38,700 )
Morgan Stanley Call 1/20/17 USD 38.00 291 (129,495 )
Morgan Stanley Call 1/20/17 USD 39.35 292 (95,389 )
Motorola Solutions, Inc. Call 1/20/17 USD 82.50 478 (81,499 )
NextEra Energy, Inc. Call 1/20/17 USD 120.00 188 (31,490 )
Northrop Grumman Corp. Call 1/20/17 USD 245.50 310 (14,911 )
Occidental Petroleum Corp. Call 1/20/17 USD 70.00 25 (5,475 )
Oracle Corp. Call 1/20/17 USD 40.00 921 (7,829 )
Pfizer, Inc. Call 1/20/17 USD 34.00 3,195 (27,158 )
Philip Morris International, Inc. Call 1/20/17 USD 95.00 80 (2,160 )
Pioneer Natural Resources Co. Call 1/20/17 USD 180.00 4 (2,000 )
Pioneer Natural Resources Co. Call 1/20/17 USD 195.00 40 (3,700 )
Praxair, Inc. Call 1/20/17 USD 120.00 285 (24,938 )
Procter & Gamble Co. Call 1/20/17 USD 85.00 344 (23,908 )
Prudential Financial, Inc. Call 1/20/17 USD 100.00 747 (380,970 )
Public Service Enterprise Group, Inc. Call 1/20/17 USD 45.00 856 (27,820 )
QUALCOMM, Inc. Call 1/20/17 USD 67.50 260 (12,740 )
QUALCOMM, Inc. Call 1/20/17 USD 70.00 248 (3,224 )
Quest Diagnostics, Inc. Call 1/20/17 USD 85.00 1,225 (851,375 )

See Notes to Financial Statements.

44 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

Description — Raytheon Co. Put/ Call — Call Expiration Date — 1/20/17 USD 145.00 217 Value — $ (26,474 )
Raytheon Co. Call 1/20/17 USD 150.00 445 (11,570 )
Reynolds American, Inc. Call 1/20/17 USD 52.50 936 (379,080 )
Reynolds American, Inc. Call 1/20/17 USD 55.00 175 (31,062 )
Rockwell Automation, Inc. Call 1/20/17 USD 135.00 94 (21,385 )
Rockwell Automation, Inc. Call 1/20/17 USD 140.00 96 (5,280 )
Schlumberger Ltd. Call 1/20/17 USD 82.50 121 (32,610 )
Schlumberger Ltd. Call 1/20/17 USD 87.50 172 (8,600 )
Suncor Energy, Inc. Call 1/20/17 USD 31.00 1,750 (337,750 )
Suncor Energy, Inc. Call 1/20/17 USD 32.00 995 (114,923 )
SunTrust Banks, Inc. Call 1/20/17 USD 55.00 1,028 (133,640 )
TOTAL SA — ADR Call 1/20/17 USD 47.50 87 (31,320 )
Travelers Cos., Inc. Call 1/20/17 USD 115.00 350 (271,250 )
Unilever NV Call 1/20/17 USD 40.20 648 (79,987 )
Union Pacific Corp. Call 1/20/17 USD 105.00 249 (54,904 )
United Parcel Service, Class B Call 1/20/17 USD 115.00 241 (36,632 )
UnitedHealth Group, Inc. Call 1/20/17 USD 150.00 111 (122,932 )
Verizon Communications, Inc. Call 1/20/17 USD 48.00 543 (293,220 )
Verizon Communications, Inc. Call 1/20/17 USD 50.00 176 (60,720 )
Wells Fargo & Co. Call 1/20/17 USD 52.50 559 (173,290 )
Wells Fargo & Co. Call 1/20/17 USD 55.00 561 (77,979 )
Weyerhaeuser Co. Call 1/20/17 USD 30.00 408 (29,580 )
Becton Dickinson and Co. Call 1/23/17 USD 173.50 240 (17,989 )
Nielsen Holdings PLC Call 1/23/17 USD 46.00 242 (10,966 )
BCE, Inc. Call 1/24/17 USD 44.51 254 (5,065 )
3M Co. Call 1/27/17 USD 180.00 92 (27,508 )
Aetna, Inc. Call 1/27/17 USD 129.00 390 (100,425 )
Altria Group, Inc. Call 1/27/17 USD 66.00 29 (7,410 )
American Express Co. Call 1/27/17 USD 76.00 145 (17,690 )
American International Group, Inc. Call 1/27/17 USD 66.50 201 (15,176 )
Anadarko Petroleum Corp. Call 1/27/17 USD 75.00 205 (11,172 )
Chevron Corp. Call 1/27/17 USD 118.00 346 (77,158 )
Citigroup, Inc. Call 1/27/17 USD 60.00 440 (68,200 )
Citigroup, Inc. Call 1/27/17 USD 61.00 862 (97,406 )
CME Group, Inc. Call 1/27/17 USD 120.00 555 (44,400 )
Comcast Corp., Class A Call 1/27/17 USD 71.00 360 (36,360 )
Dollar General Corp. Call 1/27/17 USD 79.00 294 (15,435 )
Dow Chemical Co. Call 1/27/17 USD 60.00 203 (8,830 )
EI du Pont de Nemours & Co. Call 1/27/17 USD 75.00 414 (57,960 )
Exxon Mobil Corp. Call 1/27/17 USD 92.00 353 (30,005 )
Gap, Inc. Call 1/27/17 USD 26.00 154 (2,541 )
General Electric Co. Call 1/27/17 USD 32.00 492 (21,156 )
Hess Corp. Call 1/27/17 USD 65.50 188 (25,568 )
Marathon Petroleum Corp. Call 1/27/17 USD 52.00 237 (26,662 )
Merck & Co., Inc. Call 1/27/17 USD 61.50 890 (31,150 )
Microsoft Corp. Call 1/27/17 USD 64.00 510 (52,020 )
Morgan Stanley Call 1/27/17 USD 43.00 562 (56,762 )
Occidental Petroleum Corp. Call 1/27/17 USD 74.00 333 (20,979 )
Philip Morris International, Inc. Call 1/27/17 USD 92.00 407 (63,085 )
Pioneer Natural Resources Co. Call 1/27/17 USD 195.00 79 (11,455 )
QUALCOMM, Inc. Call 1/27/17 USD 70.00 158 (8,374 )
Suncor Energy, Inc. Call 1/27/17 USD 33.00 744 (53,196 )
Suncor Energy, Inc. Call 1/27/17 USD 34.00 854 (29,463 )
U.S. Bancorp Call 1/27/17 USD 52.00 469 (35,878 )
United Parcel Service, Class B Call 1/27/17 USD 121.00 229 (5,267 )
Wells Fargo & Co. Call 1/27/17 USD 56.00 530 (59,095 )
Weyerhaeuser Co. Call 1/27/17 USD 33.00 526 (13,150 )
Aetna, Inc. Call 1/30/17 USD 124.25 312 (138,277 )
Bank of America Corp. Call 1/30/17 USD 20.08 1,318 (301,640 )
CMS Energy Corp. Call 1/30/17 USD 40.50 67 (11,689 )
Goldman Sachs Group, Inc. Call 1/30/17 USD 211.60 75 (221,685 )
Home Depot, Inc. Call 1/30/17 USD 131.60 574 (272,702 )
JPMorgan Chase & Co. Call 1/30/17 USD 79.60 195 (131,354 )
UnitedHealth Group, Inc. Call 1/30/17 USD 157.00 169 (111,008 )
Motorola Solutions, Inc. Call 1/31/17 USD 83.00 477 (81,523 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 45

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

Description — TOTAL SA — ADR Call 1/31/17 USD 47.50 87 Value — $ (32,371 )
Unilever NV Call 1/31/17 USD 40.25 412 (55,576 )
Dow Chemical Co. Call 2/03/17 USD 59.50 349 (23,558 )
FirstEnergy Corp. Call 2/03/17 USD 32.51 172 (3,482 )
General Electric Co. Call 2/03/17 USD 31.05 1,600 (164,502 )
JPMorgan Chase & Co. Call 2/03/17 USD 88.00 777 (114,219 )
Marathon Oil Corp. Call 2/03/17 USD 18.35 331 (14,947 )
QUALCOMM, Inc. Call 2/03/17 USD 69.00 61 (5,429 )
Allstate Corp. Call 2/06/17 USD 72.50 201 (49,679 )
Exelon Corp. Call 2/06/17 USD 34.50 913 (153,623 )
Prudential Financial, Inc. Call 2/06/17 USD 98.20 748 (541,154 )
CME Group, Inc. Call 2/07/17 USD 118.00 88 (14,727 )
CMS Energy Corp. Call 2/07/17 USD 42.01 67 (5,924 )
Kroger Co. Call 2/07/17 USD 34.25 967 (129,438 )
Wells Fargo & Co. Call 2/08/17 USD 57.00 641 (56,862 )
Bank of America Corp. Call 2/09/17 USD 20.16 1,475 (333,061 )
Public Service Enterprise Group, Inc. Call 2/09/17 USD 43.85 292 (50,686 )
Lockheed Martin Corp. Call 2/10/17 USD 266.00 154 (15,554 )
United Parcel Service, Class B Call 2/10/17 USD 116.00 367 (75,602 )
Verizon Communications, Inc. Call 2/10/17 USD 50.90 708 (176,753 )
UnitedHealth Group, Inc. Call 2/13/17 USD 157.00 169 (127,958 )
Travelers Cos., Inc. Call 2/16/17 USD 122.25 586 (201,893 )
Altria Group, Inc. Call 2/17/17 USD 67.50 127 (25,908 )
American International Group, Inc. Call 2/17/17 USD 65.00 200 (46,900 )
Bank of America Corp. Call 2/17/17 USD 21.00 3,416 (579,012 )
Citigroup, Inc. Call 2/17/17 USD 60.00 522 (110,664 )
Dollar General Corp. Call 2/17/17 USD 82.50 300 (14,250 )
Dominion Resources, Inc. Call 2/17/17 USD 77.50 799 (123,845 )
Dow Chemical Co. Call 2/17/17 USD 60.00 349 (28,094 )
Exxon Mobil Corp. Call 2/17/17 USD 92.50 495 (60,638 )
General Electric Co. Call 2/17/17 USD 32.45 931 (40,227 )
Hess Corp. Call 2/17/17 USD 60.00 1,235 (589,713 )
Home Depot, Inc. Call 2/17/17 USD 131.60 574 (322,023 )
JPMorgan Chase & Co. Call 2/17/17 USD 85.00 129 (43,860 )
Marathon Petroleum Corp. Call 2/17/17 USD 50.00 172 (45,580 )
MetLife, Inc. Call 2/17/17 USD 57.50 632 (48,032 )
Mondelez International, Inc., Class A Call 2/17/17 USD 46.00 128 (19,648 )
Mondelez International, Inc., Class A Call 2/17/17 USD 48.00 392 (37,044 )
Morgan Stanley Call 2/17/17 USD 41.00 583 (144,292 )
Northrop Grumman Corp. Call 2/17/17 USD 251.90 102 (12,219 )
Pfizer, Inc. Call 2/17/17 USD 33.00 1,289 (79,918 )
Procter & Gamble Co. Call 2/17/17 USD 85.00 394 (57,918 )
QUALCOMM, Inc. Call 2/17/17 USD 70.00 205 (17,630 )
Suncor Energy, Inc. Call 2/17/17 USD 33.00 116 (13,456 )
U.S. Bancorp Call 2/17/17 USD 50.00 468 (106,938 )
U.S. Bancorp Call 2/17/17 USD 52.50 550 (50,600 )
Union Pacific Corp. Call 2/17/17 USD 110.00 239 (32,743 )
United Parcel Service, Class B Call 2/17/17 USD 120.00 59 (4,838 )
Verizon Communications, Inc. Call 2/17/17 USD 52.50 708 (114,342 )
Wells Fargo & Co. Call 2/17/17 USD 52.50 600 (213,000 )
Exelon Corp. Call 2/23/17 USD 36.00 590 (47,687 )
American International Group, Inc. Call 2/24/17 USD 66.65 410 (51,804 )
Bank of America Corp. Call 2/24/17 USD 20.86 1,205 (230,418 )
Bank of America Corp. Call 2/28/17 USD 20.40 1,776 (402,122 )
Altria Group, Inc. Call 3/17/17 USD 67.50 127 (31,369 )
Bank of America Corp. Call 3/17/17 USD 23.00 3,654 (308,763 )
Total $ (22,837,415 )

See Notes to Financial Statements.

46 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

OTC Options Written

Description — Marathon Oil Corp. Put/ Call — Call Counterparty — Barclays Bank PLC Expiration Date — 1/03/17 USD 15.90 22,950 Value — $ (32,900 )
Microsoft Corp. Call Barclays Bank PLC 1/03/17 USD 60.27 26,000 (50,101 )
Philip Morris International, Inc. Call Barclays Bank PLC 1/03/17 USD 98.81 19,000 —
Aetna, Inc. Call Bank of America N.A. 1/04/17 USD 111.43 8,500 (107,198 )
Aetna, Inc. Call Morgan Stanley & Co. International PLC 1/04/17 USD 110.28 9,700 (133,333 )
Altria Group, Inc. Call Bank of America N.A. 1/04/17 USD 66.69 11,200 (13,421 )
Anthem, Inc. Call Credit Suisse International 1/04/17 USD 124.35 25,000 (485,982 )
AstraZeneca PLC Call Morgan Stanley & Co. International PLC 1/04/17 GBP 49.26 26,800 (7 )
Chevron Corp. Call Citibank N.A. 1/04/17 USD 106.84 16,000 (173,952 )
Comcast Corp., Class A Call Barclays Bank PLC 1/04/17 USD 64.50 28,600 (133,789 )
Exxon Mobil Corp. Call Barclays Bank PLC 1/04/17 USD 86.26 55,000 (222,472 )
Intel Corp. Call Morgan Stanley & Co. International PLC 1/04/17 USD 35.68 70,000 (52,961 )
JPMorgan Chase & Co. Call Société Générale 1/04/17 USD 70.45 40,000 (633,520 )
Kroger Co. Call UBS AG 1/04/17 USD 32.68 30,500 (56,555 )
Mondelez International, Inc., Class A Call Barclays Bank PLC 1/04/17 USD 45.91 17,500 (2,684 )
Occidental Petroleum Corp. Call Barclays Bank PLC 1/04/17 USD 76.13 19,800 (20 )
Oracle Corp. Call Barclays Bank PLC 1/04/17 USD 39.59 59,800 (499 )
Oracle Corp. Call UBS AG 1/04/17 USD 39.79 29,900 (124 )
Publicis Groupe SA Call UBS AG 1/04/17 EUR 59.95 21,600 (125,325 )
QUALCOMM, Inc. Call UBS AG 1/04/17 USD 68.45 53,300 (770 )
Altria Group, Inc. Call Morgan Stanley & Co. International PLC 1/05/17 USD 65.51 21,600 (47,572 )
CMS Energy Corp. Call Morgan Stanley & Co. International PLC 1/05/17 USD 42.39 24,100 (4,749 )
Exxon Mobil Corp. Call Citibank N.A. 1/05/17 USD 89.45 49,300 (65,008 )
Microsoft Corp. Call UBS AG 1/05/17 USD 61.02 75,400 (101,097 )
Morgan Stanley Call Citibank N.A. 1/05/17 USD 34.57 44,000 (338,105 )
Pfizer, Inc. Call Barclays Bank PLC 1/05/17 USD 33.26 70,100 (3,136 )
SK Telecom Co. Ltd. — ADR Call JPMorgan Chase Bank N.A. 1/05/17 USD 22.87 47,100 (1 )
U.S. Bancorp Call Goldman Sachs International 1/05/17 USD 45.33 55,900 (338,075 )
Chevron Corp. Call JPMorgan Chase Bank N.A. 1/06/17 USD 107.15 10,000 (105,878 )
Comcast Corp., Class A Call Morgan Stanley & Co. International PLC 1/06/17 USD 65.01 28,700 (120,098 )
Exxon Mobil Corp. Call Citibank N.A. 1/06/17 USD 87.61 55,000 (153,756 )
General Electric Co. Call Barclays Bank PLC 1/06/17 USD 29.86 112,800 (199,782 )
General Electric Co. Call Barclays Bank PLC 1/06/17 USD 30.16 56,500 (83,256 )
Kroger Co. Call Bank of America N.A. 1/06/17 USD 33.28 83,000 (112,647 )
Lockheed Martin Corp. Call Goldman Sachs International 1/06/17 USD 245.67 15,400 (82,381 )
Microsoft Corp. Call Barclays Bank PLC 1/06/17 USD 60.48 26,000 (47,195 )
Mondelez International, Inc., Class A Call Citibank N.A. 1/06/17 USD 45.40 20,300 (7,398 )
Oracle Corp. Call UBS AG 1/06/17 USD 39.84 49,400 (490 )
Pfizer, Inc. Call Barclays Bank PLC 1/06/17 USD 33.78 140,400 (1,815 )
Microsoft Corp. Call Barclays Bank PLC 1/10/17 USD 61.49 41,750 (49,890 )
Microsoft Corp. Call UBS AG 1/10/17 USD 62.49 41,750 (24,391 )
Experian PLC Call Credit Suisse International 1/11/17 GBP 14.85 71,000 (76,864 )
BCE, Inc. Call Barclays Bank PLC 1/12/17 USD 43.71 32,400 (8,486 )
Public Service Enterprise Group, Inc. Call Morgan Stanley & Co. International PLC 1/12/17 USD 43.21 12,000 (20,891 )
Publicis Groupe SA Call Morgan Stanley & Co. International PLC 1/18/17 EUR 63.15 14,000 (42,528 )
CMS Energy Corp. Call Barclays Bank PLC 1/19/17 USD 40.35 63,100 (104,751 )
KeyCorp Call Goldman Sachs International 1/25/17 USD 18.73 170,600 (64,082 )
Samsung Electronics Co. Ltd. — GDR Call Bank of America N.A. 1/26/17 USD 771.63 9,000 (149,430 )
AstraZeneca PLC Call Morgan Stanley & Co. International PLC 1/27/17 GBP 44.64 68,000 (95,838 )
Public Service Enterprise Group, Inc. Call Morgan Stanley & Co. International PLC 2/02/17 USD 42.23 44,000 (137,610 )
SunTrust Banks, Inc. Call Bank of America N.A. 2/02/17 USD 52.00 121,000 (474,164 )
Publicis Groupe SA Call UBS AG 2/03/17 EUR 67.36 14,000 (16,414 )
Raytheon Co. Call Goldman Sachs International 2/06/17 USD 151.00 40,000 (35,813 )
Samsung Electronics Co. Ltd. — GDR Call Credit Suisse International 2/07/17 USD 775.03 9,000 (186,676 )
AstraZeneca PLC Call UBS AG 2/10/17 GBP 43.71 80,000 (210,311 )
NextEra Energy, Inc. Call UBS AG 2/13/17 USD 120.55 18,600 (43,636 )
CMS Energy Corp. Call Citibank N.A. 2/16/17 USD 40.88 30,000 (47,536 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 47

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

Description — SunTrust Banks, Inc. Call Counterparty — Barclays Bank PLC 2/16/17 USD 52.75 121,000 Value — $ (459,919 )
NextEra Energy, Inc. Call Barclays Bank PLC 2/23/17 USD 118.51 63,300 (265,687 )
Morgan Stanley Call Citibank N.A. 2/27/17 USD 43.75 60,000 (76,853 )
Total $ (6,629,822 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
Outstanding options at beginning of year 3,071,373 $ 15,748,607 — —
Options written 20,766,909 132,990,406 — —
Options exercised (9,067) (949,160) — —
Options expired (13,166,845) (26,981,541) — —
Options closed (7,833,501) (99,883,060) — —
Outstanding options at end of year 2,828,869 $ 20,925,252 — —

As of period end, the value of portfolio securities subject to covered call options written was $893,182,646.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Total
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $29,467,237 — — $ 29,467,237

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: — Options purchased 1 — — Equity Contracts — $ (12,482 ) Foreign Currency Exchange Contracts — — Interest Rate Contracts — — Total — $ (12,482 )
Options written — — (41,352,597 ) — — (41,352,597 )
Total — — $ (41,365,079 ) — — $ (41,365,079 )
Net Change in Unrealized Appreciation (Depreciation)
on:
Options purchased 2 — — $ 6,998 — — $ 6,998
Options written — — (11,888,994 ) — — (11,888,994 )
Total — — $ (11,881,996 ) — — $ (11,881,996 )

1 Options purchased are included in net realized gain (loss) from investment.

2 Options purchased are included in net change in unrealized appreciation (depreciation) on investments.

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Options:
Average value of option contracts
purchased 1 $ 1,406
Average value of option contracts written $ 21,717,936

1 Actual amounts for the period are shown due to limited outstanding derivative financial instruments as of each quarter.

See Notes to Financial Statements.

48 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Enhanced Equity Dividend Trust (BDJ)

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments — Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Assets
Derivative Financial Instruments:
Options — $ 29,467,237
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — (22,837,415 )
Total derivative assets and liabilities subject to an MNA — $ 6,629,822

The following table presents the Trust’s derivative liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (“MNA”) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not Offset in the Consolidated
Statements of Assets and Liabilities and Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged 1 | Cash Collateral Pledged | | Net Amount of Derivative Liabilities 2 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Bank of America N.A. | $ 856,860 | — | $ (856,860 | ) | — | | — |
| Barclays Bank PLC | 1,666,382 | — | (1,666,382 | ) | — | | — |
| Citibank N.A. | 862,608 | — | (769,608 | ) | $ (93,000 | ) | — |
| Credit Suisse International | 749,522 | — | (749,522 | ) | — | | — |
| Goldman Sachs International | 520,351 | — | (520,351 | ) | — | | — |
| JPMorgan Chase Bank N.A. | 105,879 | — | — | | — | | $ 105,879 |
| Morgan Stanley & Co. International PLC | 655,587 | — | (655,587 | ) | — | | — |
| Société Générale | 633,520 | — | (633,520 | ) | — | | — |
| UBS AG | 579,113 | — | (579,113 | ) | — | | — |
| Total | $ 6,629,822 | — | $ (6,430,943 | ) | $ (93,000 | ) | $ 105,879 |

1 Excess of collateral pledged from the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Assets:
Investments:
Long-Term Investments:
Common Stocks:
Aerospace & Defense $ 76,839,734 — — $ 76,839,734
Air Freight & Logistics 19,144,880 — — 19,144,880
Banks 327,797,923 — — 327,797,923
Beverages 30,026,356 — — 30,026,356
Capital Markets 79,426,404 — — 79,426,404
Chemicals 50,348,845 — — 50,348,845
Communications Equipment 15,815,412 — — 15,815,412
Consumer Finance 3,133,584 — — 3,133,584
Diversified Telecommunication Services 29,942,004 — — 29,942,004
Electric Utilities 40,904,636 — — 40,904,636
Electrical Equipment 5,093,760 — — 5,093,760
Energy Equipment & Services 8,252,285 — — 8,252,285
Equity Real Estate Investment Trusts (REITs) 7,357,005 — — 7,357,005
Food & Staples Retailing 22,559,187 — — 22,559,187
Food Products 11,059,670 — — 11,059,670

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 49

Schedule of Investments (concluded) BlackRock Enhanced Equity Dividend Trust (BDJ)

Assets: (concluded)
Investments: (concluded)
Long-Term Investments: (concluded)
Common Stocks: (concluded)
Health Care Equipment & Supplies $ 12,052,040 — — $ 12,052,040
Health Care Providers & Services 106,918,693 — — 106,918,693
Household Products 17,835,050 — — 17,835,050
Industrial Conglomerates 79,336,243 — — 79,336,243
Insurance 114,640,077 — — 114,640,077
Media 33,275,195 $ 6,835,357 — 40,110,552
Multiline Retail 22,878,519 — — 22,878,519
Multi-Utilities 47,888,814 — — 47,888,814
Oil, Gas & Consumable Fuels 201,452,218 — — 201,452,218
Personal Products 13,073,504 — — 13,073,504
Pharmaceuticals 109,895,355 19,617,190 — 129,512,545
Professional Services 6,112,115 5,545,206 — 11,657,321
Road & Rail 15,240,960 — — 15,240,960
Semiconductors & Semiconductor Equipment 40,578,860 — — 40,578,860
Software 68,354,769 — — 68,354,769
Specialty Retail 43,235,259 — — 43,235,259
Technology Hardware, Storage & Peripherals — 34,406,313 — 34,406,313
Tobacco 27,812,511 — — 27,812,511
Water Utilities 4,182,408 — — 4,182,408
Wireless Telecommunication Services 8,105,020 — — 8,105,020
Short-Term Securities 3,630,472 — — 3,630,472
Total Investments $ 1,704,199,767 $ 66,404,066 — $ 1,770,603,833
Derivative Financial Instruments 1
Liabilities:
Equity contracts $ (15,534,705 ) $ (13,932,532 ) — $ (29,467,237 )
1 Derivative
financial instruments are options written, which are shown at value.
Transfers between Level 1 and Level 2 were as follow:
Transfers into Level 1 Transfers out of Level 1 1 Transfers into Level 2 1 Transfers out of Level 2
Assets:
Long-Term Investments:
Common Stocks — $ (9,448,258 ) $ 9,448,258 —
1 External
pricing service used to reflect any significant market movements between the time the Trust valued such foreign securities and the earlier closing of foreign markets.

See Notes to Financial Statements.

50 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Value
Australia — 0.0%
Ensogo Ltd. (a) 418,198 —
Belgium — 1.8%
Anheuser-Busch InBev SA 157,682 $ 16,689,749
Canada — 1.0%
Encana Corp. (b) 366,400 4,300,796
Potash Corp. of Saskatchewan, Inc. (b) 301,540 5,454,859
9,755,655
China — 2.6%
Alibaba Group Holding Ltd. — ADR (a)(b) 179,580 15,768,920
Baidu, Inc. — ADR (a)(b) 52,600 8,647,966
24,416,886
France — 2.5%
AXA SA 328,300 8,276,077
Iliad SA 37,000 7,105,775
Renault SA 90,600 8,046,830
23,428,682
Germany — 1.8%
Innogy SE (a)(c) 119,563 4,154,587
KION Group AG 85,500 4,747,104
thyssenkrupp AG 318,900 7,575,580
16,477,271
Hong Kong — 0.7%
AIA Group Ltd. 1,148,900 6,435,955
India — 1.8%
Bharti Infratel Ltd. 1,229,359 6,212,734
Federal Bank Ltd. 3,654,600 3,587,925
HDFC Bank Ltd. 344,382 6,699,865
16,500,524
Indonesia — 0.9%
Matahari Department Store Tbk PT 7,198,723 8,057,845
Ireland — 0.7%
Green REIT PLC 4,273,092 6,171,374
Italy — 2.5%
Atlantia SpA 215,300 5,037,251
Azimut Holding SpA 397,100 6,605,137
Eni SpA 405,100 6,567,128
Snam SpA 1,243,900 5,115,992
23,325,508
Japan — 5.7%
Alps Electric Co. Ltd. 219,900 5,283,750
FANUC Corp. 39,500 6,608,133
Mitsubishi Estate Co. Ltd. 484,000 9,614,501
Nintendo Co. Ltd. 30,500 6,340,200
SoftBank Group Corp. 193,100 12,778,211
Sumitomo Mitsui Financial Group, Inc. 321,900 12,258,909
52,883,704
Mexico — 0.6%
Fomento Economico Mexicano SAB de CV — ADR (b) 70,600 5,380,426
Netherlands — 1.0%
Koninklijke Philips NV 318,940 9,750,641
New Zealand — 0.5%
Xero Ltd. (a) 350,000 4,249,204
Norway — 1.0%
Statoil ASA 532,360 9,716,466
Peru — 0.5%
Credicorp Ltd. (b) 31,100 4,909,446
Common Stocks Value
Philippines — 0.5%
CEMEX Holdings Philippines, Inc. (a)(c) 19,451,800 $ 4,343,273
Portugal — 1.1%
Galp Energia SGPS SA 672,400 10,024,333
South Africa — 1.0%
Naspers Ltd., N Shares 66,150 9,657,349
South Korea — 1.3%
Amorepacific Corp. 17,500 4,651,238
LG Chem Ltd. 36,100 7,784,854
12,436,092
Spain — 1.2%
Cellnex Telecom SA (c) 780,578 11,204,559
Switzerland — 1.6%
Nestle SA 135,934 9,737,984
UBS Group AG 323,489 5,057,900
14,795,884
Taiwan — 0.8%
Taiwan Semiconductor Manufacturing Co. Ltd. 1,416,000 7,931,378
Thailand — 0.6%
True Corp PCL 27,688,600 5,512,348
United Kingdom — 6.3%
AstraZeneca PLC 88,500 4,832,816
CNH Industrial NV 759,300 6,588,470
Fiat Chrysler Automobiles NV (a) 810,100 7,388,112
GlaxoSmithKline PLC 228,500 4,389,170
Imperial Brands PLC 165,220 7,200,420
Lloyds Banking Group PLC 8,866,900 6,808,735
Metro Bank PLC (a) 143,208 5,148,367
Nomad Foods Ltd. (a) 520,829 4,984,334
Unilever PLC 285,620 11,550,503
58,890,927
United States — 56.6%
Acuity Brands, Inc. (b) 23,350 5,390,581
Adobe Systems, Inc. (a)(b)(d) 91,820 9,452,869
Allergan PLC (a)(b) 20,200 4,242,202
Alphabet, Inc., Class A (a)(b) 13,714 10,867,659
Alphabet, Inc., Class C (a)(b) 23,652 18,255,087
Amazon.com, Inc. (a)(b) 14,060 10,543,172
American International Group, Inc. (b) 108,600 7,092,666
Amgen, Inc. (b) 30,600 4,474,026
Apple, Inc. (b)(d) 155,600 18,021,592
Aramark (d) 245,920 8,784,262
Assured Guaranty Ltd. (b) 167,992 6,345,058
Athene Holding Ltd., Class A (a) 128,206 6,152,606
BankUnited, Inc. (b)(d) 253,563 9,556,789
Biogen, Inc. (a)(b) 14,100 3,998,478
Boston Scientific Corp. (a)(b)(d) 290,887 6,291,886
Celgene Corp. (a)(b)(d) 81,430 9,425,524
Centene Corp. (a)(b) 78,500 4,436,035
Cigna Corp. (b) 34,000 4,535,260
Citigroup, Inc. (b)(d) 266,108 15,814,798
Comcast Corp., Class A (b)(d) 136,100 9,397,705
Concho Resources, Inc. (a)(b) 53,930 7,151,118
Crown Holdings, Inc. (a)(b) 100,370 5,276,451
Delphi Automotive PLC (b) 91,710 6,176,670
Duke Energy Corp. (b) 86,800 6,737,416
Eastman Chemical Co. (b) 80,790 6,076,216
Eli Lilly & Co. (b) 90,200 6,634,210
EOG Resources, Inc. (b) 102,770 10,390,047
Facebook, Inc., Class A (a)(b) 81,000 9,319,050

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 51

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

Common Stocks Value
United States (continued)
Hartford Financial Services Group, Inc. (d) 147,300 $ 7,018,845
Intercontinental Exchange, Inc. (b) 124,400 7,018,648
Johnson Controls International PLC (b) 179,801 7,406,003
Kellogg Co. (b) 116,800 8,609,328
Kennedy-Wilson Holdings, Inc. 274,748 5,632,334
Lam Research Corp. (b) 90,800 9,600,284
Lowe’s Cos., Inc. (b) 81,030 5,762,854
Macquarie Infrastructure Corp. (b) 79,140 6,465,738
Mastercard, Inc., Class A (b) 115,260 11,900,595
McDonald’s Corp. (b)(d) 73,400 8,934,248
Medtronic PLC (b) 139,483 9,935,374
Merck & Co., Inc. (b) 108,810 6,405,645
Micron Technology, Inc. (a)(b) 203,100 4,451,952
Mondelez International, Inc., Class A (b) 135,930 6,025,777
Monsanto Co. 60,100 6,323,121
Mosaic Co. (b) 354,460 10,396,312
Newell Brands, Inc. (b) 101,000 4,509,650
Nucor Corp. (b) 103,600 6,166,272
PayPal Holdings, Inc. (a)(b) 229,300 9,050,471
Pfizer, Inc. (b) 284,430 9,238,286
Pioneer Natural Resources Co. (b) 40,100 7,220,807
Platform Specialty Products Corp. (a) 417,473 4,095,410
PPL Corp. (b) 192,700 6,561,435
Public Service Enterprise Group, Inc. (b) 153,630 6,741,284
RSP Permian, Inc. (a)(b) 109,900 4,903,738
salesforce.com, Inc. (a)(b) 112,500 7,701,750
Samsonite International SA 1,632,800 4,647,894
ServiceMaster Global Holdings, Inc. (a)(b) 159,705 6,016,087
Sherwin-Williams Co. (b) 21,800 5,858,532
Skyworks Solutions, Inc. (b) 62,500 4,666,250
Starbucks Corp. (b) 247,046 13,715,994
Strategic Growth Bancorp. (Acquired 3/10/14, Cost $5,461,692) (a)(e) 438,690 4,421,995
SVB Financial Group (a)(b) 40,800 7,003,728
Union Pacific Corp. (b) 91,274 9,463,288
UnitedHealth Group, Inc. (b) 33,277 5,325,651
Vulcan Materials Co. (b) 20,400 2,553,060
Walt Disney Co. (b) 102,900 10,724,238
Weatherford International PLC (a) 920,100 4,591,299
Wells Fargo & Co. (b)(d) 278,090 15,325,540
WestRock Co. 132,700 6,737,179
Common Stocks Value
United States (continued)
Whirlpool Corp. (b) 33,500 $ 6,089,295
526,055,624
Total Common Stocks — 96.6% 899,001,103
Preferred Stocks
India — 0.9%
Jasper Infotech Private Ltd., Series F (Acquired 5/7/14, Cost $1,888,464), 0.00% (a)(e) 266 6,484,031
Jasper Infotech Private Ltd., Series G (Acquired 10/29/14, Cost $741,913), 0.00% (a)(e) 88 2,145,093
8,629,124
United States — 1.8%
Palantir Technologies, Inc., Series I (Acquired 2/7/14, Cost $3,118,944), 0.00% (a)(e) 508,800 4,116,192
Uber Technologies, Inc., Series D (Acquired 6/6/14, Cost $3,845,800), 0.00% (a)(e) 247,908 12,249,134
16,365,326
Total Preferred Stocks — 2.7% 24,994,450
Total Long Term
Investments (Cost — $820,915,590) — 99.3% 923,995,553
Short-Term Securities
BlackRock Liquidity Funds, T-Fund, Institutional
Class, 0.36% (f)(g) 11,863,116 11,863,116
Total Short-Term Securities (Cost — $11,863,116) — 1.3% 11,863,116
Total Investments Before Options
Written (Cost — $832,778,706) — 100.6% 935,858,669
Options Written
(Premiums Received — $11,608,196) — (1.2)% (11,210,596 )
Total Investments Net of Options Written — 99.4% 924,648,073
Other Assets Less Liabilities — 0.6% 5,249,091
Net Assets — 100.0% $ 929,897,164

Notes to Schedule of Investments

(a) Non-income producing security.

(b) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(c) Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(d) All or a portion of security has been pledged as collateral in connection with outstanding OTC derivatives.

(e) Restricted securities as to resale, excluding 144A securities. As of period end, the Trust held restricted securities with a current value of $29,416,445 and an original cost of $15,056,813 which was 3.2% of its net assets.

(f) Current yield as of period end.

See Notes to Financial Statements.

52 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

(g) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliate — BlackRock Liquidity Funds, TempFund, Institutional Class 6,389,331 (6,389,331 ) — — $ 69,071 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 11,863,116 11,863,116 $11,863,116 13,069 $143
SL Liquidity Series, LLC, Money Market Series 427,550 (427,550 ) — — 19,796 1 —
Total $11,863,116 $101,936 $143

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Alibaba Group Holding Ltd. — ADR Call 1/06/17 USD 94.50 93 $ (418 )
Alphabet, Inc., Class C Call 1/06/17 USD 790.00 29 (4,132 )
Amazon.com, Inc. Call 1/06/17 USD 765.00 2 (635 )
Amgen, Inc. Call 1/06/17 USD 147.00 27 (3,092 )
Apple, Inc. Call 1/06/17 USD 115.00 144 (22,248 )
Baidu, Inc. — ADR Call 1/06/17 USD 180.00 93 (465 )
Biogen, Inc. Call 1/06/17 USD 310.00 19 (475 )
Celgene Corp. Call 1/06/17 USD 123.00 1 (10 )
Citigroup, Inc. Call 1/06/17 USD 56.50 308 (93,940 )
Comcast Corp., Class A Call 1/06/17 USD 70.00 35 (1,208 )
Facebook, Inc., Class A Call 1/06/17 USD 121.00 76 (570 )
Lowe’s Cos., Inc. Call 1/06/17 USD 76.00 75 (225 )
Mastercard, Inc., Class A Call 1/06/17 USD 105.00 301 (10,084 )
Medtronic PLC Call 1/06/17 USD 76.00 160 (480 )
Merck & Co., Inc. Call 1/06/17 USD 62.00 112 (672 )
PayPal Holdings, Inc. Call 1/06/17 USD 40.00 73 (1,387 )
Pioneer Natural Resources Co. Call 1/06/17 USD 195.00 50 (1,250 )
salesforce.com, Inc. Call 1/06/17 USD 74.00 117 (878 )
Union Pacific Corp. Call 1/06/17 USD 102.00 237 (52,970 )
Wells Fargo & Co. Call 1/06/17 USD 57.50 256 (1,664 )
Amgen, Inc. Call 1/09/17 USD 151.75 27 (2,389 )
Wells Fargo & Co. Call 1/09/17 USD 51.00 496 (207,910 )
Citigroup, Inc. Call 1/10/17 USD 54.80 195 (92,160 )
ServiceMaster Global Holdings, Inc. Call 1/10/17 USD 37.51 402 (36,501 )
Alibaba Group Holding Ltd. — ADR Call 1/11/17 USD 97.50 81 (211 )
Apple, Inc. Call 1/11/17 USD 113.00 67 (22,704 )
Celgene Corp. Call 1/12/17 USD 120.70 240 (18,325 )
Alibaba Group Holding Ltd. — ADR Call 1/13/17 USD 94.50 141 (2,961 )
Alphabet, Inc., Class C Call 1/13/17 USD 785.00 39 (22,230 )
American International Group, Inc. Call 1/13/17 USD 64.50 242 (34,848 )
Apple, Inc. Call 1/13/17 USD 113.00 66 (23,100 )
Apple, Inc. Call 1/13/17 USD 114.00 67 (18,324 )
Biogen, Inc. Call 1/13/17 USD 295.00 19 (8,075 )
Celgene Corp. Call 1/13/17 USD 118.00 116 (19,546 )
Comcast Corp., Class A Call 1/13/17 USD 70.00 198 (13,365 )
EOG Resources, Inc. Call 1/13/17 USD 105.00 28 (1,792 )
Facebook, Inc., Class A Call 1/13/17 USD 122.00 74 (1,480 )
Lowe’s Cos., Inc. Call 1/13/17 USD 72.00 145 (11,672 )
Mastercard, Inc., Class A Call 1/13/17 USD 106.00 140 (7,210 )
Merck & Co., Inc. Call 1/13/17 USD 62.00 113 (960 )
Mondelez International, Inc., Class A Call 1/13/17 USD 43.50 89 (13,795 )
Mosaic Co. Call 1/13/17 USD 30.00 229 (12,595 )
PayPal Holdings, Inc. Call 1/13/17 USD 40.00 73 (2,774 )
PayPal Holdings, Inc. Call 1/13/17 USD 40.50 105 (2,258 )
PayPal Holdings, Inc. Call 1/13/17 USD 41.00 74 (962 )
Pioneer Natural Resources Co. Call 1/13/17 USD 195.00 55 (2,888 )
Potash Corp. of Saskatchewan, Inc. Call 1/13/17 USD 19.50 375 (4,125 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 53

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

Description — salesforce.com, Inc. Call Expiration Date — 1/13/17 Strike Price — USD 72.00 86 Value — $ (2,666 )
salesforce.com, Inc. Call 1/13/17 USD 74.00 117 (2,106 )
Starbucks Corp. Call 1/13/17 USD 59.50 114 (228 )
UnitedHealth Group, Inc. Call 1/13/17 USD 162.50 32 (4,560 )
BankUnited, Inc. Call 1/18/17 USD 34.55 500 (157,000 )
Acuity Brands, Inc. Call 1/20/17 USD 260.00 64 (6,560 )
Adobe Systems, Inc. Call 1/20/17 USD 105.00 252 (27,090 )
Alibaba Group Holding Ltd. — ADR Call 1/20/17 USD 97.50 111 (1,554 )
Alphabet, Inc., Class A Call 1/20/17 USD 820.00 41 (15,580 )
Alphabet, Inc., Class C Call 1/20/17 USD 810.00 18 (3,420 )
Amgen, Inc. Call 1/20/17 USD 155.00 122 (5,490 )
Apple, Inc. Call 1/20/17 USD 115.00 95 (22,515 )
Apple, Inc. Call 1/20/17 USD 117.00 80 (10,600 )
Assured Guaranty Ltd. Call 1/20/17 USD 30.00 230 (189,750 )
Baidu, Inc. — ADR Call 1/20/17 USD 175.00 91 (7,689 )
Biogen, Inc. Call 1/20/17 USD 320.00 39 (5,362 )
Boston Scientific Corp. Call 1/20/17 USD 21.00 235 (22,325 )
Boston Scientific Corp. Call 1/20/17 USD 23.00 880 (11,000 )
Celgene Corp. Call 1/20/17 USD 125.00 90 (4,590 )
Centene Corp. Call 1/20/17 USD 60.00 176 (8,800 )
Cigna Corp. Call 1/20/17 USD 140.00 47 (9,846 )
Citigroup, Inc. Call 1/20/17 USD 50.00 659 (627,697 )
Citigroup, Inc. Call 1/20/17 USD 55.00 112 (53,480 )
Comcast Corp., Class A Call 1/20/17 USD 67.50 77 (18,672 )
Comcast Corp., Class A Call 1/20/17 USD 72.50 186 (4,743 )
Concho Resources, Inc. Call 1/20/17 USD 135.00 267 (80,767 )
Concho Resources, Inc. Call 1/20/17 USD 145.00 30 (1,650 )
Credicorp Ltd. Call 1/20/17 USD 160.00 171 (38,047 )
Crown Holdings, Inc. Call 1/20/17 USD 55.00 322 (7,245 )
Delphi Automotive PLC Call 1/20/17 USD 70.00 250 (22,500 )
Duke Energy Corp. Call 1/20/17 USD 77.50 119 (14,875 )
Eastman Chemical Co. Call 1/20/17 USD 75.00 222 (39,405 )
Encana Corp. Call 1/20/17 CAD 17.00 2,015 (18,759 )
EOG Resources, Inc. Call 1/20/17 USD 105.00 62 (6,014 )
EOG Resources, Inc. Call 1/20/17 USD 95.00 73 (49,275 )
Facebook, Inc., Class A Call 1/20/17 USD 120.00 85 (6,120 )
Fomento Economico Mexicano SAB de CV — ADR Call 1/20/17 USD 80.00 108 (8,370 )
Fomento Economico Mexicano SAB de CV — ADR Call 1/20/17 USD 85.00 108 (5,400 )
Intercontinental Exchange, Inc. Call 1/20/17 USD 60.00 365 (2,738 )
Johnson Controls International PLC Call 1/20/17 USD 44.00 490 (8,085 )
Kellogg Co. Call 1/20/17 USD 75.00 320 (28,000 )
Lam Research Corp. Call 1/20/17 USD 105.00 189 (57,645 )
Lam Research Corp. Call 1/20/17 USD 115.00 310 (6,975 )
Lowe’s Cos., Inc. Call 1/20/17 USD 75.00 225 (6,188 )
Macquarie Infrastructure Corp. Call 1/20/17 USD 85.00 215 (7,525 )
Mastercard, Inc., Class A Call 1/20/17 USD 105.00 53 (5,724 )
McDonald’s Corp. Call 1/20/17 USD 121.25 176 (38,889 )
Medtronic PLC Call 1/20/17 USD 75.00 155 (2,558 )
Merck & Co., Inc. Call 1/20/17 USD 62.50 156 (1,716 )
Mondelez International, Inc., Class A Call 1/20/17 USD 43.00 237 (50,244 )
Mondelez International, Inc., Class A Call 1/20/17 USD 44.00 185 (27,750 )
Mosaic Co. Call 1/20/17 USD 27.50 500 (111,250 )
Mosaic Co. Call 1/20/17 USD 32.50 220 (3,850 )
Nucor Corp. Call 1/20/17 USD 67.50 240 (1,560 )
PayPal Holdings, Inc. Call 1/20/17 USD 40.00 630 (36,540 )
PayPal Holdings, Inc. Call 1/20/17 USD 41.00 74 (1,998 )
Pfizer, Inc. Call 1/20/17 USD 34.00 266 (2,261 )
Pioneer Natural Resources Co. Call 1/20/17 USD 180.00 39 (19,500 )
Pioneer Natural Resources Co. Call 1/20/17 USD 195.00 55 (5,088 )
Potash Corp. of Saskatchewan, Inc. Call 1/20/17 USD 20.00 375 (3,375 )
PPL Corp. Call 1/20/17 USD 35.00 180 (3,600 )
Public Service Enterprise Group, Inc. Call 1/20/17 USD 45.00 424 (13,780 )
RSP Permian, Inc. Call 1/20/17 USD 45.00 550 (75,625 )
salesforce.com, Inc. Call 1/20/17 USD 75.00 118 (2,183 )
ServiceMaster Global Holdings, Inc. Call 1/20/17 USD 40.00 200 (4,500 )

See Notes to Financial Statements.

54 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

Description — Sherwin-Williams Co. Call Expiration Date — 1/20/17 Strike Price — USD 270.00 120 Value — $ (55,200 )
Starbucks Corp. Call 1/20/17 USD 57.50 600 (13,200 )
SVB Financial Group Call 1/20/17 USD 170.00 40 (27,400 )
Union Pacific Corp. Call 1/20/17 USD 105.00 236 (52,038 )
Vulcan Materials Co. Call 1/20/17 USD 135.00 42 (1,680 )
Walt Disney Co. Call 1/20/17 USD 100.00 244 (115,290 )
Wells Fargo & Co. Call 1/20/17 USD 52.50 255 (79,050 )
Wells Fargo & Co. Call 1/20/17 USD 55.00 256 (35,584 )
Whirlpool Corp. Call 1/20/17 USD 170.00 61 (75,792 )
Alibaba Group Holding Ltd. — ADR Call 1/27/17 USD 94.50 171 (17,955 )
Alphabet, Inc., Class A Call 1/27/17 USD 830.00 17 (18,530 )
Alphabet, Inc., Class C Call 1/27/17 USD 810.00 20 (19,700 )
Amazon.com, Inc. Call 1/27/17 USD 782.50 2 (2,285 )
American International Group, Inc. Call 1/27/17 USD 67.00 113 (6,950 )
Apple, Inc. Call 1/27/17 USD 113.00 225 (104,625 )
Comcast Corp., Class A Call 1/27/17 USD 71.00 35 (3,535 )
Eli Lilly & Co. Call 1/27/17 USD 74.00 250 (36,750 )
EOG Resources, Inc. Call 1/27/17 USD 110.00 102 (4,284 )
Mastercard, Inc., Class A Call 1/27/17 USD 106.00 140 (15,330 )
Merck & Co., Inc. Call 1/27/17 USD 61.50 217 (7,595 )
Micron Technology, Inc. Call 1/27/17 USD 22.50 350 (24,150 )
Mosaic Co. Call 1/27/17 USD 32.50 780 (19,110 )
Nucor Corp. Call 1/27/17 USD 63.50 330 (21,615 )
PayPal Holdings, Inc. Call 1/27/17 USD 41.50 232 (12,644 )
Pfizer, Inc. Call 1/27/17 USD 32.00 424 (40,492 )
Pioneer Natural Resources Co. Call 1/27/17 USD 195.00 21 (3,045 )
salesforce.com, Inc. Call 1/27/17 USD 73.00 180 (10,350 )
Skyworks Solutions, Inc. Call 1/27/17 USD 80.50 170 (23,375 )
Starbucks Corp. Call 1/27/17 USD 60.00 163 (3,994 )
Wells Fargo & Co. Call 1/27/17 USD 56.00 21 (2,342 )
Whirlpool Corp. Call 1/27/17 USD 175.00 123 (125,460 )
EOG Resources, Inc. Call 1/30/17 USD 96.00 102 (65,446 )
UnitedHealth Group, Inc. Call 1/30/17 USD 157.00 76 (49,921 )
Vulcan Materials Co. Call 1/31/17 USD 132.00 90 (11,318 )
Duke Energy Corp. Call 2/02/17 USD 79.00 357 (33,036 )
Starbucks Corp. Call 2/02/17 USD 57.75 373 (23,060 )
Alibaba Group Holding Ltd. — ADR Call 2/03/17 USD 92.00 284 (56,516 )
Alphabet, Inc., Class A Call 2/03/17 USD 815.00 17 (29,580 )
McDonald’s Corp. Call 2/03/17 USD 121.60 199 (56,734 )
Pfizer, Inc. Call 2/03/17 USD 33.00 150 (7,725 )
Wells Fargo & Co. Call 2/08/17 USD 57.00 118 (10,468 )
EOG Resources, Inc. Call 2/09/17 USD 105.00 163 (29,952 )
Micron Technology, Inc. Call 2/10/17 USD 20.20 510 (116,735 )
UnitedHealth Group, Inc. Call 2/13/17 USD 157.00 76 (57,543 )
Acuity Brands, Inc. Call 2/17/17 USD 260.00 64 (13,600 )
Alibaba Group Holding Ltd. — ADR Call 2/17/17 USD 105.00 106 (3,074 )
Alphabet, Inc., Class C Call 2/17/17 USD 795.00 24 (45,480 )
Amazon.com, Inc. Call 2/17/17 USD 785.00 37 (77,145 )
American International Group, Inc. Call 2/17/17 USD 65.00 242 (56,749 )
Apple, Inc. Call 2/17/17 USD 120.00 111 (21,423 )
Baidu, Inc. — ADR Call 2/17/17 USD 175.00 105 (32,235 )
Citigroup, Inc. Call 2/17/17 USD 60.00 236 (50,032 )
Comcast Corp., Class A Call 2/17/17 USD 72.50 217 (21,049 )
Eli Lilly & Co. Call 2/17/17 USD 75.00 250 (42,250 )
EOG Resources, Inc. Call 2/17/17 USD 105.00 35 (8,715 )
Facebook, Inc., Class A Call 2/17/17 USD 120.00 85 (25,712 )
McDonald’s Corp. Call 2/17/17 USD 121.60 199 (67,099 )
Medtronic PLC Call 2/17/17 USD 75.00 187 (11,127 )
Micron Technology, Inc. Call 2/17/17 USD 24.00 257 (13,493 )
Mondelez International, Inc., Class A Call 2/17/17 USD 46.00 88 (13,508 )
Mondelez International, Inc., Class A Call 2/17/17 USD 48.00 149 (14,080 )
Mosaic Co. Call 2/17/17 USD 30.00 220 (30,140 )
Pfizer, Inc. Call 2/17/17 USD 34.00 724 (20,272 )
Skyworks Solutions, Inc. Call 2/17/17 USD 80.00 170 (34,850 )
Starbucks Corp. Call 2/17/17 USD 60.00 113 (4,350 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 55

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

Description — Union Pacific Corp. Call 2/17/17 USD 110.00 29 Value — $ (3,973 )
Vulcan Materials Co. Call 2/17/17 USD 130.00 70 (24,850 )
Walt Disney Co. Call 2/17/17 USD 105.00 110 (30,030 )
Wells Fargo & Co. Call 2/17/17 USD 52.50 128 (45,440 )
Amazon.com, Inc. Call 3/17/17 USD 785.00 36 (93,780 )
Walt Disney Co. Call 3/17/17 USD 105.25 211 (68,479 )
Newell Brands, Inc. Put 1/20/17 USD 45.00 505 (60,600 )
Total $ (5,293,779 )
OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
AstraZeneca PLC Call Morgan Stanley & Co. International PLC 1/04/17 GBP 49.26 23,500 $ (6 )
AXA SA Call Credit Suisse International 1/04/17 EUR 22.64 60,000 (83,794 )
Cellnex Telecom SA Call Bank of America N.A. 1/04/17 EUR 15.64 40,000 —
Kennedy-Wilson Holdings, Inc. Call Barclays Bank PLC 1/04/17 USD 20.98 32,000 (2,509 )
Samsonite International SA Call BNP Paribas S.A. 1/04/17 HKD 26.17 240,000 —
Statoil ASA Call Credit Suisse International 1/04/17 NOK 141.58 65,000 (121,504 )
GlaxoSmithKline PLC Call Credit Suisse International 1/05/17 GBP 16.06 35,000 (413 )
Intercontinental Exchange, Inc. Call Citibank N.A. 1/05/17 USD 54.77 32,000 (55,408 )
Koninklijke Philips NV Call UBS AG 1/05/17 EUR 27.72 43,000 (62,299 )
Snam SpA Call Credit Suisse International 1/05/17 EUR 3.79 342,000 (44,680 )
Aramark Call Goldman Sachs International 1/06/17 USD 34.95 44,000 (41,974 )
Assured Guaranty Ltd. Call Barclays Bank PLC 1/06/17 USD 34.83 35,000 (103,731 )
Eni SpA Call Credit Suisse International 1/10/17 EUR 13.21 18,000 (41,952 )
Naspers Ltd., N Shares Call Morgan Stanley & Co. International PLC 1/10/17 ZAR 2,192.90 18,100 (4,612 )
Cellnex Telecom SA Call Credit Suisse International 1/11/17 EUR 14.75 54,000 (605 )
Eni SpA Call Bank of America N.A. 1/11/17 EUR 13.85 44,000 (71,858 )
Kennedy-Wilson Holdings, Inc. Call Barclays Bank PLC 1/11/17 USD 22.78 32,100 (132 )
Koninklijke Philips NV Call Bank of America N.A. 1/11/17 EUR 27.78 160,000 (238,636 )
Metro Bank PLC Call Morgan Stanley & Co. International PLC 1/11/17 GBP 31.41 10,000 (481 )
PPL Corp. Call Barclays Bank PLC 1/11/17 USD 33.15 66,000 (71,103 )
Renault SA Call Morgan Stanley & Co. International PLC 1/11/17 EUR 83.55 20,000 (51,640 )
WestRock Co. Call Barclays Bank PLC 1/12/17 USD 51.48 41,000 (31,102 )
Xero Ltd. Call Deutsche Bank AG 1/12/17 NZD 19.65 6,000 (9 )
Delphi Automotive PLC Call Barclays Bank PLC 1/13/17 USD 68.60 25,500 (26,962 )
Aramark Call Bank of America N.A. 1/17/17 USD 36.75 43,200 (15,928 )
Johnson Controls International PLC Call Barclays Bank PLC 1/17/17 USD 42.84 49,000 (14,531 )
Metro Bank PLC Call Morgan Stanley & Co. International PLC 1/17/17 GBP 31.41 10,000 (980 )
AIA Group Ltd. Call Citibank N.A. 1/18/17 HKD 48.10 247,000 (646 )
AXA SA Call Credit Suisse International 1/18/17 EUR 22.76 60,000 (89,603 )
Azimut Holding SpA Call Bank of America N.A. 1/18/17 EUR 14.27 55,000 (93,015 )
Cellnex Telecom SA Call Morgan Stanley & Co. International PLC 1/18/17 EUR 15.59 68,400 (197 )
CNH Industrial NV Call Bank of America N.A. 1/18/17 EUR 8.47 100,000 (11,581 )
Eni SpA Call Bank of America N.A. 1/18/17 EUR 14.31 121,000 (144,359 )
Nintendo Co. Ltd. Call Bank of America N.A. 1/18/17 JPY 28,507.25 4,800 (1,399 )
Renault SA Call Morgan Stanley & Co. International PLC 1/18/17 EUR 83.96 20,000 (56,983 )
Samsonite International SA Call JPMorgan Chase Bank N.A. 1/18/17 HKD 24.45 301,800 (348 )
SoftBank Group Corp. Call Goldman Sachs International 1/18/17 JPY 6,904.88 44,000 (322,558 )
Statoil ASA Call Credit Suisse International 1/18/17 NOK 151.65 100,000 (97,155 )
Taiwan Semiconductor Manufacturing Co. Ltd. Call JPMorgan Chase Bank N.A. 1/18/17 TWD 190.64 386,000 (2,949 )
thyssenkrupp AG Call Morgan Stanley & Co. International PLC 1/18/17 EUR 21.97 85,000 (82,204 )
UBS Group AG Call Bank of America N.A. 1/18/17 CHF 16.95 89,000 (9,155 )
Xero Ltd. Call Morgan Stanley & Co. International PLC 1/18/17 NZD 17.78 12,000 (2,531 )
Galp Energia SGPS SA Call Morgan Stanley & Co. International PLC 1/19/17 EUR 13.12 85,000 (96,917 )
Iliad SA Call Morgan Stanley & Co. International PLC 1/19/17 EUR 184.58 10,000 (42,870 )
Newell Brands, Inc. Call Morgan Stanley & Co. International PLC 1/20/17 USD 49.00 55,500 (13,875 )
Sumitomo Mitsui Financial Group, Inc. Call JPMorgan Chase Bank N.A. 1/23/17 JPY 4,749.12 111,000 (42,712 )
SVB Financial Group Call Barclays Bank PLC 1/24/17 USD 157.00 18,000 (297,268 )
Xero Ltd. Call Morgan Stanley & Co. International PLC 1/24/17 NZD 17.86 12,000 (2,771 )
Cellnex Telecom SA Call Credit Suisse International 1/25/17 EUR 13.17 80,000 (51,901 )

See Notes to Financial Statements.

56 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

Description — Galp Energia SGPS SA Call Counterparty — Morgan Stanley & Co. International PLC Expiration Date — 1/25/17 Strike Price — EUR 14.24 99,000 Value — $ (38,086 )
Metro Bank PLC Call Morgan Stanley & Co. International PLC 1/25/17 GBP 31.41 10,000 (1,881 )
Metro Bank PLC Call UBS AG 1/25/17 GBP 32.90 7,000 (306 )
Unilever PLC Call Credit Suisse International 1/25/17 GBP 31.56 74,000 (141,480 )
Anheuser-Busch InBev SA Call Morgan Stanley & Co. International PLC 1/26/17 EUR 99.21 11,000 (33,447 )
Anheuser-Busch InBev SA Call UBS AG 1/26/17 EUR 100.44 35,000 (79,064 )
Aramark Call Goldman Sachs International 1/26/17 USD 35.53 48,000 (49,779 )
Atlantia SpA Call Morgan Stanley & Co. International PLC 1/26/17 EUR 22.00 42,000 (26,356 )
AXA SA Call Credit Suisse International 1/26/17 EUR 24.37 60,000 (32,011 )
Eni SpA Call Credit Suisse International 1/26/17 EUR 15.19 61,800 (31,567 )
KION Group AG Call Morgan Stanley & Co. International PLC 1/26/17 EUR 53.81 21,000 (25,724 )
Naspers Ltd., N Shares Call UBS AG 1/26/17 ZAR 2,090.40 15,000 (44,735 )
Nestle SA Call UBS AG 1/26/17 CHF 72.90 74,000 (87,034 )
Nintendo Co. Ltd. Call Bank of America N.A. 1/26/17 JPY 25,756.50 12,000 (49,007 )
AstraZeneca PLC Call Morgan Stanley & Co. International PLC 1/27/17 GBP 44.64 20,000 (28,188 )
Mitsubishi Estate Co. Ltd. Call Bank of America N.A. 1/27/17 JPY 2,394.75 133,000 (39,880 )
Alps Electric Co. Ltd. Call Bank of America N.A. 1/31/17 JPY 2,958.16 63,000 (33,756 )
Eastman Chemical Co. Call UBS AG 1/31/17 USD 77.82 22,500 (21,725 )
Hartford Financial Services Group, Inc. Call Morgan Stanley & Co. International PLC 1/31/17 USD 47.90 54,500 (47,698 )
Kellogg Co. Call Royal Bank of Canada 1/31/17 USD 74.64 32,000 (43,564 )
KION Group AG Call Morgan Stanley & Co. International PLC 1/31/17 EUR 54.08 21,000 (25,834 )
Macquarie Infrastructure Corp. Call Deutsche Bank AG 1/31/17 USD 82.67 22,000 (31,576 )
Atlantia SpA Call Credit Suisse International 2/01/17 EUR 22.72 42,000 (15,008 )
FANUC Corp. Call JPMorgan Chase Bank N.A. 2/01/17 JPY 20,955.90 10,900 (28,631 )
LG Chem Ltd. Call UBS AG 2/01/17 KRW 271,179.17 9,000 (41,018 )
Samsonite International SA Call JPMorgan Chase Bank N.A. 2/01/17 HKD 22.05 228,000 (17,832 )
Xero Ltd. Call Deutsche Bank AG 2/01/17 NZD 18.04 5,000 (1,170 )
Adobe Systems, Inc. Call Barclays Bank PLC 2/02/17 USD 104.13 25,300 (48,798 )
Assured Guaranty Ltd. Call Barclays Bank PLC 2/02/17 USD 39.22 34,300 (16,432 )
Cellnex Telecom SA Call Credit Suisse International 2/02/17 EUR 13.72 40,000 (14,497 )
Metro Bank PLC Call UBS AG 2/02/17 GBP 33.58 16,000 (692 )
Potash Corp. of Saskatchewan, Inc. Call Citibank N.A. 2/02/17 USD 19.19 45,000 (12,332 )
Public Service Enterprise Group, Inc. Call Morgan Stanley & Co. International PLC 2/02/17 USD 42.23 42,000 (131,355 )
Fiat Chrysler Automobiles NV Call Deutsche Bank AG 2/03/17 USD 9.04 152,000 (75,603 )
SoftBank Group Corp. Call JPMorgan Chase Bank N.A. 2/03/17 JPY 7,927.44 32,700 (56,548 )
Statoil ASA Call Goldman Sachs International 2/03/17 NOK 164.01 142,000 (43,471 )
Taiwan Semiconductor Manufacturing Co. Ltd. Call Bank of America N.A. 2/03/17 TWD 189.21 393,000 (11,829 )
BankUnited, Inc. Call Deutsche Bank AG 2/06/17 USD 35.58 47,000 (122,845 )
Boston Scientific Corp. Call UBS AG 2/06/17 USD 21.31 17,300 (16,678 )
ServiceMaster Global Holdings, Inc. Call Morgan Stanley & Co. International PLC 2/06/17 USD 38.72 28,000 (28,747 )
AIA Group Ltd. Call Bank of America N.A. 2/07/17 HKD 45.04 247,000 (19,643 )
Imperial Brands PLC Call Credit Suisse International 2/07/17 GBP 36.14 61,600 (57,517 )
Lloyds Banking Group PLC Call Credit Suisse International 2/07/17 GBP 0.66 1,943,000 (18,696 )
Metro Bank PLC Call UBS AG 2/07/17 GBP 33.58 16,000 (1,024 )
Snam SpA Call Bank of America N.A. 2/07/17 EUR 3.85 342,000 (48,666 )
SoftBank Group Corp. Call JPMorgan Chase Bank N.A. 2/07/17 JPY 8,230.56 29,600 (29,792 )
WestRock Co. Call Bank of America N.A. 2/07/17 USD 52.80 32,000 (37,036 )
Cellnex Telecom SA Call Credit Suisse International 2/08/17 EUR 13.73 59,700 (22,937 )
CNH Industrial NV Call Credit Suisse International 2/08/17 EUR 8.35 318,000 (86,842 )
Iliad SA Call Morgan Stanley & Co. International PLC 2/08/17 EUR 184.58 10,000 (63,646 )
Samsonite International SA Call Citibank N.A. 2/08/17 HKD 22.76 129,000 (6,165 )
Unilever PLC Call Bank of America N.A. 2/08/17 GBP 32.28 38,000 (46,783 )
Cigna Corp. Call Goldman Sachs International 2/09/17 USD 134.75 14,000 (87,920 )
GlaxoSmithKline PLC Call Morgan Stanley & Co. International PLC 2/09/17 GBP 15.46 90,600 (51,637 )
Sumitomo Mitsui Financial Group, Inc. Call JPMorgan Chase Bank N.A. 2/09/17 JPY 4,820.40 66,000 (35,685 )
UBS Group AG Call Credit Suisse International 2/09/17 CHF 17.13 89,000 (18,393 )
Xero Ltd. Call Deutsche Bank AG 2/09/17 NZD 18.03 12,000 (3,358 )
AstraZeneca PLC Call UBS AG 2/10/17 GBP 43.71 5,000 (13,144 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 57

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

Description — Hartford Financial Services Group, Inc. Call Counterparty — Morgan Stanley & Co. International PLC 2/10/17 USD 47.90 54,500 Value — $ (69,603 )
Anheuser-Busch InBev SA Call Morgan Stanley & Co. International PLC 2/14/17 EUR 99.37 40,700 (151,894 )
Atlantia SpA Call UBS AG 2/14/17 EUR 22.30 41,000 (25,556 )
Kennedy-Wilson Holdings, Inc. Call Barclays Bank PLC 2/14/17 USD 21.94 55,000 (15,340 )
thyssenkrupp AG Call UBS AG 2/14/17 EUR 24.10 90,000 (38,462 )
Alps Electric Co. Ltd. Call JPMorgan Chase Bank N.A. 2/15/17 JPY 3,070.90 62,500 (30,942 )
Azimut Holding SpA Call Goldman Sachs International 2/15/17 EUR 16.80 163,000 (71,554 )
Crown Holdings, Inc. Call Morgan Stanley & Co. International PLC 2/15/17 USD 54.25 23,000 (22,548 )
Galp Energia SGPS SA Call Morgan Stanley & Co. International PLC 2/15/17 EUR 14.39 185,800 (86,987 )
Metro Bank PLC Call Morgan Stanley & Co. International PLC 2/15/17 GBP 31.49 9,800 (3,768 )
AIA Group Ltd. Call UBS AG 2/17/17 HKD 44.96 138,000 (13,704 )
BankUnited, Inc. Call Deutsche Bank AG 2/21/17 USD 37.85 42,000 (67,215 )
Boston Scientific Corp. Call UBS AG 2/21/17 USD 21.31 17,300 (20,184 )
Cellnex Telecom SA Call UBS AG 2/22/17 EUR 13.85 27,500 (11,230 )
FANUC Corp. Call JPMorgan Chase Bank N.A. 2/22/17 JPY 20,955.90 10,900 (27,547 )
Lloyds Banking Group PLC Call Credit Suisse International 2/22/17 GBP 0.66 1,943,000 (26,327 )
Mitsubishi Estate Co. Ltd. Call JPMorgan Chase Bank N.A. 2/22/17 JPY 2,441.88 133,000 (58,456 )
Potash Corp. of Saskatchewan, Inc. Call Citibank N.A. 2/22/17 USD 19.19 45,000 (19,753 )
Fiat Chrysler Automobiles NV Call Deutsche Bank AG 2/23/17 USD 9.04 152,000 (93,067 )
Unilever PLC Call Goldman Sachs International 2/23/17 GBP 33.39 45,100 (32,530 )
Imperial Brands PLC Call UBS AG 2/24/17 GBP 36.07 37,300 (44,495 )
Kennedy-Wilson Holdings, Inc. Call Barclays Bank PLC 2/27/17 USD 21.55 32,000 (14,863 )
Fiat Chrysler Automobiles NV Call Bank of America N.A. 3/02/17 USD 9.53 141,000 (60,146 )
LG Chem Ltd. Call JPMorgan Chase Bank N.A. 3/03/17 KRW 264,685.44 10,800 (105,276 )
Boston Scientific Corp. Call Barclays Bank PLC 3/06/17 USD 22.33 13,900 (10,456 )
Total $ (5,916,817 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
Outstanding options at beginning of year 26,290,347 $ 11,916,657 — —
Options written 129,461,729 90,508,068 505 $32,198
Options exercised (97,473 ) (277,677 ) — —
Options expired (61,305,903 ) (32,735,201 ) — —
Options closed (81,396,905 ) (57,835,849 ) — —
Outstanding options at end of year 12,951,795 $ 11,575,998 505 $32,198

As of period end, the value of portfolio securities subject to covered call options written was $442,611,294.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Commodity Contracts
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $11,210,596 — — $11,210,596

See Notes to Financial Statements.

58 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: — Forward foreign currency exchange contracts Commodity Contracts — — — Equity Contracts — — $63,790 — Total — $ 63,790
Options purchased 1 — — $ (36,189 ) — — (36,189 )
Options written — — (3,476,161 ) — — (3,476,161 )
Total — — $ (3,512,350 ) $63,790 — $ (3,448,560 )
Net Change in Unrealized Appreciation (Depreciation)
on:
Options purchased 2 — — $ 29,255 — — $ 29,255
Options written — — (3,395,482 ) — — (3,395,482 )
Total — — $ (3,366,227 ) — — $ (3,366,227 )

1 Options purchased are included in net realized gain (loss) from investments.

2 Options purchased are included in net change in unrealized appreciation (depreciation) on investments.

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Forward foreign currency exchange contracts:
Average amounts purchased — in USD $ 1,614,520
Average amounts sold — in USD $ 1,598,572
Options:
Average value of option contracts written $ 12,418,684

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments — Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Assets Liabilities
Derivative Financial Instruments:
Options — $ 11,210,596
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — (5,293,779 )
Total derivative assets and liabilities subject to an MNA — $ 5,916,817

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 59

Schedule of Investments (continued) BlackRock Global Opportunities Equity Trust (BOE)

The following table presents the Trust’s derivative assets and liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (“MNA”) and net of the related collateral pledged by the Trust:

Counterparty — Bank of America N.A. $ 932,677 — $ (932,677 ) — —
Barclays Bank PLC 653,227 — (653,227 ) — —
Citibank N.A. 94,304 — (94,304 ) — —
Credit Suisse International 996,882 — (996,882 ) — —
Deutsche Bank AG 394,843 — (394,843 ) — —
Goldman Sachs International 649,786 — (649,786 ) — —
JPMorgan Chase Bank N.A. 436,718 — — $ (436,718 ) —
Morgan Stanley & Co. International PLC 1,193,466 — (1,193,466 ) — —
Royal Bank of Canada 43,564 — — — $ 43,564
UBS AG 521,350 — (521,350 ) — —
Total $ 5,916,817 — $ (5,436,535 ) $ (436,718 ) $ 43,564

1 Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Level 1 Level 2 Level 3 Total
Assets:
Investments:
Long-Term Investments:
Common Stocks:
Australia — — — —
Belgium $ 16,689,749 — — $ 16,689,749
Canada 9,755,655 — — 9,755,655
China 24,416,886 — — 24,416,886
France — $ 23,428,682 — 23,428,682
Germany 4,154,587 12,322,684 — 16,477,271
Hong Kong — 6,435,955 — 6,435,955
India — 16,500,524 — 16,500,524
Indonesia — 8,057,845 — 8,057,845
Ireland 6,171,374 — — 6,171,374
Italy — 23,325,508 — 23,325,508
Japan — 52,883,704 — 52,883,704
Mexico 5,380,426 — — 5,380,426
Netherlands — 9,750,641 — 9,750,641
New Zealand — 4,249,204 — 4,249,204
Norway — 9,716,466 — 9,716,466
Peru 4,909,446 — — 4,909,446
Philippines 4,343,273 — — 4,343,273
Portugal — 10,024,333 — 10,024,333
South Africa — 9,657,349 — 9,657,349
South Korea — 12,436,092 — 12,436,092
Spain — 11,204,559 — 11,204,559
Switzerland — 14,795,884 — 14,795,884
Taiwan — 7,931,378 — 7,931,378
Thailand 5,512,348 — — 5,512,348
United Kingdom 12,372,446 46,518,481 — 58,890,927
United States 516,985,735 4,647,894 $ 4,421,995 526,055,624
Preferred Stocks — — 24,994,450 24,994,450
Short-Term Securities 11,863,116 — — 11,863,116
Total Investments $ 622,555,041 $ 283,887,183 $ 29,416,445 $ 935,858,669

See Notes to Financial Statements.

60 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (concluded) BlackRock Global Opportunities Equity Trust (BOE)

Derivative Financial Instruments 1
Liabilities:
Equity contracts $ (4,127,899 ) $ (7,082,697 ) — $ (11,210,596 )
1 Derivative financial
instruments are options written, which are shown at value.
Transfers between Level 1 and Level 2 were as follow:
Transfers into Level 1 1 Transfers out of Level 1 2 Transfers into Level 2 2 Transfers out of Level 2 1
Assets:
Investments:
Long-Term Investments:
Common Stocks $ 8,123,988 $ (26,614,038) $ 26,614,038 $ (8,123,988)

1 Systematic Fair Value Prices were not utilized at period end for these investments.

2 External pricing service used to reflect any significant market movements between the time the Trust valued such foreign securities and the earlier closing of foreign markets.

A reconciliation of Level 3 investments is presented when the Trust had a significant amount of Level 3 investments at the beginning and/or end of the year in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:

Common Stocks Preferred Stocks Total
Assets:
Opening Balance, as of December 31, 2015 $ 9,185,948 $ 26,668,421 $ 35,854,369
Transfers into Level 3 639,954 — 639,954
Transfers out of Level 3 (5,237,738 ) — (5,237,738 )
Accrued discounts/premiums — — —
Net realized gain (loss) — — —
Net change in unrealized
appreciation/depreciation 1,2 (166,169 ) (1,673,971 ) (1,840,140 )
Purchases — — —
Sales — — —
Closing Balance, as of December 31, 2016 $ 4,421,995 $ 24,994,450 $ 29,416,445
Net change in unrealized appreciation/depreciation on investments still held at December 31, 2016 2 $ (166,169 ) $ (1,673,971 ) $ (1,840,140 )

1 Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations.

2 Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2016 is generally due to investments no longer held or categorized as Level 3 at period end.

The following table summarizes the valuation approaches used and unobservable inputs utilized by the BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) to determine the value of certain of the Trust’s Level 3 investments as of period end.

Value Unobservable Inputs
Assets:
Common Stocks $ 4,421,995 Market Tangible Book Value Multiple 1 1.80x —
Preferred Stocks 24,994,450 Market Discount Rate 2 25.00% —
Revenue Growth Rate 1 27.00% - 72.00% 41.53%
Revenue Growth Rate 1 187.00% —
Revenue Multiple 1 11.00x - 12.00x 11.75x
Revenue Multiple 1 34.00x - 46.00x —
Exit Scenario Probability 1 20.00% - 50.00% —
Time to Exit 2 1-3 years —
Total $ 29,416,445

1 Increase in unobservable input may result in a significant increase to value, while a decrease in the unobservable input may result in a significant decrease to value.

2 Decrease in unobservable input may result in a significant increase to value, while an increase in the unobservable input may result in a significant decrease to value.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 61

Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Value
Biotechnology — 23.0%
AbbVie, Inc. (a) 38,186 $ 2,391,207
Acceleron Pharma, Inc. (a)(b) 40,400 1,031,008
Acerta Pharma BV, Series B (Acquired 2/01/16, cost $986,402) (b)(c) 17,146,440 1,452,303
Agios Pharmaceuticals, Inc. (a)(b) 9,200 383,916
Alder Biopharmaceuticals, Inc. (b) 5,829 121,243
Alkermes PLC (a)(b) 18,600 1,033,788
Amgen, Inc. (a) 69,322 10,135,570
Aquinox Pharmaceuticals, Inc. (b) 20,831 343,920
Audentes Therapeutics, Inc. (b) 8,883 162,292
Avexis, Inc. (b) 21,752 1,038,223
Biogen, Inc. (a)(b) 22,348 6,337,446
BioMarin Pharmaceutical, Inc. (a)(b) 9,900 820,116
Celgene Corp. (a)(b) 95,586 11,064,080
Genomic Health, Inc. (a)(b) 15,100 443,789
Gilead Sciences, Inc. (a) 62,500 4,475,625
Global Blood Therapeutics, Inc. (b) 16,688 241,142
Halozyme Therapeutics, Inc. (a)(b) 41,200 407,056
Incyte Corp. (a)(b) 15,300 1,534,131
Inotek Pharmaceuticals Corp. (b) 13,396 81,716
Lion Biotechnologies, Inc. (b) 56,423 392,140
Myovant Sciences Ltd. (b) 27,953 347,735
Neurocrine Biosciences, Inc. (a)(b) 28,462 1,101,479
Otonomy, Inc. (b) 8,400 133,560
Prothena Corp. PLC (b) 2,144 105,463
PTC Therapeutics, Inc. (b) 17,900 195,289
Ra Pharmaceuticals, Inc. (b) 4,900 74,431
Regeneron Pharmaceuticals, Inc. (a)(b) 8,658 3,178,265
REGENXBIO, Inc. (b) 36,250 672,438
Sage Therapeutics, Inc. (a)(b) 14,652 748,131
Sarepta Therapeutics, Inc. (a)(b) 36,350 997,082
Seattle Genetics, Inc. (a)(b) 20,867 1,101,152
Spark Therapeutics, Inc. (a)(b) 4,600 229,540
Syndax Pharmaceuticals, Inc. (b) 49,384 354,083
TESARO, Inc. (a)(b) 22,231 2,989,625
Vertex Pharmaceuticals, Inc. (a)(b) 82,605 6,085,510
62,204,494
Diversified Consumer Services — 0.4%
Service Corp. International 40,500 1,150,200
Health Care Equipment & Supplies — 20.6%
Abbott Laboratories (a) 112,800 4,332,647
Baxter International, Inc. (a) 140,900 6,247,506
Becton Dickinson and Co. (a) 21,133 3,498,568
Boston Scientific Corp. (a)(b) 334,200 7,228,746
CR Bard, Inc. (a) 25,453 5,718,271
Edwards Lifesciences Corp. (b) 11,600 1,086,920
Hologic, Inc. (a)(b) 76,600 3,073,192
Intuitive Surgical, Inc. (a)(b) 5,600 3,551,352
iRhythm Technologies, Inc. (b) 4,583 137,490
Masimo Corp. (a)(b) 21,700 1,462,580
Medtronic PLC (a) 162,200 11,553,506
Stryker Corp. (a) 64,900 7,775,669
55,666,447
Health Care Providers & Services — 29.2%
Aetna, Inc. (a) 44,311 5,495,007
Amedisys, Inc. (a)(b) 56,960 2,428,205
AmerisourceBergen Corp. (a) 18,100 1,415,239
Anthem, Inc. (a) 50,300 7,231,631
Cardinal Health, Inc. (a) 33,030 2,377,169
Centene Corp. (a)(b) 35,700 2,017,407
Cigna Corp. (a) 42,100 5,615,719
DaVita, Inc. (a)(b) 62,594 4,018,535
Common Stocks Value
Health Care Providers & Services (continued)
Express Scripts Holding Co. (a)(b) 17,900 $ 1,231,341
HCA Holdings, Inc. (a)(b) 60,294 4,462,962
HealthEquity, Inc. (a)(b) 12,300 498,396
Humana, Inc. (a) 36,700 7,487,901
McKesson Corp. (a) 28,500 4,002,825
Quest Diagnostics, Inc. (a) 55,600 5,109,640
Teladoc, Inc. (a)(b)(d) 18,800 310,200
UnitedHealth Group, Inc. (a) 137,102 21,941,804
Universal Health Services, Inc., Class B (a) 25,300 2,691,414
WellCare Health Plans, Inc. (a)(b) 6,000 822,480
79,157,875
Life Sciences Tools & Services — 1.3%
Thermo Fisher Scientific, Inc. (a) 24,000 3,386,400
Pharmaceuticals — 22.4%
Allergan PLC (a)(b) 36,085 7,578,211
AstraZeneca PLC 57,476 3,138,654
Bristol-Myers Squibb Co. (a) 137,562 8,039,123
Chugai Pharmaceutical Co. Ltd. 13,400 384,366
Dermira, Inc. (a)(b) 20,900 633,897
Eli Lilly & Co. (a) 65,900 4,846,945
GlaxoSmithKline PLC 64,300 1,235,114
Intra-Cellular Therapies, Inc. (b) 12,701 191,658
Jazz Pharmaceuticals PLC (a)(b) 13,200 1,439,196
Johnson & Johnson (a) 62,270 7,174,127
Merck & Co., Inc. (a) 105,300 6,199,011
Merck KGaA 22,800 2,373,965
Mylan NV (a)(b) 60,000 2,289,000
Pacira Pharmaceuticals, Inc. (b) 4,900 158,270
Pfizer, Inc. (a) 371,898 12,079,247
Phibro Animal Health Corp., Class A 14,600 427,780
Zoetis, Inc. (a) 46,500 2,489,145
60,677,709
Total Common Stocks — 96.9% 262,243,125
Preferred Stocks
Biotechnology — 0.2%
Ovid Therapeutics, Inc. (Acquired 8/7/15, Cost $503,166), 0.00%
(b)(c) 80,765 503,166
Rights — 0.0%
Biotechnology — 0.0%
Dyax Corp. — CVR (b) 61,727 68,517
Total Long-Term Investments (Cost — $203,676,547) — 97.1% 262,814,808

See Notes to Financial Statements.

62 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Health Sciences Trust (BME)

Short-Term Securities Value
BlackRock Liquidity Funds, T-Fund, Institutional Class, 0.36% (e)(f) 8,611,967 $ 8,611,967
SL Liquidity Series, LLC Money Market Series, 0.95% (e)(f)(g) 126,889 126,902
Total Short-Term Securities (Cost — $8,738,869) — 3.2% 8,738,869
Total Investments Before Options
Written (Cost — $212,415,416) — 100.3% 271,553,677
Options Written Value
(Premiums Received — $2,428,175) — (0.7)% $ (1,926,945 )
Total Investments Net of Options Written — 99.6% 269,626,732
Other Assets Less Liabilities — 0.4% 1,066,690
Net Assets — 100.0% $ 270,693,422

Notes to Schedule of Investments

(a) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(b) Non-income producing security.

(c) Restricted securities as to resale, excluding 144A securities. As of period end, the Trust held restricted securities with a current value of $1,955,469,and an original cost of $1,489,568 which was 0.7% of its net assets.

(d) Security, or a portion of security, is on loan.

(e) Current yield as of period end.

(f) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliates — BlackRock Liquidity Funds, TempFund, Institutional Class 8,854,560 (8,854,560 — — Income — $ 34,420 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 8,611,967 8,611,967 $8,611,967 12,113 $55
SL Liquidity Series, LLC, Money Market Series — 126,889 126,889 126,902 8,130 1 1
Total $8,738,869 $ 54,663 $56

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

(g) Security was purchased with the cash collateral from loaned securities.

• For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Abbott Laboratories Call 1/06/17 USD 39.00 110 $ (2,145 )
Amgen, Inc. Call 1/06/17 USD 147.00 110 (12,595 )
Anthem, Inc. Call 1/06/17 USD 147.00 87 (5,873 )
Baxter International, Inc. Call 1/06/17 USD 46.00 20 (70 )
Baxter International, Inc. Call 1/06/17 USD 47.00 72 (936 )
Biogen, Inc. Call 1/06/17 USD 310.00 21 (525 )
Cardinal Health, Inc. Call 1/06/17 USD 72.50 57 (4,560 )
Celgene Corp. Call 1/06/17 USD 123.00 14 (133 )
Express Scripts Holding Co. Call 1/06/17 USD 79.00 62 (3,100 )
Gilead Sciences, Inc. Call 1/06/17 USD 75.00 58 (435 )
HCA Holdings, Inc. Call 1/06/17 USD 73.50 50 (6,625 )
Johnson & Johnson Call 1/06/17 USD 116.00 92 (4,186 )
Medtronic PLC Call 1/06/17 USD 76.00 167 (501 )
Merck & Co., Inc. Call 1/06/17 USD 62.00 38 (228 )
Pfizer, Inc. Call 1/06/17 USD 31.50 62 (6,603 )
Regeneron Pharmaceuticals, Inc. Call 1/06/17 USD 392.50 15 (1,650 )
Vertex Pharmaceuticals, Inc. Call 1/06/17 USD 80.00 90 (6,750 )
Amgen, Inc. Call 1/09/17 USD 151.75 86 (7,610 )
WellCare Health Plans, Inc. Call 1/11/17 USD 129.00 20 (17,376 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 63

Schedule of Investments (continued) BlackRock Health Sciences Trust (BME)

Description — Baxter International, Inc. Call Expiration Date — 1/12/17 USD 48.50 83 Value — $ (50 )
Celgene Corp. Call 1/12/17 USD 120.70 153 (11,683 )
Abbott Laboratories Call 1/13/17 USD 40.00 95 (950 )
Biogen, Inc. Call 1/13/17 USD 295.00 14 (5,950 )
Celgene Corp. Call 1/13/17 USD 118.00 83 (13,986 )
Eli Lilly & Co. Call 1/13/17 USD 69.50 60 (23,100 )
Johnson & Johnson Call 1/13/17 USD 112.00 125 (46,250 )
Masimo Corp. Call 1/13/17 USD 61.75 43 (27,320 )
Merck & Co., Inc. Call 1/13/17 USD 62.00 61 (519 )
Mylan NV Call 1/13/17 USD 37.50 110 (15,510 )
Pfizer, Inc. Call 1/13/17 USD 32.50 80 (3,520 )
UnitedHealth Group, Inc. Call 1/13/17 USD 162.50 100 (14,250 )
Abbott Laboratories Call 1/20/17 USD 41.00 190 (1,425 )
AbbVie, Inc. Call 1/20/17 USD 62.50 50 (5,500 )
AbbVie, Inc. Call 1/20/17 USD 65.00 74 (2,035 )
Aetna, Inc. Call 1/20/17 USD 125.00 8 (2,640 )
Aetna, Inc. Call 1/20/17 USD 130.00 21 (3,434 )
Amedisys, Inc. Call 1/20/17 USD 45.00 200 (10,000 )
AmerisourceBergen Corp. Call 1/20/17 USD 80.00 72 (8,280 )
Amgen, Inc. Call 1/20/17 USD 155.00 38 (1,710 )
Anthem, Inc. Call 1/20/17 USD 130.00 30 (42,600 )
Anthem, Inc. Call 1/20/17 USD 145.00 59 (17,464 )
Baxter International, Inc. Call 1/20/17 USD 45.00 132 (6,996 )
Biogen, Inc. Call 1/20/17 USD 320.00 43 (5,912 )
BioMarin Pharmaceutical, Inc. Call 1/20/17 USD 95.00 34 (2,295 )
Boston Scientific Corp. Call 1/20/17 USD 21.00 165 (15,675 )
Bristol-Myers Squibb Co. Call 1/20/17 USD 60.00 204 (12,240 )
Cardinal Health, Inc. Call 1/20/17 USD 75.00 57 (2,993 )
Celgene Corp. Call 1/20/17 USD 115.00 26 (9,555 )
Celgene Corp. Call 1/20/17 USD 125.00 60 (3,060 )
Centene Corp. Call 1/20/17 USD 60.00 124 (6,200 )
Cigna Corp. Call 1/20/17 USD 140.00 47 (9,846 )
CR Bard, Inc. Call 1/20/17 USD 220.00 89 (63,635 )
DaVita, Inc. Call 1/20/17 USD 65.00 180 (14,400 )
Dermira, Inc. Call 1/20/17 USD 35.00 73 (2,190 )
Eli Lilly & Co. Call 1/20/17 USD 70.00 170 (67,575 )
Genomic Health, Inc. Call 1/20/17 USD 30.00 52 (15,340 )
Gilead Sciences, Inc. Call 1/20/17 USD 77.50 64 (2,080 )
Halozyme Therapeutics, Inc. Call 1/20/17 USD 13.00 144 (7,920 )
HCA Holdings, Inc. Call 1/20/17 USD 75.00 40 (5,900 )
HealthEquity, Inc. Call 1/20/17 USD 45.00 43 (2,150 )
Hologic, Inc. Call 1/20/17 USD 40.00 187 (16,362 )
Hologic, Inc. Call 1/20/17 USD 41.00 81 (3,240 )
Humana, Inc. Call 1/20/17 USD 210.00 58 (33,060 )
Incyte Corp. Call 1/20/17 USD 110.00 54 (7,155 )
Intuitive Surgical, Inc. Call 1/20/17 USD 655.00 18 (12,150 )
Jazz Pharmaceuticals PLC Call 1/20/17 USD 125.00 23 (1,840 )
McKesson Corp. Call 1/20/17 USD 145.00 76 (14,060 )
Medtronic PLC Call 1/20/17 USD 75.00 150 (2,475 )
Merck & Co., Inc. Call 1/20/17 USD 62.50 91 (1,001 )
Neurocrine Biosciences, Inc. Call 1/20/17 USD 55.00 73 (1,095 )
Pfizer, Inc. Call 1/20/17 USD 34.00 436 (3,706 )
Quest Diagnostics, Inc. Call 1/20/17 USD 85.00 106 (73,670 )
Quest Diagnostics, Inc. Call 1/20/17 USD 95.00 88 (2,860 )
Sage Therapeutics, Inc. Call 1/20/17 USD 55.00 50 (8,625 )
Seattle Genetics, Inc. Call 1/20/17 USD 65.00 57 (1,425 )
Spark Therapeutics, Inc. Call 1/20/17 USD 55.00 16 (2,160 )
Stryker Corp. Call 1/20/17 USD 115.00 115 (67,275 )
Stryker Corp. Call 1/20/17 USD 120.00 110 (26,400 )
Teladoc, Inc. Call 1/20/17 USD 17.50 65 (2,925 )
TESARO, Inc. Call 1/20/17 USD 135.00 77 (46,970 )
Thermo Fisher Scientific, Inc. Call 1/20/17 USD 150.00 53 (1,060 )
UnitedHealth Group, Inc. Call 1/20/17 USD 150.00 151 (167,232 )
Universal Health Services, Inc., Class B Call 1/20/17 USD 130.00 127 (3,810 )
Vertex Pharmaceuticals, Inc. Call 1/20/17 USD 95.00 125 (2,500 )

See Notes to Financial Statements.

64 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Health Sciences Trust (BME)

Description — Zoetis, Inc. Call 1/20/17 USD 50.00 58 Value — $ (21,460 )
Becton Dickinson and Co. Call 1/23/17 USD 173.50 70 (5,247 )
Masimo Corp. Call 1/26/17 USD 66.01 32 (7,663 )
Aetna, Inc. Call 1/27/17 USD 129.00 84 (21,630 )
Allergan PLC Call 1/27/17 USD 200.00 63 (88,515 )
Baxter International, Inc. Call 1/27/17 USD 45.50 123 (5,781 )
Baxter International, Inc. Call 1/27/17 USD 46.00 20 (680 )
Bristol-Myers Squibb Co. Call 1/27/17 USD 61.50 277 (16,481 )
HCA Holdings, Inc. Call 1/27/17 USD 77.00 121 (13,915 )
Humana, Inc. Call 1/27/17 USD 217.50 25 (11,250 )
Merck & Co., Inc. Call 1/27/17 USD 61.50 217 (7,595 )
Pfizer, Inc. Call 1/27/17 USD 32.00 212 (20,246 )
Regeneron Pharmaceuticals, Inc. Call 1/27/17 USD 392.50 15 (9,000 )
Sarepta Therapeutics, Inc. Call 1/27/17 USD 35.00 120 (6,900 )
Vertex Pharmaceuticals, Inc. Call 1/27/17 USD 80.00 75 (15,375 )
Zoetis, Inc. Call 1/27/17 USD 52.50 96 (17,760 )
Aetna, Inc. Call 1/30/17 USD 124.25 21 (9,307 )
UnitedHealth Group, Inc. Call 1/30/17 USD 157.00 114 (74,881 )
Alkermes PLC Call 2/02/17 USD 59.05 63 (10,346 )
Aetna, Inc. Call 2/07/17 USD 129.50 21 (6,384 )
Agios Pharmaceuticals, Inc. Call 2/10/17 USD 67.25 56 (706 )
UnitedHealth Group, Inc. Call 2/13/17 USD 157.00 114 (86,315 )
Acceleron Pharma, Inc. Call 2/17/17 USD 45.00 121 (3,025 )
Baxter International, Inc. Call 2/17/17 USD 47.50 43 (1,440 )
Gilead Sciences, Inc. Call 2/17/17 USD 77.50 96 (12,144 )
Humana, Inc. Call 2/17/17 USD 205.00 45 (57,375 )
Medtronic PLC Call 2/17/17 USD 75.00 125 (7,438 )
Pfizer, Inc. Call 2/17/17 USD 33.00 80 (4,960 )
Pfizer, Inc. Call 2/17/17 USD 34.00 431 (12,068 )
Becton Dickinson and Co. Call 3/17/17 USD 175.00 3 (720 )
Total $ (1,655,702 )
OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
AstraZeneca PLC Call Morgan Stanley & Co. International PLC 1/04/17 GBP 49.26 5,000 $ (1 )
GlaxoSmithKline PLC Call Morgan Stanley & Co. International PLC 1/05/17 GBP 14.73 22,000 (23,334 )
Avexis, Inc. Call Goldman Sachs International 1/09/17 USD 47.65 6,200 (13,714 )
Service Corp. International Call Barclays Bank PLC 1/09/17 USD 26.35 9,000 (19,891 )
REGENXBIO, Inc. Call Morgan Stanley & Co. International PLC 1/10/17 USD 16.97 12,500 (22,639 )
Boston Scientific Corp. Call UBS AG 2/06/17 USD 21.31 24,400 (23,523 )
Cigna Corp. Call Goldman Sachs International 2/09/17 USD 134.75 10,000 (62,800 )
AstraZeneca PLC Call UBS AG 2/10/17 GBP 43.71 15,000 (39,433 )
Boston Scientific Corp. Call Citibank N.A. 2/21/17 USD 22.18 27,000 (18,936 )
Boston Scientific Corp. Call UBS AG 2/21/17 USD 21.31 24,400 (28,467 )
Boston Scientific Corp. Call Barclays Bank PLC 3/06/17 USD 22.33 24,600 (18,505 )
Total $ (271,243 )

Transactions in Options Written for the Year Ended December 31, 2016

Calls — Contracts Premiums Received Puts — Contracts Premiums Received
Outstanding options at beginning of year 287,378 $ 2,456,919 — —
Options written 1,886,360 17,461,781 286 $ 69,934
Options exercised (14,333 ) (76,761) (94 ) (39,621 )
Options expired (884,014 ) (6,245,194) (140 ) (19,623 )
Options closed (1,085,236 ) (11,168,570) (52 ) (10,690 )
Outstanding options at end of year 190,155 $ 2,428,175 — —

As of period end, the value of portfolio securities subject to covered call options written was $84,635,698.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 65

Schedule of Investments (continued) BlackRock Health Sciences Trust (BME)

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Commodity Contracts Equity Contracts Total
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $ 1,926,945 — — $ 1,926,945

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: Commodity Contracts Credit Contracts Equity Contracts Foreign Currency Exchange Contracts Interest Rate Contracts Total
Options purchased 1 — — $ (678 ) — — $ (678 )
Options written — — 1,486,350 — — 1,486,350
Total — — $ 1,485,672 — — $ 1,485,672
Net Change in Unrealized Appreciation (Depreciation) on:
Options written — — $ 656,007 — — $ 656,007

1 Options purchased are included in net realized gain (loss) from investments.

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Options:
Average value of option contracts
purchased 1 $ 678
Average value of option contracts written $ 2,064,690

1 Actual amounts for the period are shown due to limited outstanding derivative financial instruments as of each quarter.

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments — Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Assets Liabilities
Derivative Financial Instruments:
Options — $ 1,926,945
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — (1,655,702 )
Total derivative assets and liabilities subject to an MNA. — $ 271,243

See Notes to Financial Statements.

66 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Health Sciences Trust (BME)

The following table presents the Trust’s derivative liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (MNA) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not Offset in the Consolidated Statements of Assets and
Liabilities and Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged | Cash Collateral Pledged | Net Amount of Derivative Liabilities 1 |
| --- | --- | --- | --- | --- | --- |
| Barclays Bank PLC | $ 38,396 | — | — | — | $ 38,396 |
| Citibank N.A. | 18,936 | — | — | — | 18,936 |
| Goldman Sachs International | 76,514 | — | — | — | 76,514 |
| Morgan Stanley & Co. International PLC | 45,974 | — | — | — | 45,974 |
| UBS AG | 91,423 | — | — | — | 91,423 |
| Total | $271,243 | — | — | — | $271,243 |

1 Net amount represents the net amount payable due to the counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Level 1 Level 2 Total
Assets:
Investments:
Long-Term Investments:
Common Stocks:
Biotechnology $ 60,752,191 — $ 1,452,303 $ 62,204,494
Diversified Consumer Services 1,150,200 — — 1,150,200
Health Care Equipment & Supplies 55,666,447 — — 55,666,447
Health Care Providers & Services 79,157,875 — — 79,157,875
Life Sciences Tools & Services 3,386,400 — — 3,386,400
Pharmaceuticals 53,545,610 $ 7,132,099 — 60,677,709
Preferred Stocks — — 503,166 503,166
Rights — — 68,517 68,517
Short-Term Securities 8,611,967 — — 8,611,967
Subtotal $ 262,270,690 $ 7,132,099 $ 2,023,986 $ 271,426,775
Investments Valued at NAV 1 126,902
Total Investments $ 271,553,677
Derivative Financial Instruments 2
Liabilities:
Equity contracts $ (1,390,814 ) $ (536,131 ) — $ (1,926,945 )

1 As of December 31, 2016, certain of the Fund’s investments were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

2 Derivative financial instruments are options written, which are shown at value.

During the year ended December 31, 2016, there were no transfers between levels.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 67

Schedule of Investments (concluded) BlackRock Health Sciences Trust (BME)

A reconciliation of Level 3 investments is presented when the Trust had a significant amount of Level 3 investments at the beginning and/or end of the year in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:

Common Stocks Preferred Stocks Total
Assets:
Opening Balance, as of December 31, 2015 — $ 5,907,930 — $ 5,907,930
Transfers into Level 3 $ 986,401 — $ 25,848 1,012,249
Transfers out of Level 3 — (3,261,938 ) — (3,261,938 )
Accrued discounts/premiums — — — —
Net realized gain — 1,287,939 — 1,287,939
Net change in unrealized
appreciation/depreciation 1,2 465,902 (937,224 ) 42,669 (428,653 )
Purchases — — — —
Sales — (2,493,541 ) — (2,493,541 )
Closing Balance, as of December 31, 2016 $ 1,452,303 $ 503,166 $ 68,517 $ 2,023,986
Net change in unrealized appreciation/depreciation on investments still held at December 31, 2016 2 $ 465,902 — $ 42,669 $ 508,571

1 Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations.

2 Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2016 is generally due to investments no longer held or categorized as Level 3 at period end.

See Notes to Financial Statements.

68 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Shares
Australia — 1.3%
Commonwealth Bank of Australia 147,500 $ 8,750,325
Belgium — 2.1%
Anheuser-Busch InBev SA 133,496 14,129,795
Canada — 5.3%
Canadian Pacific Railway Ltd. (a) 50,950 7,269,193
Encana Corp. (a) 572,300 6,717,646
Fairfax Financial Holdings Ltd. 6,892 3,328,836
Potash Corp. of Saskatchewan, Inc. (a) 400,032 7,237,014
Toronto-Dominion Bank 242,100 11,940,463
36,493,152
China — 4.7%
Alibaba Group Holding Ltd. — ADR (a)(b) 101,674 8,927,995
China Construction Bank Corp., Class H 14,985,000 11,475,969
China Unicom Hong Kong Ltd. 3,694,000 4,275,284
Tencent Holdings Ltd. 321,800 7,802,721
32,481,969
France — 8.8%
AXA SA 466,000 11,747,341
BNP Paribas SA 220,164 14,010,823
Dassault Aviation SA 5,513 6,153,168
Renault SA 86,900 7,718,207
Sanofi 61,500 4,973,225
Societe Generale SA 121,270 5,964,905
Unibail-Rodamco SE — REIT 43,900 10,461,616
61,029,285
Germany — 5.8%
Continental AG 21,254 4,094,740
Innogy SE (b)(c) 113,216 3,934,041
KION Group AG 72,080 4,002,003
SAP SE 96,900 8,382,367
thyssenkrupp AG 434,790 10,328,587
Wacker Chemie AG 86,678 8,996,288
39,738,026
Hong Kong — 1.8%
AIA Group Ltd. 2,193,952 12,290,170
India — 2.2%
Bharti Infratel Ltd. 1,232,919 6,230,725
HDFC Bank Ltd. 454,502 8,842,222
15,072,947
Indonesia — 1.0%
Matahari Department Store Tbk PT 6,296,080 7,047,477
Ireland — 1.9%
Green REIT PLC 4,017,426 5,802,131
Ryanair Holdings PLC — ADR (b) 83,936 6,988,511
12,790,642
Italy — 5.4%
Atlantia SpA 239,700 5,608,124
Azimut Holding SpA 365,500 6,079,521
Buzzi Unicem SpA 199,600 4,722,923
Eni SpA 543,200 8,805,885
Snam SpA 1,326,300 5,454,892
Telecom Italia SpA (b) 7,398,400 6,532,364
37,203,709
Japan — 8.2%
Don Quijote Holdings Co. Ltd. 125,200 4,620,546
FANUC Corp. 27,400 4,583,869
Mitsubishi Estate Co. Ltd. 426,000 8,462,350
Nintendo Co. Ltd. 34,900 7,254,852
Common Stocks Shares
Japan (continued)
ORIX Corp. 398,600 $ 6,203,912
Sumitomo Mitsui Financial Group, Inc. 446,800 17,015,473
TOTO Ltd. 87,100 3,440,326
Toyota Motor Corp. 89,800 5,264,832
56,846,160
Mexico — 1.0%
Fomento Economico Mexicano SAB de CV — ADR (a) 94,200 7,178,982
Netherlands — 5.7%
Aalberts Industries NV 203,452 6,591,453
ASML Holding NV 74,800 8,382,898
Koninklijke Philips NV 256,700 7,847,838
Royal Dutch Shell PLC, B Shares 571,919 16,432,422
39,254,611
New Zealand — 0.6%
Xero Ltd. (b) 359,605 4,365,814
Norway — 1.4%
Statoil ASA 530,400 9,680,693
Peru — 0.6%
Credicorp Ltd. (a) 27,400 4,325,364
Philippines — 0.4%
CEMEX Holdings Philippines, Inc. (b)(c) 13,601,200 3,036,929
Portugal — 1.2%
Galp Energia SGPS SA 528,600 7,880,521
South Africa — 1.2%
Naspers Ltd., N Shares 58,019 8,470,291
South Korea — 2.7%
LG Chem Ltd. 38,400 8,280,842
Samsung Electronics Co. Ltd. 7,000 10,418,192
18,699,034
Spain — 1.1%
Cellnex Telecom SA (c) 529,740 7,603,984
Sweden — 1.1%
Hexagon AB, B Shares 213,966 7,620,600
Switzerland — 4.4%
Nestle SA 208,700 14,950,764
Roche Holding AG 29,423 6,707,048
UBS Group AG 543,300 8,494,746
30,152,558
Taiwan — 1.3%
Taiwan Semiconductor Manufacturing Co. Ltd. 1,556,000 8,715,554
Thailand — 0.7%
True Corp PCL 25,614,200 5,099,369
United Kingdom — 15.8%
AstraZeneca PLC 138,400 7,557,759
BAE Systems PLC 753,700 5,482,106
CNH Industrial NV 452,200 3,923,753
Diageo PLC 250,600 6,503,077
GlaxoSmithKline PLC 197,100 3,786,019
Imperial Brands PLC 185,300 8,075,522
Kennedy Wilson Europe Real Estate PLC 286,739 3,385,837
Liberty Global PLC, Class A (a)(b) 317,400 9,709,266
Lloyds Banking Group PLC 8,845,300 6,792,149
Metro Bank PLC (b) 125,326 4,505,504
Nomad Foods Ltd. (b) 284,394 2,721,651
Reckitt Benckiser Group PLC 74,800 6,336,195
Rio Tinto PLC 235,200 8,979,520

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 69

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

Common Stocks Value
United Kingdom (continued)
Sophos Group PLC (c) 1,546,000 $ 4,993,966
Unilever PLC 332,000 13,426,115
Vodafone Group PLC 2,263,600 5,570,481
Worldpay Group PLC (c) 2,269,500 7,534,993
109,283,913
United States — 3.4%
Pfizer, Inc. (a)(d) 240,800 7,821,184
Samsonite International SA 1,933,500 5,503,860
Shire PLC — ADR (a) 60,900 10,376,142
23,701,186
Total Common Stocks — 91.1% 628,943,060
Investment Companies
United States — 4.8%
WisdomTree Japan Hedged Equity Fund (a)(d) 675,510 33,464,765
Preferred Stocks
China — 0.4%
Xiaoju Kuaizhi, Inc., Series A-17 (Acquired 7/28/15, Cost $2,106,332), 0.00%
(b)(e) 76,800 2,936,064
Preferred Stocks Shares
India — 1.9%
Jasper Infotech Private Ltd., Series F (Acquired 5/7/14, cost $2,825,580), 0.00% (b)(e) 398 $ 9,701,670
Jasper Infotech Private Ltd., Series G (Acquired 10/29/14, cost $1,112,870), 0.00%
(b)(e) 132 3,217,640
Total Preferred Stocks — 2.3% 15,855,374
Total Long-Term Investments (Cost — $651,151,015) — 98.2% 678,263,199
Short-Term Securities
BlackRock Liquidity Funds, T-Fund, Institutional
Class, 0.36% (f)(g) 22,641,400 22,641,400
Total Short-Term
Securities (Cost — $22,641,400) — 3.3% 22,641,400
Total Investments Before Options
Written (Cost — $673,792,415) — 101.5% 700,904,599
Options Written
(Premiums Received — $7,043,095) — (1.3)% (8,662,185 )
Total Investments Net of Options Written — 100.2% 692,242,414
Liabilities in Excess of Other Assets — (0.2)% (1,614,734 )
Net Assets — 100.0% $ 690,627,680

Notes to Schedule of Investments

(a) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(b) Non-income producing security.

(c) Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(d) All or a portion of security has been pledged as collateral in connection with outstanding OTC derivatives.

(e) Restricted security as to resale, excluding 144A securities. As of report date, the Trust held restricted securities with a current value of $15,855,374 and an original cost of $6,044,782 which was 2.3% of its net assets.

(f) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliates — BlackRock Liquidity Funds, TempFund, Institutional Class 37,105,203 (37,105,203 ) — Value at December 31, 2016 — — Income — $ 161,550 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 22,641,400 22,641,400 $ 22,641,400 27,253 $186
SL Liquidity Series, LLC, Money Market Series 2,751,247 (2,751,247 ) — — 21,839 1 —
Total $ 22,641,400 $ 210,642 $186

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

(g) Current yield as of period end.

See Notes to Financial Statements.

70 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Alibaba Group Holding Ltd. — ADR Call 1/06/17 USD 94.50 56 $ (252 )
Pfizer, Inc. Call 1/06/17 USD 31.50 89 (9,478 )
WisdomTree Japan Hedged Equity Fund Call 1/06/17 USD 49.20 980 (64,415 )
Alibaba Group Holding Ltd. — ADR Call 1/11/17 USD 97.50 68 (177 )
Alibaba Group Holding Ltd. — ADR Call 1/13/17 USD 94.50 53 (1,113 )
Shire PLC — ADR Call 1/13/17 USD 180.00 80 (7,400 )
WisdomTree Japan Hedged Equity Fund Call 1/13/17 USD 52.00 250 (1,875 )
Alibaba Group Holding Ltd. — ADR Call 1/20/17 USD 97.50 57 (798 )
Canadian Pacific Railway Ltd. Call 1/20/17 CAD 200.00 158 (14,592 )
Credicorp Ltd. Call 1/20/17 USD 160.00 136 (30,260 )
Encana Corp. Call 1/20/17 CAD 17.00 960 (8,938 )
Fomento Economico Mexicano SAB de CV — ADR Call 1/20/17 USD 80.00 142 (11,005 )
Fomento Economico Mexicano SAB de CV — ADR Call 1/20/17 USD 85.00 142 (7,100 )
Liberty Global PLC, Class A Call 1/20/17 USD 35.00 800 (8,000 )
Potash Corp. of Saskatchewan, Inc. Call 1/20/17 CAD 24.00 860 (50,922 )
Shire PLC — ADR Call 1/20/17 USD 200.00 70 (1,755 )
WisdomTree Japan Hedged Equity Fund Call 1/20/17 USD 46.00 39 (15,892 )
WisdomTree Japan Hedged Equity Fund Call 1/20/17 USD 47.00 7 (1,970 )
WisdomTree Japan Hedged Equity Fund Call 1/20/17 USD 48.00 2 (381 )
Alibaba Group Holding Ltd. — ADR Call 1/27/17 USD 94.50 83 (8,715 )
Pfizer, Inc. Call 1/27/17 USD 32.00 382 (36,481 )
Shire PLC — ADR Call 1/27/17 USD 172.50 75 (33,000 )
WisdomTree Japan Hedged Equity Fund Call 1/27/17 USD 52.50 411 (5,754 )
Alibaba Group Holding Ltd. — ADR Call 2/03/17 USD 92.00 146 (29,054 )
Pfizer, Inc. Call 2/03/17 USD 33.00 811 (41,766 )
Shire PLC — ADR Call 2/03/17 USD 172.50 75 (38,625 )
Alibaba Group Holding Ltd. — ADR Call 2/17/17 USD 105.00 92 (2,668 )
Pfizer, Inc. Call 2/17/17 USD 34.00 42 (1,176 )
Potash Corp. of Saskatchewan, Inc. Call 2/17/17 CAD 25.00 700 (53,439 )
Total $ (487,001 )
OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
AstraZeneca PLC Call Morgan Stanley & Co. International PLC 1/04/17 GBP 49.26 45,000 $ (11)
Cellnex Telecom SA Call Bank of America N.A. 1/04/17 EUR 15.64 50,000 (1)
Dassault Aviation SA Call Credit Suisse International 1/04/17 EUR 1,068.90 600 (3,841)
Samsonite International SA Call BNP Paribas S.A. 1/04/17 HKD 26.17 324,000 —
Statoil ASA Call Credit Suisse International 1/04/17 NOK 141.58 230,000 (429,936)
BAE Systems PLC Call Credit Suisse International 1/05/17 GBP 6.24 200,000 (158)
Buzzi Unicem SpA Call Goldman Sachs International 1/05/17 EUR 19.92 46,500 (125,939)
GlaxoSmithKline PLC Call Credit Suisse International 1/05/17 GBP 15.47 75,000 (20,506)
Koninklijke Philips NV Call UBS AG 1/05/17 EUR 27.72 66,000 (95,621)
Snam SpA Call Credit Suisse International 1/05/17 EUR 3.79 296,000 (38,669)
Sophos Group PLC Call Credit Suisse International 1/06/17 GBP 2.44 75,000 (16,853)
Ryanair Holdings PLC — ADR Call Barclays Bank PLC 1/09/17 USD 84.00 20,000 (19,220)
Hexagon AB, B Shares Call Morgan Stanley & Co. International PLC 1/10/17 SEK 323.23 55,000 (39,131)
Naspers Ltd., N Shares Call Morgan Stanley & Co. International PLC 1/10/17 ZAR 2,192.90 5,700 (1,452)
Toronto-Dominion Bank Call Citibank N.A. 1/10/17 CAD 64.00 43,000 (71,130)
Worldpay Group PLC Call UBS AG 1/10/17 GBP 2.86 172,000 (1,022)
Aalberts Industries NV Call Morgan Stanley & Co. International PLC 1/11/17 EUR 28.92 25,000 (50,341)
AXA SA Call Credit Suisse International 1/11/17 EUR 23.11 74,000 (79,857)
Cellnex Telecom SA Call Credit Suisse International 1/11/17 EUR 14.75 44,000 (493)
China Construction Bank Corp., Class H Call Citibank N.A. 1/11/17 HKD 5.63 4,000,000 (169,774)
Dassault Aviation SA Call Credit Suisse International 1/11/17 EUR 1,064.33 700 (9,243)
Eni SpA Call Bank of America N.A. 1/11/17 EUR 13.85 75,000 (122,485)
Koninklijke Philips NV Call Bank of America N.A. 1/11/17 EUR 27.78 128,000 (190,909)
LG Chem Ltd. Call Deutsche Bank AG 1/11/17 KRW 240,307.06 9,200 (161,464)

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 71

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

Description — Metro Bank PLC Call Counterparty — Morgan Stanley & Co. International PLC Expiration Date — 1/11/17 Strike Price — GBP 31.41 8,700 Value — $ (418 )
ORIX Corp. Call Bank of America N.A. 1/11/17 JPY 1,796.83 79,000 (38,426 )
Royal Dutch Shell PLC, B Shares Call Credit Suisse International 1/11/17 GBP 20.89 180,000 (539,918 )
Samsung Electronics Co. Ltd. Call BNP Paribas S.A. 1/11/17 KRW 1,801,470.00 2,300 (74,493 )
Sanofi Call Credit Suisse International 1/11/17 EUR 76.45 15,800 (23,647 )
SAP SE Call Credit Suisse International 1/11/17 EUR 76.55 23,000 (138,668 )
Societe Generale SA Call Credit Suisse International 1/11/17 EUR 40.68 30,000 (191,905 )
Societe Generale SA Call Morgan Stanley & Co. International PLC 1/11/17 EUR 41.20 42,000 (246,227 )
Sophos Group PLC Call Credit Suisse International 1/11/17 GBP 2.55 150,000 (16,617 )
Telecom Italia SpA Call Morgan Stanley & Co. International PLC 1/11/17 EUR 0.73 950,000 (111,858 )
Worldpay Group PLC Call Credit Suisse International 1/11/17 GBP 2.74 100,000 (2,326 )
Encana Corp. Call Credit Suisse International 1/12/17 CAD 15.00 96,000 (64,986 )
Xero Ltd. Call Deutsche Bank AG 1/12/17 NZD 19.65 6,000 (9 )
Tencent Holdings Ltd. Call Goldman Sachs International 1/13/17 HKD 204.69 76,000 (1,970 )
Toyota Motor Corp. Call JPMorgan Chase Bank N.A. 1/13/17 JPY 6,071.04 22,000 (147,348 )
Vodafone Group PLC Call UBS AG 1/13/17 GBP 2.16 610,000 (1,862 )
Canadian Pacific Railway Ltd. Call Goldman Sachs International 1/17/17 CAD 198.08 10,000 (7,189 )
Metro Bank PLC Call Morgan Stanley & Co. International PLC 1/17/17 GBP 31.41 8,700 (852 )
AIA Group Ltd. Call Citibank N.A. 1/18/17 HKD 48.10 540,000 (1,412 )
ASML Holding NV Call Morgan Stanley & Co. International PLC 1/18/17 EUR 100.37 4,100 (29,992 )
AXA SA Call Credit Suisse International 1/18/17 EUR 24.13 70,000 (37,558 )
Azimut Holding SpA Call Bank of America N.A. 1/18/17 EUR 14.27 48,000 (81,177 )
BAE Systems PLC Call Credit Suisse International 1/18/17 GBP 5.97 154,700 (15,313 )
Cellnex Telecom SA Call Morgan Stanley & Co. International PLC 1/18/17 EUR 15.59 29,600 (85 )
CNH Industrial NV Call Bank of America N.A. 1/18/17 EUR 8.47 73,000 (8,454 )
Continental AG Call UBS AG 1/18/17 EUR 185.79 5,900 (19,313 )
Diageo PLC Call Credit Suisse International 1/18/17 GBP 20.98 87,000 (35,924 )
Don Quijote Holdings Co. Ltd. Call Bank of America N.A. 1/18/17 JPY 4,238.10 30,700 (38,907 )
Eni SpA Call Bank of America N.A. 1/18/17 EUR 14.31 150,000 (178,958 )
Lloyds Banking Group PLC Call Credit Suisse International 1/18/17 GBP 0.59 1,150,000 (53,450 )
Rio Tinto PLC Call Morgan Stanley & Co. International PLC 1/18/17 GBP 33.36 64,000 (11,031 )
Sanofi Call Credit Suisse International 1/18/17 EUR 78.96 13,600 (9,499 )
Taiwan Semiconductor Manufacturing Co. Ltd. Call JPMorgan Chase Bank N.A. 1/18/17 TWD 190.64 331,000 (2,529 )
thyssenkrupp AG Call Morgan Stanley & Co. International PLC 1/18/17 EUR 21.97 105,000 (101,546 )
Toronto-Dominion Bank Call Morgan Stanley & Co. International PLC 1/18/17 CAD 64.27 39,600 (57,631 )
Wacker Chemie AG Call Morgan Stanley & Co. International PLC 1/18/17 EUR 94.08 15,000 (84,708 )
Xero Ltd. Call Morgan Stanley & Co. International PLC 1/18/17 NZD 17.78 14,000 (2,953 )
Galp Energia SGPS SA Call Morgan Stanley & Co. International PLC 1/19/17 EUR 13.12 70,000 (79,814 )
Kennedy Wilson Europe Real Estate PLC Call UBS AG 1/19/17 GBP 9.58 45,000 (8,908 )
Sophos Group PLC Call Morgan Stanley & Co. International PLC 1/19/17 GBP 2.36 75,000 (24,056 )
Unibail-Rodamco SE — REIT Call UBS AG 1/19/17 EUR 215.24 9,400 (120,678 )
Worldpay Group PLC Call Morgan Stanley & Co. International PLC 1/19/17 GBP 2.93 186,000 (1,333 )
Sumitomo Mitsui Financial Group, Inc. Call JPMorgan Chase Bank N.A. 1/23/17 JPY 4,749.12 169,000 (65,030 )
AXA SA Call Credit Suisse International 1/24/17 EUR 24.25 70,000 (38,810 )
BNP Paribas SA Call Bank of America N.A. 1/24/17 EUR 55.48 12,000 (69,756 )
China Unicom Hong Kong Ltd. Call Citibank N.A. 1/24/17 HKD 9.36 1,000,000 (24,497 )
Sophos Group PLC Call Morgan Stanley & Co. International PLC 1/24/17 GBP 2.39 90,000 (26,384 )
Xero Ltd. Call Morgan Stanley & Co. International PLC 1/24/17 NZD 17.86 14,000 (3,233 )
Commonwealth Bank of Australia Call Bank of America N.A. 1/25/17 AUD 80.09 41,000 (82,690 )
Galp Energia SGPS SA Call Morgan Stanley & Co. International PLC 1/25/17 EUR 14.24 76,000 (29,238 )
Metro Bank PLC Call Morgan Stanley & Co. International PLC 1/25/17 GBP 31.41 8,700 (1,636 )
TOTO Ltd. Call Bank of America N.A. 1/25/17 JPY 4,581.75 13,800 (17,810 )
Unilever PLC Call Credit Suisse International 1/25/17 GBP 31.56 59,000 (112,802 )
Aalberts Industries NV Call UBS AG 1/26/17 EUR 30.94 22,000 (11,682 )
Anheuser-Busch InBev SA Call UBS AG 1/26/17 EUR 100.44 22,000 (49,697 )
Atlantia SpA Call Morgan Stanley & Co. International PLC 1/26/17 EUR 22.00 56,000 (35,142 )
AXA SA Call Credit Suisse International 1/26/17 EUR 24.37 19,000 (10,137 )
BNP Paribas SA Call Credit Suisse International 1/26/17 EUR 60.32 67,000 (143,134 )
Eni SpA Call Credit Suisse International 1/26/17 EUR 15.19 73,700 (37,645 )
Imperial Brands PLC Call Credit Suisse International 1/26/17 GBP 35.50 56,000 (51,225 )
KION Group AG Call Morgan Stanley & Co. International PLC 1/26/17 EUR 53.81 16,000 (19,600 )

See Notes to Financial Statements.

72 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

Description — Naspers Ltd., N Shares Call Counterparty — UBS AG Expiration Date — 1/26/17 Strike Price — ZAR 2,090.40 7,000 Value — $ (20,876 )
Nestle SA Call UBS AG 1/26/17 CHF 72.90 114,700 (134,902 )
Nintendo Co. Ltd. Call Bank of America N.A. 1/26/17 JPY 25,756.50 16,900 (69,018 )
Reckitt Benckiser Group PLC Call Credit Suisse International 1/26/17 GBP 67.33 30,100 (75,605 )
Renault SA Call Bank of America N.A. 1/26/17 EUR 84.46 40,000 (114,978 )
Telecom Italia SpA Call UBS AG 1/26/17 EUR 0.81 1,600,000 (90,203 )
UBS Group AG Call Bank of America N.A. 1/26/17 CHF 16.95 165,900 (26,000 )
Vodafone Group PLC Call UBS AG 1/26/17 GBP 2.01 580,600 (30,218 )
AstraZeneca PLC Call Morgan Stanley & Co. International PLC 1/27/17 GBP 44.64 37,000 (52,147 )
Dassault Aviation SA Call Morgan Stanley & Co. International PLC 1/27/17 EUR 1,063.50 400 (8,503 )
Encana Corp. Call Morgan Stanley & Co. International PLC 1/27/17 CAD 15.71 19,900 (9,851 )
Hexagon AB, B Shares Call Morgan Stanley & Co. International PLC 1/27/17 SEK 323.23 55,000 (58,764 )
Mitsubishi Estate Co. Ltd. Call Bank of America N.A. 1/27/17 JPY 2,394.75 117,000 (35,082 )
Toronto-Dominion Bank Call Citibank N.A. 1/30/17 CAD 64.00 43,000 (71,130 )
Commonwealth Bank of Australia Call Bank of America N.A. 1/31/17 AUD 83.21 35,000 (25,675 )
KION Group AG Call Morgan Stanley & Co. International PLC 1/31/17 EUR 54.08 16,000 (19,683 )
Rio Tinto PLC Call Bank of America N.A. 1/31/17 GBP 31.66 56,000 (55,034 )
Sophos Group PLC Call Morgan Stanley & Co. International PLC 1/31/17 GBP 2.39 90,000 (26,771 )
Worldpay Group PLC Call UBS AG 1/31/17 GBP 2.62 170,000 (22,901 )
ASML Holding NV Call UBS AG 2/01/17 EUR 106.76 32,500 (109,188 )
Atlantia SpA Call Credit Suisse International 2/01/17 EUR 22.72 48,500 (17,331 )
Don Quijote Holdings Co. Ltd. Call JPMorgan Chase Bank N.A. 2/01/17 JPY 4,501.10 29,000 (16,927 )
FANUC Corp. Call JPMorgan Chase Bank N.A. 2/01/17 JPY 20,955.90 6,900 (18,124 )
LG Chem Ltd. Call UBS AG 2/01/17 KRW 271,179.17 9,600 (43,753 )
Telecom Italia SpA Call UBS AG 2/01/17 EUR 0.87 1,519,100 (47,780 )
TOTO Ltd. Call Morgan Stanley & Co. International PLC 2/01/17 JPY 4,851.60 26,500 (14,798 )
Wacker Chemie AG Call UBS AG 2/01/17 EUR 99.39 15,000 (45,412 )
BNP Paribas SA Call Morgan Stanley & Co. International PLC 2/02/17 EUR 62.43 41,300 (64,307 )
Cellnex Telecom SA Call Credit Suisse International 2/02/17 EUR 13.72 50,000 (18,122 )
Metro Bank PLC Call UBS AG 2/02/17 GBP 33.58 12,000 (519 )
Statoil ASA Call Goldman Sachs International 2/03/17 NOK 164.01 25,000 (7,653 )
Taiwan Semiconductor Manufacturing Co. Ltd. Call Bank of America N.A. 2/03/17 TWD 189.21 385,000 (11,588 )
Potash Corp. of Saskatchewan, Inc. Call Morgan Stanley & Co. International PLC 2/06/17 CAD 23.87 35,000 (23,016 )
Aalberts Industries NV Call UBS AG 2/07/17 EUR 30.31 25,000 (27,130 )
AIA Group Ltd. Call Bank of America N.A. 2/07/17 HKD 45.04 354,000 (28,153 )
Imperial Brands PLC Call Credit Suisse International 2/07/17 GBP 36.14 20,000 (18,674 )
Lloyds Banking Group PLC Call Credit Suisse International 2/07/17 GBP 0.59 1,150,000 (59,602 )
Lloyds Banking Group PLC Call Credit Suisse International 2/07/17 GBP 0.66 1,200,000 (11,547 )
Metro Bank PLC Call UBS AG 2/07/17 GBP 33.58 12,000 (768 )
Snam SpA Call Bank of America N.A. 2/07/17 EUR 3.85 328,000 (46,673 )
Toyota Motor Corp. Call Goldman Sachs International 2/07/17 JPY 7,131.97 25,000 (24,373 )
Worldpay Group PLC Call Bank of America N.A. 2/07/17 GBP 2.72 395,500 (29,608 )
Buzzi Unicem SpA Call Credit Suisse International 2/08/17 EUR 23.60 54,200 (23,498 )
Cellnex Telecom SA Call Credit Suisse International 2/08/17 EUR 13.73 21,300 (8,184 )
China Unicom Hong Kong Ltd. Call JPMorgan Chase Bank N.A. 2/08/17 HKD 9.48 914,000 (26,512 )
Dassault Aviation SA Call Morgan Stanley & Co. International PLC 2/08/17 EUR 1,069.14 900 (20,383 )
Diageo PLC Call UBS AG 2/08/17 GBP 21.08 40,000 (23,159 )
ORIX Corp. Call Bank of America N.A. 2/08/17 JPY 1,918.38 113,900 (38,307 )
Samsonite International SA Call Citibank N.A. 2/08/17 HKD 22.76 366,000 (17,490 )
Unilever PLC Call Bank of America N.A. 2/08/17 GBP 32.28 52,000 (64,019 )
Naspers Ltd., N Shares Call UBS AG 2/09/17 ZAR 2,089.53 8,700 (39,980 )
Ryanair Holdings PLC — ADR Call Goldman Sachs International 2/09/17 USD 82.40 21,000 (79,830 )
Samsung Electronics Co. Ltd. Call Goldman Sachs International 2/09/17 KRW 1,801,320.00 1,100 (66,798 )
Sumitomo Mitsui Financial Group, Inc. Call JPMorgan Chase Bank N.A. 2/09/17 JPY 4,820.40 54,400 (29,413 )
Tencent Holdings Ltd. Call Bank of America N.A. 2/09/17 HKD 189.47 81,000 (55,296 )
UBS Group AG Call Credit Suisse International 2/09/17 CHF 17.13 125,000 (25,833 )
Unibail-Rodamco SE — REIT Call Morgan Stanley & Co. International PLC 2/09/17 EUR 224.22 12,200 (100,745 )
Wacker Chemie AG Call UBS AG 2/09/17 EUR 91.47 17,600 (157,235 )
Xero Ltd. Call Deutsche Bank AG 2/09/17 NZD 18.03 12,000 (3,358 )
Royal Dutch Shell PLC, B Shares Call Morgan Stanley & Co. International PLC 2/10/17 GBP 24.23 56,000 (22,382 )
SAP SE Call Morgan Stanley & Co. International PLC 2/10/17 EUR 80.49 24,400 (80,817 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 73

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

Description — Sophos Group PLC Call Credit Suisse International Expiration Date — 2/10/17 GBP 2.64 75,000 Value — $ (8,089 )
Anheuser-Busch InBev SA Call Morgan Stanley & Co. International PLC 2/14/17 EUR 99.37 46,300 (172,794 )
Atlantia SpA Call UBS AG 2/14/17 EUR 22.30 11,000 (6,857 )
thyssenkrupp AG Call UBS AG 2/14/17 EUR 24.10 90,000 (38,462 )
Aalberts Industries NV Call UBS AG 2/15/17 EUR 30.87 27,600 (23,612 )
Azimut Holding SpA Call Goldman Sachs International 2/15/17 EUR 16.80 37,000 (16,242 )
Continental AG Call UBS AG 2/15/17 EUR 188.23 5,000 (22,866 )
Encana Corp. Call Morgan Stanley & Co. International PLC 2/15/17 CAD 16.89 66,500 (23,802 )
Galp Energia SGPS SA Call Morgan Stanley & Co. International PLC 2/15/17 EUR 14.39 144,700 (67,745 )
Metro Bank PLC Call Morgan Stanley & Co. International PLC 2/15/17 GBP 31.49 8,400 (3,229 )
Worldpay Group PLC Call UBS AG 2/15/17 GBP 2.67 186,000 (21,370 )
Sophos Group PLC Call Credit Suisse International 2/16/17 GBP 2.61 60,000 (7,658 )
FANUC Corp. Call JPMorgan Chase Bank N.A. 2/22/17 JPY 20,955.90 6,900 (17,438 )
Lloyds Banking Group PLC Call Credit Suisse International 2/22/17 GBP 0.66 1,200,000 (16,260 )
Mitsubishi Estate Co. Ltd. Call JPMorgan Chase Bank N.A. 2/22/17 JPY 2,441.88 100,000 (43,952 )
Unilever PLC Call Goldman Sachs International 2/23/17 GBP 33.39 44,900 (32,386 )
Sophos Group PLC Call Credit Suisse International 2/24/17 GBP 2.67 76,000 (7,573 )
Sophos Group PLC Call Morgan Stanley & Co. International PLC 3/02/17 GBP 2.63 115,500 (14,651 )
LG Chem Ltd. Call JPMorgan Chase Bank N.A. 3/03/17 KRW 264,685.44 2,300 (22,420 )
Total $ (8,175,184 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
BGY
Outstanding options at beginning of year 37,604,404 $ 8,979,694 — —
Options written 225,577,889 61,029,672 — —
Options exercised (13,658 ) (270,705 ) — —
Options expired (120,829,172 ) (32,307,015 ) — —
Options closed (115,448,497 ) (30,388,551 ) — —
Outstanding options at end of year 26,890,966 $ 7,043,095 — —

As of period end, the value of portfolio securities subject to covered call options written was $282,294,414.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Commodity Contracts Equity Contracts Total
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $ 8,662,185 — — $ 8,662,185

See Notes to Financial Statements.

74 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: Commodity Contracts Credit Contracts Equity Contracts Foreign Currency Exchange Contracts Interest Rate Contracts Total
Forward foreign currency exchange contracts — — — $14,390 — $ 14,390
Futures — — $ 6,658,849 — — $ 6,658,849
Options purchased 1 — — (76,865 ) — — (76,865 )
Options written — — (417,318 ) — — (417,318 )
Total — — $ 6,164,666 $14,390 — $ 6,179,056
Net Change in Unrealized Appreciation (Depreciation)
on:
Options Written — — $ (4,135,248 ) — — $ (4,135,248 )

1 Options purchased are included in net realized gain (loss) from investments.

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Financial futures contracts:
Average notional value of contracts — long $ 15,274,986
Forward foreign currency exchange contracts:
Average amounts sold — in USD 1 $ 2,434,643
Options:
Average value of option contracts written $ 9,315,761

1 Actual amounts for the period are shown due to limited outstanding derivative financial instruments as of each quarter.

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments - Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Liabilities
Derivative Financial Instruments:
Options — $ 8,662,185
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — (487,001 )
Total derivative assets and liabilities subject to an MNA — $ 8,175,184

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 75

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

The following table presents the Trust’s derivative assets and liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (“MNA”) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not
Offset in the Consolidated Statements of Assets and Liabilities and Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged 1 | Cash Collateral Pledged 1 | | Net Amount
of Derivative Liabilities 2 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Bank of America N.A. | $ 1,429,004 | — | $ (1,429,004 | ) | — | | — |
| Barclays Bank PLC | 19,220 | — | — | | — | | $ 19,220 |
| BNP Paribas S.A. | 74,493 | — | — | | — | | 74,493 |
| Citibank N.A. | 355,433 | — | — | $ | (100,000 | ) | 255,433 |
| Credit Suisse International | 2,421,096 | — | (2,371,096 | ) | (50,000 | ) | — |
| Deutsche Bank AG | 164,831 | — | (137,831 | ) | (27,000 | ) | — |
| Goldman Sachs International | 362,380 | — | (362,380 | ) | — | | — |
| JPMorgan Chase Bank N.A. | 389,693 | — | — | | (389,693 | ) | — |
| Morgan Stanley & Co. International PLC | 1,743,060 | — | (1,743,060 | ) | — | | — |
| UBS AG | 1,215,974 | — | — | | (1,215,974 | ) | — |
| Total | $ 8,175,184 | — | (6,043,371 | ) | (1,782,667 | ) | $ 349,146 |

1 Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Level 1 Level 2 Total
Assets:
Investments:
Long-Term Investments:
Common Stocks:
Australia — $ 8,750,325 — $ 8,750,325
Belgium $ 14,129,795 — — 14,129,795
Canada 36,493,152 — — 36,493,152
China 8,927,995 23,553,974 — 32,481,969
France — 61,029,285 — 61,029,285
Germany 3,934,041 35,803,985 — 39,738,026
Hong Kong — 12,290,170 — 12,290,170
India — 15,072,947 — 15,072,947
Indonesia — 7,047,477 — 7,047,477
Ireland 12,790,642 — — 12,790,642
Italy — 37,203,709 — 37,203,709
Japan — 56,846,160 — 56,846,160
Mexico 7,178,982 — — 7,178,982
Netherlands — 39,254,611 — 39,254,611
New Zealand — 4,365,814 — 4,365,814
Norway — 9,680,693 — 9,680,693
Peru 4,325,364 — — 4,325,364
Philippines 3,036,929 — — 3,036,929
Portugal — 7,880,521 — 7,880,521
South Africa — 8,470,291 — 8,470,291
South Korea — 18,699,034 — 18,699,034
Spain — 7,603,984 — 7,603,984
Sweden — 7,620,600 — 7,620,600
Switzerland — 30,152,558 — 30,152,558
Taiwan — 8,715,554 — 8,715,554
Thailand 5,099,369 — — 5,099,369
United Kingdom 12,430,917 96,852,996 — 109,283,913

See Notes to Financial Statements.

76 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock International Growth and Income Trust (BGY)

Assets: (concluded)
Investments: (concluded)
Long-Term Investments: (concluded)
Common Stocks: (concluded)
United States $ 18,197,326 $ 5,503,860 — $ 23,701,186
Investment Companies 33,464,765 — — 33,464,765
Preferred Stocks — — $ 15,855,374 15,855,374
Short-Term Securities 22,641,400 — — 22,641,400
Total Investments $ 182,650,677 $ 502,398,548 $ 15,855,374 $ 700,904,599
Derivative Financial Instruments 1
Liabilities:
Equity contracts $ (422,409 ) $ (8,239,776 ) — $ (8,662,185 )
1 Derivative financial instruments are options written, which are shown at value.
Transfers into Level 1 1 Transfers out of Level 1 2 Transfers into Level 2 2 Transfers out of Level 2 1
Assets:
Long-Term Investments:
Common Stocks $ 6,627,779 $ (48,171,170 ) $ 48,171,170 $ (6,627,779 )

1 Systematic Fair Value Prices were not utilized at period end for these investments.

2 External pricing service used to reflect any significant market movements between the time the Trust valued such foreign securities and the earlier closing of foreign markets.

A reconciliation of Level 3 investments is presented when the Trust had a significant amount of Level 3 investments at the beginning and/or end of the year in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:

Common Stocks Total
Assets:
Opening Balance, as of December 31, 2015 $ 4,465,011 $ 15,504,609 $ 19,969,620
Transfers into Level 3 — — —
Transfers out of Level 3 (4,465,011 ) — (4,465,011 )
Accrued discounts/premiums — — —
Net realized gain (loss) — — —
Net change in unrealized
appreciation/depreciation 1,2 — 350,765 350,765
Purchases — — —
Sales — — —
Closing Balance, as of December 31, 2016 — $ 15,855,374 $ 15,855,374
Net change in unrealized appreciation/depreciation on investments still held at December 31, 2016 2 — $ 350,765 $ 350,765

1 Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations.

2 Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2016 is generally due to investments no longer held or categorized as Level 3 at period end.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 77

Schedule of Investments (concluded) BlackRock International Growth and Income Trust (BGY)

The following table summarizes the valuation approaches used and unobservable inputs utilized by the BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) to determine the value of certain of the Trust’s Level 3 investments as of period end.

Value Valuation Approach
Assets:
Preferred Stocks $ 15,855,374 Market Discount Rate 2 25.00%
Revenue Growth Rate 1 27.00%
Revenue Growth Rate 1 348.00%
Revenue Multiple 1 34.00x-46.00x
Revenue Multiple 1 4.50x
Exit Scenario Probability 1 20.00% - 50.00%
Time to Exit 2 1-3 years
Total $ 15,855,374

1 Increase in unobservable input may result in a significant increase to value, while a decrease in the unobservable input may result in a significant decrease to value.

2 Decrease in unobservable input may result in a significant increase to value, while an increase in the unobservable input may result in a significant decrease to value.

See Notes to Financial Statements.

78 ANNUAL REPORT DECEMBER 31, 2016

Consolidated Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Value
Chemicals — 18.3%
Agrium, Inc. (a) 186,959 $ 18,792,676
CF Industries Holdings, Inc. (a) 871,270 27,427,580
Monsanto Co. (b) 428,247 45,055,867
Potash Corp. of Saskatchewan, Inc. (a) 1,570,907 28,417,708
Syngenta AG 123,221 48,684,978
Yara International ASA 266,000 10,464,191
178,843,000
Containers & Packaging — 5.6%
International Paper Co. (a) 558,175 29,616,766
Packaging Corp. of America (a) 294,719 24,998,066
54,614,832
Energy Equipment & Services — 2.7%
Baker Hughes, Inc. (a) 202,777 13,174,422
Schlumberger Ltd. (a) 163,552 13,730,190
26,904,612
Food & Staples Retailing — 2.1%
Fyffes PLC 8,479,549 20,172,825
Food Products — 5.5%
AGT Food & Ingredients, Inc. 433,633 11,833,548
BRF SA — ADR (a) 346,157 5,109,277
Elders Ltd. (c) 1,246,695 3,571,728
First Resources Ltd. 8,361,900 10,953,543
Glanbia PLC 234,673 3,898,124
Golden Agri-Resources Ltd. 31,419,900 9,302,690
Kerry Group PLC 127,448 9,109,370
53,778,280
Independent Power and Renewable Electricity Producers — 0.0%
Greenko Group PLC (c) 59,000 1
Machinery — 1.0%
Deere & Co. (a) 93,587 9,643,204
Metals & Mining — 29.6%
ArcelorMittal (c) 1,874,279 13,771,338
Barrick Gold Corp. (a) 1,698,044 27,134,743
Boliden AB 478,793 12,436,648
Detour Gold Corp. (a)(c) 1,235,496 16,830,315
Eldorado Gold Corp. (c) 3,372,003 10,849,479
First Quantum Minerals Ltd. 1,566,807 15,578,798
Glencore PLC (c) 10,997,246 37,158,648
Lundin Mining Corp. (c) 2,363,318 11,265,211
MMC Norilsk Nickel PJSC — ADR 1,394,368 23,207,440
Nevsun Resources Ltd. 3,087,129 9,542,014
Newcrest Mining Ltd. 1,350,000 19,357,773
Rio Tinto PLC — ADR (a) 990,526 38,095,630
Silver Wheaton Corp. 1,257,718 24,299,112
Vale SA — ADR (a) 3,861,399 29,423,860
288,951,009
Common Stocks Value
Oil, Gas & Consumable Fuels — 33.9%
Anadarko Petroleum Corp. (a) 248,125 $ 17,301,756
BP PLC — ADR (a) 1,432,852 53,560,006
Cairn Energy PLC (c) 2,826,530 8,212,484
Chevron Corp. (a)(b) 136,002 16,007,435
Cimarex Energy Co. (a) 95,217 12,939,990
ConocoPhillips (a)(b) 495,694 24,854,097
Devon Energy Corp. (a) 335,300 15,313,151
Enbridge, Inc. (a) 479,410 20,174,033
Eni SpA — ADR (a) 392,070 12,640,337
EOG Resources, Inc. (a) 191,918 19,402,910
Exxon Mobil Corp. (a)(b) 208,754 18,842,136
Hess Corp. (a) 228,622 14,240,864
Occidental Petroleum Corp. (a) 226,450 16,130,034
Pioneer Natural Resources Co. (a) 85,550 15,404,990
Royal Dutch Shell PLC, A Shares 215,918 5,960,137
Royal Dutch Shell PLC, A Shares — ADR (a) 1,111,324 60,433,799
331,418,159
Paper & Forest Products — 1.0%
Precious Woods Holding AG (c) 20,000 117,843
TFS Corp. Ltd. (d) 7,903,565 9,453,285
9,571,128
Total Long-Term Investments (Cost — $835,757,398) — 99.7% 973,897,050
Short-Term Securities
BlackRock Liquidity Funds, T-Fund, Institutional Class, 0.36% (e)(f) 12,603,929 12,603,929
SL Liquidity Series, LLC Money Market Series, 0.95% (e)(f)(g) 3,936,869 3,937,262
Total Short-Term Securities (Cost — $16,540,987) — 1.7% 16,541,191
Total Investments Before Options
Written (Cost — $852,298,385) — 101.4% 990,438,241
Options Written
(Premiums Received — $10,175,756) — (1.1)% (10,145,685 )
Total Investments Net of Options Written — 100.3% 980,292,556
Liabilities in Excess of Other Assets — (0.3)% (3,393,444 )
Net Assets — 100.0% $ 976,899,112

Notes to Schedule of Investments

(a) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(b) All or a portion of security has been pledged as collateral in connection with outstanding OTC derivatives.

(c) Non-income producing security.

(d) Security, or a portion of security, is on loan.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 79

Consolidated Schedule of Investments (continued) BlackRock Resources & Commodities Strategy Trust (BCX)

(e) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliates — BlackRock Liquidity Funds, TempFund, Institutional Class 6,170,241 (6,170,241 — — Income — $ 38,573 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 12,603,929 12,603,929 $12,603,929 7,198 $ 52
SL Liquidity Series, LLC, Money Market Series 35,689 3,901,180 3,936,869 3,937,262 134,174 1 2,130
Total $16,541,191 $ 179,945 $2,182

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

(f) Current yield as of period end.

(g) Security was purchased with the cash collateral from loaned securities.

• For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Exxon Mobil Corp. Call 1/04/17 USD 89.00 65 $ (10,213 )
CF Industries Holdings, Inc. Call 1/06/17 USD 29.00 660 (169,620 )
Devon Energy Corp. Call 1/06/17 USD 49.00 445 (2,448 )
Exxon Mobil Corp. Call 1/06/17 USD 89.00 70 (10,990 )
International Paper Co. Call 1/06/17 USD 50.50 546 (140,049 )
Occidental Petroleum Corp. Call 1/06/17 USD 70.00 93 (14,136 )
Occidental Petroleum Corp. Call 1/06/17 USD 73.00 217 (3,255 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/06/17 USD 52.50 520 (141,700 )
Schlumberger Ltd. Call 1/06/17 USD 86.00 97 (1,261 )
Vale SA — ADR Call 1/06/17 USD 9.00 2,200 (6,600 )
Barrick Gold Corp. Call 1/09/17 USD 16.25 1,500 (60,116 )
Anadarko Petroleum Corp. Call 1/13/17 USD 69.00 40 (7,920 )
Barrick Gold Corp. Call 1/13/17 USD 17.50 1,000 (17,000 )
BP PLC — ADR Call 1/13/17 USD 36.50 540 (60,750 )
CF Industries Holdings, Inc. Call 1/13/17 USD 30.00 612 (120,258 )
Exxon Mobil Corp. Call 1/13/17 USD 90.00 284 (36,494 )
Hess Corp. Call 1/13/17 USD 58.00 267 (122,820 )
Occidental Petroleum Corp. Call 1/13/17 USD 73.50 219 (7,446 )
Pioneer Natural Resources Co. Call 1/13/17 USD 195.00 157 (8,242 )
Potash Corp. of Saskatchewan, Inc. Call 1/13/17 USD 19.00 1,600 (24,000 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/13/17 USD 53.00 520 (96,200 )
Schlumberger Ltd. Call 1/13/17 USD 86.50 97 (3,056 )
Agrium, Inc. Call 1/20/17 CAD 135.00 372 (58,322 )
Anadarko Petroleum Corp. Call 1/20/17 USD 65.00 451 (237,902 )
Baker Hughes, Inc. Call 1/20/17 USD 62.50 187 (61,523 )
Baker Hughes, Inc. Call 1/20/17 USD 65.00 128 (21,760 )
Barrick Gold Corp. Call 1/20/17 USD 19.00 1,000 (10,000 )
BP PLC — ADR Call 1/20/17 USD 35.00 548 (137,822 )
BP PLC — ADR Call 1/20/17 USD 37.00 547 (49,777 )
BRF SA — ADR Call 1/20/17 USD 15.00 330 (9,900 )
CF Industries Holdings, Inc. Call 1/20/17 USD 29.00 550 (160,050 )
CF Industries Holdings, Inc. Call 1/20/17 USD 32.00 500 (51,750 )
Chevron Corp. Call 1/20/17 USD 108.75 70 (67,479 )
Cimarex Energy Co. Call 1/20/17 USD 140.00 216 (44,820 )
ConocoPhillips Call 1/20/17 USD 46.00 426 (193,830 )
ConocoPhillips Call 1/20/17 USD 47.50 95 (29,212 )
Detour Gold Corp. Call 1/20/17 CAD 20.00 500 (15,268 )
Detour Gold Corp. Call 1/20/17 CAD 24.00 380 (2,264 )
Devon Energy Corp. Call 1/20/17 USD 45.00 447 (83,589 )
Enbridge, Inc. Call 1/20/17 CAD 58.00 615 (14,424 )
Eni SpA — ADR Call 1/20/17 USD 30.00 454 (111,230 )

See Notes to Financial Statements.

80 ANNUAL REPORT DECEMBER 31, 2016

Consolidated Schedule of Investments (continued) BlackRock Resources & Commodities Strategy Trust (BCX)

Description — EOG Resources, Inc. Call 1/20/17 USD 105.00 70 Value — $ (6,790 )
EOG Resources, Inc. Call 1/20/17 USD 95.00 204 (137,700 )
Exxon Mobil Corp. Call 1/20/17 USD 90.00 136 (20,944 )
Hess Corp. Call 1/20/17 USD 60.00 111 (38,018 )
International Paper Co. Call 1/20/17 USD 52.50 498 (66,483 )
Occidental Petroleum Corp. Call 1/20/17 USD 70.00 100 (21,900 )
Pioneer Natural Resources Co. Call 1/20/17 USD 180.00 5 (2,500 )
Pioneer Natural Resources Co. Call 1/20/17 USD 195.00 180 (16,650 )
Potash Corp. of Saskatchewan, Inc. Call 1/20/17 USD 18.00 880 (44,000 )
Rio Tinto PLC — ADR Call 1/20/17 USD 40.00 1,304 (74,980 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/20/17 USD 52.50 1,612 (382,850 )
Schlumberger Ltd. Call 1/20/17 USD 82.50 229 (61,716 )
Schlumberger Ltd. Call 1/20/17 USD 87.50 97 (4,850 )
Vale SA — ADR Call 1/20/17 USD 8.00 1,315 (27,615 )
Anadarko Petroleum Corp. Call 1/27/17 USD 75.00 326 (17,767 )
Baker Hughes, Inc. Call 1/27/17 USD 65.50 122 (36,112 )
Baker Hughes, Inc. Call 1/27/17 USD 66.50 187 (29,826 )
Baker Hughes, Inc. Call 1/27/17 USD 67.00 187 (51,892 )
Barrick Gold Corp. Call 1/27/17 USD 16.00 1,000 (86,500 )
BP PLC — ADR Call 1/27/17 USD 36.50 777 (106,449 )
CF Industries Holdings, Inc. Call 1/27/17 USD 33.00 275 (23,375 )
CF Industries Holdings, Inc. Call 1/27/17 USD 34.00 275 (15,538 )
Chevron Corp. Call 1/27/17 USD 118.00 70 (15,610 )
ConocoPhillips Call 1/27/17 USD 51.50 464 (42,224 )
ConocoPhillips Call 1/27/17 USD 52.00 285 (20,948 )
Deere & Co. Call 1/27/17 USD 102.00 149 (42,167 )
Devon Energy Corp. Call 1/27/17 USD 50.00 445 (15,798 )
EOG Resources, Inc. Call 1/27/17 USD 110.00 130 (5,460 )
Hess Corp. Call 1/27/17 USD 65.50 83 (11,288 )
International Paper Co. Call 1/27/17 USD 53.50 452 (45,652 )
Occidental Petroleum Corp. Call 1/27/17 USD 74.00 276 (17,388 )
Potash Corp. of Saskatchewan, Inc. Call 1/27/17 USD 19.00 1,500 (40,500 )
Potash Corp. of Saskatchewan, Inc. Call 1/27/17 USD 19.50 723 (16,268 )
Royal Dutch Shell PLC, A Shares — ADR Call 1/27/17 USD 53.00 753 (175,072 )
EOG Resources, Inc. Call 1/30/17 USD 96.00 131 (84,053 )
Vale SA — ADR Call 1/30/17 USD 8.50 3,220 (47,811 )
CF Industries Holdings, Inc. Call 2/03/17 USD 30.00 245 (61,618 )
CF Industries Holdings, Inc. Call 2/03/17 USD 31.00 368 (70,288 )
ConocoPhillips Call 2/03/17 USD 53.00 195 (14,040 )
Devon Energy Corp. Call 2/03/17 USD 48.50 4 (356 )
International Paper Co. Call 2/03/17 USD 54.50 238 (22,015 )
Vale SA — ADR Call 2/06/17 USD 9.10 3,000 (31,380 )
EOG Resources, Inc. Call 2/09/17 USD 105.00 89 (16,354 )
BP PLC — ADR Call 2/10/17 USD 37.50 821 (84,563 )
ConocoPhillips Call 2/10/17 USD 52.00 83 (9,545 )
Vale SA — ADR Call 2/15/17 USD 8.50 3,220 (76,688 )
Agrium, Inc. Call 2/17/17 CAD 135.00 375 (109,625 )
Barrick Gold Corp. Call 2/17/17 USD 17.00 1,000 (76,500 )
BP PLC — ADR Call 2/17/17 USD 37.00 1,677 (223,041 )
Chevron Corp. Call 2/17/17 USD 115.00 404 (195,940 )
ConocoPhillips Call 2/17/17 USD 49.00 290 (81,780 )
ConocoPhillips Call 2/17/17 USD 55.00 133 (6,850 )
Deere & Co. Call 2/17/17 USD 105.00 225 (68,962 )
Detour Gold Corp. Call 2/17/17 CAD 20.00 500 (32,771 )
Enbridge, Inc. Call 2/17/17 CAD 58.00 360 (23,327 )
EOG Resources, Inc. Call 2/17/17 USD 105.00 143 (35,607 )
Exxon Mobil Corp. Call 2/17/17 USD 92.50 103 (12,618 )
Hess Corp. Call 2/17/17 USD 60.00 453 (216,308 )
International Paper Co. Call 2/17/17 USD 52.50 498 (99,351 )
Schlumberger Ltd. Call 2/17/17 USD 87.50 134 (15,544 )
Vale SA — ADR Call 2/17/17 USD 8.00 2,500 (101,250 )
BP PLC — ADR Call 3/17/17 USD 38.00 821 (81,279 )
Total $ (6,047,790 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 81

Consolidated Schedule of Investments (continued) BlackRock Resources & Commodities Strategy Trust (BCX)

OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
Boliden AB Call Morgan Stanley & Co. International PLC 1/05/17 SEK 225.36 28,500 $ (38,129 )
Exxon Mobil Corp. Call Citibank N.A. 1/05/17 USD 89.45 19,200 (25,318 )
AGT Food & Ingredients, Inc. Call Citibank N.A. 1/06/17 CAD 38.00 20,000 (1,604 )
ArcelorMittal Call UBS AG 1/06/17 EUR 6.26 355,000 (275,192 )
Rio Tinto PLC — ADR Call Barclays Bank PLC 1/06/17 USD 34.10 80,400 (361,566 )
Royal Dutch Shell PLC, A Shares — ADR Call Goldman Sachs International 1/09/17 USD 50.50 104,000 (411,486 )
First Quantum Minerals Ltd. Call UBS AG 1/10/17 CAD 14.49 250,000 (27,062 )
Nevsun Resources Ltd. Call Citibank N.A. 1/10/17 CAD 4.34 250,000 (6,234 )
TFS Corp. Ltd. Call Citibank N.A. 1/10/17 AUD 1.48 200,000 (25,574 )
AGT Food & Ingredients, Inc. Call Morgan Stanley & Co. International PLC 1/11/17 CAD 37.07 18,000 (6,625 )
Detour Gold Corp. Call Deutsche Bank AG 1/11/17 CAD 20.02 50,000 (7,976 )
Golden Agri-Resources Ltd. Call Morgan Stanley & Co. International PLC 1/11/17 SGD 0.44 3,150,000 (24,954 )
Syngenta AG Call Bank of America N.A. 1/11/17 CHF 398.92 9,900 (71,389 )
TFS Corp. Ltd. Call Bank of America N.A. 1/11/17 AUD 1.75 250,000 (1,571 )
Elders Ltd. Call Goldman Sachs International 1/12/17 AUD 3.88 35,000 (2,928 )
Elders Ltd. Call UBS AG 1/17/17 AUD 3.89 75,000 (6,453 )
Packaging Corp. of America Call Goldman Sachs International 1/17/17 USD 86.10 49,300 (56,719 )
AGT Food & Ingredients, Inc. Call Deutsche Bank AG 1/18/17 CAD 35.68 20,000 (20,953 )
ArcelorMittal Call Credit Suisse International 1/18/17 EUR 7.22 360,000 (60,188 )
Elders Ltd. Call Deutsche Bank AG 1/18/17 AUD 4.06 100,000 (3,044 )
Glanbia PLC Call Morgan Stanley & Co. International PLC 1/18/17 EUR 15.75 16,000 (7,470 )
Glencore PLC Call Credit Suisse International 1/18/17 GBP 2.99 1,250,000 (23,750 )
Golden Agri-Resources Ltd. Call JPMorgan Chase Bank N.A. 1/18/17 SGD 0.44 3,150,000 (21,676 )
Lundin Mining Corp. Call Citibank N.A. 1/18/17 CAD 7.16 325,000 (6,763 )
Syngenta AG Call Morgan Stanley & Co. International PLC 1/18/17 CHF 412.24 14,500 (42,834 )
TFS Corp. Ltd. Call Deutsche Bank AG 1/18/17 AUD 1.52 200,000 (20,232 )
Yara International ASA Call Morgan Stanley & Co. International PLC 1/18/17 NOK 326.41 35,500 (74,163 )
Rio Tinto PLC — ADR Call Deutsche Bank AG 1/19/17 USD 36.58 51,200 (122,792 )
Boliden AB Call Morgan Stanley & Co. International PLC 1/24/17 SEK 242.56 64,400 (35,883 )
Glanbia PLC Call Morgan Stanley & Co. International PLC 1/24/17 EUR 15.82 16,000 (7,907 )
Glencore PLC Call Credit Suisse International 1/24/17 GBP 3.00 1,250,000 (32,952 )
Syngenta AG Call Morgan Stanley & Co. International PLC 1/24/17 CHF 416.22 14,500 (41,703 )
TFS Corp. Ltd. Call Goldman Sachs International 1/24/17 AUD 1.47 200,000 (27,338 )
AGT Food & Ingredients, Inc. Call Citibank N.A. 1/25/17 CAD 35.96 20,000 (20,288 )
Elders Ltd. Call Morgan Stanley & Co. International PLC 1/25/17 AUD 4.03 50,000 (2,331 )
Eni SpA — ADR Call Citibank N.A. 1/25/17 USD 30.68 26,100 (52,300 )
Golden Agri-Resources Ltd. Call Morgan Stanley & Co. International PLC 1/25/17 SGD 0.44 3,150,000 (25,204 )
Kerry Group PLC Call Bank of America N.A. 1/25/17 EUR 68.13 19,300 (34,037 )
Lundin Mining Corp. Call Morgan Stanley & Co. International PLC 1/25/17 CAD 7.19 325,000 (10,527 )
Rio Tinto PLC — ADR Call Deutsche Bank AG 1/25/17 USD 42.60 45,000 (7,790 )
TFS Corp. Ltd. Call Bank of America N.A. 1/25/17 AUD 1.77 250,000 (3,220 )
Detour Gold Corp. Call Morgan Stanley & Co. International PLC 1/26/17 CAD 17.48 75,000 (90,933 )
Royal Dutch Shell PLC, A Shares Call UBS AG 1/26/17 GBP 21.76 43,000 (50,127 )
Yara International ASA Call Bank of America N.A. 1/26/17 NOK 332.61 35,500 (63,109 )
MMC Norilsk Nickel PJSC — ADR Call Credit Suisse International 1/27/17 USD 16.84 70,000 (30,764 )
AGT Food & Ingredients, Inc. Call Goldman Sachs International 1/31/17 CAD 36.32 15,000 (14,153 )
BRF SA — ADR Call Goldman Sachs International 1/31/17 USD 15.03 33,000 (12,636 )
Elders Ltd. Call Bank of America N.A. 1/31/17 AUD 4.06 100,000 (4,578 )
Eni SpA — ADR Call JPMorgan Chase Bank N.A. 1/31/17 USD 30.75 45,300 (93,076 )
Packaging Corp. of America Call Citibank N.A. 1/31/17 USD 86.80 38,500 (55,094 )
Boliden AB Call UBS AG 2/01/17 SEK 252.62 38,700 (18,524 )
Glanbia PLC Call UBS AG 2/01/17 EUR 16.19 61,800 (25,638 )
ArcelorMittal Call Credit Suisse International 2/02/17 EUR 7.12 355,000 (122,928 )
Potash Corp. of Saskatchewan, Inc. Call Credit Suisse International 2/02/17 USD 17.75 158,000 (123,246 )
Rio Tinto PLC — ADR Call Goldman Sachs International 2/06/17 USD 39.35 39,200 (49,450 )
Rio Tinto PLC — ADR Call Morgan Stanley & Co. International PLC 2/06/17 USD 40.90 50,000 (33,642 )
Anadarko Petroleum Corp. Call Barclays Bank PLC 2/07/17 USD 70.90 17,500 (45,197 )
Enbridge, Inc. Call Goldman Sachs International 2/07/17 CAD 56.92 58,000 (53,440 )
Eni SpA — ADR Call Barclays Bank PLC 2/07/17 USD 32.02 40,000 (52,536 )
Glencore PLC Call Morgan Stanley & Co. International PLC 2/07/17 GBP 2.91 1,898,900 (144,501 )
Kerry Group PLC Call Bank of America N.A. 2/07/17 EUR 65.92 20,000 (74,219 )

See Notes to Financial Statements.

82 ANNUAL REPORT DECEMBER 31, 2016

Consolidated Schedule of Investments (continued) BlackRock Resources & Commodities Strategy Trust (BCX)

Description — MMC Norilsk Nickel PJSC — ADR Call Morgan Stanley & Co. International PLC 2/07/17 USD 17.38 292,700 Value — $ (74,893 )
MMC Norilsk Nickel PJSC — ADR Call UBS AG 2/07/17 USD 18.36 75,000 (8,726 )
TFS Corp. Ltd. Call Morgan Stanley & Co. International PLC 2/07/17 AUD 1.57 200,000 (17,115 )
AGT Food & Ingredients, Inc. Call Deutsche Bank AG 2/08/17 CAD 36.94 20,000 (16,365 )
Boliden AB Call UBS AG 2/08/17 SEK 254.08 60,000 (30,047 )
BRF SA — ADR Call Morgan Stanley & Co. International PLC 2/08/17 USD 14.15 72,500 (75,088 )
Golden Agri-Resources Ltd. Call Citibank N.A. 2/08/17 SGD 0.44 3,150,000 (37,260 )
First Quantum Minerals Ltd. Call Morgan Stanley & Co. International PLC 2/09/17 CAD 15.65 152,000 (29,435 )
Royal Dutch Shell PLC, A Shares Call Morgan Stanley & Co. International PLC 2/09/17 GBP 22.52 43,300 (33,321 )
Cimarex Energy Co. Call UBS AG 2/14/17 USD 138.00 16,400 (93,112 )
Lundin Mining Corp. Call Morgan Stanley & Co. International PLC 2/14/17 CAD 6.71 300,000 (54,052 )
MMC Norilsk Nickel PJSC —ADR Call Credit Suisse International 2/15/17 USD 17.36 120,000 (50,010 )
ArcelorMittal Call Credit Suisse International 2/16/17 EUR 7.67 355,000 (76,319 )
Packaging Corp. of America Call Citibank N.A. 2/22/17 USD 86.70 30,000 (77,569 )
TFS Corp. Ltd. Call Deutsche Bank AG 2/22/17 AUD 1.72 200,000 (7,402 )
Yara International ASA Call UBS AG 2/23/17 NOK 335.89 35,400 (70,434 )
First Quantum Minerals Ltd. Call UBS AG 2/27/17 CAD 14.95 225,000 (110,518 )
Enbridge, Inc. Call Deutsche Bank AG 3/06/17 CAD 58.60 36,000 (22,313 )
Total $ (4,097,895 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
Outstanding options at beginning of year 16,708,177 $ 7,049,614 — —
Options written 119,866,832 70,132,544 — —
Options exercised (429,982 ) (258,282 ) — —
Options expired (36,145,141 ) (18,398,998 ) — —
Options closed (75,471,371 ) (48,349,122 ) — —
Outstanding options at end of year 24,528,515 $ 10,175,756 — —

As of period end, the value of portfolio securities subject to covered call options written was $321,719,890.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Commodity Contracts Credit Contracts Foreign Currency Exchange Contracts Interest Rate Contracts
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $10,145,685 — — $10,145,685

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 83

Consolidated Schedule of Investments (continued) BlackRock Resources & Commodities Strategy Trust (BCX)

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: Commodity Contracts Credit Contracts Equity Contracts Foreign Currency Exchange Contracts Interest Rate Contracts Total
Options purchased 1 — — $ (22,559 ) — — $ (22,559 )
Options written — — (36,777,894 ) — — (36,777,894 )
Total — — $ (36,800,453 ) — — $ (36,800,453 )
Net Change in Unrealized Appreciation (Depreciation) on:
Options purchased 2 — — $ 2,849 — — $ 2,849
Options written — — (1,642,793 ) — — (1,642,793 )
Total — — $ (1,639,944 ) — — $ (1,639,944 )

1 Options purchased are included in net realized gain (loss) from investments.

2 Options purchased are included in net change in unrealized appreciation (depreciation) on investments.

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Options:
Average value of option contracts
purchased 1 $ 18,030
Average value of option contracts written $ 10,740,231

1 Actual amounts for the period are shown due to limited outstanding derivative financial instruments as of each quarter.

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments - Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Liabilities
Derivative Financial Instruments:
Options — $ 10,145,685
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — $ (6,047,790 )
Total derivative assets and liabilities subject to an MNA — $ 4,097,895

The following table presents the Trust’s derivative liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (MNA) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not Offset in the Consolidated Statements of Assets and
Liabilities and Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged 1 | Cash Collateral Pledged | Net Amount of Derivative Liabilities 2 | |
| --- | --- | --- | --- | --- | --- | --- |
| Bank of America N.A. | $ 252,123 | — | $ (252,123 | ) | — | — |
| Barclays Bank PLC | 459,299 | — | (459,299 | ) | — | — |
| Citibank N.A. | 308,004 | — | (308,004 | ) | — | — |
| Credit Suisse International | 520,157 | — | (520,157 | ) | — | — |
| Deutsche Bank AG | 228,867 | — | (228,867 | ) | — | — |
| Goldman Sachs International | 628,150 | — | (549,236 | ) | — | $ 78,914 |
| JPMorgan Chase Bank N.A. | 114,752 | — | — | | — | 114,752 |
| Morgan Stanley & Co. International PLC | 870,710 | — | (870,710 | ) | — | — |
| UBS AG | 715,833 | — | (715,833 | ) | — | — |
| Total | $4,097,895 | — | $ (3,904,229 | ) | — | $ 193,666 |

1 Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Consolidated Statements of Assets and Liabilities.

See Notes to Financial Statements.

84 ANNUAL REPORT DECEMBER 31, 2016

Consolidated Schedule of Investments (concluded) BlackRock Resources & Commodities Strategy Trust (BCX)

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Level 1 Level 2 Total
Assets:
Investments:
Long-Term Investments:
Common Stocks:
Chemicals $ 119,693,831 $ 59,149,169 — $ 178,843,000
Containers & Packaging 54,614,832 — — 54,614,832
Energy Equipment & Services 26,904,612 — — 26,904,612
Food & Staples Retailing 20,172,825 — — 20,172,825
Food Products 33,522,047 20,256,233 — 53,778,280
Independent Power and Renewable Electricity Producers — — $ 1 1
Machinery 9,643,204 — — 9,643,204
Metals & Mining 183,019,162 105,931,847 — 288,951,009
Oil, Gas & Consumable Fuels 317,245,538 14,172,621 — 331,418,159
Paper & Forest Products — 9,571,128 — 9,571,128
Short-Term Securities 12,603,929 — — 12,603,929
Subtotal $ 777,419,980 $ 209,080,998 $ 1 $ 986,500,979
Investments Valued at NAV 1 3,937,262
Total Investments $ 990,438,241
Derivative Financial Instruments 2
Liabilities:
Equity contracts $ (5,653,696 ) $ (4,491,989 ) — $ (10,145,685 )

1 As of December 31, 2016, certain of the Fund’s investments were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

2 Derivative financial instruments are options written, which are shown at value.

Transfers out of Level 1 1 Transfers into Level 2 1
Assets:
Long-Term Investments:
Common Stocks — $ (15,470,918 ) $ 15,470,918 —

1 External pricing service used to reflect any significant market movements between the time the Trust valued such foreign securities and the earlier closing of foreign markets.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 85

Schedule of Investments December 31, 2015
(Percentages shown are based on Net Assets)
Common Stocks Value
Communications Equipment — 1.1%
Juniper Networks, Inc. (a) 106,100 $ 2,998,387
Quantenna Communications, Inc. (b) 119,773 2,171,484
5,169,871
Diversified Telecommunication Services — 0.5%
Zayo Group Holdings, Inc. (b) 62,600 2,057,036
Electronic Equipment, Instruments & Components — 2.3%
Coherent, Inc. (a)(b) 19,700 2,706,486
Fabrinet (a)(b) 44,500 1,793,350
Flex Ltd. (a)(b) 185,400 2,664,198
Largan Precision Co. Ltd. 26,000 3,030,596
10,194,630
Equity Real Estate Investment Trusts (REITs) — 4.3%
Crown Castle International Corp. (a) 78,800 6,837,476
CyrusOne, Inc. (a) 99,600 4,455,108
Equinix, Inc. (a) 22,451 8,024,212
19,316,796
Household Durables — 0.9%
Sony Corp. 140,700 3,931,430
Internet & Direct Marketing Retail — 6.8%
Amazon.com, Inc. (a)(b) 25,300 18,971,711
Ensogo Ltd. (b) 173,282 —
Expedia, Inc. (a) 22,400 2,537,472
Netflix, Inc. (a)(b) 35,220 4,360,236
Priceline Group, Inc. (a)(b) 2,300 3,371,938
Yoox Net-A-Porter Group SpA (b) 61,500 1,739,046
30,980,403
Internet Software & Services — 20.0%
Akamai Technologies, Inc. (a)(b) 45,800 3,053,944
Alibaba Group Holding Ltd. — ADR (a)(b) 136,300 11,968,503
Alphabet, Inc., Class A (a)(b) 36,400 28,845,180
Coupa Software, Inc. (a)(b) 55,195 1,380,427
Criteo SA - ADR (a)(b) 49,400 2,029,352
Facebook, Inc., Class A (a)(b) 133,000 15,301,650
GoDaddy, Inc., Class A (a)(b) 56,000 1,957,200
MercadoLibre, Inc. (a) 22,900 3,575,606
Shopify, Inc., Class A (a)(b) 62,600 2,683,662
Takeaway.com Holding BV (b)(c) 47,800 1,182,812
Tencent Holdings Ltd. 643,200 15,595,744
Yandex NV, Class A (a)(b) 142,700 2,872,551
90,446,631
IT Services — 10.9%
Cielo SA 249,200 2,135,431
Computer Sciences Corp. (a) 49,800 2,959,116
Euronet Worldwide, Inc. (a)(b) 31,100 2,252,573
Fidelity National Information Services, Inc. 53,200 4,024,048
Global Payments, Inc. (a) 49,200 3,414,972
InterXion Holding NV (a)(b) 91,600 3,212,412
Mastercard, Inc., Class A (a) 100,200 10,345,650
PayPal Holdings, Inc. (a)(b) 93,200 3,678,604
Square, Inc., Class A (a)(b) 298,700 4,071,281
Visa, Inc., A Shares (a) 142,400 11,110,048
Wirecard AG 49,800 2,136,801
49,340,936
Media — 2.1%
Comcast Corp., Class A (a) 39,200 2,706,760
Eros International PLC (b)(d) 132,805 1,733,105
Common Stocks Value
Media (continued)
Naspers Ltd., N Shares 35,000 $ 5,109,708
9,549,573
Professional Services — 0.4%
Equifax, Inc. (a) 15,900 1,879,857
Semiconductors & Semiconductor Equipment — 19.4%
Advanced Micro Devices, Inc. (a)(b) 325,300 3,688,902
Applied Materials, Inc. (a) 140,400 4,530,708
ASML Holding NV 74,800 8,382,898
BE Semiconductor Industries NV 59,300 1,972,560
Broadcom Ltd. (a) 64,196 11,347,927
Dialog Semiconductor PLC (b) 62,200 2,613,336
Lam Research Corp. (a) 55,600 5,878,588
MACOM Technology Solutions Holdings, Inc. (a)(b) 55,400 2,563,912
Maxim Integrated Products, Inc. (a) 71,000 2,738,470
Megachips Corp. 107,700 2,380,304
Micron Technology, Inc. (a)(b) 135,700 2,974,544
Microsemi Corp. (a)(b) 49,100 2,649,927
Monolithic Power Systems, Inc. (a) 23,700 1,941,741
NVIDIA Corp. (a) 77,100 8,229,654
NXP Semiconductors NV (b) 56,600 5,547,366
Silicon Laboratories, Inc. (b) 33,300 2,164,500
Skyworks Solutions, Inc. (a) 47,600 3,553,816
SOITEC (b) 1,847,500 2,854,802
STMicroelectronics NV 405,400 4,595,001
Taiwan Semiconductor Manufacturing Co. Ltd. 1,278,000 7,158,405
87,767,361
Software — 20.7%
Activision Blizzard, Inc. (a) 148,000 5,344,280
Adobe Systems, Inc. (a)(b) 60,400 6,218,180
Altium Ltd. 223,000 1,299,795
Autodesk, Inc. (a)(b) 64,500 4,773,645
Blackline, Inc. (b) 62,015 1,713,474
Electronic Arts, Inc. (a)(b) 67,600 5,324,176
ESI Group (b) 30,000 1,427,083
Gridsum Holding, Inc. — ADR (b) 185,244 1,887,636
HubSpot, Inc. (a)(b) 41,400 1,945,800
Intuit, Inc. (a) 19,700 2,257,817
Linx SA 395,900 2,110,445
Microsoft Corp. (a) 423,000 26,285,220
Nintendo Co. Ltd. 35,900 7,462,727
Oracle Corp. (a) 56,600 2,176,270
Proofpoint, Inc. (a)(b) 47,200 3,334,680
PTC, Inc. (a)(b) 59,900 2,771,573
salesforce.com, Inc. (a)(b) 117,800 8,064,588
Symantec Corp. (a) 92,700 2,214,603
Take-Two Interactive Software, Inc. (a)(b) 82,200 4,051,638
Xero Ltd. (b) 123,900 1,504,218
Zendesk, Inc. (a)(b) 79,400 1,683,280
93,851,128
Technology Hardware, Storage & Peripherals — 7.0%
Apple, Inc. (a) 231,400 26,800,748
Samsung Electronics Co. Ltd. 3,300 4,911,433
31,712,181
Total Common Stocks — 96.4% 436,197,833

See Notes to Financial Statements.

86 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Science and Technology Trust (BST)

Preferred Stocks Value
Internet & Direct Marketing Retail — 0.6%
Jasper Infotech Private Ltd., Series I (Acquired 8/18/15, Cost
1,998,435) (b)(e) 1,054 $ 2,570,706
Internet Software & Services — 2.6%
Uber Technologies, Inc., Series E (Acquired 12/4/14, Cost $3,000,048), 0.00% (b)(e) 90,044 4,449,074
Xiaoju Kuaizhi, Inc., Series A-17 (Acquired 7/28/15, Cost $3,016,964) (b)(e) 110,003 4,205,415
Zuora, Inc. (Acquired 1/16/15, Cost $3,894,522), 0.00% (b)(e) 1,025,063 3,290,452
11,944,941
Software — 0.3%
Illumio, Inc., Series C (Acquired 3/11/15, Cost $1,500,001),
0.00% (b)(e) 466,730 1,442,196
Total Preferred Stocks — 3.5% 15,957,843
Total Long-Term Investments (Cost — $355,438,442) — 99.9% 452,155,676
Short-Term Securities — BlackRock Liquidity Funds, T-Fund, Institutional Class, 0.36% (f)(g) 2,902,077 Value — $ 2,902,077
SL Liquidity Series, LLC Money Market Series, 0.95% (f)(g)(h) 128,952 128,965
Total Short-Term Securities (Cost — $3,031,030) — 0.7% 3,031,042
Total Investments Before Options
Written (Cost — $358,469,472) — 100.6% 455,186,718
Options Written
(Premiums Received — $4,136,623) — (0.8)% (3,450,347 )
Total Investments Net of Options Written — 99.8% 451,736,371
Other Assets Less Liabilities — 0.2% 706,610
Net Assets — 100.0% $ 452,442,981

Notes to Schedule of Investments

(a) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(b) Non-income producing security.

(c) Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(d) Security, or a portion of security, is on loan.

(e) Restricted security as to resale, excluding 144A securities. As of report date, the Trust held restricted securities with a current value of $15,957,843 and an original cost of $13,409,970 which was 3.5% of its net assets.

(f) Current yield as of period end.

(g) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliates — BlackRock Liquidity Funds, TempFund, Institutional Class 604,146 (604,146 — — $ 5,708 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 2,902,077 2,902,077 $2,902,077 1,787 $ 11
SL Liquidity Series, LLC, Money Market Series 119,000 9,952 128,952 128,965 125,365 1 123
Total $3,031,042 $132,860 $134

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

(h) Security was purchased with the cash collateral from loaned securities.

• For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Akamai Technologies, Inc. Call 1/06/17 USD 65.00 50 $ (10,000 )
Alibaba Group Holding Ltd. — ADR Call 1/06/17 USD 94.50 63 (284 )
Amazon.com, Inc. Call 1/06/17 USD 765.00 59 (18,732 )
Apple, Inc. Call 1/06/17 USD 115.00 57 (8,806 )
Broadcom Ltd. Call 1/06/17 USD 175.00 50 (17,750 )
Comcast Corp., Class A Call 1/06/17 USD 70.50 130 (2,730 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 87

Schedule of Investments (continued) BlackRock Science and Technology Trust (BST)

Description — Electronic Arts, Inc. Call Expiration Date — 1/06/17 USD 79.00 90 Value — $ (8,730 )
Expedia, Inc. Call 1/06/17 USD 128.00 31 (155 )
Facebook, Inc., Class A Call 1/06/17 USD 121.00 37 (278 )
Mastercard, Inc., Class A Call 1/06/17 USD 104.00 55 (3,328 )
Mastercard, Inc., Class A Call 1/06/17 USD 105.00 59 (1,976 )
Microsoft Corp. Call 1/06/17 USD 60.50 281 (51,142 )
Netflix, Inc. Call 1/06/17 USD 122.00 76 (21,736 )
PayPal Holdings, Inc. Call 1/06/17 USD 40.00 58 (1,102 )
PayPal Holdings, Inc. Call 1/06/17 USD 40.50 102 (663 )
salesforce.com, Inc. Call 1/06/17 USD 74.00 32 (240 )
salesforce.com, Inc. Call 1/06/17 USD 75.00 122 (793 )
Skyworks Solutions, Inc. Call 1/06/17 USD 82.50 105 (4,725 )
Symantec Corp. Call 1/06/17 USD 25.00 81 (446 )
Visa, Inc., A Shares Call 1/06/17 USD 80.00 153 (1,760 )
GoDaddy, Inc., Class A Call 1/09/17 USD 34.51 204 (18,077 )
Alibaba Group Holding Ltd. — ADR Call 1/11/17 USD 97.50 56 (146 )
Apple, Inc. Call 1/11/17 USD 113.00 43 (14,571 )
Activision Blizzard, Inc. Call 1/13/17 USD 38.00 164 (3,198 )
Advanced Micro Devices, Inc. Call 1/13/17 USD 8.50 160 (48,880 )
Akamai Technologies, Inc. Call 1/13/17 USD 67.50 50 (4,425 )
Alibaba Group Holding Ltd. — ADR Call 1/13/17 USD 94.50 56 (1,176 )
Apple, Inc. Call 1/13/17 USD 113.00 43 (15,050 )
Apple, Inc. Call 1/13/17 USD 114.00 44 (12,034 )
Comcast Corp., Class A Call 1/13/17 USD 70.00 7 (472 )
Electronic Arts, Inc. Call 1/13/17 USD 82.50 100 (3,650 )
Expedia, Inc. Call 1/13/17 USD 128.00 48 (480 )
Facebook, Inc., Class A Call 1/13/17 USD 122.00 38 (760 )
Juniper Networks, Inc. Call 1/13/17 USD 29.00 185 (3,978 )
Mastercard, Inc., Class A Call 1/13/17 USD 106.00 42 (2,163 )
Microsoft Corp. Call 1/13/17 USD 61.00 153 (24,327 )
Microsoft Corp. Call 1/13/17 USD 61.50 153 (18,819 )
PayPal Holdings, Inc. Call 1/13/17 USD 40.00 58 (2,204 )
PayPal Holdings, Inc. Call 1/13/17 USD 40.50 16 (344 )
PayPal Holdings, Inc. Call 1/13/17 USD 41.00 57 (741 )
salesforce.com, Inc. Call 1/13/17 USD 72.00 96 (2,976 )
salesforce.com, Inc. Call 1/13/17 USD 74.00 31 (558 )
Visa, Inc., A Shares Call 1/13/17 USD 80.00 177 (6,460 )
Yandex NV, Class A Call 1/13/17 USD 21.00 120 (4,500 )
CyrusOne, Inc. Call 1/17/17 USD 42.00 177 (56,891 )
Equinix, Inc. Call 1/19/17 USD 345.00 44 (75,048 )
Proofpoint, Inc. Call 1/19/17 USD 87.10 84 (208 )
Activision Blizzard, Inc. Call 1/20/17 USD 40.00 368 (3,312 )
Adobe Systems, Inc. Call 1/20/17 USD 105.00 100 (10,750 )
Advanced Micro Devices, Inc. Call 1/20/17 USD 11.00 426 (38,979 )
Alibaba Group Holding Ltd. — ADR Call 1/20/17 USD 97.50 92 (1,288 )
Alphabet, Inc., Class A Call 1/20/17 USD 820.00 67 (25,460 )
Amazon.com, Inc. Call 1/20/17 USD 770.00 28 (23,170 )
Apple, Inc. Call 1/20/17 USD 115.00 124 (29,388 )
Apple, Inc. Call 1/20/17 USD 117.00 50 (6,625 )
Applied Materials, Inc. Call 1/20/17 USD 31.00 170 (28,390 )
Applied Materials, Inc. Call 1/20/17 USD 32.00 180 (18,090 )
Autodesk, Inc. Call 1/20/17 USD 77.50 121 (13,250 )
Autodesk, Inc. Call 1/20/17 USD 82.50 84 (3,066 )
Broadcom Ltd. Call 1/20/17 USD 185.00 125 (18,438 )
Coherent, Inc. Call 1/20/17 USD 135.00 8 (4,640 )
Computer Sciences Corp. Call 1/20/17 USD 62.50 166 (4,980 )
Coupa Software, Inc. Call 1/20/17 USD 30.00 193 (3,860 )
Criteo SA — ADR Call 1/20/17 USD 45.00 170 (13,600 )
Crown Castle International Corp. Call 1/20/17 USD 87.50 103 (15,708 )
CyrusOne, Inc. Call 1/20/17 USD 45.00 171 (18,382 )
Electronic Arts, Inc. Call 1/20/17 USD 80.00 107 (14,712 )
Equifax, Inc. Call 1/20/17 USD 125.00 48 (1,440 )
Fabrinet Call 1/20/17 USD 45.00 155 (2,712 )
Facebook, Inc., Class A Call 1/20/17 USD 120.00 200 (14,400 )
Global Payments, Inc. Call 1/20/17 USD 75.00 60 (3,450 )

See Notes to Financial Statements.

88 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Science and Technology Trust (BST)

Description — HubSpot, Inc. Call Expiration Date — 1/20/17 USD 60.00 135 Value — $ (6,750 )
InterXion Holding NV Call 1/20/17 USD 35.00 84 (7,770 )
InterXion Holding NV Call 1/20/17 USD 36.00 236 (11,210 )
Intuit, Inc. Call 1/20/17 USD 120.00 70 (1,925 )
Lam Research Corp. Call 1/20/17 USD 105.00 74 (22,570 )
Lam Research Corp. Call 1/20/17 USD 115.00 120 (2,700 )
MACOM Technology Solutions Holdings, Inc. Call 1/20/17 USD 50.00 55 (2,612 )
Mastercard, Inc., Class A Call 1/20/17 USD 105.00 153 (16,524 )
Maxim Integrated Products, Inc. Call 1/20/17 USD 40.00 124 (6,510 )
MercadoLibre, Inc. Call 1/20/17 USD 165.00 102 (15,555 )
Microsemi Corp. Call 1/20/17 USD 60.00 170 (8,925 )
Microsoft Corp. Call 1/20/17 USD 60.00 69 (17,422 )
Microsoft Corp. Call 1/20/17 USD 62.50 430 (36,980 )
Monolithic Power Systems, Inc. Call 1/20/17 USD 90.00 48 (5,280 )
Netflix, Inc. Call 1/20/17 USD 130.00 47 (20,680 )
NVIDIA Corp. Call 1/20/17 USD 90.00 280 (487,900 )
Oracle Corp. Call 1/20/17 USD 42.00 200 (200 )
PayPal Holdings, Inc. Call 1/20/17 USD 40.00 152 (8,816 )
PayPal Holdings, Inc. Call 1/20/17 USD 41.00 57 (1,539 )
Priceline Group, Inc. Call 1/20/17 USD 1,510.00 4 (4,220 )
Proofpoint, Inc. Call 1/20/17 USD 75.00 48 (3,840 )
PTC, Inc. Call 1/20/17 USD 50.00 105 (4,725 )
salesforce.com, Inc. Call 1/20/17 USD 75.00 31 (574 )
Shopify, Inc., Class A Call 1/20/17 USD 45.00 113 (9,040 )
Square, Inc., Class A Call 1/20/17 USD 13.00 680 (54,400 )
Square, Inc., Class A Call 1/20/17 USD 14.00 315 (7,875 )
Symantec Corp. Call 1/20/17 USD 25.00 81 (1,256 )
Take-Two Interactive Software, Inc. Call 1/20/17 USD 49.00 145 (20,662 )
Yandex NV, Class A Call 1/20/17 USD 20.00 100 (7,250 )
Advanced Micro Devices, Inc. Call 1/27/17 USD 11.00 416 (47,008 )
Advanced Micro Devices, Inc. Call 1/27/17 USD 13.00 11 (456 )
Akamai Technologies, Inc. Call 1/27/17 USD 69.50 60 (4,410 )
Alibaba Group Holding Ltd. — ADR Call 1/27/17 USD 94.50 118 (12,390 )
Alphabet, Inc., Class A Call 1/27/17 USD 830.00 29 (31,610 )
Amazon.com, Inc. Call 1/27/17 USD 782.50 42 (47,985 )
Apple, Inc. Call 1/27/17 USD 113.00 75 (34,875 )
Applied Materials, Inc. Call 1/27/17 USD 33.00 280 (18,480 )
Broadcom Ltd. Call 1/27/17 USD 182.50 50 (13,875 )
Electronic Arts, Inc. Call 1/27/17 USD 85.00 74 (3,108 )
Juniper Networks, Inc. Call 1/27/17 USD 29.50 185 (17,853 )
Mastercard, Inc., Class A Call 1/27/17 USD 106.00 42 (4,599 )
Micron Technology, Inc. Call 1/27/17 USD 22.50 192 (13,248 )
Microsoft Corp. Call 1/27/17 USD 64.00 394 (40,188 )
PayPal Holdings, Inc. Call 1/27/17 USD 41.50 15 (818 )
Priceline Group, Inc. Call 1/27/17 USD 1,525.00 4 (4,160 )
salesforce.com, Inc. Call 1/27/17 USD 76.00 100 (3,050 )
Skyworks Solutions, Inc. Call 1/27/17 USD 80.50 30 (4,125 )
Symantec Corp. Call 1/27/17 USD 25.00 162 (3,807 )
Visa, Inc., A Shares Call 1/27/17 USD 82.00 168 (9,828 )
Yandex NV, Class A Call 1/27/17 USD 21.00 180 (8,550 )
Coherent, Inc. Call 2/02/17 USD 126.50 70 (103,882 )
Alphabet, Inc., Class A Call 2/03/17 USD 815.00 31 (53,940 )
Applied Materials, Inc. Call 2/03/17 USD 33.50 142 (8,307 )
Zendesk, Inc. Call 2/06/17 USD 24.00 160 (4,318 )
Flex Ltd. Call 2/08/17 USD 14.80 288 (6,676 )
Advanced Micro Devices, Inc. Call 2/10/17 USD 12.00 125 (10,625 )
Yandex NV, Class A Call 2/10/17 USD 21.00 100 (5,500 )
Shopify, Inc., Class A Call 2/14/17 USD 45.00 106 (16,220 )
Alibaba Group Holding Ltd. — ADR Call 2/17/17 USD 105.00 92 (2,668 )
Amazon.com, Inc. Call 2/17/17 USD 785.00 8 (16,680 )
Apple, Inc. Call 2/17/17 USD 120.00 373 (71,989 )
Coherent, Inc. Call 2/17/17 USD 135.00 30 (32,400 )
Euronet Worldwide, Inc. Call 2/17/17 USD 80.00 37 (3,145 )
Facebook, Inc., Class A Call 2/17/17 USD 120.00 200 (60,500 )
Global Payments, Inc. Call 2/17/17 USD 75.00 112 (11,760 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 89

Schedule of Investments (continued) BlackRock Science and Technology Trust (BST)

Description — GoDaddy, Inc., Class A Call 2/17/17 USD 37.00 104 Value — $ (9,620 )
MACOM Technology Solutions Holdings, Inc. Call 2/17/17 USD 45.00 248 (90,520 )
Maxim Integrated Products, Inc. Call 2/17/17 USD 40.00 124 (9,920 )
Micron Technology, Inc. Call 2/17/17 USD 24.00 283 (14,858 )
Proofpoint, Inc. Call 2/17/17 USD 75.00 48 (12,960 )
Proofpoint, Inc. Call 2/17/17 USD 80.00 80 (10,800 )
PTC, Inc. Call 2/17/17 USD 50.00 105 (9,712 )
Skyworks Solutions, Inc. Call 2/17/17 USD 80.00 30 (6,150 )
Amazon.com, Inc. Call 3/17/17 USD 785.00 2 (5,210 )
Equinix, Inc. Call 3/17/17 USD 370.00 34 (40,970 )
MercadoLibre, Inc. Call 3/17/17 USD 165.00 22 (16,170 )
Total $ (2,551,235 )
OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
Flex Ltd. Call Barclays Bank PLC 1/05/17 USD 14.14 36,000 $ (10,716 )
Naspers Ltd., N Shares Call Morgan Stanley & Co. International PLC 1/10/17 ZAR 2,192.90 1,100 (280 )
Xero Ltd. Call Deutsche Bank AG 1/12/17 NZD 19.65 2,000 (3 )
Tencent Holdings Ltd. Call Goldman Sachs International 1/13/17 HKD 204.69 47,000 (1,218 )
Fidelity National Information Services, Inc. Call Bank of America N.A. 1/17/17 USD 76.21 19,200 (22,539 )
Altium Ltd. Call Morgan Stanley & Co. International PLC 1/18/17 AUD 8.70 122,300 (5,447 )
ASML Holding NV Call Morgan Stanley & Co. International PLC 1/18/17 EUR 100.37 22,000 (160,933 )
Dialog Semiconductor PLC Call UBS AG 1/18/17 EUR 39.06 11,700 (20,483 )
ESI Group Call UBS AG 1/18/17 EUR 48.04 10,500 (2,055 )
Largan Precision Co. Ltd. Call Bank of America N.A. 1/18/17 TWD 3,841.90 9,000 (25,279 )
Nintendo Co. Ltd. Call Bank of America N.A. 1/18/17 JPY 28,507.25 4,200 (1,224 )
Sony Corp. Call JPMorgan Chase Bank N.A. 1/18/17 JPY 3,382.02 43,500 (15,046 )
Taiwan Semiconductor Manufacturing Co. Ltd. Call Goldman Sachs International 1/18/17 TWD 182.39 102,000 (6,829 )
Taiwan Semiconductor Manufacturing Co. Ltd. Call JPMorgan Chase Bank N.A. 1/18/17 TWD 190.64 96,000 (733 )
STMicroelectronics NV Call Credit Suisse International 1/19/17 EUR 10.47 7,900 (4,001 )
STMicroelectronics NV Call UBS AG 1/19/17 EUR 11.26 7,900 (1,058 )
Eros International PLC Call Barclays Bank PLC 1/23/17 USD 16.75 26,000 (731 )
Euronet Worldwide, Inc. Call Barclays Bank PLC 1/23/17 USD 75.30 13,400 (7,864 )
Silicon Laboratories, Inc. Call Citibank N.A. 1/23/17 USD 67.25 6,200 (5,193 )
BE Semiconductor Industries NV Call Morgan Stanley & Co. International PLC 1/24/17 EUR 33.25 20,700 (4,706 )
Monolithic Power Systems, Inc. Call Barclays Bank PLC 1/24/17 USD 83.10 8,200 (13,621 )
Yoox Net-A-Porter Group SpA Call Morgan Stanley & Co. International PLC 1/25/17 EUR 26.92 22,000 (19,005 )
Naspers Ltd., N Shares Call UBS AG 1/26/17 ZAR 2,090.40 2,800 (8,351 )
Nintendo Co. Ltd. Call Bank of America N.A. 1/26/17 JPY 25,756.50 8,400 (34,305 )
SOITEC Call Bank of America N.A. 1/26/17 EUR 1.54 323,000 (16,829 )
Take-Two Interactive Software, Inc. Call Barclays Bank PLC 1/31/17 USD 50.85 14,200 (12,935 )
ASML Holding NV Call UBS AG 2/01/17 EUR 106.76 4,100 (13,774 )
Xero Ltd. Call Deutsche Bank AG 2/01/17 NZD 18.04 2,000 (468 )
Adobe Systems, Inc. Call Barclays Bank PLC 2/02/17 USD 104.13 11,100 (21,409 )
Taiwan Semiconductor Manufacturing Co. Ltd. Call Bank of America N.A. 2/03/17 TWD 189.21 249,000 (7,495 )
Zayo Group Holdings, Inc. Call Barclays Bank PLC 2/06/17 USD 33.31 17,200 (22,216 )
SOITEC Call UBS AG 2/07/17 EUR 1.55 324,000 (21,181 )
STMicroelectronics NV Call Morgan Stanley & Co. International PLC 2/08/17 EUR 10.99 126,000 (50,648 )
Dialog Semiconductor PLC Call UBS AG 2/09/17 EUR 41.05 10,000 (16,857 )
Naspers Ltd., N Shares Call UBS AG 2/09/17 ZAR 2,089.53 8,300 (38,142 )
Samsung Electronics Co. Ltd. Call Goldman Sachs International 2/09/17 KRW 1,801,320.00 1,100 (66,798 )
Sony Corp. Call Goldman Sachs International 2/09/17 JPY 3,445.56 6,000 (2,653 )
Tencent Holdings Ltd. Call Bank of America N.A. 2/09/17 HKD 189.47 179,000 (122,201 )
Xero Ltd. Call Deutsche Bank AG 2/09/17 NZD 18.03 1,000 (280 )
Eros International PLC Call Barclays Bank PLC 2/14/17 USD 14.32 25,600 (13,873 )
Crown Castle International Corp. Call Bank of America N.A. 2/22/17 USD 88.09 17,100 (41,162 )
Silicon Laboratories, Inc. Call Morgan Stanley & Co. International PLC 2/23/17 USD 69.53 5,400 (9,618 )
Zayo Group Holdings, Inc. Call Barclays Bank PLC 2/23/17 USD 33.31 17,200 (27,452 )

See Notes to Financial Statements.

90 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Science and Technology Trust (BST)

Description — Yoox Net-A-Porter Group SpA Call Goldman Sachs International 2/24/17 EUR 27.69 11,900 Value — $ (11,236 )
BE Semiconductor Industries NV Call UBS AG 2/28/17 EUR 32.93 11,900 (10,265 )
Total $ (899,112 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
Outstanding options at beginning of year 5,291,725 $ 4,168,452 — —
Options written 27,045,961 36,926,519 261,878 $ 653,524
Options exercised (1,818 ) (174,500) (7,577 ) (132,869 )
Options expired (12,346,386 ) (10,808,240) (144,975 ) (420,333 )
Options closed (17,957,160 ) (25,975,608) (109,326 ) (100,322 )
Outstanding options at end of year 2,032,322 $ 4,136,623 — —

As of period end, the value of portfolio securities subject to covered call options written was $155,795,423.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Commodity Contracts Equity Contracts Total
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $ 3,450,347 — — $ 3,450,347

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: Commodity Contracts Credit Contracts Equity Contracts Foreign Currency Exchange Contracts Interest Rate Contracts Total
Options purchased 1 — — $ (5,993 ) — — $ (5,993 )
Options written — — (2,474,731 ) — — (2,474,731 )
Total — — $ (2,480,724 ) — — $ (2,480,724 )
Net Change in Unrealized Appreciation (Depreciation)
on:
Options written — — $ (783,027 ) — — $ (783,027 )

1 Options purchased are included in net realized gain (loss) from investments.

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Options:
Average value of option contracts
purchased 1 $ 5,993
Average value of option contracts written $ 4,646,316

1 Actual amounts for the period are shown due to limited outstanding derivative financial instruments as of each quarter.

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 91

Schedule of Investments (continued) BlackRock Science and Technology Trust (BST)

Derivative Financial Instruments — Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Assets Liabilities
Derivative Financial Instruments:
Options — $ 3,450,347
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — (2,551,235 )
Total derivative assets and liabilities subject to an MNA — $ 899,112

The following table presents the Trust’s derivative liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (“MNA”) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not Offset in the Consolidated Statements of Assets and
Liabilities and Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged | Cash Collateral Pledged 1 | Net Amount of Derivative Liabilities 2 | |
| --- | --- | --- | --- | --- | --- | --- |
| Bank of America N.A. | $271,034 | — | — | $ (271,034 | ) | — |
| Barclays Bank PLC | 130,817 | — | — | — | | $130,817 |
| Citibank N.A. | 5,193 | — | — | (5,193 | ) | — |
| Credit Suisse International | 4,001 | — | — | — | | 4,001 |
| Deutsche Bank AG | 751 | — | — | (751 | ) | — |
| Goldman Sachs International | 88,734 | — | — | — | | 88,734 |
| JPMorgan Chase Bank N.A. | 15,779 | — | — | — | | 15,779 |
| Morgan Stanley & Co. International PLC | 250,637 | — | — | (250,637 | ) | — |
| UBS AG | 132,166 | — | — | (110,000 | ) | 22,166 |
| Total | $899,112 | — | — | $ (637,615 | ) | $261,497 |

1 Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities.

See Notes to Financial Statements.

92 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Science and Technology Trust (BST)

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Assets:
Investments:
Long-Term Investments:
Common Stocks:
Communications Equipment $ 5,169,871 — — $ 5,169,871
Diversified Telecommunication Services 2,057,036 — — 2,057,036
Electronic Equipment, Instruments & Components 7,164,034 $ 3,030,596 — 10,194,630
Equity Real Estate Investment Trusts (REITs) 19,316,796 — — 19,316,796
Household Durables — 3,931,430 — 3,931,430
Internet & Direct Marketing Retail 29,241,357 1,739,046 — 30,980,403
Internet Software & Services 73,668,075 16,778,556 — 90,446,631
IT Services 47,204,135 2,136,801 — 49,340,936
Media 4,439,865 5,109,708 — 9,549,573
Professional Services 1,879,857 — — 1,879,857
Semiconductors & Semiconductor Equipment 57,810,055 29,957,306 — 87,767,361
Software 83,584,388 10,266,740 — 93,851,128
Technology Hardware, Storage & Peripherals 26,800,748 4,911,433 — 31,712,181
Preferred Stocks — — $ 15,957,843 15,957,843
Short-Term Securities 2,902,077 — — 2,902,077
Subtotal $ 361,238,294 $ 77,861,616 $ 15,957,843 $ 455,057,753
Investments Valued at NAV 1 128,965
Total Investments $ 455,186,718
Derivative Financial Instruments 2
Liabilities:
Equity contracts $ (2,255,198 ) $ (1,195,149 ) — $ (3,450,347 )
1 As of
December 31, 2016, certain of the Fund’s investments were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.
2 Derivative financial
instruments are options written, which are shown at value.
Transfers into Level 1 Transfers out of Level 1 1 Transfers into Level 2 1 Transfers out of Level 2
Assets:
Long-Term Investments:
Common Stocks — $ (12,465,565 ) $ 12,465,565 —
1 External pricing
service used to reflect any significant market movements between the time the Trust valued such foreign securities and the earlier closing of foreign markets.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 93

Schedule of Investments (concluded) BlackRock Science and Technology Trust (BST)

A reconciliation of Level 3 investments and derivative financial instruments is presented when the Trust had a significant amount of Level 3 investments and derivative financial instruments at the beginning and/or end of the year in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:

Common Stocks Preferred Stocks Total
Assets:
Opening Balance, as of December 31, 2015 — $ 15,696,540 $ 15,696,540
Transfers into Level 3 $ 265,167 — 265,167
Transfers out of Level 3 — — —
Accrued discounts/premiums — — —
Net realized gain (loss) — — —
Net change in unrealized
appreciation/depreciation 1,2 (265,167 ) 261,303 (3,864 )
Purchases — — —
Sales — — —
Closing Balance, as of December 31, 2016 — $ 15,957,843 $ 15,957,843
Net change in unrealized appreciation/depreciation on investments still held at December 31, 2016 2 $ (265,167 ) $ 261,303 $ (3,864 )

1 Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations.

2 Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2016 is generally due to investments no longer held or categorized as Level 3 at period end.

The following table summarizes the valuation approaches used and unobservable inputs utilized by the BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) to determine the value of certain of the Trust’s Level 3 investments as of period end.

Value
Assets:
Preferred Stocks $ 15,957,843 Market Discount Rate 2 25.00% —
Revenue Growth Rate 1 187.00% - 348.00% 260.20%
Revenue Growth Rate 1 23.00% - 27.00% 24.75%
Revenue Multiple 1 4.50x - 12.00x 7.71x
Revenue Multiple 1 14.25x - 46.00x 34.61x
Exit Scenario Probability 1 15.00% - 55.00% 35.00%
Time to Exit 2 1-3 years —
Total $ 15,957,843

1 Increase in unobservable input may result in a significant increase to value, while a decrease in the unobservable input may result in a significant decrease to value.

2 Decrease in unobservable input may result in a significant increase to value, while an increase in the unobservable input may result in a significant decrease to value.

See Notes to Financial Statements.

94 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments December 31, 2016
(Percentages shown are based on Net Assets)
Common Stocks Value
Construction & Engineering — 3.2%
Ferrovial SA 432,700 $ 7,716,903
Vinci SA 41,100 2,795,823
10,512,726
Diversified Telecommunication Services — 2.0%
SBA Communications Corp., Class A (a)(b)(c) 22,500 2,323,350
Verizon Communications, Inc. (b) 79,500 4,243,710
6,567,060
Electric Utilities — 27.9%
American Electric Power Co., Inc. (b) 96,800 6,094,528
Duke Energy Corp. (b) 134,068 10,406,358
Edison International (b) 109,400 7,875,706
El Paso Electric Co. 36,900 1,715,850
Enel SpA 1,732,447 7,615,343
Eversource Energy 80,900 4,468,107
Exelon Corp. (b) 306,600 10,881,234
FirstEnergy Corp. (b) 92,200 2,855,434
Iberdrola SA 198,600 1,300,414
NextEra Energy, Inc. (b)(c) 224,900 26,866,554
Pinnacle West Capital Corp. (b) 47,000 3,667,410
PPL Corp. (b) 115,400 3,929,370
Xcel Energy, Inc. 91,700 3,732,190
91,408,498
Equity Real Estate Investment Trusts (REITs) — 3.1%
American Tower Corp. (b) 53,300 5,632,744
Crown Castle International Corp. (b) 51,100 4,433,947
10,066,691
Gas Utilities — 1.3%
Italgas SpA (a) 148,760 585,344
New Jersey Resources Corp. 57,000 2,023,500
Spire, Inc. (b) 27,400 1,768,670
4,377,514
Independent Power and Renewable Electricity Producers — 3.9%
EDP Renovaveis SA 342,100 2,172,728
NextEra Energy Partners LP 130,100 3,322,754
NRG Yield, Inc., Class A 173,400 2,663,424
NRG Yield, Inc., Class C (b) 173,400 2,739,720
Pattern Energy Group, Inc. (b) 103,500 1,965,465
12,864,091
Multi-Utilities — 22.0%
CMS Energy Corp. (b)(c) 446,300 18,575,006
Dominion Resources, Inc. (b) 215,100 16,474,509
DTE Energy Co. (b) 46,900 4,620,119
National Grid PLC 184,900 2,160,338
NiSource, Inc. (b) 133,900 2,964,546
NorthWestern Corp. 45,792 2,604,191
Public Service Enterprise Group, Inc. (b) 241,056 10,577,537
Sempra Energy (b) 83,800 8,433,632
Veolia Environnement SA 101,800 1,729,776
WEC Energy Group, Inc. 70,600 4,140,690
72,280,344
Oil, Gas & Consumable Fuels — 19.9%
Antero Midstream Partners LP 76,200 2,353,056
Columbia Pipeline Partners LP 74,400 1,275,960
Delek Logistics Partners LP (b) 29,000 827,950
Dominion Midstream Partners LP (b) 276,571 8,172,673
Enbridge, Inc. (b) 93,800 3,950,858
Energy Transfer Partners LP (b) 73,096 2,617,568
Common Stocks Value
Oil, Gas & Consumable Fuels (continued)
Enterprise Products Partners LP (b) 172,854 $ 4,673,972
EQT Midstream Partners LP (b) 27,900 2,139,372
Genesis Energy LP (b) 111,969 4,033,123
Magellan Midstream Partners LP (b) 57,800 4,371,414
MPLX LP (b) 105,419 3,649,606
ONEOK Partners LP (b) 71,345 3,068,548
Phillips 66 Partners LP 41,200 2,003,968
Plains All American Pipeline LP (b) 120,670 3,896,434
Shell Midstream Partners LP 238,681 6,943,230
Snam SpA 725,000 2,981,827
Sunoco Logistics Partners LP (b) 76,800 1,844,736
Targa Resources Corp. (b) 44,700 2,506,329
Valero Energy Partners LP 35,400 1,567,158
Western Gas Partners LP (b) 18,314 1,076,131
Williams Partners LP (b) 38,815 1,476,134
65,430,047
Road & Rail — 0.3%
East Japan Railway Co. 9,900 853,565
Transportation Infrastructure — 14.2%
Abertis Infraestructuras SA 401,400 5,608,179
Aeroports de Paris 38,400 4,112,148
Atlantia SpA 489,884 11,461,536
China Merchants Holdings International Co. Ltd. 250,000 617,649
Flughafen Zuerich AG 14,200 2,631,360
Fraport AG Frankfurt Airport Services Worldwide 29,100 1,717,138
Groupe Eurotunnel SE 358,200 3,402,885
Japan Airport Terminal Co. Ltd. (d) 63,500 2,294,512
Sydney Airport (e) 1,491,766 6,439,137
Transurban Group (e) 1,119,600 8,332,420
46,616,964
Water Utilities — 2.1%
American Water Works Co., Inc. (b) 93,600 6,772,896
Total Long-Term Investments (Cost — $274,312,101) — 99.9% 327,750,396
Short-Term Securities
BlackRock Liquidity Funds, T-Fund, Institutional Class, 0.36% (f)(g) 4,151,064 4,151,064
SL Liquidity Series, LLC Money Market Series, 0.95% (f)(g)(h) 456,105 456,151
Total Short-Term Securities (Cost — $4,607,170) — 1.4% 4,607,215
Total Investments Before Options
Written (Cost — $278,919,271) — 101.3% 332,357,611
Options Written
(Premiums Received — $2,620,284) — (1.2)% (3,868,196 )
Total Investments Net of Options Written — 100.1% 328,489,415
Liabilities in Excess of Other Assets — (0.1)% (192,653 )
Net Assets — 100.0% $ 328,296,762

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 95

Schedule of Investments (continued) BlackRock Utility and Infrastructure Trust (BUI)

Notes to Schedule of Investments

(a) Non-income producing security.

(b) All or a portion of security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(c) All or a portion of security has been pledged as collateral in connection with outstanding OTC derivatives.

(d) Security, or a portion of security, is on loan.

(e) A security contractually bound to one or more other securities to form a single saleable unit which cannot be sold separately.

(f) During the year ended December 31, 2016, investments in issuers considered to be affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliates — BlackRock Liquidity Funds, TempFund, Institutional Class 8,391,615 (8,391,615) — — $22,346 —
BlackRock Liquidity Funds, T-Fund, Institutional Class — 4,151,064 4,151,064 $4,151,064 3,159 $11
SL Liquidity Series, LLC, Money Market Series — 456,105 456,105 456,151 31,191 1 60
Total $4,607,215 $56,696 $71

1 Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

(g) Current yield as of period end.

(h) Security was purchased with the cash collateral from loaned securities.

• For Trust compliance purposes, the Trust’s industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written — Description Put/ Call Expiration Date Strike Price Contracts Value
Enterprise Products Partners LP Call 1/06/17 USD 26.50 108 $ (6,750 )
American Water Works Co., Inc. Call 1/12/17 USD 72.71 148 (15,652 )
American Tower Corp. Call 1/13/17 USD 106.00 112 (16,800 )
American Electric Power Co., Inc. Call 1/20/17 USD 60.00 228 (71,250 )
American Tower Corp. Call 1/20/17 USD 105.00 74 (18,131 )
Crown Castle International Corp. Call 1/20/17 USD 87.50 78 (11,895 )
Delek Logistics Partners LP Call 1/20/17 USD 30.00 103 (6,180 )
Dominion Resources, Inc. Call 1/20/17 USD 72.50 376 (165,440 )
DTE Energy Co. Call 1/20/17 USD 95.00 64 (28,160 )
Duke Energy Corp. Call 1/20/17 USD 77.50 154 (19,250 )
Edison International Call 1/20/17 USD 70.00 191 (49,183 )
Edison International Call 1/20/17 USD 72.50 191 (18,623 )
Enbridge, Inc. Call 1/20/17 USD 42.50 168 (11,760 )
Energy Transfer Partners LP Call 1/20/17 USD 40.00 83 (1,453 )
Enterprise Products Partners LP Call 1/20/17 USD 26.00 384 (47,040 )
EQT Midstream Partners LP Call 1/20/17 USD 75.00 50 (12,125 )
Exelon Corp. Call 1/20/17 USD 34.00 280 (49,700 )
FirstEnergy Corp. Call 1/20/17 USD 32.00 93 (2,325 )
FirstEnergy Corp. Call 1/20/17 USD 35.00 25 (250 )
FirstEnergy Corp. Call 1/20/17 USD 36.00 68 (680 )
Genesis Energy LP Call 1/20/17 USD 35.00 330 (47,025 )
Magellan Midstream Partners LP Call 1/20/17 USD 70.00 104 (59,800 )
Magellan Midstream Partners LP Call 1/20/17 USD 72.50 103 (35,020 )
MPLX LP Call 1/20/17 USD 34.00 90 (10,125 )
NextEra Energy, Inc. Call 1/20/17 USD 120.00 184 (30,820 )
NiSource, Inc. Call 1/20/17 USD 23.00 268 (4,020 )
ONEOK Partners LP Call 1/20/17 USD 42.00 113 (18,363 )
ONEOK Partners LP Call 1/20/17 USD 44.00 59 (3,245 )
Pattern Energy Group, Inc. Call 1/20/17 USD 20.00 137 (2,740 )
Pinnacle West Capital Corp. Call 1/20/17 USD 75.00 82 (28,290 )
Plains All American Pipeline LP Call 1/20/17 USD 31.00 247 (40,138 )
PPL Corp. Call 1/20/17 USD 35.00 100 (2,000 )
Public Service Enterprise Group, Inc. Call 1/20/17 USD 45.00 100 (3,250 )
SBA Communications Corp., Class A Call 1/20/17 USD 105.00 80 (10,600 )

See Notes to Financial Statements.

96 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Utility and Infrastructure Trust (BUI)

Description — Sempra Energy Call 1/20/17 USD 100.00 47 Value — $ (10,105 )
Sempra Energy Call 1/20/17 USD 105.00 120 (5,100 )
Spire, Inc. Call 1/20/17 USD 65.00 95 (8,313 )
Sunoco Logistics Partners LP Call 1/20/17 USD 24.00 78 (5,655 )
Targa Resources Corp. Call 1/20/17 USD 55.00 43 (9,568 )
Targa Resources Corp. Call 1/20/17 USD 57.50 166 (18,260 )
Verizon Communications, Inc. Call 1/20/17 USD 48.00 61 (32,940 )
Verizon Communications, Inc. Call 1/20/17 USD 50.00 21 (7,245 )
Williams Partners LP Call 1/20/17 USD 37.50 79 (9,678 )
Dominion Midstream Partners LP Call 1/24/17 USD 28.01 41 (8,747 )
American Water Works Co., Inc. Call 1/25/17 USD 73.35 25 (3,238 )
Enterprise Products Partners LP Call 1/27/17 USD 26.50 128 (12,800 )
CMS Energy Corp. Call 1/30/17 USD 40.50 800 (139,572 )
EQT Midstream Partners LP Call 1/30/17 USD 75.00 50 (10,781 )
Enbridge, Inc. Call 1/31/17 USD 42.51 168 (15,134 )
Targa Resources Corp. Call 1/31/17 USD 56.50 43 (6,125 )
Duke Energy Corp. Call 2/02/17 USD 79.00 315 (29,149 )
DTE Energy Co. Call 2/03/17 USD 98.95 100 (26,858 )
FirstEnergy Corp. Call 2/03/17 USD 32.51 136 (2,753 )
Exelon Corp. Call 2/06/17 USD 34.50 300 (50,479 )
CMS Energy Corp. Call 2/07/17 USD 42.01 800 (70,735 )
Pinnacle West Capital Corp. Call 2/07/17 USD 77.01 82 (13,619 )
Dominion Midstream Partners LP Call 2/09/17 USD 27.71 176 (41,038 )
Public Service Enterprise Group, Inc. Call 2/09/17 USD 43.85 10 (1,736 )
Verizon Communications, Inc. Call 2/10/17 USD 50.90 126 (31,456 )
American Electric Power Co., Inc. Call 2/17/17 USD 62.50 110 (20,625 )
Dominion Resources, Inc. Call 2/17/17 USD 77.50 377 (58,435 )
NRG Yield, Inc., Class C Call 2/17/17 USD 17.50 80 (1,400 )
Sunoco Logistics Partners LP Call 2/17/17 USD 25.00 78 (5,265 )
Verizon Communications, Inc. Call 2/17/17 USD 52.50 70 (11,305 )
Western Gas Partners LP Call 2/17/17 USD 56.25 103 (35,433 )
Exelon Corp. Call 2/23/17 USD 36.00 493 (39,847 )
Energy Transfer Partners LP Call 3/17/17 USD 36.00 180 (34,200 )
Genesis Energy LP Call 3/17/17 USD 35.00 300 (60,750 )
MPLX LP Call 3/17/17 USD 34.00 126 (23,940 )
Williams Partners LP Call 3/17/17 USD 37.50 68 (13,600 )
Total $ (1,723,967 )
OTC Options Written — Description Put/ Call Counterparty Expiration Date Strike Price Contracts Value
Xcel Energy, Inc. Call Deutsche Bank AG 1/03/17 USD 42.58 16,000 $ (264 )
EDP Renovaveis SA Call Goldman Sachs International 1/04/17 EUR 7.07 13,200 —
Pattern Energy Group, Inc. Call Goldman Sachs International 1/04/17 USD 21.50 7,000 —
CMS Energy Corp. Call Morgan Stanley & Co. International PLC 1/05/17 USD 42.39 29,900 (5,892 )
Vinci SA Call UBS AG 1/06/17 EUR 68.16 6,500 (18 )
Eversource Energy Call Goldman Sachs International 1/09/17 USD 55.00 14,400 (10,981 )
Dominion Midstream Partners LP Call Barclays Bank PLC 1/10/17 USD 25.43 17,500 (72,322 )
China Merchants Holdings International Co. Ltd. Call UBS AG 1/11/17 HKD 19.83 14,000 (236 )
Enel SpA Call Credit Suisse International 1/11/17 EUR 3.68 85,200 (44,677 )
NRG Yield, Inc., Class A Call Barclays Bank PLC 1/11/17 USD 15.20 30,300 (14,924 )
PPL Corp. Call Barclays Bank PLC 1/11/17 USD 33.15 9,700 (10,450 )
Transurban Group Call Morgan Stanley & Co. International PLC 1/11/17 AUD 9.85 148,000 (52,218 )
Williams Partners LP Call Deutsche Bank AG 1/11/17 USD 37.64 7,100 (6,519 )
Antero Midstream Partners LP Call Barclays Bank PLC 1/12/17 USD 30.39 13,600 (13,035 )
Japan Airport Terminal Co. Ltd. Call JPMorgan Chase Bank N.A. 1/12/17 JPY 4,386.00 17,500 (6,017 )
Public Service Enterprise Group, Inc. Call Morgan Stanley & Co. International PLC 1/12/17 USD 43.21 48,300 (84,088 )
Veolia Environnement SA Call Bank of America N.A. 1/12/17 EUR 20.14 25,700 —
Enel SpA Call Credit Suisse International 1/17/17 EUR 3.68 85,100 (44,947 )
NiSource, Inc. Call Barclays Bank PLC 1/17/17 USD 22.68 23,800 (3,961 )

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 97

Schedule of Investments (continued) BlackRock Utility and Infrastructure Trust (BUI)

Description — Snam SpA Call Counterparty — Credit Suisse International Expiration Date — 1/17/17 EUR 3.59 60,000 Value — $ (20,096 )
Transurban Group Call Morgan Stanley & Co. International PLC 1/17/17 AUD 9.85 148,000 (54,532 )
Aeroports de Paris Call Credit Suisse International 1/18/17 EUR 95.08 4,000 (28,117 )
American Water Works Co., Inc. Call Barclays Bank PLC 1/18/17 USD 72.81 31,700 (40,256 )
EDP Renovaveis SA Call Credit Suisse International 1/18/17 EUR 5.91 13,300 (2,874 )
Enel SpA Call Bank of America N.A. 1/18/17 EUR 4.07 209,000 (32,395 )
Groupe Eurotunnel SE Call Morgan Stanley & Co. International PLC 1/18/17 EUR 8.42 77,600 (53,207 )
New Jersey Resources Corp. Call Bank of America N.A. 1/18/17 USD 36.51 10,000 (4,782 )
NRG Yield, Inc., Class C Call Barclays Bank PLC 1/18/17 USD 16.39 26,600 (6,800 )
Vinci SA Call Credit Suisse International 1/18/17 EUR 62.95 1,800 (4,166 )
CMS Energy Corp. Call Barclays Bank PLC 1/19/17 USD 40.35 21,500 (35,692 )
Flughafen Zuerich AG Call Morgan Stanley & Co. International PLC 1/19/17 CHF 179.06 6,500 (62,369 )
WEC Energy Group, Inc. Call Bank of America N.A. 1/23/17 USD 56.45 14,200 (43,338 )
Eversource Energy Call Citibank N.A. 1/24/17 USD 52.27 14,100 (50,639 )
NextEra Energy Partners LP Call Morgan Stanley & Co. International PLC 1/24/17 USD 24.76 13,000 (13,658 )
NRG Yield, Inc., Class A Call Barclays Bank PLC 1/24/17 USD 15.85 4,300 (1,643 )
Shell Midstream Partners LP Call Bank of America N.A. 1/24/17 USD 28.33 42,800 (57,768 )
Valero Energy Partners LP Call UBS AG 1/24/17 USD 40.69 6,300 (25,275 )
American Water Works Co., Inc. Call Barclays Bank PLC 1/25/17 USD 73.34 2,400 (3,123 )
Abertis Infraestructuras SA Call UBS AG 1/26/17 EUR 13.09 28,000 (11,342 )
Antero Midstream Partners LP Call Morgan Stanley & Co. International PLC 1/26/17 USD 29.32 28,300 (55,280 )
Atlantia SpA Call Morgan Stanley & Co. International PLC 1/26/17 EUR 22.00 61,000 (38,279 )
EDP Renovaveis SA Call Bank of America N.A. 1/26/17 EUR 5.80 23,500 (7,550 )
Iberdrola SA Call Bank of America N.A. 1/26/17 EUR 6.06 70,000 (12,118 )
Sydney Airport Call Deutsche Bank AG 1/27/17 AUD 6.51 174,000 (1,396 )
NiSource, Inc. Call Citibank N.A. 1/30/17 USD 22.48 23,000 (7,791 )
El Paso Electric Co. Call Goldman Sachs International 1/31/17 USD 47.62 13,000 (9,823 )
Enel SpA Call Bank of America N.A. 1/31/17 EUR 4.02 147,000 (24,268 )
New Jersey Resources Corp. Call Citibank N.A. 1/31/17 USD 36.50 9,800 (7,075 )
NorthWestern Corp. Call Deutsche Bank AG 1/31/17 USD 58.03 16,000 (14,076 )
ONEOK Partners LP Call Barclays Bank PLC 1/31/17 USD 44.88 23,000 (7,167 )
Plains All American Pipeline LP Call Goldman Sachs International 1/31/17 USD 32.92 18,600 (9,715 )
Aeroports de Paris Call UBS AG 2/01/17 EUR 102.57 8,600 (14,331 )
Atlantia SpA Call Credit Suisse International 2/01/17 EUR 22.72 60,500 (21,619 )
EDP Renovaveis SA Call Credit Suisse International 2/01/17 EUR 6.30 18,000 (1,533 )
EDP Renovaveis SA Call Morgan Stanley & Co. International PLC 2/01/17 EUR 6.10 14,000 (2,296 )
NextEra Energy Partners LP Call Barclays Bank PLC 2/01/17 USD 25.50 13,000 (8,897 )
Dominion Midstream Partners LP Call Barclays Bank PLC 2/02/17 USD 26.30 17,000 (59,495 )
NextEra Energy, Inc. Call Morgan Stanley & Co. International PLC 2/02/17 USD 119.61 33,800 (80,142 )
Public Service Enterprise Group, Inc. Call Morgan Stanley & Co. International PLC 2/02/17 USD 42.23 25,000 (78,188 )
Plains All American Pipeline LP Call Credit Suisse International 2/03/17 USD 32.50 23,000 (19,822 )
Transurban Group Call Deutsche Bank AG 2/03/17 AUD 10.73 100,000 (6,515 )
Xcel Energy, Inc. Call Barclays Bank PLC 2/03/17 USD 41.02 16,000 (17,640 )
Groupe Eurotunnel SE Call Morgan Stanley & Co. International PLC 2/07/17 EUR 8.42 77,600 (55,906 )
Snam SpA Call Bank of America N.A. 2/07/17 EUR 3.85 140,000 (19,922 )
Veolia Environnement SA Call UBS AG 2/07/17 EUR 16.43 10,000 (3,924 )
Abertis Infraestructuras SA Call UBS AG 2/08/17 EUR 13.63 112,500 (17,902 )
Ferrovial SA Call Credit Suisse International 2/08/17 EUR 17.02 11,100 (5,305 )
Ferrovial SA Call Morgan Stanley & Co. International PLC 2/08/17 EUR 17.63 75,500 (17,705 )
Fraport AG Frankfurt Airport Services Worldwide Call Morgan Stanley & Co. International PLC 2/08/17 EUR 56.81 10,200 (10,679 )
Aeroports de Paris Call UBS AG 2/09/17 EUR 102.57 8,600 (16,919 )
East Japan Railway Co. Call Goldman Sachs International 2/09/17 JPY 10,201.65 3,500 (5,846 )
Phillips 66 Partners LP Call UBS AG 2/09/17 USD 48.00 8,200 (10,285 )
Sydney Airport Call Deutsche Bank AG 2/09/17 AUD 6.16 174,100 (12,279 )
NextEra Energy, Inc. Call UBS AG 2/13/17 USD 120.55 21,600 (50,674 )
Atlantia SpA Call UBS AG 2/14/17 EUR 22.30 50,000 (31,166 )
Japan Airport Terminal Co. Ltd. Call Morgan Stanley & Co. International PLC 2/14/17 JPY 4,320.85 17,500 (20,484 )
Enel SpA Call Credit Suisse International 2/15/17 EUR 4.17 80,000 (7,450 )
Eversource Energy Call Citibank N.A. 2/15/17 USD 54.24 15,900 (30,934 )
National Grid PLC Call UBS AG 2/15/17 GBP 9.41 64,800 (24,063 )
Snam SpA Call Morgan Stanley & Co. International PLC 2/15/17 EUR 4.01 53,800 (4,003 )
CMS Energy Corp. Call Citibank N.A. 2/16/17 USD 40.88 34,000 (53,875 )

See Notes to Financial Statements.

98 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (continued) BlackRock Utility and Infrastructure Trust (BUI)

Description — EDP Renovaveis SA Call UBS AG 2/16/17 EUR 6.11 14,100 Value — $ (2,700 )
Crown Castle International Corp. Call Bank of America N.A. 2/22/17 USD 88.09 10,000 (24,071 )
Sydney Airport Call Deutsche Bank AG 2/22/17 AUD 6.51 174,000 (4,432 )
NextEra Energy, Inc. Call Barclays Bank PLC 2/23/17 USD 118.51 49,700 (208,604 )
WEC Energy Group, Inc. Call Barclays Bank PLC 2/23/17 USD 57.65 24,600 (57,401 )
Valero Energy Partners LP Call Bank of America N.A. 2/27/17 USD 43.00 6,000 (14,407 )
EDP Renovaveis SA Call Bank of America N.A. 2/28/17 EUR 6.08 24,000 (5,656 )
Total $ (2,144,229 )

Transactions in Options Written for the Year Ended December 31, 2016

Contracts Premiums Received Contracts Premiums Received
Outstanding options at beginning of year 3,321,328 $ 2,174,098 — —
Options written 24,364,984 18,822,658 — —
Options exercised (219 ) (18,995) — —
Options expired (13,095,648 ) (7,310,703) — —
Options closed (11,024,175 ) (11,046,774) — —
Outstanding options at end of year 3,566,270 $ 2,620,284 — —

As of period end, the value of portfolio securities subject to covered call options written was $123,811,675.

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

Commodity Contracts Equity Contracts Total
Liabilities — Derivative Financial Instruments
Options written Options written, at value — — $ 3,868,196 — — $ 3,868,196

For the year ended December 31, 2016, the effect of derivative financial instruments in the Statements of Operations was as follows:

Net Realized Gain (Loss) from: — Options written — — Equity Contracts — $ 601,519 Foreign Currency Exchange Contracts — — Interest Rate Contracts — — Total — $ 601,519
Net Change in Unrealized Appreciation (Depreciation)
on:
Options written — — $ (529,936 ) — — $ (529,936 )

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Options:
Average value of option contracts written $ 3,933,288

For more information about the Trust’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 99

Schedule of Investments (continued) BlackRock Utility and Infrastructure Trust (BUI)

Derivative Financial Instruments — Offsetting as of Period End

The Trust’s derivative assets and liabilities (by type) are as follows:

Assets Liabilities
Derivative Financial Instruments:
Options — $ 3,868,196
Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”) — (1,723,967 )
Total derivative assets and liabilities subject to an MNA — $ 2,144,229

The following table presents the Trust’s derivative liabilities by counterparty net of amounts available for offset under an Master Netting Agreement (“MNA”) and net of the related collateral pledged by the Trust:

| Counterparty | Gross Amounts Not Offset in the Consolidated Statements of Assets and
Liabilities and Subject to an MNA — Derivative Liabilities Subject to an MNA by Counterparty | Derivatives Available for Offset | Non-cash Collateral Pledged 1 | | Cash Collateral Pledged | Net Amount of Derivative Liabilities 2 |
| --- | --- | --- | --- | --- | --- | --- |
| Bank of America N.A. | $ 246,275 | — | — | | — | $ 246,275 |
| Barclays Bank PLC | 561,410 | — | — | | — | 561,410 |
| Citibank N.A. | 150,314 | — | $ (150,314 | ) | — | — |
| Credit Suisse International | 200,606 | — | (200,606 | ) | — | — |
| Deutsche Bank AG | 45,481 | — | (45,481 | ) | — | — |
| Goldman Sachs International | 36,365 | — | — | | — | 36,365 |
| JPMorgan Chase Bank N.A. | 6,017 | — | — | | — | 6,017 |
| Morgan Stanley & Co. International PLC | 688,926 | — | (658,583 | ) | — | 30,343 |
| UBS AG | 208,835 | — | — | | — | 208,835 |
| Total | $2,144,229 | — | $ (1,054,984 | ) | — | $1,089,245 |

1 Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes.

2 Net amount represents the net amount payable due to the counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities.

See Notes to Financial Statements.

100 ANNUAL REPORT DECEMBER 31, 2016

Schedule of Investments (concluded) BlackRock Utility and Infrastructure Trust (BUI)

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

Assets:
Investments:
Long-Term Investments:
Common Stocks:
Construction & Engineering — $ 10,512,726 — $ 10,512,726
Diversified Telecommunication Services $ 6,567,060 — — 6,567,060
Electric Utilities 82,492,741 8,915,757 — 91,408,498
Equity Real Estate Investment Trusts (REITs) 10,066,691 — — 10,066,691
Gas Utilities 4,377,514 — — 4,377,514
Independent Power and Renewable Electricity Producers 10,691,363 2,172,728 — 12,864,091
Multi-Utilities 68,390,230 3,890,114 — 72,280,344
Oil, Gas & Consumable Fuels 62,448,220 2,981,827 — 65,430,047
Road & Rail — 853,565 — 853,565
Transportation Infrastructure — 46,616,964 — 46,616,964
Water Utilities 6,772,896 — — 6,772,896
Short-Term Securities 4,151,064 — — 4,151,064
Subtotal $ 255,957,779 $ 75,943,681 — $ 331,901,460
Investments Valued at NAV 1 456,151
Total Investments $ 332,357,611
Derivative Financial Instruments 2
Liabilities:
Equity contracts $ (1,181,615 ) $ (2,686,581 ) — $ (3,868,196 )
1 As of December 31, 2016, certain of the Fund’s investments were fair valued using NAV per share as no quoted market value is available and
therefore have been excluded from the fair value hierarchy.
2 Derivative
financial instruments are options written, which are shown at value.

During the year ended December 31, 2016, there were no transfers between levels.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 101

Statements of Assets and Liabilities

| December 31, 2016 | BlackRock Energy
and Resources Trust (BGR) | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Assets | | | | | | | | | |
| Investments at value —
unaffiliated 1,2 | $ 490,125,533 | | $649,720,921 | $ | 1,766,973,361 | | $923,995,553 | $ | 262,814,808 |
| Investments at value — affiliated 3 | 3,936,617 | | 25,410,634 | | 3,630,472 | | 11,863,116 | | 8,738,869 |
| Cash | 8,183 | | — | | 8,914 | | — | | 178,166 |
| Cash pledged: | | | | | | | | | |
| Collateral — options written | — | | — | | — | | 2,386,125 | | — |
| Collateral — OTC derivatives | — | | 420,000 | | 93,000 | | 540,000 | | — |
| Futures contracts | — | | 499,000 | | — | | — | | — |
| Foreign currency at value 4 | 13,033 | | 1,783 | | 9,613 | | 1,089,372 | | 30,691 |
| Receivables: | | | | | | | | | |
| Investments sold | 73,582 | | 505,470 | | — | | 2,082,551 | | 1,181,504 |
| Options written | 25,099 | | 136,296 | | 75,879 | | 102,093 | | — |
| Securities lending income — affiliated | 482 | | 174 | | 2 | | — | | 786 |
| Capital shares sold | — | | — | | — | | — | | 229,167 |
| Dividends — affiliated | 850 | | 5,361 | | 884 | | 4,360 | | 2,075 |
| Dividends — unaffiliated | 429,222 | | 735,613 | | 3,076,700 | | 1,187,369 | | 249,871 |
| Prepaid offering costs | — | | — | | — | | — | | 23,807 |
| Other assets | 11,109 | | 15,744 | | 40,347 | | 35,469 | | 92,178 |
| Total assets | 494,623,710 | | 677,450,996 | | 1,773,909,172 | | 943,286,008 | | 273,541,922 |
| Liabilities | | | | | | | | | |
| Bank overdraft | — | | 14,720 | | — | | 7,365 | | — |
| Cash collateral on securities loaned at value | — | | 695,531 | | — | | — | | 126,901 |
| Options written at value 5 | 6,152,354 | | 10,302,482 | | 29,467,237 | | 11,210,596 | | 1,926,945 |
| Payables: | | | | | | | | | |
| Investments purchased | 70,766 | | — | | — | | 32,771 | | 393,264 |
| Income dividends | 193,945 | | 243,917 | | 363,831 | | 224,492 | | — |
| Investment advisory fees | 454,393 | | 479,249 | | 1,183,098 | | 749,898 | | 230,004 |
| Officer’s and Trustees’ fees | 465,046 | | 162,982 | | 877,536 | | 667,193 | | 27,628 |
| Options written | 35,326 | | 104,307 | | 15,273 | | 182,149 | | 8,413 |
| Other accrued expenses | 187,910 | | 242,423 | | 353,362 | | 314,380 | | 135,345 |
| Variation margin on futures contracts | — | | 45,938 | | — | | — | | — |
| Total liabilities | 7,559,740 | | 12,291,549 | | 32,260,337 | | 13,388,844 | | 2,848,500 |
| Net Assets | $ 487,063,970 | | $665,159,447 | $ | 1,741,648,835 | | $929,897,164 | $ | 270,693,422 |
| Net Assets Consist of | | | | | | | | | |
| Paid-in capital | $ 615,225,359 | | $641,272,545 | $ | 1,332,901,059 | | $838,850,643 | $ | 211,709,324 |
| Undistributed (distributions in excess of) net investment income | (694,483 | ) | (146,960 | ) | (842,079 | ) | (2,475,540 | ) | 29,892 |
| Accumulated net realized loss | (173,388,109 | ) | (39,393,563 | ) | (70,770,626 | ) | (9,929,003 | ) | (679,412) |
| Net unrealized appreciation (depreciation) | 45,921,203 | | 63,427,425 | | 480,360,481 | | 103,451,064 | | 59,633,618 |
| Net Assets | $ 487,063,970 | | $665,159,447 | $ | 1,741,648,835 | | $929,897,164 | $ | 270,693,422 |
| Net asset value 6,7 | $ 16.33 | | $15.08 | $ | 9.22 | | $ 13.38 | $ | 31.30 |
| 1 Investments at cost
— unaffiliated | $ 442,857,418 | | $584,067,285 | $ | 1,278,067,603 | | $820,915,590 | $ | 203,676,547 |
| 2 Securities loaned at
value | — | | $ 676,613 | | — | | — | $ | 123,156 |
| 3 Investments at cost
— affiliated | $ 3,936,617 | | $ 25,410,580 | $ | 3,630,472 | | $ 11,863,116 | $ | 8,738,869 |
| 4 Foreign currency at
cost | $ 13,061 | | $ 9,142 | $ | 9,645 | | $ 1,091,423 | $ | 31,014 |
| 5 Premiums
received | $ 4,804,608 | | $ 8,212,203 | $ | 20,925,252 | | $ 11,608,196 | $ | 2,428,175 |
| 6 Shares outstanding, unlimited
number of shares authorized, $0.001 par value | 29,825,326 | | — | | 188,978,322 | | 69,483,161 | | 8,648,080 |
| 7 Shares outstanding,
200 million shares authorized, $0.10 par value | — | | 44,121,400 | | — | | — | | — |

See Notes to Financial Statements.

102 ANNUAL REPORT DECEMBER 31, 2016

Statements of Assets and Liabilities

| December 31, 2016 | BlackRock International Growth
and Income Trust (BGY) | | | | BlackRock Science and Technology Trust (BST) | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Assets | | | | | | | |
| Investments at value —
unaffiliated 2,3 | $ 678,263,199 | $ | 973,897,050 | | $ 452,155,676 | $ | 327,750,396 |
| Investments at value — affiliated 4 | 22,641,400 | | 16,541,191 | | 3,031,042 | | 4,607,215 |
| Cash | 5,854 | | 586,383 | | 5,659 | | 24,135 |
| Cash pledged: | | | | | | | |
| Collateral — options written | 2,040,780 | | — | | 159,285 | | — |
| Collateral — OTC derivatives | 2,467,000 | | — | | 1,060,000 | | — |
| Foreign currency at value 5 | 8,290,731 | | — | | 90,175 | | 1,504 |
| Receivables: | | | | | | | |
| Investments sold | 1,705,177 | | 156,363 | | 10,990 | | — |
| Options written | 21,742 | | 231,623 | | 70,566 | | 6,250 |
| Dividends — unaffiliated | 1,047,684 | | 1,994,726 | | 139,060 | | 848,175 |
| Dividends — affiliated | 7,426 | | 2,462 | | 511 | | 533 |
| Securities lending income — affiliated | — | | 8,502 | | 2,678 | | 1,966 |
| Other assets | 17,566 | | 23,964 | | 12,899 | | 8,271 |
| Total assets | 716,508,559 | | 993,442,264 | | 456,738,541 | | 333,248,445 |
| Liabilities | | | | | | | |
| Foreign bank overdraft 5 | — | | 48,722 | | — | | — |
| Options written at value 6 | 8,662,185 | | 10,145,685 | | 3,450,347 | | 3,868,196 |
| Cash collateral on securities loaned at value | — | | 3,934,928 | | 128,830 | | 456,046 |
| Payables: | | | | | | | |
| Investments purchased | 15,565,780 | | 151,641 | | 24,384 | | — |
| Options written | — | | 348,670 | | 34,756 | | — |
| Income dividends | 246,622 | | 408,385 | | 100,603 | | 141,331 |
| Investment advisory fees | 524,500 | | 824,929 | | 307,253 | | 274,182 |
| Officer’s and Trustees’ fees | 591,199 | | 345,262 | | 16,743 | | 11,073 |
| Other accrued expenses payable | 290,593 | | 334,930 | | 232,644 | | 200,855 |
| Total liabilities | 25,880,879 | | 16,543,152 | | 4,295,560 | | 4,951,683 |
| Net Assets | $ 690,627,680 | $ | 976,899,112 | | $ 452,442,981 | $ | 328,296,762 |
| Net Assets Consist of | | | | | | | |
| Paid-in capital | $ 781,683,771 | $ | 1,341,227,271 | | $ 373,358,508 | $ | 280,924,430 |
| Undistributed (distributions in excess of) net investment income | (2,275,343 | ) | (728,229 | ) | 1,662 | | 2,439,628 |
| Accumulated net realized loss | (114,090,009 | ) | (501,753,305 | ) | (18,318,953 | ) | (7,246,903) |
| Net unrealized appreciation (depreciation) | 25,309,261 | | 138,153,375 | | 97,401,764 | | 52,179,607 |
| Net Assets | $ 690,627,680 | $ | 976,899,112 | | $ 452,442,981 | $ | 328,296,762 |
| Net asset value 7 | $ 6.28 | $ | 9.86 | | $ 20.10 | $ | 19.42 |
| 1 Consolidated
Statement of Assets and Liabilities | | | | | | | |
| 2 Investments at cost
— unaffiliated | $ 651,151,015 | $ | 835,757,398 | | $ 355,438,442 | $ | 274,312,101 |
| 3 Securities loaned at
value | — | $ | 3,699,056 | | $ 124,536 | $ | 433,609 |
| 4 Investments at cost
— affiliated | $ 22,641,400 | $ | 16,540,987 | | $ 3,031,030 | $ | 4,607,170 |
| 5 Foreign currency at
cost | $ 8,318,691 | $ | (45,789 | ) | $ 92,297 | $ | 1,499 |
| 6 Premiums
received | $ 7,043,095 | $ | 10,175,756 | | $ 4,136,623 | $ | 2,620,284 |
| 7 Shares outstanding,
unlimited number of shares authorized, $0.001 par value | 109,989,277 | | 99,059,784 | | 22,507,592 | | 16,906,964 |

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 103

Statements of Operations

Year Ended December 31, 2016 BlackRock Energy and Resources Trust (BGR)
Investment Income
Dividends — affiliated $ 32,046 $ 74,655 $ 25,190 $ 82,140 $ 46,533
Dividends — unaffiliated 13,892,277 11,705,433 45,461,384 21,813,501 3,329,257
Securities lending — affiliated — net 26,579 2,681 133 19,796 8,130
Foreign taxes withheld (510,328 ) (84,850 ) (200,804 ) (1,439,118 ) (30,033)
Total income 13,440,574 11,697,919 45,285,903 20,476,319 3,353,887
Expenses
Investment advisory 5,306,489 5,416,380 13,095,900 9,335,143 2,766,482
Custodian 113,125 281,735 223,166 236,522 105,762
Transfer agent 102,534 91,190 213,479 141,247 50,803
Officer and Trustees 101,922 84,388 277,242 181,372 30,436
Professional 95,503 114,144 175,347 161,279 96,025
Printing 16,891 30,878 56,856 40,813 18,434
Registration 11,949 17,368 74,680 27,352 12,069
Insurance 10,745 18,482 34,871 24,593 7,647
Offering costs — — — — 58,865
Miscellaneous 46,418 16,851 10,110 117,604 28,541
Total expenses 5,805,576 6,071,416 14,161,651 10,265,925 3,175,064
Less fees waived by the Manager (343,229 ) (15,568 ) (203,722 ) (483,059 ) (9,713)
Total expenses after fees waived 5,462,347 6,055,848 13,957,929 9,782,866 3,165,351
Net investment income 7,978,227 5,642,071 31,327,974 10,693,453 188,536
Realized and Unrealized Gain (Loss)
Net realized gain (loss) from:
Investments — unaffiliated (56,045,342 ) (24,500,308 ) 44,139,491 4,676,974 20,981,655
Investments — affiliated 1,435 3 36 — 1
Capital gain distributions from investment companies — affiliated 18 160 — 143 55
Options written (4,190,501 ) (8,774,735 ) (41,352,597 ) (3,476,161 ) 1,486,350
Futures contracts — 301,677 — — —
Forward foreign currency exchange contracts — — — 63,790 —
Foreign currency transactions (288,068 ) 368 (63,092 ) (157,927 ) 8,608
(60,522,458 ) (32,972,835 ) 2,723,838 1,106,819 22,476,669
Net change in unrealized appreciation (depreciation) on:
Investments — unaffiliated 154,021,490 80,436,622 181,880,305 4,092,362 (39,586,895)
Investments — affiliated — 54 — — —
Options written (3,690,895 ) (3,640,497 ) (11,888,994 ) (3,395,482 ) 656,007
Futures contracts — (128,627 ) — — —
Foreign currency translations 2,133 (406 ) 1,077 39,343 (2,780)
150,332,728 76,667,146 169,992,388 736,223 (38,933,668)
Net realized and unrealized gain (loss) 89,810,270 43,694,311 172,716,226 1,843,042 (16,456,999)
Net Increase (Decrease) in Net Assets Resulting from Operations $ 97,788,497 $ 49,336,382 $ 204,044,200 $ 12,536,495 $ (16,268,463)

See Notes to Financial Statements.

104 ANNUAL REPORT DECEMBER 31, 2016

Statements of Operations

| Year Ended December 31, 2016 | BlackRock International Growth and Income Trust (BGY) | | BlackRock Resources
& Commodities Strategy Trust (BCX) 1 | | | BlackRock Utility and Infrastructure Trust (BUI) |
| --- | --- | --- | --- | --- | --- | --- |
| Investment Income | | | | | | |
| Dividends — affiliated | $ 188,803 | | $ 45,771 | | $ 7,495 | $ 25,505 |
| Dividends — unaffiliated | 18,932,756 | | 24,995,241 | | 3,989,216 | 13,568,278 |
| Securities lending — affiliated — net | 21,839 | | 134,174 | | 125,365 | 31,191 |
| Foreign taxes withheld | (1,884,554 | ) | (1,194,382 | ) | (130,781) | (339,216) |
| Total income | 17,258,844 | | 23,980,804 | | 3,991,295 | 13,285,758 |
| Expenses | | | | | | |
| Investment advisory | 7,114,404 | | 8,924,260 | | 4,341,376 | 3,360,762 |
| Custodian | 217,243 | | 215,493 | | 129,860 | 130,972 |
| Officer and Trustees | 159,409 | | 133,986 | | 46,799 | 35,413 |
| Professional | 142,211 | | 137,634 | | 113,210 | 98,176 |
| Transfer agent | 131,250 | | 92,507 | | 55,221 | 61,505 |
| Registration | 43,297 | | 41,521 | | 8,126 | 9,569 |
| Printing | 32,994 | | 20,411 | | 7,227 | 18,997 |
| Insurance | 19,024 | | 35,187 | | 10,724 | 8,149 |
| Miscellaneous | 138,602 | | 64,569 | | 60,841 | 67,663 |
| Total expenses | 7,998,434 | | 9,665,568 | | 4,773,384 | 3,791,206 |
| Less fees waived by the Manager | (748,846 | ) | (9,102 | ) | (869,782) | (4,851) |
| Total expenses after fees waived | 7,249,588 | | 9,656,466 | | 3,903,602 | 3,786,355 |
| Net investment income | 10,009,256 | | 14,324,338 | | 87,693 | 9,499,403 |
| Realized and Unrealized Gain (Loss) | | | | | | |
| Net realized gain (loss) from: | | | | | | |
| Investments — unaffiliated | (32,864,289 | ) | (59,317,759 | ) | 11,035,064 | 8,590,356 |
| Investments — affiliated | — | | 2,130 | | 123 | 60 |
| Capital gain distributions received from affiliated investment companies | 186 | | 52 | | 11 | 11 |
| Options written | (417,318 | ) | (36,777,894 | ) | (2,474,731) | 601,519 |
| Futures contracts | 6,658,849 | | — | | — | — |
| Forward foreign currency exchange contracts | 14,390 | | — | | — | — |
| Foreign currency transactions | (547,288 | ) | (120,363 | ) | (119,738) | (19,029) |
| | (27,155,470 | ) | (96,213,834 | ) | 8,440,729 | 9,172,917 |
| Net change in unrealized appreciation (depreciation) on: | | | | | | |
| Investments — unaffiliated | 5,203,286 | 2 | 290,540,919 | | 28,233,757 | 4,956,421 |
| Investments — affiliated | — | | 204 | | 12 | 45 |
| Options written | (4,135,248 | ) | (1,642,793 | ) | (783,027) | (529,936) |
| Foreign currency translations | (34,231 | ) | 7,879 | | (3,918) | (388) |
| | 1,033,807 | | 288,906,209 | | 27,446,824 | 4,426,142 |
| Net realized and unrealized gain (loss) | (26,121,663 | ) | 192,692,375 | | 35,887,553 | 13,599,059 |
| Net Increase (Decrease) in Net Assets Resulting from Operations | $ (16,112,407 | ) | $ 207,016,713 | | $35,975,246 | $ 23,098,462 |

1 Consolidated Statement of Operations.

2 Net of $(103,833) foreign capital gain tax.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 105

Statements of Changes in Net Assets

BlackRock Energy and Resources Trust (BGR) BlackRock Enhanced Capital and Income Fund, Inc. (CII)
Year Ended December 31, Year Ended December 31,
Increase (Decrease) in Net Assets: 2016 2015 2016 2015
Operations
Net investment income $ 7,978,227 $ 8,686,290 $ 5,642,071 $ 4,876,418
Net realized gain (loss) (60,522,458 ) (105,484,599 ) (32,972,835 ) 155,685,181
Net change in unrealized appreciation/depreciation 150,332,728 (70,456,190 ) 76,667,146 (132,503,358)
Net increase (decrease) in net assets resulting from operations 97,788,497 (167,254,499 ) 49,336,382 28,058,241
Distributions to Shareholders 1
From net investment income (7,985,951 ) (8,567,540 ) (5,818,337 ) (6,318,821)
From net realized gains — — (1,682,938 ) (46,626,859)
From return of capital (21,720,074 ) (36,005,387 ) (43,167,741 ) —
Decrease in net assets resulting from distributions to shareholders (29,706,025 ) (44,572,927 ) (50,669,016 ) (52,945,680)
Capital Share Transactions
Reinvestment of dividends — 1,205,970 — —
Net Assets
Total increase (decrease) in net assets 68,082,472 (210,621,456 ) (1,332,634 ) (24,887,439)
Beginning of year 418,981,498 629,602,954 666,492,081 691,379,520
End of year $ 487,063,970 $ 418,981,498 $ 665,159,447 $ 666,492,081
Distributions in excess of net investment income, end of year $ (694,483 ) $ (398,691 ) $ (146,960 ) $ (112,579)

1 Distributions for annual periods determined in accordance with federal income tax regulations.

See Notes to Financial Statements.

106 ANNUAL REPORT DECEMBER 31, 2016

Statements of Changes in Net Assets

BlackRock Enhanced Equity Dividend Trust (BDJ) BlackRock Global Opportunities Equity Trust (BOE)
Year Ended December 31, Year Ended December 31,
Increase (Decrease) in Net Assets: 2016 2015 2016 2015
Operations
Net investment income $ 31,327,974 $ 31,195,998 $ 10,693,453 $ 7,638,770
Net realized gain 2,723,838 31,480,464 1,106,819 29,095,008
Net change in unrealized appreciation/depreciation 169,992,388 (60,335,311 ) 736,223 (26,224,116)
Net increase in net assets resulting from operations 204,044,200 2,341,151 12,536,495 10,509,662
Distributions to Shareholders 1
From net investment income (31,386,331 ) (31,248,083 ) (6,886,585 ) (11,517,508)
Distributions in excess of net investment income — — — (7,284,361)
From return of capital (74,517,121 ) (74,655,369 ) (66,070,734 ) (62,076,530)
Decrease in net assets resulting from distributions to shareholders (105,903,452 ) (105,903,452 ) (72,957,319 ) (80,878,399)
Net Assets
Total increase (decrease) in net assets 98,140,748 (103,562,301 ) (60,420,824 ) (70,368,737)
Beginning of year 1,643,508,087 1,747,070,388 990,317,988 1,060,686,725
End of year $ 1,741,648,835 $ 1,643,508,087 $ 929,897,164 $ 990,317,988
Distributions in excess of net investment income, end of year $ (842,079 ) $ (720,631 ) $ (2,475,540 ) $ (6,725,341)

1 Distributions for annual periods determined in accordance with federal income tax regulations.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 107

Statements of Changes in Net Assets

BlackRock Health Sciences Trust (BME) BlackRock International Growth and Income Trust (BGY)
Year Ended December 31, Year Ended December 31,
Increase (Decrease) in Net Assets: 2016 2015 2016 2015
Operations
Net investment income (loss) $ 188,536 $ (443,773 ) $ 10,009,256 $ 9,034,062
Net realized gain (loss) 22,476,669 51,654,340 (27,155,470 ) (7,249,095)
Net change in unrealized appreciation/depreciation (38,933,668 ) (17,934,847 ) 1,033,807 (9,508,537)
Net increase (decrease) in net assets resulting from operations (16,268,463 ) 33,275,720 (16,112,407 ) (7,723,570)
Distributions to Shareholders 1
From net investment income (246,021 ) (5,039,768 ) (7,270,081 ) (12,357,754)
From net realized gains (24,902,380 ) (48,696,568 ) — —
From return of capital — — (50,144,321 ) (52,315,941)
Decrease in net assets resulting from distributions to shareholders (25,148,401 ) (53,736,336 ) (57,414,402 ) (64,673,695)
Capital Share Transactions
Net proceeds from the issuance of shares 12,480,900 10,367,053 — —
Reinvestment of distributions 2,099,426 4,520,259 — —
Net increase in net assets derived from shares transactions 14,580,326 14,887,312 — —
Net Assets
Total decrease in net assets (26,836,538 ) (5,573,304 ) (73,526,809 ) (72,397,265)
Beginning of year 297,529,960 303,103,264 764,154,489 836,551,754
End of year $ 270,693,422 $ 297,529,960 $ 690,627,680 $ 764,154,489
Undistributed (distributions in excess of) net investment income, end of year $ 29,892 $ (631,796 ) $ (2,275,343 ) $ (5,670,754)

1 Distributions for annual periods determined in accordance with federal income tax regulations.

See Notes to Financial Statements.

108 ANNUAL REPORT DECEMBER 31, 2016

Statements of Changes in Net Assets

| | BlackRock Resources &
Commodities Strategy Trust (BCX) 1 | | | | BlackRock Science and Technology Trust (BST) | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | Year Ended December 31, | | | | Year Ended December 31, | | |
| Increase (Decrease) in Net Assets: | 2016 | | 2015 | | 2016 | 2015 | |
| Operations | | | | | | | |
| Net investment income | $ 14,324,338 | | $ 24,601,192 | | $ 87,693 | $ | 676,774 |
| Net realized gain (loss) | (96,213,834 | ) | (101,358,837 | ) | 8,440,729 | | (25,812,735) |
| Net change in unrealized appreciation/depreciation | 288,906,209 | | (172,541,820 | ) | 27,446,824 | | 58,241,453 |
| Net increase (decrease) in net assets resulting from operations | 207,016,713 | | (249,299,465 | ) | 35,975,246 | | 33,105,492 |
| Distributions to Shareholders 2 | | | | | | | |
| From net investment income | (14,753,944 | ) | (24,837,338 | ) | — | | (603,909) |
| Distributions in excess of net investment income | — | | — | | — | | (144,770) |
| From return of capital | (42,403,551 | ) | (55,321,839 | ) | (27,009,110 | ) | (26,260,431) |
| Decrease in net assets resulting from distributions to shareholders | (57,157,495 | ) | (80,159,177 | ) | (27,009,110 | ) | (27,009,110) |
| Net Assets | | | | | | | |
| Total increase (decrease) in net assets | 149,859,218 | | (329,458,642 | ) | 8,966,136 | | 6,096,382 |
| Beginning of year | 827,039,894 | | 1,156,498,536 | | 443,476,845 | | 437,380,463 |
| End of year | $ 976,899,112 | | $ 827,039,894 | | $ 452,442,981 | $ | 443,476,845 |
| Undistributed (distributions in excess of) net investment income, end of year | $ (728,229 | ) | $ (315,958 | ) | $ 1,662 | $ | 148 |

1 Consolidated Statements of Changes in Net Assets.

2 Distributions for annual periods determined in accordance with federal income tax regulations.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 109

Statements of Changes in Net Assets

| | BlackRock Utility
and Infrastructure Trust (BUI) | | |
| --- | --- | --- | --- |
| | Year Ended December 31, | | |
| Increase (Decrease) in Net Assets: | 2016 | 2015 | |
| Operations | | | |
| Net investment income | $ 9,499,403 | $ | 7,916,511 |
| Net realized gain | 9,172,917 | | 7,100,028 |
| Net change in unrealized appreciation/depreciation | 4,426,142 | | (40,550,712) |
| Net increase (decrease) in net assets resulting from operations | 23,098,462 | | (25,534,173) |
| Distributions to Shareholders 1 | | | |
| From net investment income | (8,366,572 | ) | (7,096,542) |
| From net realized gains | (8,911,166 | ) | (9,103,053) |
| From return of capital | (7,271,174 | ) | (8,349,317) |
| Decrease in net assets resulting from distributions to shareholders | (24,548,912 | ) | (24,548,912) |
| Net Assets | | | |
| Total decrease in net assets | (1,450,450 | ) | (50,083,085) |
| Beginning of year | 329,747,212 | | 379,830,297 |
| End of year | $ 328,296,762 | $ | 329,747,212 |
| Undistributed net investment income, end of year | $ 2,439,628 | $ | 1,934,397 |

1 Distributions for annual periods determined in accordance with federal income tax regulations.

See Notes to Financial Statements.

110 ANNUAL REPORT DECEMBER 31, 2016

Statements of Cash Flows

| Year Ended December 31, 2016 | BlackRock Energy
and Resources Trust (BGR) | | | | |
| --- | --- | --- | --- | --- | --- |
| Cash Provided by Operating Activities | | | | | |
| Net increase in net assets resulting from operations | $ 97,788,497 | $ | 49,336,382 | $ | 204,044,200 |
| Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by operating
activities: | | | | | |
| Proceeds from sales of long-term investments | 167,700,307 | | 401,783,596 | | 641,386,432 |
| Purchases of long-term investments | (144,753,453 | ) | (340,854,282 | ) | (542,085,650) |
| Net (purchases) sales of short-term securities | 2,403,980 | | (9,702,635 | ) | 10,140,472 |
| Premiums paid on closing options written | (34,119,574 | ) | (64,656,109 | ) | (168,203,027) |
| Premiums received from options written | 31,504,354 | | 57,994,384 | | 133,107,977 |
| Net realized (gain) loss on investments and options written | 60,234,390 | | 33,274,880 | | (2,786,930) |
| Net unrealized gain on investments, options written and foreign currency translations | (150,330,179 | ) | (76,796,585 | ) | (169,991,219) |
| (Increase) decrease in assets: | | | | | |
| Cash Pledged: | | | | | |
| Collateral — OTC derivatives | — | | — | | 5,000 |
| Futures contracts | — | | (499,000 | ) | — |
| Receivables: | | | | | |
| Dividends — unaffiliated | 152,019 | | 8,765 | | 16,576 |
| Dividends — affiliated | 952 | | (2,037 | ) | 3,478 |
| Securities lending income — affiliated | 5,722 | | 21 | | (2) |
| Other assets | 583 | | 2,098 | | 470 |
| Increase (decrease) in liabilities: | | | | | |
| Collateral on securities loaned at value | (944,554 | ) | 695,531 | | — |
| Payables: | | | | | |
| Investment advisory fees | 31,669 | | (3,380 | ) | 100,134 |
| Officer’s and Trustees’ fees | 56,520 | | 37,524 | | 130,067 |
| Other accrued expenses | 46,801 | | 59,158 | | 78,316 |
| Variation margin on futures contracts | — | | 45,938 | | — |
| Net cash provided by operating activities | 29,778,034 | | 50,724,249 | | 105,946,294 |
| Cash Used for Financing Activities | | | | | |
| Cash dividends paid to shareholders | (29,805,724 | ) | (50,739,781 | ) | (105,929,511) |
| Increase in bank overdraft | — | | 14,720 | | — |
| Net cash used for financing activities | (29,805,724 | ) | (50,725,061 | ) | (105,929,511) |
| Cash Impact from Foreign Exchange Fluctuations | | | | | |
| Cash impact from foreign exchange fluctuations | (416 | ) | 406 | | (92) |
| Cash and Foreign Currency | | | | | |
| Net increase (decrease) in cash and foreign currency | (28,106 | ) | (406 | ) | 16,691 |
| Cash and foreign currency at beginning of year | 49,322 | | 2,189 | | 1,836 |
| Cash and foreign currency at end of year | $ 21,216 | $ | 1,783 | $ | 18,527 |

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 111

Statements of Cash Flows (continued)

| Year Ended December 31, 2016 | BlackRock Global Opportunities Equity Trust (BOE) | | | | BlackRock International Growth
and Income Trust
(BGY) |
| --- | --- | --- | --- | --- | --- |
| Cash Provided by Operating Activities | | | | | |
| Net increase (decrease) in net assets resulting from operations | $ 12,536,495 | $ | (16,268,463 | ) | $ (16,112,407) |
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by operating
activities: | | | | | |
| Proceeds from sales of long-term investments | 671,501,968 | | 164,709,690 | | 511,076,162 |
| Purchases of long-term investments | (596,898,785 | ) | (156,764,516 | ) | (476,560,478) |
| Net (purchases) sales of short-term securities | (5,046,092 | ) | 115,747 | | 17,215,236 |
| Premiums paid on closing options written | (93,993,049 | ) | (15,951,483 | ) | (63,112,884) |
| Premiums received from options written | 90,534,741 | | 17,559,836 | | 61,007,930 |
| Net realized (gain) loss on investments and options written | (1,200,956 | ) | (22,468,061 | ) | 33,281,421 |
| Net unrealized (gain) loss on investments, options written and foreign currency translations | (690,348 | ) | 38,930,580 | | (984,352) |
| (Increase) decrease in assets: | | | | | |
| Cash Pledged: | | | | | |
| Collateral — exchange traded options written | (2,386,125 | ) | — | | 73,220 |
| Collateral — OTC derivatives | (540,000 | ) | — | | 1,589,619 |
| Receivables: | | | | | |
| Dividends — unaffiliated | 147,018 | | 109,050 | | 484,862 |
| Dividends — affiliated | (2,971 | ) | 2,165 | | (360) |
| Securities lending income — affiliated | 346 | | (786 | ) | 6,690 |
| Prepaid offering costs | — | | 56,365 | | — |
| Other assets | 3,662 | | (80,854 | ) | 4,895 |
| Increase (decrease) in liabilities: | | | | | |
| Collateral on securities loaned at value | (427,550 | ) | 126,901 | | (2,751,247) |
| Payables: | | | | | |
| Investment advisory fees | (50,074 | ) | (28,821 | ) | (56,875) |
| Officer’s and Trustees’ fees | 90,839 | | 2,625 | | 89,662 |
| Foreign taxes | — | | — | | (147,618) |
| Other accrued expenses | 105,514 | | 19,748 | | 108,180 |
| Net cash provided by operating activities | 73,684,633 | | 10,069,723 | | 65,211,656 |
| Cash Used for Financing Activities | | | | | |
| Cash dividends paid to shareholders | (72,998,493 | ) | (23,049,891 | ) | (57,502,048) |
| Increase in bank overdraft | 7,365 | | — | | — |
| Net proceeds from issuance of shares | — | | 13,187,505 | | — |
| Net cash used for financing activities | (72,991,128 | ) | (9,862,386 | ) | (57,502,048) |
| Cash Impact from Foreign Exchange Fluctuations | | | | | |
| Cash impact from foreign exchange fluctuations | (6,532 | ) | 308 | | 20,147 |
| Cash and Foreign Currency | | | | | |
| Net increase in cash and foreign currency | 686,973 | | 207,645 | | 7,729,755 |
| Cash and foreign currency at beginning of year | 402,399 | | 1,212 | | 566,830 |
| Cash and foreign currency at end of year | $ 1,089,372 | $ | 208,857 | | $ 8,296,585 |
| Non-Cash Financing Activities | | | | | |
| Capital shares issued in reinvestment of dividends paid to shareholders | — | $ | 2,099,426 | | — |

See Notes to Financial Statements.

112 ANNUAL REPORT DECEMBER 31, 2016

Statements of Cash Flows (concluded)

| Year Ended December 31, 2016 | BlackRock Resources
& Commodities Strategy Trust
(BCX) 1 | | | | |
| --- | --- | --- | --- | --- | --- |
| Cash Provided by Operating Activities | | | | | |
| Net increase in net assets resulting from operations | $ 207,016,713 | $ | 35,975,246 | $ | 23,098,462 |
| Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by operating
activities: | | | | | |
| Proceeds from sales of long-term investments | 984,680,123 | | 357,250,911 | | 37,552,758 |
| Purchases of long-term investments | (900,994,404 | ) | (325,555,607 | ) | (27,749,591) |
| Net (purchases) sales of short-term securities | (10,332,875 | ) | (2,307,750 | ) | 3,784,516 |
| Premiums paid on closing options written | (103,279,231 | ) | (39,746,248 | ) | (17,755,958) |
| Premiums received from options written | 70,323,865 | | 37,547,545 | | 18,837,753 |
| Net realized (gain) loss on investments and options written | 96,093,471 | | (8,560,467 | ) | (9,191,946) |
| Net unrealized (gain) loss on investments, options written and foreign currency translations | (288,898,626 | ) | (27,454,956 | ) | (4,426,484) |
| (Increase) decrease in assets: | | | | | |
| Cash Pledged: | | | | | |
| Collateral — exchange traded options written | — | | (159,285 | ) | — |
| Collateral — OTC derivatives | — | | 40,000 | | — |
| Receivables: | | | | | |
| Dividends — unaffiliated | (850,557 | ) | 19,438 | | (118,179) |
| Dividends — affiliated | (134 | ) | (183 | ) | 2,578 |
| Securities lending income — affiliated | (8,431 | ) | (1,237 | ) | (1,966) |
| Other assets | 16,830 | | (1,357 | ) | 611 |
| Increase (decrease) in liabilities: | | | | | |
| Collateral on securities loaned at value | 3,899,239 | | 9,830 | | 456,046 |
| Payables: | | | | | |
| Investment advisory fees | 125,018 | | 5,319 | | 2,045 |
| Officer’s and Trustees’ fees | 34,263 | | 3,280 | | 1,339 |
| Other accrued expenses | (18,571 | ) | 16,796 | | 68,316 |
| Net cash provided by operating activities | 57,806,693 | | 27,081,275 | | 24,560,300 |
| Cash Used for Financing Activities | | | | | |
| Cash dividends paid to shareholders | (57,021,582 | ) | (27,078,257 | ) | (24,558,368) |
| Decrease in bank overdraft on foreign currency at value | (199,024 | ) | — | | — |
| Net cash used for financing activities | (57,220,606 | ) | (27,078,257 | ) | (24,558,368) |
| Cash Impact from Foreign Exchange Fluctuations | | | | | |
| Cash impact from foreign exchange fluctuations | 296 | | 4,214 | | (46) |
| Cash and Foreign Currency | | | | | |
| Net increase in cash and foreign currency | 586,383 | | 7,232 | | 1,886 |
| Cash and foreign currency at beginning of year | — | | 88,602 | | 23,753 |
| Cash and foreign currency at end of year | $ 586,383 | $ | 95,834 | $ | 25,639 |

1 Consolidated Statement of Cash Flows.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 113

Financial Highlights BlackRock Energy and Resources Trust (BGR)

Year Ended December 31,
2016 2015 2014 2013 2012
Per Share Operating Performance
Net asset value, beginning of period $ 14.05 $ 21.15 $ 24.90 $ 30.12 $ 25.95 $ 28.33
Net investment income 1 0.27 0.29 0.07 0.25 0.12 0.13
Net realized and unrealized gain (loss) 3.01 (5.89 ) (2.41 ) (1.21 ) 5.67 (0.74 )
Net increase (decrease) from investment operations 3.28 (5.60 ) (2.34 ) (0.96 ) 5.79 (0.61 )
Distributions: 2
From net investment income (0.27 ) (0.29 ) (0.47 ) (0.44 ) — (0.03 )
From net realized gain — — (0.94 ) (3.82 ) (1.62 ) (1.44 )
From return of capital (0.73 ) (1.21 ) — — — (0.30 )
Total distributions (1.00 ) (1.50 ) (1.41 ) (4.26 ) (1.62 ) (1.77 )
Net asset value, end of period $ 16.33 $ 14.05 $ 21.15 $ 24.90 $ 30.12 $ 25.95
Market price, end of period $ 14.44 $ 12.53 $ 19.95 $ 23.78 $ 26.82 $ 24.28
Total Return 3
Based on net asset value 25.07 % (27.47 )% (9.06 )% 4 (2.36 )% 23.68 % (1.76 )%
Based on market price 24.01 % (31.42 )% (10.18 )% 4 4.73 % 17.70 % (1.88 )%
Ratios to Average Net Assets
Total expenses 1.31 % 1.29 % 1.30 % 5 1.26 % 1.26 % 1.28 %
Total expenses after fees waived and/or reimbursed 1.24 % 1.26 % 1.26 % 5 1.26 % 1.25 % 1.22 %
Net investment income 1.80 % 1.60 % 1.82 % 5 0.89 % 0.42 % 0.50 %
Supplemental Data
Net assets, end of period (000) $ 487,064 $ 418,981 $ 629,603 $ 741,109 $ 896,635 $ 772,457
Portfolio turnover rate 33 % 56 % 4 % 85 % 132 % 86 %

1 Based on average shares outstanding.

2 Distributions for annual periods determined in accordance with federal income tax regulations.

3 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

4 Aggregate total return.

5 Annualized.

See Notes to Financial Statements.

114 ANNUAL REPORT DECEMBER 31, 2016

Financial Highlights BlackRock Enhanced Capital and Income Fund, Inc. (CII)

Year Ended December 31,
2016 2015 2014 2013 2012
Per Share Operating Performance
Net asset value, beginning of period $ 15.11 $ 15.67 $ 15.47 $ 15.31 $ 14.11 $ 13.87
Net investment income 1 0.13 0.11 0.04 0.55 0.31 0.33
Net realized and unrealized gain 0.99 0.53 0.36 0.91 2.09 1.29
Net increase from investment operations 1.12 0.64 0.40 1.46 2.40 1.62
Distributions: 2
From net investment income (0.13 ) (0.14 ) (0.10 ) (0.65 ) (0.32 ) (0.33 ) 3
In excess of net investment income 4 — — — — — (0.20 ) 3
From net realized gain (0.04 ) (1.06 ) — — — (0.13 )
From return of capital (0.98 ) — (0.10 ) (0.65 ) (0.88 ) (0.72 )
Total distributions (1.15 ) (1.20 ) (0.20 ) (1.30 ) (1.20 ) (1.38 )
Net asset value, end of period $ 15.08 $ 15.11 $ 15.67 $ 15.47 $ 15.31 $ 14.11
Market price, end of period $ 13.71 $ 14.14 $ 13.97 $ 14.89 $ 13.52 $ 12.99
Total Return 5
Based on net asset value 8.66 % 4.66 % 2.69 % 6 10.49 % 18.97 % 12.94 %
Based on market price 5.56 % 9.86 % (4.88 )% 6 20.43 % 14.11 % 16.39 %
Ratios to Average Net Assets
Total expenses 0.95 % 0.94 % 0.99 % 7 0.93 % 0.93 % 0.94 %
Total expenses after fees waived and/or reimbursed 0.95 % 0.94 % 0.95 % 7 0.93 % 0.93 % 0.94 %
Net investment income 0.89 % 0.71 % 1.42 % 7 3.56 % 2.15 % 2.34 %
Supplemental Data
Net assets, end of period (000) $ 665,159 $ 666,492 $ 691,380 $ 682,485 $ 675,472 $ 622,657
Portfolio turnover rate 54 % 133 % 2 % 80 % 218 % 205 %

1 Based on average shares outstanding.

2 Distributions for annual periods determined in accordance with federal income tax regulations.

3 The amount of distributions to shareholders from net investment income reported in October 31, 2012 has been reclassified to allocate the amount between distributions from net investment income and distributions in excess of net investment income; both of which were included in the prior year net investment income in the amount of $0.53.

4 Taxable distribution.

5 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

6 Aggregate total return.

7 Annualized.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 115

Financial Highlights BlackRock Enhanced Equity Dividend Trust (BDJ)

Year Ended December 31,
2016 2015 2014 2013 2012
Per Share Operating Performance
Net asset value, beginning of period $ 8.70 $ 9.24 $ 9.19 $ 8.88 $ 8.30 $ 8.03
Net investment income 1 0.17 0.17 0.04 0.16 0.18 0.18
Net realized and unrealized gain (loss) 0.91 (0.15 ) 0.10 0.76 0.96 0.77
Net increase from investment operations 1.08 0.02 0.14 0.92 1.14 0.95
Distributions: 2
From net investment income (0.17 ) (0.17 ) (0.03 ) (0.17 ) (0.18 ) (0.18 ) 3
In excess of net investment income 4 — — — — (0.20 ) (0.22 ) 3
From net realized gain — — — — (0.18 ) —
From return of capital (0.39 ) (0.39 ) (0.06 ) (0.44 ) — (0.28 )
Total distributions (0.56 ) (0.56 ) (0.09 ) (0.61 ) (0.56 ) (0.68 )
Net asset value, end of period $ 9.22 $ 8.70 $ 9.24 $ 9.19 $ 8.88 $ 8.30
Market price, end of period $ 8.15 $ 7.61 $ 8.12 $ 8.35 $ 7.72 $ 7.41
Total Return 5
Based on net asset value 13.90 % 1.10 % 1.69 % 6 11.40 % 15.11 % 13.22 %
Based on market price 15.11 % 0.63 % (1.65 )% 6 16.42 % 12.09 % 11.34 %
Ratios to Average Net Assets
Total expenses 0.87 % 0.86 % 0.87 % 7 0.87 % 8 0.87 % 0.95 %
Total expenses after fees waived and/or reimbursed 0.85 % 0.85 % 0.84 % 7 0.86 % 8 0.87 % 0.95 %
Net investment income 1.91 % 1.85 % 2.30 % 7 1.81 % 2.13 % 2.16 %
Supplemental Data
Net assets, end of period (000) $ 1,741,649 $ 1,643,508 $1,747,070 $ 1,648,683 $ 1,594,223 $ 1,490,096
Portfolio turnover rate 33 % 26 % 0 % 9 63 % 180 % 185 %

1 Based on average shares outstanding.

2 Distributions for annual periods determined in accordance with federal income tax regulations.

3 The amount of distributions to shareholders from net investment income reported in October 31, 2012 has been reclassified to allocate the amount between distributions from net investment income and distributions in excess of net investment income; both of which were included in the prior year net investment income in the amount of $0.40.

4 Taxable distribution.

5 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

6 Aggregate total return.

7 Annualized.

8 Includes reorganization costs associated with the Trust’s merger. Without these costs, total expenses and total expenses after fees waived would have been 0.86% and 0.86%, respectively

9 Amount is less than 0.5%.

See Notes to Financial Statements.

116 ANNUAL REPORT DECEMBER 31, 2016

Financial Highlights BlackRock Global Opportunities Equity Trust (BOE)

Year Ended December 31,
2016 2015 2014 2013 2012
Per Share Operating Performance
Net asset value, beginning of period $ 14.25 $ 15.27 $ 15.54 $ 16.68 $ 14.99 $ 16.03
Net investment income 1 0.15 0.11 0.00 2 0.14 0.12 0.20
Net realized and unrealized gain (loss) 0.03 0.03 (0.07 ) 0.07 2.82 0.72
Net increase (decrease) from investment operations 0.18 0.14 (0.07 ) 0.21 2.94 0.92
Distributions: 3
From net investment income (0.10 ) (0.17 ) — (0.17 ) (0.17 ) (0.22 )
In excess of net investment income 4 — (0.10 ) — (0.28 ) (0.91 ) —
From net realized gain — — — — — —
From return of capital (0.95 ) (0.89 ) (0.20 ) (0.90 ) (0.17 ) (1.74 )
Total distributions (1.05 ) (1.16 ) (0.20 ) (1.35 ) (1.25 ) (1.96 )
Net asset value, end of period $ 13.38 $ 14.25 $ 15.27 $ 15.54 $ 16.68 $ 14.99
Market price, end of period $ 11.57 $ 12.76 $ 13.13 $ 14.00 $ 14.74 $ 13.24
Total Return 5
Based on net asset value 2.62 % 1.81 % (0.27 )% 6 2.10 % 21.93 % 7.36 %
Based on market price (0.90 )% 6.03 % (4.82 )% 6 4.09 % 21.99 % 1.68 %
Ratios to Average Net Assets
Total expenses 1.10 % 1.08 % 7 1.10 % 8 1.08 % 1.08 % 1.10 %
Total expenses after fees waived and/or reimbursed 1.05 % 1.05 % 7 1.07 % 8 1.08 % 1.08 % 1.10 %
Net investment income 1.15 % 0.73 % 7 0.00 % 8,9 0.83 % 0.77 % 1.34 %
Supplemental Data
Net assets, end of period (000) $ 929,897 $ 990,318 $ 1,060,687 $ 1,079,862 $ 1,159,072 $ 1,041,210
Portfolio turnover rate 64 % 72 % 16 % 150 % 279 % 298 %

1 Based on average shares outstanding.

2 Amount is less than $0.005 per share.

3 Distributions for annual periods determined in accordance with federal income tax regulations.

4 Taxable distribution.

5 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

6 Aggregate total return.

7 Excludes expenses incurred indirectly as a result of investments in underlying funds of 0.01%.

8 Annualized.

9 Amount is less than 0.005%.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 117

Financial Highlights BlackRock Health Sciences Trust (BME)

Year Ended December 31,
2016 2015 2014 2013 2012
Per Share Operating Performance
Net asset value, beginning of period $ 36.19 $ 38.61 $ 40.22 $ 34.92 $ 28.34 $ 26.65
Net investment income (loss) 1 0.02 (0.06 ) (0.01 ) (0.00 ) 2 0.12 0.08
Net realized and unrealized gain (loss) (1.91 ) 4.34 1.10 9.14 8.85 4.11
Net increase (decrease) from investment operations (1.89 ) 4.28 1.09 9.14 8.97 4.19
Distributions: 3
From net investment income (0.03 ) (0.63 ) (0.01 ) (0.10 ) (0.06 ) (0.09 )
From net realized gain (2.97 ) (6.07 ) (2.69 ) (3.74 ) (2.33 ) (2.41 )
Total distributions (3.00 ) (6.70 ) (2.70 ) (3.84 ) (2.39 ) (2.50 )
Net asset value, end of period $ 31.30 $ 36.19 $ 38.61 $ 40.22 $ 34.92 $ 28.34
Market price, end of period $ 31.75 $ 39.35 $ 42.70 $ 41.37 $ 33.56 $ 27.86
Total Return 4
Based on net asset value (5.36 )% 10.70 % 2.38 % 5 28.00 % 33.37 % 16.42 %
Based on market price (11.71 )% 8.87 % 10.07 % 5 36.99 % 30.38 % 18.17 %
Ratios to Average Net Assets
Total expenses 1.15 % 6 1.13 % 1.16 % 7 1.11 % 1.12 % 1.13 %
Total expenses after fees waived and/or reimbursed and excluding amortization of offering costs 1.14 % 1.12 % 1.11 % 7 1.11 % 1.12 % 1.13 %
Net investment income (loss) 0.07 % (0.14 )% (0.10 )% 7 (0.01 )% 0.38 % 0.29 %
Supplemental Data
Net assets, end of period (000) $ 270,693 $ 297,530 $ 303,103 $ 313,933 $ 270,161 $ 218,377
Portfolio turnover rate 59 % 68 % 6 % 74 % 155 % 209 %

1 Based on average shares outstanding.

2 Amount is greater than $(0.005) per share.

3 Distributions for annual periods determined in accordance with federal income tax regulations.

4 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

5 Aggregate total return.

6 Offering costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 1.16%.

7 Annualized.

See Notes to Financial Statements.

118 ANNUAL REPORT DECEMBER 31, 2016

Financial Highlights BlackRock International Growth and Income Trust (BGY)

Year Ended December 31,
2016 2015 2014 2013 2012
Per Share Operating Performance
Net asset value, beginning of period $ 6.95 $ 7.61 $ 7.89 $ 9.05 $ 8.28 $ 8.72
Net investment income (loss) 1 0.09 0.08 (0.00 ) 2 0.10 0.13 0.16
Net realized and unrealized gain (loss) (0.24 ) (0.15 ) (0.17 ) (0.53 ) 1.31 0.35
Net increase (decrease) from investment operations (0.15 ) (0.07 ) (0.17 ) (0.43 ) 1.44 0.51
Distributions: 3
From net investment income (0.07 ) (0.11 ) — (0.13 ) (0.17 ) (0.18 )
In excess of net investment income 4 — — — (0.08 ) — —
From return of capital (0.45 ) (0.48 ) (0.11 ) (0.52 ) (0.50 ) (0.77 )
Total distributions (0.52 ) (0.59 ) (0.11 ) (0.73 ) (0.67 ) (0.95 )
Net asset value, end of period $ 6.28 $ 6.95 $ 7.61 $ 7.89 $ 9.05 $ 8.28
Market price, end of period $ 5.51 $ 6.24 $ 6.74 $ 7.26 $ 8.14 $ 7.41
Total Return 5
Based on net asset value (1.12 )% (0.47 )% (2.10 )% 6 (4.49 )% 19.25 % 7.65 %
Based on market price (3.37 )% 0.90 % (5.77 )% 6 (2.29 )% 19.86 % 6.61 %
Ratios to Average Net Assets
Total expenses 7 1.12 % 1.09 % 1.12 % 8 1.10 % 1.09 % 1.11 %
Total expenses after fees waived and/or
reimbursed 7 1.02 % 1.01 % 1.03 % 8 1.05 % 1.07 % 1.11 %
Net investment income (loss) 7 1.41 % 1.09 % (0.13 )% 8 1.17 % 1.49 % 1.97 %
Supplemental Data
Net assets, end of period (000) $ 690,628 $ 764,154 $ 836,552 $ 867,986 $ 995,736 $ 910,481
Portfolio turnover rate 74 % 67 % 14 % 195 % 266 % 226 %

1 Based on average shares outstanding.

2 Amount is greater than $(0.005) per share.

3 Distributions for annual periods determined in accordance with federal income tax regulations.

4 Taxable distribution.

5 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

6 Aggregate total return.

7 Excludes expenses incurred indirectly as a result of investments in underlying funds as follows:

Year Ended December 31, — 2016 2015 Period November 1, 2014 to December 31, 2014 Year Ended October 31, — 2014 2013 2012
Investments in underlying funds 0.01% 0.01% — — — —

8 Annualized.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 119

Consolidated Financial Highlights BlackRock Resources & Commodities Strategy Trust (BCX)

Year Ended December 31,
2016 2015 2014 2013 2012
Per Share Operating Performance
Net asset value, beginning of period $ 8.35 $ 11.67 $ 12.50 $ 13.54 $ 15.42 $ 16.83
Net investment income 1 0.14 0.25 0.04 0.23 0.25 0.18
Net realized and unrealized gain (loss) 1.95 (2.76 ) (0.72 ) (0.27 ) (0.97 ) (0.19 )
Net increase (decrease) from investment operations 2.09 (2.51 ) (0.68 ) (0.04 ) (0.72 ) (0.01 )
Distributions: 2
From net investment income (0.15 ) (0.25 ) (0.02 ) (0.31 ) (0.14 ) (0.26 )
From net realized gain — — — — — (0.01 )
From return of capital (0.43 ) (0.56 ) (0.13 ) (0.69 ) (1.02 ) (1.13 )
Total distributions (0.58 ) (0.81 ) (0.15 ) (1.00 ) (1.16 ) (1.40 )
Net asset value, end of period $ 9.86 $ 8.35 $ 11.67 $ 12.50 $ 13.54 $ 15.42
Market price, end of period $ 8.27 $ 7.11 $ 9.71 $ 10.78 $ 11.68 $ 14.12
Total Return 3
Based on net asset value 27.41 % (21.31 )% (5.20 )% 4 0.61 % (3.61 )% 5 0.90 %
Based on market price 25.50 % (19.47 )% (8.53 )% 4 0.58 % (9.19 )% 4.02 %
Ratios to Average Net Assets
Total expenses 1.08 % 1.07 % 1.15 % 6 1.35 % 7 1.27 % 1.25 %
Total expenses after fees waived and/or reimbursed 1.08 % 1.07 % 1.04 % 6 1.06 % 7 1.07 % 1.05 %
Net investment income 1.61 % 2.43 % 2.01 % 6 1.70 % 1.76 % 1.14 %
Supplemental Data
Net assets, end of period (000) $ 976,899 $ 827,040 $ 1,156,499 $ 582,220 $ 630,617 $ 718,016
Portfolio turnover rate 101 % 74 % 2 % 62 % 156 % 100 %

1 Based on average shares outstanding.

2 Distributions for annual periods determined in accordance with federal income tax regulations.

3 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

4 Aggregate total return.

5 Includes a payment from an affiliate to compensate for foregone securities lending revenue which impacted the Trust’s total return. Not including this payment the Trust’s 6 total return would have been (3.68)%.

6 Annualized.

7 Includes reorganization costs associated with the Trust’s merger. Without these costs, total expenses and total expenses after fees waived would have been 1.26% and 1.06%, respectively.

See Notes to Financial Statements.

120 ANNUAL REPORT DECEMBER 31, 2016

Financial Highlights BlackRock Science and Technology Trust (BST)

Year Ended December 31,
2016 2015
Per Share Operating Performance
Net asset value, beginning of period $ 19.70 $ 19.43 $ 19.10 2
Net investment income (loss) 3 0.00 4 0.03 (0.01 )
Net realized and unrealized gain (loss) 1.60 1.44 0.48
Net increase from investment operations 1.60 1.47 0.47
Distributions: 5
From net investment income — (0.03 ) (0.00 ) 6
In excess of net investment income — (0.01 ) —
From return of capital (1.20 ) (1.16 ) (0.10 )
Total distributions (1.20 ) (1.20 ) (0.10 )
Capital Charges with respect to the issuance of Shares — — (0.04 )
Net asset value, end of period $ 20.10 $ 19.70 $ 19.43
Market price, end of period $ 17.94 $ 17.31 $ 17.59
Total Return 7
Based on net asset value 9.36 % 8.61 % 2.31 % 8
Based on market price 11.08 % 5.36 % (11.55 )% 8
Ratios to Average Net Assets
Total expenses 1.10 % 1.12 % 1.19 % 9
Total expenses after fees waived and paid indirectly 0.90 % 0.92 % 0.97 % 9
Net investment income (loss) 0.02 % 0.15 % (0.24 )% 9
Supplemental Data
Net assets, end of period (000) $ 452,443 $ 443,477 $ 437,380
Portfolio turnover rate 74 % 91 % 7 %

1 Commencement of investment operations. This information includes the initial investment by BlackRock HoldCo2, Inc.

2 Net asset value, beginning of period, reflects a deduction of $0.8975 per share sales charge from the initial offering price of $20.00 per share.

3 Based on average shares outstanding.

4 Amount is less than $0.005 per share.

5 Distributions for annual periods determined in accordance with federal income tax regulations.

6 Amount is greater than $(0.005) per share.

7 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

8 Aggregate total return.

9 Annualized.

See Notes to Financial Statements.

ANNUAL REPORT DECEMBER 31, 2016 121

Financial Highlights BlackRock Utility and Infrastructure Trust (BUI)

Year Ended December 31,
2016 2015 2014 2013
Per Share Operating Performance
Net asset value, beginning of period $ 19.50 $ 22.47 $ 22.40 $ 20.78 $ 20.22 $ 19.10 2
Net investment income 3 0.56 0.47 0.11 0.51 0.57 0.54
Net realized and unrealized gain (loss) 0.81 (1.99 ) 0.20 2.68 1.44 1.71
Net increase (decrease) from investment operations 1.37 (1.52 ) 0.31 3.19 2.01 2.25
Distributions: 4
From net investment income (0.49 ) (0.42 ) (0.10 ) (0.51 ) (0.52 ) (0.49 )
From net realized gain (0.53 ) (0.54 ) — (0.37 ) (0.42 ) (0.41 )
From return of capital (0.43 ) (0.49 ) (0.14 ) (0.69 ) (0.51 ) (0.19 )
Total distributions (1.45 ) (1.45 ) (0.24 ) (1.57 ) (1.45 ) (1.09 )
Capital charges with respect to the issuance of shares — — — — — (0.04 )
Net asset value, end of period $ 19.42 $ 19.50 $ 22.47 $ 22.40 $ 20.78 $ 20.22
Market price, end of period $ 18.41 $ 16.78 $ 20.74 $ 20.02 $ 18.36 $ 19.03
Total Return 5
Based on net asset value 7.57 % (6.09 )% 1.50 % 6 16.94 % 11.18 % 12.05 % 6
Based on market price 18.50 % (12.45 )% 4.82 % 6 18.29 % 4.37 % 0.71 % 6
Ratios to Average Net Assets
Total expenses 1.13 % 1.11 % 1.17 % 7 1.10 % 1.11 % 1.12 % 7
Total expenses after fees waived and/or reimbursed 1.13 % 1.11 % 1.11 % 7 1.10 % 1.10 % 1.11 % 7
Total expenses after fees waived and/or reimbursed and excluding excise tax 1.13 % 1.11 % 1.11 % 7 1.10 % 1.10 % 1.10 % 7
Net investment income 2.83 % 2.24 % 2.83 % 7 2.36 % 2.83 % 2.94 % 7
Supplemental Data
Net assets, end of period (000) $ 328,297 $ 329,747 $ 379,830 $ 378,762 $ 351,325 $ 341,939
Portfolio turnover rate 8 % 20 % 2 % 41 % 133 % 90 %

1 Commencement of investment operations. This information includes the initial investment by BlackRock HoldCo2, Inc.

2 Net asset value, beginning of period, reflects a deduction of $0.8975 per share sales charge from initial offering price of $20.00 per share.

3 Based on average shares outstanding.

4 Distributions for annual periods determined in accordance with federal income tax regulations.

5 Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

6 Aggregate total return.

7 Annualized.

See Notes to Financial Statements.

122 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements

1. Organization:

The following are registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as closed-end management investment companies and are referred to herein collectively as the “Trusts”, or individually, as a “Trust”:

Fund Name Herein Referred To As Organized
BlackRock Energy and Resources Trust BGR Delaware Non-diversified
BlackRock Enhanced Capital and Income Fund, Inc. CII Maryland Diversified
BlackRock Enhanced Equity Dividend Trust BDJ Delaware Diversified
BlackRock Global Opportunities Equity Trust BOE Delaware Diversified
BlackRock Health Sciences Trust BME Delaware Non-diversified
BlackRock International Growth and Income Trust BGY Delaware Non-diversified
BlackRock Resources & Commodities Strategy Trust BCX Delaware Non-diversified
BlackRock Science and Technology Trust BST Delaware Non-diversified
BlackRock Utility and Infrastructure Trust BUI Delaware Non-diversified

The Boards of Directors/Boards of Trustees of the Trusts are collectively referred to throughout this report as the “Board of Trustees” or the “Board”, and the directors/trustees thereof are collectively referred to throughout this report as “Trustees.” The Trusts determine and make available for publication the net asset values (“NAVs”) of their common shares on a daily basis.

The Trusts, together with certain other registered investment companies advised by BlackRock Advisors, LLC (the “Manager”) or its affiliates, are included in a complex of closed-end funds referred to as the Closed-End Complex.

Basis of Consolidation: The accompanying consolidated financial statements of BCX include the accounts of BlackRock Cayman Resources & Commodities Strategy Fund, Ltd. (the “Subsidiary”), which is a wholly owned subsidiary of BCX and primarily invests in commodity-related instruments. The Subsidiary enables BCX to hold these commodity-related instruments and satisfy regulated investment company tax requirements. BCX may invest up to 25% of its total assets in the Subsidiary. During the year ended December 31, 2016, there were no transactions in the Subsidiary. Intercompany accounts and transactions, if any, have been eliminated. The Subsidiary is subject to the same investment policies and restrictions that apply to BCX, except that the Subsidiary may invest without limitation in commodity-related instruments.

2. Significant Accounting Policies:

The Trusts’ financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Trust is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. The following is a summary of significant accounting policies:

Foreign Currency: The Trusts’ books and records are maintained in U.S. dollars. Purchases and sales of investments are recorded at the rates of exchange prevailing on the respective dates of such transactions. Generally, when the U.S. dollar rises in value against a foreign currency, the investments denominated in that currency will lose value; the opposite effect occurs if the U.S. dollar falls in relative value.

Each Trust does not isolate the portion of the results of operations arising as a result of changes in the exchange rates from the changes in the market prices of investments held or sold for financial reporting purposes. Accordingly, the effects of changes in exchange rates on investments are not segregated in the Statements of Operations from the effects of changes in market prices of those investments but are included as a component of net realized and unrealized gain (loss) from investments. Each Trust reports realized currency gains (losses) on foreign currency related transactions as components of net realized gain (loss) for financial reporting purposes, whereas such components are generally treated as ordinary income for federal income tax purposes.

Segregation and Collateralization: In cases where a Trust enters into certain investments (e.g., futures contracts, options written and forward foreign currency exchange contracts), that would be treated as “senior securities” for 1940 Act purposes, such Trust may segregate or designate on its books and records cash or liquid assets having a market value at least equal to the amount of its future obligations under such investments. Doing so allows the investment to be excluded from treatment as a “senior security.” Furthermore, if required by an exchange or counterparty agreement, a Trust may be required to deliver/deposit cash and/or securities to/with an exchange, or broker-dealer or custodian as collateral for certain investments or obligations.

ANNUAL REPORT DECEMBER 31, 2016 123

Notes to Financial Statements (continued)

Investment Transactions and Investment Income: For financial reporting purposes, investment transactions are recorded on the dates the transactions are entered into (the trade dates). Realized gains and losses on investment transactions are determined on the identified cost basis. Dividend income is recorded on the ex-dividend dates. Dividends from foreign securities where the ex-dividend date may have passed are subsequently recorded when the Trust is informed of the ex-dividend date. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Upon notification from issuers, some of the dividend income received from a real estate investment trust may be redesignated as a reduction of cost of the related investment and/or realized gain. Interest income, including amortization and accretion of premiums and discounts on debt securities, is recognized on the accrual basis.

Distributions: Distributions paid by the Trusts are recorded on the ex-dividend date. Subject to each Trust’s level distribution plan, each Trust intends to make monthly cash distributions to shareholders, which may consist of net investment income, net options premium, net realized and unrealized gains on investments, and/or return of capital.

Portions of return of capital distributions under U.S. GAAP may be taxed at ordinary income rates.

The character of distributions is determined in accordance with federal income tax regulations, which may differ from U.S. GAAP. The portion of distributions that exceeds a Trust’s current and accumulated earnings and profits, which are measured on a tax basis, will constitute a non-taxable return of capital. Realized net capital gains can be offset by capital losses carried forward from prior years. However, certain Trusts have capital loss carryforwards from pre-2012 tax years that offset realized net capital gains but do not offset current earnings and profits. Consequently, if distributions in any tax year are less than a Trust’s current earnings and profits but greater than net investment income and net realized capital gains (taxable income), distributions in excess of taxable income are not treated as non-taxable return of capital, but rather may be taxable to shareholders at ordinary income rates. Under certain circumstances, taxable excess distributions could be significant. See Note 8, Income Tax Information, for the tax character of each Trust’s distributions paid during the period.

Net income and realized gains from investments held by the Subsidiary are treated as ordinary income for tax purposes. If a net loss is realized by the Subsidiary in any taxable year, the loss will generally not be available to offset the Trusts’ ordinary income and/or capital gains for that year.

Deferred Compensation Plan: Under the Deferred Compensation Plan (the “Plan”) approved by each Trust’s Board, the independent Trustees (“Independent Trustees”) may defer a portion of their annual complex-wide compensation. Deferred amounts earn an approximate return as though equivalent dollar amounts had been invested in common shares of certain other BlackRock Closed-End Funds selected by the Independent Trustees. This has the same economic effect for the Independent Trustees as if the Independent Trustees had invested the deferred amounts directly in certain other BlackRock Closed-End Funds.

The Plan is not funded and obligations thereunder represent general unsecured claims against the general assets of each Trust, if applicable. Deferred compensation liabilities are included in officer’s and trustees fees payable in the Statements of Assets and Liabilities and will remain as a liability of the Trusts until such amounts are distributed in accordance with the Plan.

Recent Accounting Standard: In April 2015, the Financial Accounting Standards Board issued “Disclosures for Investments in Certain Entities that Calculate Net Asset Value (“NAV”) per Share” which eliminates the requirement to categorize investments within the fair value hierarchy when fair value is based on the NAV per share and no quoted market value is available. As of December 31, 2016, certain of the Trust’s investments were valued using NAV per share or its equivalent as no quoted market value is available and have been excluded from the fair value hierarchy.

In November 2016, the Financial Accounting Standards Board issued Accounting Standards Update “Restricted Cash” which will require entities to include the total of cash, cash equivalents, restricted cash, and restricted cash equivalents in the beginning and ending cash balances in the Statements of Cash Flows. The guidance will be applied retrospectively and is effective for fiscal years beginning after December 15, 2017, and interim periods within those years. Management is evaluating the impact, if any, of this guidance on each Trust’s presentation in the Statements of Cash Flows.

Indemnifications: In the normal course of business, the Trusts enter into contracts that contain a variety of representations that provide general indemnification. The Trusts’ maximum exposure under these arrangements is unknown because it involves future potential claims against the Trust, which cannot be predicted with any certainty.

Other: Expenses directly related to a Trust are charged to that Trust. Other operating expenses shared by several Trusts, including other funds managed by the Manager, are prorated among those Trusts on the basis of relative net assets or other appropriate methods.

124 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements (continued)

Certain Trusts have an arrangement with their custodian whereby credits are earned on uninvested cash balances, which could be used to reduce custody fees and/or overdraft charges. The Funds may incur charges on certain uninvested cash balances and overdrafts, subject to certain conditions.

Correction of Previously Issued Financial Statements: For the year ended December 31, 2015, the Distributions in excess of net investment income was overstated by $168,242 within the section “Net Assets Consist of” on the Statements of Assets and Liabilities for BGY. As a result, there was a corresponding understatement of Net Assets within this section. In addition, the Statements of Changes in Net Assets and the Financial Highlights reflected the immaterial error in the Distributions in excess of net investment income and Net Assets amounts, respectively. The affiliated income disclosed in the Notes to the Schedule of Investments was overstated by $168,242 as well. Management elected to revise the financial statements to correct these errors. The corrections have no impact on the amounts previously reported for net investment income, performance or net asset value per share. In addition, there is no impact to reports previously filed for other interim or annual periods.

3. Investment Valuation and Fair Value Measurements:

Investment Valuation Policies: The Trusts’ investments are valued at fair value (also referred to as “market value” within the financial statements) as of the close of trading on the New York Stock Exchange (“NYSE”) (generally 4:00 p.m., Eastern time, or if the reporting date falls on a day the NYSE is closed, investments are valued at fair value as of the period end). U.S. GAAP defines fair value as the price the Trusts would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Trusts determine the fair values of its financial instruments using various independent dealers or pricing services under policies approved by the Board of Trustees of each Trust. The BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) is the committee formed by management to develop global pricing policies and procedures and to oversee of the pricing function for all financial instruments.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Trust’s assets and liabilities:

• Equity investments traded on a recognized securities exchange are valued at the official closing price each day, if available. For equity investments traded on more than one exchange, the official closing price on the exchange where the stock is primarily traded is used. Equity investments traded on a recognized exchange for which there were no sales on that day may be valued at the last available bid (long positions) or ask (short positions) price.

• Generally, trading in foreign instruments is substantially completed each day at various times prior to the close of trading on the NYSE. Occasionally, events affecting the values of such instruments may occur between the foreign market close and the close of trading on the NYSE that may not be reflected in the computation of the Trust’s net assets. Each business day, the Trusts use a pricing service to assist with the valuation of certain foreign exchange-traded equity securities and foreign exchange-traded and over-the-counter (“OTC”) options (the “Systematic Fair Value Price”). Using current market factors, the Systematic Fair Value Price is designed to value such foreign securities and foreign options at fair value as of the close of trading on the NYSE, which follows the close of the local markets.

• Investments in open-end U.S. mutual funds are valued at NAV each business day.

• Each Trust values its investment in SL Liquidity Series, LLC, Money Market Series (the “Money Market Series”) at fair value, which is ordinarily based upon its pro rata ownership in the underlying fund’s net assets. The Money Market Series seeks current income consistent with maintaining liquidity and preserving capital. Although the Money Market Series is not registered under the 1940 Act, its investments may follow the parameters of investments by a money market fund that is subject to Rule 2a-7 under the 1940 Act.

• Futures contracts traded on exchanges are valued at their last sale price.

• Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates determined as of the close of trading on the NYSE. Forward foreign currency exchange contracts are valued at the mean between the bid and ask prices and are determined as of the close of trading on the NYSE. Interpolated values are derived when the settlement date of the contract is an interim date for which quotations are not available.

• Exchange-traded options are valued at the mean between the last bid and ask prices at the close of the options market in which the options trade. An exchange-traded option for which there is no mean price is valued at the last bid (long positions) or ask (short positions) price. If no bid or ask price is available, the prior day’s price will be used, unless it is determined that the prior day’s price no longer reflects the fair value of the option. Over-the-counter (“OTC”) options and options on swaps (“swaptions”) are valued by an independent pricing service using a mathematical model, which incorporates a number of market data factors, such as the trades and prices of the underlying instruments.

If events (e.g., a company announcement, market volatility or a natural disaster) occur that are expected to materially affect the value of such investments, or in the event that the application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Global Valuation Committee, or its delegate, in accordance with a policy approved by the Board as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that

ANNUAL REPORT DECEMBER 31, 2016 125

Notes to Financial Statements (continued)

may be used by the Global Valuation Committee will include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and typically used in determining fair value. When determining the price for Fair Valued Investments, the Global Valuation Committee, or its delegate, seeks to determine the price that each Trust might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Global Valuation Committee, or its delegate, deems relevant and consistent with the principles of fair value measurement.

The Global Valuation Committee, or its delegate, employs various methods for calibrating valuation approaches for investments where an active market does not exist, including regular due diligence of Trust’s pricing vendors, regular reviews of key inputs and assumptions, transactional back-testing or disposition analysis to compare unrealized gains and losses to realized gains and losses, reviews of missing or stale prices and large movements in market values and reviews of any market related activity. The pricing of all Fair Valued Investments is subsequently reported to the Board or a committee thereof on a quarterly basis. As a result of the inherent uncertainty in valuation of these investments, the fair values may differ from the values that would have been used had an active market existed.

For investments in equity or debt issued by privately-held companies or funds (“Private Company” or collectively, the “Private Companies”) and other Fair Valued Investments, the fair valuation approaches that are used by third party pricing services utilize one or a combination of, but not limited to, the following inputs.

Market approach Standard Inputs Generally Considered By Third Party Pricing Services — (i) recent market transactions, including subsequent rounds of financing, in the underlying investment or comparable issuers;
(ii) recapitalizations and other transactions across the capital structure; and
(iii) market multiples of comparable issuers.
Income approach (i) future cash flows discounted to present and adjusted as appropriate for liquidity, credit and/or market risks;
(ii) quoted prices for similar investments or assets in active markets; and
(iii) other risk factors, such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, recovery rates, liquidation amounts and/or default
rates.
Cost approach (i) audited or unaudited financial statements, investor communications and financial or operational metrics issued by the Private Company;
(ii) changes in the valuation of relevant indices or publicly traded companies comparable to the Private Company;
(iii) relevant news and other public sources; and
(iv) known secondary market transactions in the Private Company’s interests and merger or acquisition activity in companies comparable to the Private Company.

Investments in series of preferred stock issued by Private Companies are typically valued utilizing market approach in determining the enterprise value of the company. Such investments often contain rights and preferences that differ from other series of preferred and common stock of the same issuer. Valuation techniques such as an option pricing model (“OPM”), a probability weighted expected return model (“PWERM”) or a hybrid of those techniques are used in allocating enterprise value of the company, as deemed appropriate under the circumstances. The use of OPM and PWERM techniques involve a determination of the exit scenarios of the investment in order to appropriately allocate the enterprise value of the company among the various parts of its capital structure.

The Private Companies are not subject to the public company disclosure, timing, and reporting standards as other investments held by a Trust. Typically, the most recently available information by a Private Company is as of a date that is earlier than the date a Trust is calculating its NAV. This factor may result in a difference between the value of the investment and the price a Trust could receive upon the sale of the investment.

Fair Value Hierarchy: Various inputs are used in determining the fair value of investments and derivative financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial statement purposes as follows:

• Level 1 — unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Trust has the ability to access

• Level 2 — other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market–corroborated inputs)

126 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements (continued)

• Level 3 — unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including each Trust’s own assumptions used in determining the fair value of investments and derivative financial instruments)

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Global Valuation Committee in determining the price for Fair Valued investments. Level 3 investments include equity or debt issued by Private Companies. There may not be a secondary market, and/or there are a limited number of investors. Level 3 investments may also be adjusted to reflect illiquidity and/or non-transferability, with the amount of such discount estimated by the Global Valuation Committee in the absence of market information.

Changes in valuation techniques may result in transfers into or out of an assigned level within the hierarchy. In accordance with each Trust’s policy, transfers between different levels of the fair value hierarchy are deemed to have occurred as of the beginning of the reporting period. The categorization of a value determined for investments and derivative financial instruments is based on the pricing transparency of the investments and derivative financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

As of December 31, 2016, certain of the Trust’s investments were fair valued using NAV per share as no quoted market value is available and have been excluded from the fair value hierarchy.

4. Securities and Other Investments:

Preferred Stock: Preferred stock has a preference over common stock in liquidation (and generally in receiving dividends as well) but is subordinated to the liabilities of the issuer in all respects. As a general rule, the market value of preferred stock with a fixed dividend rate and no conversion element varies inversely with interest rates and perceived credit risk, while the market price of convertible preferred stock generally also reflects some element of conversion value. Because preferred stock is junior to debt securities and other obligations of the issuer, deterioration in the credit quality of the issuer will cause greater changes in the value of a preferred stock than in a more senior debt security with similar stated yield characteristics. Unlike interest payments on debt securities, preferred stock dividends are payable only if declared by the issuer’s board of directors. Preferred stock also may be subject to optional or mandatory redemption provisions.

Securities Lending: Certain Trusts may lend their securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Trusts collateral consisting of cash, an irrevocable letter of credit issued by a bank, or securities issued or guaranteed by the U.S. Government. The initial collateral received by each Trust is required to have a value of at least 102% of the current value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter, at a value equal to at least 100% of the current market value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Trust and any additional required collateral is delivered to the Trust, or excess collateral returned by the Trust, on the next business day. During the term of the loan, the Trusts are entitled to all distributions made on or in respect of the loaned securities but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

The market value of any securities on loan, all of which were classified as common stocks in the Trusts’ Schedules of Investments, and the value of any related collateral are shown separately in the Statements of Assets and Liabilities as a component of investments at value — unaffiliated, and collateral on securities loaned at value, respectively. As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested by the securities lending agent, BlackRock Investment Management, LLC (“BIM”), if any, is disclosed in the Schedules of Investments.

Securities lending transactions are entered into by the Trusts under Master Securities Lending Agreements (each an “MSLA”) which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Trusts as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the Trust can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties, obligations to return the securities or collateral to the other party

ANNUAL REPORT DECEMBER 31, 2016 127

Notes to Financial Statements (continued)

are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.

As of period end, the following table is a summary of the Trusts’ securities lending agreements by counterparty which are subject to offset under an MSLA:

| CII — Counterparty | Securities Loaned at Value | Cash
Collateral Received 1 | Net Amount | |
| --- | --- | --- | --- | --- |
| Morgan Stanley & Co. LLC | $ 676,613 | $ (676,613 | ) | — |
| BME | | | | |
| Counterparty | Securities Loaned at Value | Cash
Collateral Received 1 | Net Amount | |
| JP Morgan Securities LLC | $ 114,906 | $ (114,906 | ) | — |
| National Financial Services LLC | 8,250 | (8,250 | ) | — |
| Total | $ 123,156 | $ (123,156 | ) | — |
| BCX | | | | |
| Counterparty | Securities Loaned at Value | Cash
Collateral Received 1 | Net Amount | |
| Goldman Sachs & Co. | $ 1,136,275 | $ (1,136,275 | ) | — |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. | 1,797,986 | (1,797,986 | ) | — |
| Morgan Stanley & Co. LLC | 764,795 | (764,795 | ) | — |
| Total | $ 3,699,056 | $ (3,699,056 | ) | — |
| BST | | | | |
| Counterparty | Securities Loaned at Value | Cash
Collateral Received 1 | Net Amount | |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. | $ 124,536 | $ (124,536 | ) | — |
| BUI | | | | |
| Counterparty | Securities Loaned at Value | Cash
Collateral Received 1 | Net Amount | |
| Goldman Sachs & Co. | $ 433,609 | $ (433,609 | ) | — |

1 Collateral with a value of $695,531, $126,901, $3,934,928, $128,830, and $456,046 has been received in connection with securities lending agreements for CII, BME, BCX, BST and BUI, respectively. Collateral received in excess of the value of securities loaned from the individual counterparty is not shown for financial reporting purposes in the table above.

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, the Trusts benefit from a borrower default indemnity provided by BIM. BIM’s indemnity allows for full replacement of the securities loaned if the collateral received does not cover the value on the securities loaned in the event of borrower default. The Trusts could suffer a loss if the value of an investment purchased with cash collateral falls below the market value of loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received.

5. Derivative Financial Instruments:

The Trusts engage in various portfolio investment strategies using derivative contracts both to increase the returns of the Trusts and/or to manage their exposure to certain risks such as equity risk or commodity price risk. Derivative financial instruments categorized by risk exposure are included in the Schedule of Investments. These contracts may be transacted on an exchange or OTC.

Futures Contracts: Certain Trusts invest in long and/or short positions in futures and options on futures contracts to gain exposure to, or manage exposure to, changes in the value of equity securities (equity risk).

Futures contracts are agreements between the Trusts and a counterparty to buy or sell a specific quantity of an underlying instrument at a specified price and on a specified date. Depending on the terms of a contract, it is settled either through physical delivery of the underlying instrument on the settlement date or by payment of a cash amount on the settlement date. Upon entering into a futures contract, the Trusts are required to deposit

128 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements (continued)

initial margin with the broker in the form of cash or securities in an amount that varies depending on a contract’s size and risk profile. The initial margin deposit must then be maintained at an established level over the life of the contract.

Securities deposited as initial margin are designated in the Schedules of Investments and cash deposited, if any, is shown as cash pledged for futures contracts in the Statements of Assets and Liabilities. Pursuant to the contract, the Trusts agree to receive from or pay to the broker an amount of cash equal to the daily fluctuation in market value of the contract (“variation margin”). Variation margin is recorded as unrealized appreciation (depreciation) and, if any, shown as variation margin receivable or payable on futures contracts in the Statements of Assets and Liabilities. When the contract is closed, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. The use of futures contracts involves the risk of an imperfect correlation in the movements in the price of futures contracts and interest foreign currency exchange rates or underlying assets.

Forward Foreign Currency Exchange Contracts: Certain Trusts enter into forward foreign currency exchange contracts to gain or reduce exposure, to foreign currencies (foreign currency exchange rate risk).

A forward foreign currency exchange contract is an agreement between two parties to buy and sell a currency at a set exchange rate on a specified date. These contracts help to manage the overall exposure to the currencies in which some of the investments held by the Trusts are denominated and in some cases, may be used to obtain exposure to a particular market.

The contract is marked to market daily and the change in market value is recorded as unrealized appreciation (depreciation) in the Statements of Assets and Liabilities. When a contract is closed, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the value at the time it was opened and the value at the time it was closed. Non-deliverable forward foreign currency exchange contracts are settled with the counterparty in cash without the delivery of foreign currency. The use of forward foreign currency exchange contracts involves the risk that the value of a forward foreign currency exchange contract changes unfavorably due to movements in the value of the referenced foreign currencies.

Options: Certain Trusts purchase and write call and put options to increase or decrease their exposure to the risks of underlying instruments including equity risk and/or commodity price risk and/or, in the case of options written, to generate gains from options premiums.

A call option gives the purchaser (holder) of the option the right (but not the obligation) to buy, and obligates the seller (writer) to sell (when the option is exercised), the underlying instrument at the exercise or strike price at any time or at a specified time during the option period. A put option gives the holder the right to sell and obligates the writer to buy the underlying instrument at the exercise or strike price at any time or at a specified time during the option period.

Premiums paid on options purchased (and premiums received on options written) as well as the daily fluctuation in market value, are included in investments at value — unaffiliated and options written at value, respectively, in the Statements of Assets and Liabilities. When an instrument is purchased or sold through the exercise of an option, the premium is offset against the cost or proceeds of the underlying instrument. When an option expires a realized gain or loss is recorded in the Statements of Operations to the extent of the premiums received or paid. When an option is closed or sold, a gain or loss is recorded in the Statements of Operations to the extent the cost of the closing transaction exceeds the premiums received or paid). When the Trusts write a call option, such option is typically “covered,” meaning that they hold the underlying instrument subject to being called by the option counterparty. When the Trusts write a put option, such option is covered by cash in an amount sufficient to cover the obligation.

In purchasing and writing options, the Trusts bear the risk of an unfavorable change in the value of the underlying instrument or the risk that the Trusts may not be able to enter into a closing transaction due to an illiquid market. Exercise of a written option could result in the Trusts purchasing or selling a security when they otherwise would not, or at a price different from the current market value.

Master Netting Arrangements: In order to define their contractual rights and to secure rights that will help them mitigate their counterparty risk, the Trusts may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or similar agreement with their counterparties. An ISDA Master Agreement is a bilateral agreement between each Trust and a counterparty that governs certain OTC derivatives and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, each Trust may, under certain circumstances, offset with the counterparty certain derivative financial instruments’ payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default including the bankruptcy or insolvency of the counterparty. Bankruptcy or insolvency laws of a particular jurisdiction may restrict or prohibit the right of offset in bankruptcy, insolvency or other events. In addition, certain ISDA Master Agreements allow counterparties to terminate derivative contracts prior to maturity in the event the Trusts’ net assets decline by a stated percentage or the Trusts fail to meet the terms of their ISDA Master Agreements. The result would cause the Trusts to accelerate payment of any net liability owed to the counterparty.

ANNUAL REPORT DECEMBER 31, 2016 129

Notes to Financial Statements (continued)

Collateral Requirements: For derivatives traded under an ISDA Master Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement and comparing that amount to the value of any collateral currently pledged by a Trust and the counterparty.

Cash collateral that has been pledged to cover obligations of the Trusts and cash collateral received from the counterparty, if any, is reported separately on the Statements of Assets and Liabilities as cash pledged as collateral and cash received as collateral, respectively. Non-cash collateral pledged by the Trusts, if any, is noted in the Schedules of Investments. Generally, the amount of collateral due from or to a counterparty is subject to a certain minimum transfer amount threshold before a transfer is required, which is determined at the close of business of the Trusts. Any additional required collateral is delivered to/pledged by the Trusts on the next business day. Typically, a Trust’s counterparty is not permitted to sell, re-pledge or use cash and non-cash collateral it receives. A Trust generally agrees not to use non-cash collateral that it receives but may, absent default or certain other circumstances defined in the underlying ISDA Master Agreement, be permitted to use cash collateral received. In such cases, interest may be paid pursuant to the collateral arrangement with the counterparty. To the extent amounts due to the Trusts from their counterparties are not fully collateralized, they bear the risk of loss from counterparty non-performance. Likewise, to the extent the Trusts have delivered collateral to a counterparty and stand ready to perform under the terms of their agreement with such counterparty, they bear the risk of loss from a counterparty in the amount of the value of the collateral in the event the counterparty fails to return such collateral. Based on the terms of agreements, collateral may not be required for all derivative contracts.

For financial reporting purposes, the Trusts do not offset derivative assets and derivative liabilities that are subject to netting arrangements, if any, in the Statements of Assets and Liabilities.

6. Investment Advisory Agreement and Other Transactions with Affiliates:

The PNC Financial Services Group, Inc. is the largest stockholder and an affiliate of BlackRock, Inc. (“BlackRock”) for 1940 Act purposes.

Investment Advisory: Each Trust entered into an Investment Advisory Agreement with the Manager, the Trusts’ investment adviser, an indirect, wholly owned subsidiary of BlackRock, to provide investment advisory and administration services. The Manager is responsible for the management of each Trust’s portfolio and provides the personnel, facilities, equipment and certain other services necessary to the operations of each Trust. For such services, each Trust, except BCX and BST, pays the Manager a monthly fee at the following annual rates:

Average weekly value of each Trust’s net assets:
BGR 1.20%
BDJ 0.80%
BOE 1.00%
BME 1.00%
Average daily value of each Trust’s net assets:
CII 0.85%
BGY 1.00%
BUI 1.00%

For such services, BCX pays the Manager a monthly fee of 1.00% of the sum of the average daily value of the net assets of the Trust (excluding the value of the Trust’s interest in its subsidiary) and the average daily value of the net assets of its subsidiary, which fee is allocated pro rata between the Trust and its subsidiary based on the average daily value of their respective net assets (excluding, in the case of the Trust, the value of the Trust’s interest in its subsidiary).

BST pays the Manager a monthly fee of 1.00% of its average daily managed assets. “Managed Assets” mean the total assets of the Trust (including any assets attributable to money borrowed for investment purposes) minus the sum of the Trust’s accrued liabilities (other than money borrowed for investment purposes).

The Manager entered into separate sub-advisory agreements with BlackRock International Limited (“BIL”), an affiliate of the Manager, to serve as sub-advisor for BGR and BCX. The Manager pays BIL for services it provides to each Trust, a monthly fee that is a percentage of the investment advisory fees paid by each Trust to the Manager.

Expense Limitations, Waivers, Reimbursements and Recoupments: The Manager has agreed to waive a portion of the investment advisory fees on BST as a percentage of its average daily managed assets as follows:

0.20 % Expiration Date — December 31, 2018
0.15 % December 31, 2019
0.10 % December 31, 2020
0.05 % December 31, 2021

130 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements (continued)

The Manager has voluntarily agreed to waive a portion of its investment advisory fees on the following Trusts as a percentage of average weekly net assets as follows:

BGR 0.10
BOE 0.05 %

1 Effective July 1, 2016.

With respect to BGY, the Manager has voluntarily agreed to waive a portion of its investment advisory fees equal to the annual rate of 0.10% of BGY’s average daily net assets.

Prior to July 1, 2016, the Manager voluntarily agreed to waive a portion of its investment advisory fees equal to the annual rate of 0.05% and 0.025% of BGR and BDJ’s average weekly net assets, respectively.

These voluntary waivers may be reduced or discontinued at any time without notice.

For the year ended December 31, 2016, investment advisory fees waived which is included in fees waived by the Manager in the Statements of Operations were as follows:

BGR $
BDJ $ 198,531
BOE $ 466,755
BGY $ 711,439
BST $ 868,275

The Manager provides investment management and other services to BCX’s Subsidiary. The Manager does not receive separate compensation from the Subsidiary for providing investment management or administrative services. However, BCX pays the Manager based on the Trust’s net assets which includes the assets of the Subsidiary.

The Manager voluntarily agreed to waive its investment advisory fees by the amount of investment advisory fees each Trust pays to the Manager indirectly through its investment in affiliated money market funds. These amounts are included in fees waived by the Manager in the Statements of Operations. For the year ended December 31, 2016, the amounts waived pursuant to this arrangement were as follows:

BGR $
CII $ 15,568
BDJ $ 5,191
BOE $ 16,304
BME $ 9,713
BGY $ 37,407
BCX $ 9,102
BST $ 1,507
BUI $ 4,851

Effective September 1, 2016, the Manager voluntarily agreed to waive its investment advisory fee with respect to any portion of each Trust’s assets invested in affiliated equity or fixed-income mutual funds or affiliated exchange-traded funds that have a contractual management fee. Prior to September 1, 2016 the Manager did not waive such fees. On December 2, 2016, the Manager entered into a Master Advisory Fee Waiver Agreement (the “Agreement”), contractually committing to this arrangement through June 30, 2017. The Agreement can be renewed for annual periods thereafter, and may be terminated on 90 days’ notice, each subject to approval by a majority of the Trusts’ independent trustees. For the year ended December 31, 2016, there were no advisory fees waived pursuant to these arrangements in the Trusts.

Service and Distribution Fees: BME has entered into a Distribution Agreement with BlackRock Investments, LLC (“BRIL”), an affiliate of the Manager, to provide for distribution of BME common shares on a reasonable best efforts basis through an equity shelf offering (a “Shelf Offering”) (the “Distribution Agreement”). Pursuant to the Distribution Agreement, BME compensates BRIL with respect to sales of common shares at a commission rate of 1.00% of the gross proceeds of the sale of BME’s common shares and a portion of such commission is re-allowed to broker-dealers engaged by BRIL. The commissions retained by BRIL during the year ended December 31, 2016 amounted to $25,214.

Securities Lending: The U.S. Securities and Exchange Commission (“SEC”) has issued an exemptive order which permits BIM, an affiliate of the Manager, to serve as securities lending agent for the Trusts, subject to applicable conditions. As securities lending agent, BIM bears all operational costs directly related to securities lending. The Trusts are responsible for expenses in connection with the investment of cash collateral received for securities on loan (the “collateral investment expenses”). The cash collateral is invested in a private investment company managed by the Manager or

ANNUAL REPORT DECEMBER 31, 2016 131

Notes to Financial Statements (continued)

its affiliates. However, BIM has agreed to cap the collateral investment expenses of the private investment company to an annual rate of 0.04%. The investment adviser to the private investment company will not charge any advisory fees with respect to shares purchased by the Trusts.

Securities lending income is equal to the total of income earned from the reinvestment of cash collateral, net of fees and other payments to and from borrowers of securities, and less the collateral investment expenses. Each Trust retains a portion of securities lending income and remits a remaining portion to BIM as compensation for its services as securities lending agent. Pursuant to a securities lending agreement, BIM may lend securities only when the difference between the borrower rebate rate and the risk free rate exceeds a certain level (such securities, the “specials only securities”).

Pursuant to such agreement, each Trust retains 80% of securities lending income. In addition, commencing the business day following the date that the aggregate securities lending income earned across the Closed-End Complex in a calendar year exceeds the breakpoint dollar threshold applicable in the given year as set forth in the securities lending agreement, each Trust, pursuant to the securities lending agreement, will retain for the remainder of the calendar year securities lending income in an amount equal to 85% of securities lending income.

The share of securities lending income earned by each Trust is shown as securities lending — affiliated — net in the Statements of Operations. For the year ended December 31, 2016, each Trust paid BIM the following amounts for securities lending agent services:

BGR $
CII $ 682
BDJ $ 34
BOE $ 4,945
BME $ 2,104
BGY $ 5,416
BCX $ 34,448
BST $ 31,681
BUI $ 7,860

Officers and Trustees: Certain officers and/or trustees of the Trusts are officers and/or trustees of BlackRock or its affiliates. The Trusts reimburse the Manager for a portion of the compensation paid to the Trusts’ Chief Compliance Officer, which is included in Officer and Trustees in the Statements of Operations.

Other Transactions: The Trusts may purchase securities from, or sell securities to, an affiliated fund provided the affiliation is due solely to having a common investment adviser, common officers, or common trustees. For the year ended December 31, 2016, the purchase and sale transactions and any net realized gains (losses) with an affiliated fund in compliance with Rule 17a-7 under the 1940 Act were as follows:

Purchases Sales Net Realized Gains
BDJ $ 1,771,064 — —
BME $ 328,120 — —
BGY $ 752,100 — —
BCX $ 435,002 — —
BST $ 154,956 $ 1,431,650 $ 189,901

7. Purchases and Sales:

For the year ended December 31, 2016, purchases and sales of investments, excluding short-term securities, were as follows:

BGR $ 144,823,813 $ 167,679,896
CII $ 340,854,282 $ 402,247,629
BDJ $ 539,736,538 $ 638,534,616
BOE $ 596,931,556 $ 671,349,791
BME $ 156,745,335 $ 164,489,516
BGY $ 492,126,258 $ 512,308,134
BCX $ 901,128,015 $ 984,257,917
BST $ 325,573,998 $ 357,262,106
BUI $ 27,749,591 $ 37,480,064

8. Income Tax Information:

It is the Trusts’ policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of their taxable income to their shareholders. Therefore, no federal income tax provision is required.

132 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements (continued)

The Trusts file U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on each Trust’s U.S. federal tax returns generally remains open for the each of the two years ended December 31, 2016, the period ended December 31, 2014 and each of the two years ended October 31, 2014 with the exception of BST. The statutes of limitations on BST’s U.S. federal tax returns remains open for each of the two years ended December 31, 2016 and the period ended December 31, 2014. The statute of limitations on each Trust’s state and local tax returns may remain open for an additional year depending upon the jurisdiction.

Management has analyzed tax laws and regulations and their application to the Trusts’ as of December 31, 2016, inclusive of the open tax return years and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Trusts’ financial statements.

US GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or net asset values per share. As of period end, the following permanent differences attributable to foreign currency transactions, the sale of stock of passive foreign investment companies, net operating losses, non-deductible expenses, the characterization of corporate actions, income recognized from investments in partnerships and the expiration of capital loss carryforwards were reclassified to the following accounts:

Paid-in capital — $ (4,870,467 $ (61,470,174 ) $ (38,148,041 $ (58,865 )
Undistributed (distributions in excess of) net investment income $ (288,068 ) $ 141,885 $ (63,091 ) $ 442,933 $ 719,173
Accumulated net realized loss $ 288,068 $ 4,728,582 $ 61,533,265 $ 37,705,108 $ (660,308 )
Paid-in capital $ (458,843,934 $ (2,659,643 $ (19,487 ) —
Undistributed (distributions in excess of) net investment income $ 656,236 $ 17,335 $ (86,179 ) $ (627,600 )
Accumulated net realized gain (loss) $ 458,187,698 $ 2,642,308 $ 105,666 $ 627,600

The tax character of distributions paid was as follows:

Ordinary income
12/31/16 $ 7,985,951 $ 5,818,337 $ 31,386,331 $ 6,886,585 $ 2,208,132
12/31/15 $ 8,567,540 $ 6,318,821 $ 31,248,083 $ 18,801,869 $ 21,088,719
Long-term capital gains
12/31/16 — $ 1,682,938 — — $ 22,940,269
12/31/15 — $ 46,626,859 — — $ 32,647,617
Return of capital
12/31/16 $ 21,720,074 $ 43,167,741 $ 74,517,121 $ 66,070,734 —
12/31/15 $ 36,005,387 — $ 74,655,369 $ 62,076,530 —
Total
12/31/16 $ 29,706,025 $ 50,669,016 $ 105,903,452 $ 72,957,319 $ 25,148,401
12/31/15 $ 44,572,927 $ 52,945,680 $ 105,903,452 $ 80,878,399 $ 53,736,336
Ordinary income
12/31/16 $ 7,270,081 $ 14,753,944 — $ 12,931,397
12/31/15 $ 12,357,754 $ 24,837,338 $ 748,679 $ 14,070,240
Long-term capital gains
12/31/16 — — — $ 4,346,341
12/31/15 — — — 2,129,355
Return of capital
12/31/16 $ 50,144,321 $ 42,403,551 $ 27,009,110 $ 7,271,174
12/31/15 $ 52,315,941 $ 55,321,839 $ 26,260,431 $ 8,349,317
Total
12/31/16 $ 57,414,402 $ 57,157,495 $ 27,009,110 $ 24,548,912
12/31/15 $ 64,673,695 $ 80,159,177 $ 27,009,110 $ 24,548,912

ANNUAL REPORT DECEMBER 31, 2016 133

Notes to Financial Statements (continued)

As of period end, the tax components of accumulated net earnings (losses) were as follows:

BGR CII BDJ BOE BME
Undistributed ordinary income — — — — $ 46,485
Undistributed long-term capital gains — — — — 3,662,160
Capital loss carryforwards $(155,077,777) (33,955,344) $(28,867,074) $ (807,221) —
Net unrealized gains 1 26,916,388 57,842,558 437,618,577 91,853,759 55,929,225
Qualified late-year losses 2 (312) (3,727) (17) (653,772)
Total $(128,161,389) $23,886,902 $408,747,776 $91,046,521 $58,984,098
BGY BCX BST BUI
Capital loss carryforwards $(103,102,527) $(466,926,878) $(13,469,302) —
Net unrealized gains 1 12,406,673 102,598,719 92,553,775 $47,376,950
Qualified late-year losses 2 (360,237) — — (4,618)
Total $ (91,056,091) $(364,328,159) $79,084,473 $47,372,332

1 The difference between book-basis and tax-basis net unrealized gains (losses) was attributable primarily to the tax deferral of losses on wash sales and straddles, the realization for tax purposes of unrealized gains/losses on certain options and foreign currency contracts, the realization for tax purposes of unrealized gains on investments in passive foreign investment companies, the timing and recognition of partnership income, the characterization of corporate actions, and the deferral of compensation to Trustees.

2 The Trust has elected to defer certain qualified late-year losses and recognize such losses in the next taxable period.

As of December 31, 2016, the Trusts had capital loss carryforwards available to offset future realized capital gains through the indicated expiration dates as follows:

Expires December 31, — No expiration date 3 $155,077,777 $31,423,316 $20,340,326 $807,221 $47,497,065 $465,131,677 $13,469,302
2017 — 2,532,028 8,526,748 — 55,605,462 1,795,201 —
Total $155,077,777 $33,955,344 $28,867,074 $807,221 $103,102,527 $466,926,878 $13,469,302

3 Must be utilized prior to losses subject to expiration.

During the year ended December 31, 2016, BST utilized $3,714,136 of its capital loss carryforward.

As of December 31, 2016, gross unrealized appreciation and gross unrealized depreciation based on cost for federal income tax purposes were as follows:

Tax cost BGR — $462,547,629 CII — $612,974,677 BDJ — $1,308,170,059 BOE — $836,755,803 BME — $213,987,813
Gross unrealized appreciation $ 50,320,086 $ 77,651,900 $ 470,321,000 $124,887,052 $ 63,825,553
Gross unrealized depreciation (18,805,565 ) (15,495,022 ) (7,887,226 ) (25,784,186 ) (6,259,689 )
Net unrealized appreciation $ 31,514,521 $ 62,156,878 $ 462,433,774 $ 99,102,866 $ 57,565,864
Tax cost BGY — $676,677,844 BCX — $878,632,645 BST — $360,081,489 BUI — $265,849,683
Gross unrealized appreciation $ 53,610,387 $127,022,409 $100,735,156 $ 78,236,637
Gross unrealized depreciation (29,383,632 ) (15,216,813 ) (5,629,927 ) (11,728,709 )
Net unrealized appreciation $ 24,226,755 $111,805,596 $ 95,105,229 $ 66,507,928

9. Principal Risks:

In the normal course of business, the Trusts invest in securities and enter into transactions where risks exist due to fluctuations in the market (market risk) or failure of the issuer to meet all its obligations, including the ability to pay principal and interest when due (issuer credit risk). The value of securities held by the Trusts may decline in response to certain events, including those directly involving the issuers of securities owned by the Trusts. Changes arising from the general economy, the overall market and local, regional or global political or/and social or instability, as well as currency, interest rate and price fluctuations also affect the securities’ value.

134 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements (continued)

On October 11, 2016, BlackRock implemented certain changes required by amendments to Rule 2a-7 under the 1940 Act, which governs the operations of U.S. money market funds. The Trusts may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00 and which may be subject to redemption gates or liquidity fees under certain circumstances.

Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. A Trust may invest in illiquid investments and may experience difficulty in selling those investments in a timely manner at the price that it believes the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause each Trust’s NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of a Trust may lose value, regardless of the individual results of the securities and other instruments in which the Trust invests.

The price a Trust could receive upon the sale of any particular portfolio investment may differ from the Trust’s valuation of the investment, particularly for securities that trade in thin or volatile markets or that are valued using a fair valuation technique or a price provided by an independent pricing service. Changes to significant unobservable inputs and assumptions (i.e., publicly traded company multiples, growth rate, time to exit) due to the lack of observable inputs may significantly impact the resulting fair value and therefore the Trust’s results of operations. As a result, the price received upon the sale of an investment may be less than the value ascribed by a Trust, and a Trust could realize a greater than expected loss or lesser than expected gain upon the sale of the investment. The Trust’s ability to value its investments may also be impacted by technological issues and/or errors by pricing services or other third party service providers.

Counterparty Credit Risk: Similar to issuer credit risk, the Trusts may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions. The Trusts manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Trusts to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Trusts’ exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Trusts.

A derivative contract may suffer a mark-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform under the contract.

The Trusts’ risk of loss from counterparty credit risk on OTC derivatives is generally limited to the aggregate unrealized gain less the value of any collateral held by the Trust.

For OTC options purchased, each Trust bears the risk of loss in the amount of the premiums paid plus the positive change in market values net of any collateral held by the Trusts should the counterparty fail to perform under the contracts. Options written by the Trusts do not typically give rise to counterparty credit risk, as options written generally obligate the Trusts, and not the counterparty, to perform. The Trusts may be exposed to counterparty credit risk with respect to options written to the extent the Trusts deposit collateral with its counterparty to a written option.

With exchange-traded options purchased and futures, there is less counterparty credit risk to the Trusts since the exchange or clearinghouse, as counterparty to such instruments, guarantees against a possible default. The clearinghouse stands between the buyer and the seller of the contract; therefore, credit risk is limited to failure of the clearinghouse. While offset rights may exist under applicable law, a Trust does not have a contractual right of offset against a clearing broker or clearinghouse in the event of a default (including the bankruptcy or insolvency). Additionally, credit risk exists in exchange-traded options and futures with respect to initial and variation margin that is held in a clearing broker’s customer accounts. While clearing brokers are required to segregate customer margin from their own assets, in the event that a clearing broker becomes insolvent or goes into bankruptcy and at that time there is a shortfall in the aggregate amount of margin held by the clearing broker for all its clients, typically the shortfall would be allocated on a pro rata basis across all the clearing broker’s customers, potentially resulting in losses to the Trusts.

Concentration Risk: As of period end, the Trusts listed below invested a significant portion of their assets in securities in the following sectors:

Energy BGR, BCX
Financials BDJ, BGY
Health Care BME
Information Technology CII, BST
Materials BCX
Utilities BUI

ANNUAL REPORT DECEMBER 31, 2016 135

Notes to Financial Statements (continued)

Changes in economic conditions affecting such sectors would have a greater impact on these Trusts and could affect the value, income and/or liquidity of positions in such securities.

BOE and BGY invest a substantial amount of their assets in issuers located in a single country or a limited number of countries. When a Trust concentrates its investments in this manner, it assumes the risk that economic, political and social conditions in those countries may have a significant impact on their investment performance. Foreign issuers may not be subject to the same uniform accounting, auditing and financial reporting standards and practices as used in the United States. Foreign securities markets may also be less liquid, more volatile, and less subject to governmental supervision not typically associated with investing in United States securities. Investment percentages in specific countries are presented in the Schedule of Investments.

BGY and BCX invests a significant portion of their assets in securities of issuers located in Europe or with significant exposure to European issuers or countries. The European financial markets have recently experienced volatility and adverse trends due to concerns about economic downturns in, or rising government debt levels of, several European countries. These events may spread to other countries in Europe and may affect the value and liquidity of certain of the Trusts’ investments.

The United Kingdom voted on June 23, 2016 to withdraw from the European Union, which may introduce significant new uncertainties and instability in the financial markets across Europe.

10. Capital Share Transactions:

There are an unlimited number of $0.001 par value common shares of beneficial interest authorized for each Trust, with the exception of CII. CII is authorized to issue 200 million shares of $0.10 par value shares, all of which were initially classified as Common Shares. The Board is authorized, however, to reclassify any unissued Common Shares to Preferred Shares without approval of Common Shareholders.

For the periods shown, shares issued and outstanding increased by the following amounts as a result of shares issued through the Shelf Offering:

Year Ended December 31, 2016 Year Ended December 31, 2015
BME 363,708 252,980

For the periods shown, shares issued and outstanding increased by the following amounts as a result of dividend reinvestments:

BGR — Year Ended December 31, 2015 — 59,109
BME 63,264 117,681

For the year ended December 31, 2016, BGR, CII, BDJ, BOE, BGY, BCX, BST and BUI and for the year ended December 31, 2015, CII, BDJ, BOE, BGY, BCX, BST and BUI, shares issued and outstanding remained constant.

On October 26, 2016, the Board approved an open market share repurchase program that allows each Trust to purchase up to 5% of its outstanding common shares from time to time in open market transactions through November 30, 2017, subject to certain conditions. There is no assurance that the Trusts will purchase shares in any particular amounts.

On June 9, 2016, BME filed a final prospectus with the U.S. Securities and Exchange Commission (“SEC”) allowing it to issue an additional 2,500,000 Common Shares through a Shelf Offering. Under the Shelf Offering, BME, subject to market conditions, may raise additional equity capital from time to time in varying amounts and utilizing various offering methods at a net price at or above BME’s net asset value (“NAV”) per Common Share (calculated within 48 hours of pricing). As of period end, 2,136,292 Common Shares remain available for issuance under the Shelf Offering. From August 12, 2015 to June 9, 2016, BME was authorized to issue 453,000 Common Shares under a previous Shelf Offering. See Additional Information — Shelf Offering Program for additional information about the Shelf Offering.

Costs incurred by BME in connection with the Shelf Offering are recorded as a deferred charge and amortized over 12 months.

136 ANNUAL REPORT DECEMBER 31, 2016

Notes to Financial Statements (concluded)

11. Subsequent Events:

Management’s evaluation of the impact of all subsequent events on the Trusts’ financial statements was completed through the date the financial statements were issued and the following items were noted:

The Trusts paid a distribution on January 31, 2017 to shareholders of record on January 13, 2017 as follows:

Common Dividend Per Share
BGR $ 0.0776
CII $ 0.0828
BDJ $ 0.0467
BOE $ 0.0780
BME $ 0.2000
BGY $ 0.0380
BCX $ 0.0446
BST $ 0.1000
BUI $ 0.1210

Additionally, certain Trusts declared a distribution in the following amounts per share on February 28, 2017 payable to shareholders of record on February 15, 2017 as follows:

Common Dividend Per Share
BGR $ 0.0776
CII $ 0.0828
BDJ $ 0.0467
BOE $ 0.0780
BME $ 0.2000
BGY $ 0.0380
BCX $ 0.0446
BST $ 0.1000
BUI $ 0.1210

ANNUAL REPORT DECEMBER 31, 2016 137

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of BlackRock Energy and Resources Trust, BlackRock Enhanced Equity Dividend Trust, BlackRock Global Opportunities Equity Trust, BlackRock Health Sciences Trust, BlackRock International Growth and Income Trust, BlackRock Resources & Commodities Strategy Trust, BlackRock Science and Technology Trust, BlackRock Utility and Infrastructure Trust, and the Board of Directors and Shareholder of BlackRock Enhanced Capital and Income Fund, Inc.:

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of BlackRock Energy and Resources Trust, BlackRock Enhanced Capital and Income Fund, Inc., BlackRock Enhanced Equity Dividend Trust, BlackRock Global Opportunities Equity Trust, BlackRock Health Sciences Trust, BlackRock International Growth and Income Trust, BlackRock Science and Technology Trust and BlackRock Utility and Infrastructure Trust, as of December 31, 2016, and the related statements of operations and cash flows for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, and the financial highlights for each of the periods presented. We have also audited the consolidated statement of assets and liabilities, including the consolidated schedule of investments of BlackRock Resources & Commodities Strategy Trust (collectively with BlackRock Energy and Resources Trust, BlackRock Enhanced Capital and Income Fund, Inc., BlackRock Enhanced Equity Dividend Trust, BlackRock Global Opportunities Equity Trust, BlackRock Health Sciences Trust, BlackRock International Growth and Income Trust, BlackRock Science and Technology Trust and BlackRock Utility and Infrastructure Trust, the “Trusts”), as of December 31, 2016, and the related consolidated statements of operations and cash flows for the year then ended, the consolidated statements of changes in net assets for each of the two years in the period then ended and the consolidated financial highlights for each of the periods presented. These financial statements and financial highlights are the responsibility of the Trusts’ management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Trusts are not required to have, nor were we engaged to perform, an audit of their internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Trusts’ internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of December 31, 2016, by correspondence with the custodian and brokers; where replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of the BlackRock Energy and Resources Trust, BlackRock Enhanced Capital and Income Fund, Inc., BlackRock Enhanced Equity Dividend Trust, BlackRock Global Opportunities Equity Trust, BlackRock Health Sciences Trust, BlackRock International Growth and Income Trust, BlackRock Science and Technology Trust and BlackRock Utility and Infrastructure Trust as of December 31, 2016, the results of their operations and cash flows for the year then ended, the changes in their net assets for each of the two years in the period then ended, and the financial highlights for each of the periods presented, and the consolidated financial position of BlackRock Resources & Commodities Strategy Trust as of December 31, 2016, the consolidated results of its operations and cash flows for the year then ended, the consolidated changes in net assets for each of the two years in the period then ended, and its consolidated financial highlights for each of the periods presented in conformity with accounting principles generally accepted in the United States of America.

Deloitte & Touche LLP

Philadelphia, Pennsylvania

February 23, 2017

138 ANNUAL REPORT DECEMBER 31, 2016

Important Tax Information (Unaudited)

During the taxable period ended December 31, 2016, the following information is provided with respect to the distributions paid by the Trusts:

BGR 01/29/16 - 12/30/16 — 73.11 % 26.89 % 19.55 % — — —
CII 01/29/16 38.14 % 51.79 % 10.07 % 10.07 % — — —
02/29/16 - 12/30/16 — 88.37 % 11.63 % 11.63 % — — —
BDJ 01/29/16 - 12/30/16 — 70.36 % 29.64 % 29.64 % — — —
BOE 01/29/16 - 12/30/16 — 90.56 % 9.44 % 9.44 % — — —
BME 01/29/16 - 04/29/16 97.19 % — 0.51 % 0.39 % 2.26 % — —
05/31/16 91.47 % — 7.81 % 7.14 % 7.56 % — —
06/30/16 - 12/30/16 88.86 % — 11.14 % 10.23 % 9.98 % — —
BGY 01/29/16 - 12/30/16 — 87.33 % 12.67 % — — 12.67 % 3.28 %
BCX 01/29/16 - 12/30/16 — 74.17 % 25.83 % 14.78 % — — —
BST 01/29/16 - 12/30/16 — 100.00 % — — — — —
BUI 01/29/16 - 12/30/16 17.76 % 29.43 % 38.46 % 24.58 % 18.73 % — —

1 The Trusts hereby designate the percentages indicated above to the maximum amount allowable by law.

2 Represents the portion of the dividends eligible for exemption from U.S. withholding tax for nonresident aliens and foreign corporations.

3 The foreign taxes paid represent taxes incurred by the Trust on interest received from foreign sources. Foreign taxes paid may be included in taxable income with an offsetting deduction from gross income or may be taken as a credit for taxes paid to foreign governments. You should consult your tax advisor regarding the appropriate treatment of foreign taxes paid.

ANNUAL REPORT DECEMBER 31, 2016 139

Automatic Dividend Reinvestment Plans

Pursuant to each Trust’s Dividend Reinvestment Plan (the “Reinvestment Plan”), Common Shareholders are automatically enrolled, to have all distributions of dividends and capital gains and other distributions reinvested by Computershare Trust Company, N.A. (the “Reinvestment Plan Agent”) in the respective Trust’s shares pursuant to the Reinvestment Plan. Shareholders who do not participate in the Reinvestment Plan will receive all distributions in cash paid by check and mailed directly to the shareholders of record (or if the shares are held in street name or other nominee name, then to the nominee) by the Reinvestment Plan Agent, which serves as agent for the shareholders in administering the Reinvestment Plan.

After the Trusts declare a dividend or determines to make a capital gain or other distribution, the Reinvestment Plan Agent will acquire shares for the participants’ accounts, depending upon the following circumstances, either (i) through receipt of unissued but authorized shares from the Trust (“newly issued shares”) or (ii) by purchase of outstanding shares on the open market, on a Trust’s primary exchange (“open market purchases”). If, on the dividend payment date, the net asset value per share (“NAV”) is equal to or less than the market price per share plus estimated brokerage commissions (such condition often referred to herein as a “market premium”), the Reinvestment Plan Agent will invest the dividend amount in newly issued shares acquired on behalf of the participants. The number of newly issued shares to be credited to each participant’s account will be determined by dividing the dollar amount of the dividend by the NAV on the date the shares are issued. However, if the NAV is less than 95% of the market price on the dividend payment date, the dollar amount of the dividend will be divided by 95% of the market price on the dividend payment date. If, on the dividend payment date, the NAV is greater than the market price per share plus estimated brokerage commissions (such condition often referred to herein as “market discount”), the Reinvestment Plan Agent will invest the dividend amount in shares acquired on behalf of the participants in open-market purchases. If the Reinvestment Plan Agent is unable to invest the full dividend amount in open market purchases, or if the market discount shifts to a market premium during the purchase period, the Reinvestment Plan Agent will invest any un-invested portion in newly issued shares. Investments in newly issued shares made in this manner would be made pursuant to the same process described above and the date of issue for such newly issued shares will substitute for the dividend payment date.

You may elect not to participate in the Reinvestment Plan and to receive all dividends in cash by contacting the Reinvestment Plan Agent, at the address set forth below.

Participation in the Reinvestment Plan is completely voluntary and may be terminated or resumed at any time without penalty by notice if received and processed by the Reinvestment Plan Agent prior to the dividend record date. Additionally, the Reinvestment Plan Agent seeks to process notices received after the record date but prior to the payable date and such notices often will become effective by the payable date. Where late notices are not processed by the applicable payable date, such termination or resumption will be effective with respect to any subsequently declared dividend or other distribution.

The Reinvestment Plan Agent’s fees for the handling of the reinvestment of all distributions will be paid by each Trust. However, each participant will pay a pro rata share of brokerage commissions incurred with respect to the Reinvestment Plan Agent’s open market purchases in connection with the reinvestment of all distributions. The automatic reinvestment of all distributions will not relieve participants of any federal income tax that may be payable on such dividends or distributions.

Each Trust reserves the right to amend or terminate the Reinvestment Plan. There is no direct service charge to participants in the Reinvestment Plan; however, each Trust reserves the right to amend the Reinvestment Plan to include a service charge payable by the participants. Participants that request a sale of shares are subject to a $0.02 per share sold brokerage commission. All correspondence concerning the Reinvestment Plan should be directed to Computershare Trust Company, N.A. through the internet at http://www.computershare.com/blackrock, or in writing to Computershare, P.O. Box 30170, College Station, TX 77842-3170, Telephone: (800) 699-1236. Overnight correspondence should be directed to the Reinvestment Plan Agent at Computershare, 211 Quality Circle, Suite 210, College Station, TX 77845.

140 ANNUAL REPORT DECEMBER 31, 2016

Officers and Trustees

| Name, Address 1 , and Year of Birth | Position(s) Held with the Trusts | Length of
Time Served as a Trustee 3 | Principal Occupation(s) During Past Five Years | Number of BlackRock- Advised Registered Investment Companies (“RICs”) Consisting of Investment
Portfolios (“Portfolios”) Overseen 4 | Public Directorships |
| --- | --- | --- | --- | --- | --- |
| Independent
Trustees 2 | | | | | |
| Richard E. Cavanagh 1946 | Chairman of the Board and Trustee | Since 2007 | Director, The Guardian Life Insurance Company of America since 1998; Director, Arch Chemical (chemical and allied products) from 1999 to 2011;
Trustee, Educational Testing Service from 1997 to 2009 and Chairman thereof from 2005 to 2009; Senior Advisor, The Fremont Group since 2008 and Director thereof since 1996; Faculty Member/Adjunct Lecturer, Harvard University since 2007; President
and Chief Executive Officer, The Conference Board, Inc. (global business research organization) from 1995 to 2007. | 74 RICs consisting of 74 Portfolios | None |
| Karen P. Robards 1950 | Vice Chair of the Board and Trustee | Since 2007 | Principal of Robards & Company, LLC (consulting and private investing) since 1987; Co-founder and Director of the Cooke Center for Learning
and Development (a not-for-profit organization) since 1987; Investment Banker at Morgan Stanley from 1976 to 1987. | 74 RICs consisting of 74 Portfolios | AtriCure, Inc. (medical devices); Greenhill & Co., Inc. |
| Michael J. Castellano 1946 | Trustee | Since 2011 | Chief Financial Officer of Lazard Group LLC from 2001 to 2011; Chief Financial Officer of Lazard Ltd from 2004 to 2011; Director, Support Our
Aging Religious (non-profit) from 2009 to June 2015; Director, National Advisory Board of Church Management at Villanova University since 2010; Trustee, Domestic Church Media Foundation since 2012; Director, CircleBlack Inc. (financial technology
company) since 2015. | 74 RICs consisting of 74 Portfolios | None |
| Cynthia L. Egan 1955 | Trustee | Since 2016 | Advisor, U.S. Department of the Treasury from 2014 to 2015; a President at T. Rowe Price Group, Inc. from 2007 to 2012. | 74 RICs consisting of 74 Portfolios | Unum (insurance); The Hanover Insurance Group (insurance); Envestnet (investment platform) from 2013 until 2016 |
| Frank J. Fabozzi 1948 | Trustee | Since 2007 | Editor of and Consultant for The Journal of Portfolio Management since 2006; Professor of Finance, EDHEC Business School since 2011; Visiting
Professor, Princeton University from 2013 to 2014; Professor in the Practice of Finance and Becton Fellow, Yale University School of Management from 2006 to 2011 | 74 RICs consisting of 74 Portfolios | None |
| Jerrold B. Harris 1942 | Trustee | Since 2007 | Trustee, Ursinus College from 2000 to 2012; Director, Ducks Unlimited - Canada (conservation) since 2015; Director, Waterfowl Chesapeake
(conservation) since 2014; Director, Ducks Unlimited, Inc. since 2013; Director, Troemner LLC (scientific equipment) since 2000; Director of Delta Waterfowl Foundation from 2010 to 2012; President and Chief Executive Officer, VWR Scientific Products
Corporation from 1990 to 1999. | 74 RICs consisting of 74 Portfolios | BlackRock Capital Corp. (business development company) |
| R. Glenn Hubbard 1958 | Trustee | Since 2007 | Dean, Columbia Business School since 2004; Faculty member, Columbia Business School since 1988. | 74 RICs consisting of 74 Portfolios | ADP (data and information services), Metropolitan Life Insurance Company (insurance) |
| W. Carl Kester 1951 | Trustee | Since 2007 | George Fisher Baker Jr. Professor of Business Administration, Harvard Business School since 2008, Deputy Dean for Academic Affairs from 2006 to
2010, Chairman of the Finance Unit, from 2005 to 2006, Senior Associate Dean and Chairman of the MBA Program from 1999 to 2005; Member of the faculty of Harvard Business School since 1981. | 74 RICs consisting of 74 Portfolios | None |

ANNUAL REPORT DECEMBER 31, 2016 141

Officers and Trustees (continued)

| Name, Address 1 , and Year of Birth | Position(s) Held with the Trusts | Length of
Time Served as a Trustee 3 | Principal Occupation(s) During Past Five Years | Number of BlackRock- Advised Registered Investment Companies (“RICs”) Consisting of Investment
Portfolios (“Portfolios”) Overseen 4 | Public Directorships |
| --- | --- | --- | --- | --- | --- |
| Independent Trustees 2 (concluded) | | | | | |
| Catherine A. Lynch 1961 | Trustee | Since 2016 | Chief Executive Officer, Chief Investment Officer and various other positions, National Railroad Retirement Investment Trust from 2003 to 2016;
Associate Vice President for Treasury Management, The George Washington University from 1999 to 2003; Assistant Treasurer, Episcopal Church of America from 1995 to 1999. | 74 RICs consisting of 74 Portfolios | None |

| | 1 The address of
each Trustee is c/o BlackRock, Inc., Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055. 2 Each Independent Trustee will serve until his or her successor is elected and qualifies, or until his or her earlier death, resignation, retirement or
removal, or until December 31 of the year in which he or she turns 75. The maximum age limitation may be waived as to any Trustee by action of a majority of the Trustees upon finding of good cause therefor. 3 Following the
combination of Merrill Lynch Investment Managers, L.P. (“MLIM”) and BlackRock, Inc. (“BlackRock”) in September 2006, the various legacy MLIM and legacy BlackRock fund boards were realigned and consolidated into three new fund
boards in 2007. As a result, although the chart shows certain Independent Trustees as joining the Board in 2007, each Trustee first became a member of the boards of other legacy MLIM or legacy BlackRock funds as follows: Richard E. Cavanagh, 1994;
Frank J. Fabozzi, 1988; Jerrold B. Harris, 1999; R. Glenn Hubbard, 2004; W. Carl Kester, 1995 and Karen P. Robards, 1998. 4 For purposes of this chart, “RICs” refers to investment companies registered under the 1940 Act
and “Portfolios” refers to the investment programs of the BlackRock-advised funds. The Closed-End Complex is comprised of 74 RICs. Mr. Perlowski, Dr. Fabozzi and Ms. Novick are also board members of certain complexes of
BlackRock registered open-end funds. Mr. Perlowski is also a board member of the BlackRock Equity-Bond Complex and the BlackRock Equity-Liquidity Complex, and Ms. Novick is also a board members of the BlackRock Equity-Liquidity
Complex. | | | | |
| --- | --- | --- | --- | --- | --- |
| Interested
Trustees 5 | | | | | |
| Barbara G. Novick 1960 | Trustee | Since 2015 | Vice Chairman of BlackRock, Inc. since 2006; Chair of BlackRock’s Government Relations Steering Committee since 2009; Head of the Global
Client Group of BlackRock, Inc. from 1988 to 2008. | 100 RICs consisting of 220 Portfolios | None |
| John M. Perlowski 1964 | Trustee, President and Chief Executive Officer | Since 2015 (Trustee); Since 2011 (President and Chief Executive Officer) | Managing Director of BlackRock, Inc. since 2009; Head of BlackRock Global Fund & Accounting Services since 2009; Managing Director and Chief
Operating Officer of the Global Product Group at Goldman Sachs Asset Management, L.P. from 2003 to 2009; Treasurer of Goldman Sachs Mutual Funds from 2003 to 2009 and Senior Vice President thereof from 2007 to 2009; Director of Goldman Sachs
Offshore Funds from 2002 to 2009; Director of Family Resource Network (charitable foundation) since 2009. | 128 RICs consisting of 318 Portfolios | None |
| | 5 Mr. Perlowski
and Ms. Novick are both “interested persons,” as defined in the 1940 Act, of the Trust based on their positions with BlackRock and its affiliate. Mr. Perlowski and Ms. Novick are also board members of certain complexes of BlackRock
registered open-end funds. Mr. Perlowski is also a board member of the BlackRock Equity-Bond Complex and the BlackRock Equity-Liquidity Complex, and Ms. Novick is also a board member of the BlackRock Equity-Liquidity Complex. Interested Trustees
serve until their resignation, removal or death, or until December 31 of the year in which they turn 72. The maximum age limitation may be waived as to any Trustee by action of a majority of the Trustees upon a finding of good cause
therefor. | | | | |

142 ANNUAL REPORT DECEMBER 31, 2016

Officers and Trustees (continued)

| Name, Address 1 , and Year of Birth | Position(s) Held with the Trusts | Length of
Time Served as a Trustee | Principal Occupation(s) During Past Five Years |
| --- | --- | --- | --- |
| Officers 2 | | | |
| Jonathan Diorio 1980 | Vice President | Since 2015 | Managing Director of BlackRock, Inc. since 2015; Director of BlackRock, Inc. from 2011 to 2015; Director of Deutsche Asset & Wealth
Management from 2009 to 2011. |
| Neal J. Andrews 1966 | Chief Financial Officer | Since 2007 | Managing Director of BlackRock, Inc. since 2006; Senior Vice President and Line of Business Head of Fund Accounting and Administration at PNC
Global Investment Servicing (U.S.) Inc. from 1992 to 2006. |
| Jay M. Fife 1970 | Treasurer | Since 2007 | Managing Director of BlackRock, Inc. since 2007; Director of BlackRock, Inc. in 2006; Assistant Treasurer of the MLIM and Fund Asset Management,
L.P. advised funds from 2005 to 2006; Director of MLIM Fund Services Group from 2001 to 2006. |
| Charles Park 1967 | Chief Compliance Officer | Since 2014 | Anti-Money Laundering Compliance Officer for the BlackRock-advised Funds in the Equity-Bond Complex, the Equity-Liquidity Complex and the
Closed-End Complex from 2014 to 2015; Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the Equity-Bond Complex, the Equity-Liquidity Complex and the Closed-End Complex since 2014; Principal of and Chief
Compliance Officer for iShares ® Delaware Trust Sponsor LLC since 2012 and BlackRock Fund Advisors (“BFA”) since 2006; Chief Compliance Officer for the
BFA-advised iShares ® exchange traded funds since 2006; Chief Compliance Officer for BlackRock Asset Management International Inc. since 2012. |
| Janey Ahn 1975 | Secretary | Since 2012 | Director of BlackRock, Inc. since 2009; Assistant Secretary of the funds in the Closed-End Complex from 2008 to 2012. |
| | 1 The address of each Officer is c/o BlackRock, Inc., Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055. 2 Officers of the Trusts serve at the pleasure of the Board. | | |

ANNUAL REPORT DECEMBER 31, 2016 143

Officers and Trustees (concluded)

Investment Advisor
BlackRock Advisors, LLC
Wilmington, DE 19809
Sub-Advisors
BlackRock International LTD. 1
Edinburgh, EH3 8JB
United Kingdom
Accounting Agent
The Bank of New York Mellon
Brooklyn, NY 11217
Custodians
The Bank of New York Mellon
New York, NY 10286 2
Brown Brothers, Harriman & Co.
Boston, MA 02109 3
Transfer Agent
Computershare Trust Company, N.A.
Canton, MA 02021
Independent Registered Public Accounting Firm
Deloitte & Touche LLP
Philadelphia, PA 19103
Distributor
BlackRock Investments, LLC 4
New York, NY 10022
Legal Counsel
Skadden, Arps, Slate, Meagher & Flom LLP
Boston, MA 02116
Address of the Trusts
100 Bellevue Parkway
Wilmington, DE 19809

1 For BGR and BCX.

2 For all Trusts except CII.

3 For CII.

4 For BME.

144 ANNUAL REPORT DECEMBER 31, 2016

Additional Information

Proxy Results

The Annual Meeting of Shareholders was held on July 26, 2016 for shareholders of record on May 31, 2016, to elect board member nominees for each Trust except for CII. There were no broker non-votes with regard to any of the Trusts.

| Votes For | Catherine A. Lynch 1 — Votes Withheld | Abstain | Votes For | Richard E. Cavanagh 2 — Votes Withheld | Abstain | Votes For | Cynthia L.
Egan 2 — Votes Withheld | Abstain | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| BDJ | 165,252,985 | 7,463,464 | 0 | 164,861,918 | 7,854,530 | 0 | 165,264,724 | 7,451,725 | 0 |
| BGR | 25,014,391 | 650,823 | 0 | 24,992,192 | 673,022 | 0 | 25,019,534 | 645,681 | 0 |
| BOE | 60,224,628 | 2,998,293 | 0 | 60,247,422 | 2,975,499 | 0 | 60,217,648 | 3,005,273 | 0 |
| BME | 7,253,643 | 124,106 | 0 | 7,262,974 | 114,775 | 0 | 7,251,026 | 126,723 | 0 |
| BGY | 95,983,235 | 3,973,692 | 0 | 95,915,306 | 4,041,621 | 0 | 96,003,479 | 3,953,448 | 0 |
| BCX | 84,818,672 | 3,439,057 | 0 | 84,813,124 | 3,444,605 | 0 | 84,804,392 | 3,453,337 | 0 |
| BUI | 14,973,373 | 341,861 | 0 | 14,819,726 | 495,508 | 0 | 14,981,741 | 333,493 | 0 |
| BST | 18,970,717 | 1,586,524 | 0 | 18,985,763 | 1,571,478 | 0 | 18,966,896 | 1,590,345 | 0 |

Jerrold B. Harris 2 — Votes For Votes Withheld Abstain Barbara G. Novick 2 — Votes For Votes Withheld Abstain
BDJ 165,066,108 7,650,340 0 164,902,681 7,813,768 0
BGR 24,974,466 690,748 0 25,019,689 645,525 0
BOE 60,216,168 3,006,753 0 60,232,701 2,990,220 0
BME 7,239,290 138,459 0 7,251,124 126,625 0
BGY 95,887,556 4,069,371 0 95,980,959 3,975,968 0
BCX 84,759,518 3,498,211 0 84,831,682 3,426,047 0
BUI 14,997,646 317,588 0 14,806,288 508,946 0
BST 18,954,844 1,602,397 0 18,952,563 1,604,678 0

For the Trusts listed above, Trustees whose term of office continued after the Annual Meeting of Shareholders because they were not up for election are Michael J. Castellano, Frank J. Fabozzi, R. Glenn Hubbard, W. Carl Kester, John M. Perlowski, and Karen P. Robards.

1 Class II.

2 Class III.

The Annual Meeting of Shareholders was held on July 26, 2016 for shareholders of record on May 31, 2016, to elect board member nominees for CII. There were no broker non-votes with regard to the Trust.

Approved the Trustees as follows for CII only:

Votes For Votes Withheld Abstain
Michael J. Castellano 39,626,392 1,306,400 0
Richard E. Cavanagh 39,636,992 1,295,800 0
Cynthia L. Egan 39,553,274 1,379,518 0
Frank J. Fabozzi 39,622,539 1,310,253 0
Jerrold B. Harris 39,604,838 1,327,954 0
R. Glenn Hubbard 39,663,274 1,269,518 0
W. Carl Kester 39,676,843 1,255,949 0
Catherine A. Lynch 39,571,333 1,361,459 0
Barbara G. Novick 39,563,837 1,368,955 0
John M. Perlowski 39,653,860 1,278,932 0
Karen P. Robards 39,545,939 1,386,853 0

Trust Certification

All Trusts are listed for trading on the NYSE and have filed with the NYSE their annual chief executive officer certification regarding compliance with the NYSE’s listing standards. The Trusts filed with the SEC the certification of its chief executive officer and chief financial officer required by section 302 of the Sarbanes-Oxley Act.

ANNUAL REPORT DECEMBER 31, 2016 145

Additional Information

General Information

The Trusts do not make available copies of their Statements of Additional Information because the Trusts’ shares, except for BME, are not continuously offered, which means that the Statements of Additional Information of each Trust have not been updated after completion of the respective Trust’s offerings and the information contained in each Trust’s Statement of Additional Information may have become outdated.

The prospectus for BME includes additional information about the Trustees of the Trusts and is available, without charge, upon request, by calling 1-800-882-0052.

During the period, there were no material changes in the Trusts’ investment objectives or policies or to the Trusts’ charters or by-laws that would delay or prevent a change of control of the Trusts that were not approved by the shareholders or in the principal risk factors associated with investment in the Trusts. Other than as described on page 142, there have been no changes in the persons who are primarily responsible for the day-to-day management of the Trusts’ portfolios.

Quarterly performance, semi-annual and annual reports and other information regarding the Trusts may be found on BlackRock’s website, which can be accessed at http://www.blackrock.com. Any reference to BlackRock’s website in this report is intended to allow investors public access to information regarding the Trusts and does not, and is not intended to, incorporate BlackRock’s website in this report.

Electronic Delivery

Shareholders can sign up for e-mail notifications of quarterly statements, annual and semi-annual shareholder reports by enrolling in the electronic delivery program. Electronic copies of shareholder reports are available on BlackRock’s website.

To enroll in electronic delivery:

Shareholders Who Hold Accounts with Investment Advisors, Banks or Brokerages:

Please contact your financial advisor. Please note that not all investment advisors, banks or brokerages may offer this service.

Householding

The Trusts will mail only one copy of shareholder documents, including annual and semi-annual reports and proxy statements, to shareholders with multiple accounts at the same address. This practice is commonly called “householding” and is intended to reduce expenses and eliminate duplicate mailings of shareholder documents. Mailings of your shareholder documents may be householded indefinitely unless you instruct us otherwise. If you do not want the mailing of these documents to be combined with those for other members of your household, please call the Trusts at (800) 882-0052.

Availability of Quarterly Schedule of Investments

The Trusts file their complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. The Trusts’ Forms N-Q are available on the SEC’s website at http://www.sec.gov. and may also be reviewed and copied at the SEC’s Public Reference Room in Washington, DC. Information on how to access documents on the SEC’s website without charge may be obtained by calling (800) SEC-0330. The Trusts’ Forms N-Q may also be obtained upon request and without charge by calling (800) 882-0052.

Availability of Proxy Voting Policies and Procedures

A description of the policies and procedures that the Trusts use to determine how to vote proxies relating to portfolio securities is available upon request and without charge (1) by calling (800) 882-0052; (2) at http://www.blackrock.com; and (3) on the SEC’s website http://www.sec.gov.

Availability of Proxy Voting Record

Information about how the Trusts voted proxies relating to securities held in the Trusts’ portfolio during the most recent 12-month period ended June 30 is available upon request and without charge (1) at http://www.blackrock.com or by calling (800) 882-0052 and (2) on the SEC’s website at http://www.sec.gov.

Availability of Trust Updates

BlackRock will update performance and certain other data for the Trusts on a monthly basis on its website in the “Closed-end Funds” section of http://www.blackrock.com as well as certain other material information as necessary from time to time. Investors and others are advised to check the website for updated performance information and the release of other material information about the Trusts. This reference to BlackRock’s website is intended to allow investors public access to information regarding the Trusts and does not, and is not intended to, incorporate BlackRock’s website in this report.

146 ANNUAL REPORT DECEMBER 31, 2016

Additional Information (concluded)

Shelf Offering Program

From time-to-time, each Trust may seek to raise additional equity capital through an equity shelf program (a “Shelf Offering”). In a Shelf Offering, a Trust may, subject to market conditions, raise additional equity capital by issuing new Common Shares from time to time in varying amounts at a net price at or above the Trust’s net asset value (“NAV”) per Common Share (calculated within 48 hours of pricing). While any such Shelf Offering may allow a Trust to pursue additional investment opportunities without the need to sell existing portfolio investments, it could also entail risks — including that the issuance of additional Common Shares may limit the extent to which the Common Shares are able to trade at a premium to NAV in the secondary market.

On August 12, 2015 and June 9, 2016, BME filed a final prospectus with the SEC in connection with its Shelf Offering. This report and the prospectus of BME are not offers to sell BME Common Shares or solicitations of an offer to buy BME Common Shares in any jurisdiction where such offers or sales are not permitted. The prospectus of BME contains important information about the Fund, including its investment objective, risks, charges and expenses. Investors are urged to read the prospectus of BME carefully and in its entirety before investing. Copies of the final prospectus for BME can be obtained from BlackRock at http://www.blackrock.com .

Dividend Policy

Each Trust’s dividend policy is to distribute all or a portion of its net investment income to its shareholders on a monthly basis. In order to provide shareholders with a more stable level of dividend distributions, the dividends paid by the Trusts for any particular month may be more or less than the amount of net investment income earned by the Trusts during such month. The portion of dividend distributions that exceeds a Trust’s current and accumulated earnings and profits, which are measured on a tax basis, will constitute a nontaxable return of capital. Distributions in excess of a Trust’s taxable income and net capital gains, but not in excess of a Trust’s earnings and profits, will be taxable to shareholders as ordinary income and will not constitute a nontaxable return of capital. The Trusts’ current accumulated but undistributed net investment income, if any, is disclosed in the Statements of Assets and Liabilities, which comprises part of the financial information included in this report.

BlackRock Privacy Principles

BlackRock is committed to maintaining the privacy of its current and former fund investors and individual clients (collectively, “Clients”) and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information BlackRock collects, how we protect that information and why in certain cases we share such information with select parties.

If you are located in a jurisdiction where specific laws, rules or regulations require BlackRock to provide you with additional or different privacy-related rights beyond what is set forth below, then BlackRock will comply with those specific laws, rules or regulations.

BlackRock obtains or verifies personal non-public information from and about you from different sources, including the following: (i) information we receive from you or, if applicable, your financial intermediary, on applications, forms or other documents; (ii) information about your transactions with us, our affiliates, or others; (iii) information we receive from a consumer reporting agency; and (iv) from visits to our websites.

BlackRock does not sell or disclose to non-affiliated third parties any non-public personal information about its Clients, except as permitted by law or as is necessary to respond to regulatory requests or to service Client accounts. These non-affiliated third parties are required to protect the confidentiality and security of this information and to use it only for its intended purpose.

We may share information with our affiliates to service your account or to provide you with information about other BlackRock products or services that may be of interest to you. In addition, BlackRock restricts access to non-public personal information about its Clients to those BlackRock employees with a legitimate business need for the information. BlackRock maintains physical, electronic and procedural safeguards that are designed to protect the non-public personal information of its Clients, including procedures relating to the proper storage and disposal of such information.

ANNUAL REPORT DECEMBER 31, 2016 147

| This report is intended for current holders. It is not a prospectus. Past
performance results shown in this report should not be considered a representation of future performance. Statements and other information herein are as dated and are subject to change. | |
| --- | --- |
| CEF-BK9-12/16-AR | ● |

| Item 2 – | Code of Ethics – The registrant (or the “Fund”) has adopted a code of ethics, as of the end of the period covered by this report, applicable to the registrant’s principal executive officer, principal financial
officer, principal accounting officer or controller, or persons performing similar functions. During the period covered by this report, the code of ethics was amended to update certain information and to make other non-material changes. During the period covered by this report, there have been no waivers granted under the code of ethics. The registrant undertakes to provide a copy of the code of ethics to any person upon
request, without charge, by calling 1-800-882-0052, option 4. |
| --- | --- |
| Item 3 – | Audit Committee Financial Expert – The registrant’s board of directors (the “board of directors”), has determined that (i) the registrant has the following audit committee financial experts serving on its
audit committee and (ii) each audit committee financial expert is independent: |
| | Michael Castellano Frank J. Fabozzi James T. Flynn W. Carl Kester Karen P. Robards The registrant’s board of directors has determined that W. Carl Kester and Karen P. Robards qualify as financial experts pursuant to Item 3(c)(4) of Form N-CSR. Prof. Kester has a thorough understanding of
generally accepted accounting principles, financial statements and internal control over financial reporting as well as audit committee functions. Prof. Kester has been involved in providing valuation and other financial consulting services to
corporate clients since 1978. Prof. Kester’s financial consulting services present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to
be raised by the registrant’s financial statements. Ms. Robards has a
thorough understanding of generally accepted accounting principles, financial statements and internal control over financial reporting as well as audit committee functions. Ms. Robards has been President of Robards & Company, a
financial advisory firm, since 1987. Ms. Robards was formerly an investment banker for more than 10 years where she was responsible for evaluating and assessing the performance of companies based on their financial results. Ms. Robards has
over 30 years of experience analyzing financial statements. She also is a member of the audit committee of one publicly held company and a non-profit organization. Under applicable securities laws, a person determined to be an audit committee financial
expert will not be deemed an “expert” for any purpose, including without limitation for the purposes of Section 11 of the Securities Act of 1933, as a result of being designated or identified as an audit committee financial expert.
The designation or identification as an audit committee financial expert does not impose on such person any duties, obligations, or liabilities greater than the duties, obligations, and liabilities imposed on such person as a member of the audit
committee and board of directors in the absence of such designation or identification. The designation or identification of a person as an audit committee financial expert does not affect the duties, obligations, or liability of any other member of
the audit committee or board of directors. |

2

Item 4 – Principal Accountant Fees and Services

The following table presents fees billed by Deloitte & Touche LLP (“D&T”) in each of the last two fiscal years for the services rendered to the Fund:

| Entity Name | (a) Audit Fees — Current Fiscal Year End | Previous Fiscal Year End | (b) Audit-Related Fees 1 — Current Fiscal Year End | Previous Fiscal Year End | (c) Tax Fees 2 — Current Fiscal Year End | Previous Fiscal Year End | (d) All Other
Fees 3 — Current Fiscal Year End | Previous Fiscal Year End |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| BlackRock Global Opportunities Equity Trust | $56,688 | $56,688 | $0 | $0 | $15,147 | $15,147 | $0 | $0 |

The following table presents fees billed by D&T that were required to be approved by the registrant’s audit committee (the “Committee”) for services that relate directly to the operations or financial reporting of the Fund and that are rendered on behalf of BlackRock Advisors, LLC (“Investment Adviser” or “BlackRock”) and entities controlling, controlled by, or under common control with BlackRock (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund (“Fund Service Providers”):

Current Fiscal Year End Previous Fiscal Year End
(b) Audit-Related Fees 1 $0 $0
(c) Tax Fees 2 $0 $0
(d) All Other Fees 3 $2,129,000 $2,391,000

1 The nature of the services includes assurance and related services reasonably related to the performance of the audit of financial statements not included in Audit Fees.

2 The nature of the services includes tax compliance, tax advice and tax planning.

3 Aggregate fees borne by BlackRock in connection with the review of compliance procedures and attestation thereto performed by D&T with respect to all of the registered closed-end funds and some of the registered open-end funds advised by BlackRock.

(e)(1) Audit Committee Pre-Approval Policies and Procedures:

The Committee has adopted policies and procedures with regard to the pre-approval of services. Audit, audit-related and tax compliance services provided to the registrant on an annual basis require specific pre-approval by the Committee. The Committee also must approve other non-audit services provided to the registrant and those non-audit services provided to the Investment Adviser and Fund Service Providers that relate directly to the operations and the financial reporting of the registrant. Certain of these non-audit services that the Committee believes are (a) consistent with the SEC’s auditor independence rules and (b) routine and recurring services that will not impair the independence of the independent accountants may be approved by the Committee without consideration on a specific case-by-case basis (“general pre-approval”). The term of any general pre-approval is 12 months from the date of the pre-approval, unless the Committee provides for a different period. Tax or other non-audit services provided to the registrant which have a direct impact on the operations or financial reporting of the registrant will only be deemed pre-approved provided that any individual project does not exceed $10,000 attributable to the registrant or $50,000 per project. For this purpose, multiple projects will be aggregated to determine if they exceed the previously mentioned cost levels.

3

Any proposed services exceeding the pre-approved cost levels will require specific pre-approval by the Committee, as will any other services not subject to general pre-approval (e.g., unanticipated but permissible services). The Committee is informed of each service approved subject to general pre-approval at the next regularly scheduled in-person board meeting. At this meeting, an analysis of such services is presented to the Committee for ratification. The Committee may delegate to the Committee Chairman the authority to approve the provision of and fees for any specific engagement of permitted non-audit services, including services exceeding pre-approved cost levels.

(e)(2) None of the services described in each of Items 4(b) through (d) were approved by the Committee pursuant to the de minimis exception in paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

(f) Not Applicable

(g) The aggregate non-audit fees paid to the accountant for services rendered by the accountant to the registrant, the Investment Adviser and the Fund Service Providers were:

Entity Name Current Fiscal Year End Previous Fiscal Year End
BlackRock Global Opportunities Equity Trust $15,147 $15,147

Additionally, SSAE 16 Review (Formerly, SAS No. 70) fees for the current and previous fiscal years of $2,129,000 and $2,391,000, respectively, were billed by D&T to the Investment Adviser.

(h) The Committee has considered and determined that the provision of non-audit services that were rendered to the Investment Adviser, and the Fund Service Providers that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant’s independence.

Item 5 – Audit Committee of Listed Registrants

(a) The following individuals are members of the registrant’s separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 (15 U.S.C. 78c(a)(58)(A)):

Michael Castellano

Frank J. Fabozzi

James T. Flynn

W. Carl Kester

Karen P. Robards

(b) Not Applicable

Item 6 – Investments

(a) The registrant’s Schedule of Investments is included as part of the Report to Stockholders filed under Item 1 of this Form.

4

(b) Not Applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.

Item 7 – Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies – The board of directors has delegated the voting of proxies for the Fund’s portfolio securities to the Investment Adviser pursuant to the Investment Adviser’s proxy voting guidelines. Under these guidelines, the Investment Adviser will vote proxies related to Fund securities in the best interests of the Fund and its stockholders. From time to time, a vote may present a conflict between the interests of the Fund’s stockholders, on the one hand, and those of the Investment Adviser, or any affiliated person of the Fund or the Investment Adviser, on the other. In such event, provided that the Investment Adviser’s Equity Investment Policy Oversight Committee, or a sub-committee thereof (the “Oversight Committee”) is aware of the real or potential conflict or material non-routine matter and if the Oversight Committee does not reasonably believe it is able to follow its general voting guidelines (or if the particular proxy matter is not addressed in the guidelines) and vote impartially, the Oversight Committee may retain an independent fiduciary to advise the Oversight Committee on how to vote or to cast votes on behalf of the Investment Adviser’s clients. If the Investment Adviser determines not to retain an independent fiduciary, or does not desire to follow the advice of such independent fiduciary, the Oversight Committee shall determine how to vote the proxy after consulting with the Investment Adviser’s Portfolio Management Group and/or the Investment Adviser’s Legal and Compliance Department and concluding that the vote cast is in its client’s best interest notwithstanding the conflict. A copy of the Fund’s Proxy Voting Policy and Procedures are attached as Exhibit 99.PROXYPOL. Information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available without charge, (i) at www.blackrock.com and (ii) on the SEC’s website at http://www.sec.gov .

Item 8 – Portfolio Managers of Closed-End Management Investment Companies – as of the Date of This Report.

(a)(1) The registrant is managed by a team of investment professionals comprised of Thomas P. Callan, CFA, Managing Director at BlackRock, Erin Xie, PhD, MBA, Managing Director at BlackRock, Ian Jamieson, CFA, Managing Director at BlackRock, Kyle G. McClements, CFA, Managing Director at BlackRock, Christopher Accettella, Director at BlackRock and Simon McGeough, Director at BlackRock. Messrs. Callan, Jamieson, McClements, Accettella and McGeough and Ms. Xie are the Fund’s portfolio managers and are responsible for the day-to-day management of the Fund’s portfolio and the selection of its investments. Messrs. Callan and McClements have been members of the Fund’s portfolio management team since 2005. Mr. Accettella has been a member of the Fund’s portfolio management team since 2012. Ms. Xie and Mr. Jamieson have been members of the Fund’s portfolio management team since 2013. Mr. McGeough has been a member of the Fund’s portfolio management team since 2015.

Portfolio Manager Biography
Thomas P. Callan, CFA Managing Director of BlackRock since 1998; Head of BlackRock’s Global Opportunities equity team.
Erin Xie, PhD, MBA Managing Director of BlackRock since 2006; Director of BlackRock from 2005 to 2006; Senior Vice President of
State Street Research & Management from 2001 to 2005.

5

Ian Jamieson, CFA Director of BlackRock since 2007; Vice President of BlackRock from 2004 to 2007.
Kyle G. McClements, CFA Managing Director of BlackRock since 2009; Director of BlackRock from 2006 to 2008; Vice President of BlackRock
in 2005; Vice President of State Street Research & Management from 2004 to 2005.
Christopher Accettella Director of BlackRock since 2008; Vice President of BlackRock, Inc. from 2005 to 2008.
Simon McGeough Director of BlackRock since 2015; Vice President of BlackRock from 2009 to 2015.

(a)(2) As of December 31, 2016:

| (i) Name of Portfolio Manager | (ii) Number of Other Accounts Managed and Assets by Account Type — Other Registered Investment Companies | Other
Pooled Investment Vehicles | Other Accounts | (iii) Number of Other Accounts and Assets for Which Advisory Fee is Performance-Based — Other Registered Investment Companies | Other
Pooled Investment Vehicles | Other Accounts |
| --- | --- | --- | --- | --- | --- | --- |
| Thomas P. Callan, CFA | 10 | 8 | 1 | 0 | 0 | 1 |
| | $9.92 Billion | $4.18 Billion | $872.6 Million | $0 | $0 | $872.6 Million |
| Erin Xie, PhD, MBA | 4 | 2 | 1 | 0 | 0 | 1 |
| | $6.29 Billion | $3.19 Billion | $872.6 Million | $0 | $0 | $872.6 Million |
| Ian Jamieson, CFA | 5 | 6 | 0 | 0 | 0 | 0 |
| | $2.89 Billion | $985.9 Million | $0 | $0 | $0 | $0 |
| Kyle G. McClements, CFA | 10 | 13 | 0 | 0 | 0 | 0 |
| | $7.76 Billion | $5.68 Billion | $0 | $0 | $0 | $0 |
| Christopher Accettella | 10 | 13 | 0 | 0 | 0 | 0 |
| | $7.76 Billion | $5.68 Billion | $0 | $0 | $0 | $0 |
| Simon McGeough | 4 | 4 | $0 | 0 | 0 | 0 |
| | $1.68 Billion | $504.1 Million | 0 | $0 | $0 | $0 |

(iv) Portfolio Manager Potential Material Conflicts of Interest

BlackRock has built a professional working environment, firm-wide compliance culture and compliance procedures and systems designed to protect against potential incentives that may favor one account over another. BlackRock has adopted policies and procedures that address the allocation of investment opportunities, execution of portfolio transactions, personal trading by employees and other potential conflicts of interest that are designed to ensure that all client accounts are treated equitably over time. Nevertheless, BlackRock furnishes investment management and advisory services to numerous clients in addition to the Fund, and BlackRock may, consistent with applicable law, make investment recommendations to other clients or accounts (including accounts which are hedge funds or have performance or higher fees paid to BlackRock, or in which portfolio managers have a personal interest in the receipt of such fees), which may be the same as or different from those made to the Fund. In addition, BlackRock, Inc., its affiliates and significant shareholders and any officer, director, shareholder or employee may or may not have an interest in the securities whose purchase and sale BlackRock recommends to the Fund. BlackRock, Inc., or any of its affiliates or significant shareholders, or any

5

officer, director, shareholder, employee or any member of their families may take different actions than those recommended to the Fund by BlackRock with respect to the same securities. Moreover, BlackRock may refrain from rendering any advice or services concerning securities of companies of which any of BlackRock, Inc.’s (or its affiliates’ or significant shareholders’) officers, directors or employees are directors or officers, or companies as to which BlackRock, Inc. or any of its affiliates or significant shareholders or the officers, directors and employees of any of them has any substantial economic interest or possesses material non-public information. Certain portfolio managers also may manage accounts whose investment strategies may at times be opposed to the strategy utilized for a fund. It should also be noted that Messrs. Callan, Jamieson and McGeough and Ms. Xie may be managing hedge fund and/or long only accounts, or may be part of a team managing hedge fund and/or long only accounts, subject to incentive fees. Messrs. Callan, Jamieson and McGeough and Ms. Xie may therefore be entitled to receive a portion of any incentive fees earned on such accounts.

As a fiduciary, BlackRock owes a duty of loyalty to its clients and must treat each client fairly. When BlackRock purchases or sells securities for more than one account, the trades must be allocated in a manner consistent with its fiduciary duties. BlackRock attempts to allocate investments in a fair and equitable manner among client accounts, with no account receiving preferential treatment. To this end, BlackRock, Inc. has adopted policies that are intended to ensure reasonable efficiency in client transactions and provide BlackRock with sufficient flexibility to allocate investments in a manner that is consistent with the particular investment discipline and client base, as appropriate.

(a)(3) As of December 31, 2016:

Portfolio Manager Compensation Overview

The discussion below describes the portfolio managers’ compensation as of December 31, 2016.

BlackRock’s financial arrangements with its portfolio managers, its competitive compensation and its career path emphasis at all levels reflect the value senior management places on key resources. Compensation may include a variety of components and may vary from year to year based on a number of factors. The principal components of compensation include a base salary, a performance-based discretionary bonus, participation in various benefits programs and one or more of the incentive compensation programs established by BlackRock.

Base Compensation. Generally, portfolio managers receive base compensation based on their position with the firm.

Discretionary Incentive Compensation

Messrs. Callan, Jamieson and McGeough and Ms. Xie

Generally, discretionary incentive compensation for Active Equity portfolio managers is based on a formulaic compensation program. BlackRock’s formulaic portfolio manager compensation program is based on team revenue and pre-tax investment performance relative to appropriate competitors or benchmarks over 1-, 3- and 5-year performance periods, as applicable. In most cases, these benchmarks are the same as the benchmark or benchmarks against which the

7

performance of the Funds or other accounts managed by the portfolio managers are measured. BlackRock’s Chief Investment Officers determine the benchmarks or rankings against which the performance of funds and other accounts managed by each portfolio management team is compared and the period of time over which performance is evaluated. With respect to these portfolio managers, such benchmarks for the Fund and other accounts are: Lipper Mid-Cap Core Fund classification; Lipper International Multi-Cap Core fund classification; Lipper Global/Health/Biotechnology Fund classification.

A smaller element of portfolio manager discretionary compensation may include consideration of: financial results, expense control, profit margins, strategic planning and implementation, quality of client service, market share, corporate reputation, capital allocation, compliance and risk control, leadership, technology and innovation. These factors are considered collectively by BlackRock management and the relevant Chief Investment Officers.

Discretionary Incentive Compensation

Messrs. Accettella and McClements

Discretionary incentive compensation is a function of several components: the performance of BlackRock, Inc., the performance of the portfolio manager’s group within BlackRock, the investment performance, including risk-adjusted returns, of the firm’s assets or strategies under management or supervision by that portfolio manager, and/or the individual’s performance and contribution to the overall performance of these portfolios and BlackRock. Among other things, BlackRock’s Chief Investment Officers make a subjective determination with respect to each portfolio manager’s compensation based on the performance of the Funds, other accounts or strategies managed by each portfolio manager. Performance is generally measured on a pre-tax basis over various time periods including 1-, 3- and 5- year periods, as applicable. The performance of some Funds, other accounts or strategies may not be measured against a specific benchmark.

Distribution of Discretionary Incentive Compensation. Discretionary incentive compensation is distributed to portfolio managers in a combination of cash and BlackRock, Inc. restricted stock units which vest ratably over a number of years. For some portfolio managers, discretionary incentive compensation is also distributed in deferred cash awards that notionally track the returns of select BlackRock investment products they manage and that vest ratably over a number of years. The BlackRock, Inc. restricted stock units, upon vesting, will be settled in BlackRock, Inc. common stock. Typically, the cash portion of the discretionary incentive compensation, when combined with base salary, represents more than 60% of total compensation for the portfolio managers. Paying a portion of discretionary incentive compensation in BlackRock, Inc. stock puts compensation earned by a portfolio manager for a given year “at risk” based on BlackRock’s ability to sustain and improve its performance over future periods. Providing a portion of discretionary incentive compensation in deferred cash awards that notionally track the BlackRock investment products they manage provides direct alignment with investment product results.

Long-Term Incentive Plan Awards — From time to time long-term incentive equity awards are granted to certain key employees to aid in retention, align their interests with long-term shareholder interests and motivate performance. Equity awards are generally granted in the form of BlackRock, Inc.

8

restricted stock units that, once vested, settle in BlackRock, Inc. common stock. The portfolio managers of this Fund have unvested long-term incentive awards.

Deferred Compensation Program — A portion of the compensation paid to eligible United States-based BlackRock employees may be voluntarily deferred at their election for defined periods of time into an account that tracks the performance of certain of the firm’s investment products. Any portfolio manager who is either a managing director or director at BlackRock with compensation above a specified threshold is eligible to participate in the deferred compensation program.

Other Compensation Benefits. In addition to base salary and discretionary incentive compensation, portfolio managers may be eligible to receive or participate in one or more of the following:

Incentive Savings Plans — BlackRock, Inc. has created a variety of incentive savings plans in which BlackRock, Inc. employees are eligible to participate, including a 401(k) plan, the BlackRock Retirement Savings Plan (RSP), and the BlackRock Employee Stock Purchase Plan (ESPP). The employer contribution components of the RSP include a company match equal to 50% of the first 8% of eligible pay contributed to the plan capped at $5,000 per year, and a company retirement contribution equal to 3-5% of eligible compensation up to the Internal Revenue Service limit ($265,000 for 2016). The RSP offers a range of investment options, including registered investment companies and collective investment funds managed by the firm. BlackRock, Inc. contributions follow the investment direction set by participants for their own contributions or, absent participant investment direction, are invested into a target date fund that corresponds to, or is closest to, the year in which the participant attains age 65. The ESPP allows for investment in BlackRock, Inc. common stock at a 5% discount on the fair market value of the stock on the purchase date. Annual participation in the ESPP is limited to the purchase of 1,000 shares of common stock or a dollar value of $25,000 based on its fair market value on the purchase date. All of the eligible portfolio managers are eligible to participate in these plans.

(a)(4) Beneficial Ownership of Securities – As of December 31, 2016.

Portfolio Manager Dollar Range of Equity Securities of the Fund Beneficially Owned
Thomas P. Callan, CFA None
Erin Xie, PhD, MBA None
Ian Jamieson, CFA $100,001 - $500,000
Kyle G. McClements, CFA $10,001 - $50,000
Christopher Accettella None
Simon McGeough None

(b) Not Applicable

Item 9 – Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers – Not Applicable due to no such purchases during the period covered by this report.

Item 10 – Submission of Matters to a Vote of Security Holders – There have been no material changes to these procedures.

9

Item 11 – Controls and Procedures

(a) – The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing of this report based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended.

(b) – There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the second fiscal quarter of the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12 – Exhibits attached hereto

(a)(1) – Code of Ethics – See Item 2

(a)(2) – Certifications – Attached hereto

(a)(3) – Not Applicable

(b) – Certifications – Attached hereto

12(c) – Notices to the registrant’s common shareholders in accordance with the order under Section 6(c) of the 1940 Act granting an exemption from Section 19(b) of the 1940 Act and Rule 19b-1 under the 1940 Act, dated May 9, 2009 1

1 The Fund has received exemptive relief from the Securities and Exchange Commission permitting it to make periodic distributions of long-term capital gains with respect to its outstanding common stock as frequently as twelve times each year, and as frequently as distributions are specified by or in accordance with the terms of its outstanding preferred stock. This relief is conditioned, in part, on an undertaking by the Fund to make the disclosures to the holders of the Fund’s common shares, in addition to the information required by Section 19(a) of the 1940 Act and Rule 19a-1 thereunder. The Fund is likewise obligated to file with the SEC the information contained in any such notice to shareholders and, in that regard, has attached hereto copies of each such notice made during the period.

10

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BlackRock Global Opportunities Equity Trust

By:
John M. Perlowski
Chief Executive Officer (principal executive officer) of
BlackRock Global Opportunities Equity Trust

Date: March 6, 2017

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:
John M. Perlowski
Chief Executive Officer (principal executive officer) of
BlackRock Global Opportunities Equity Trust

Date: March 6, 2017

By:
Neal J. Andrews
Chief Financial Officer (principal financial officer) of
BlackRock Global Opportunities Equity Trust

Date: March 6, 2017

11

Talk to a Data Expert

Have a question? We'll get back to you promptly.